P0ABI8	UniProtKB	Mutagenesis	54	54	.	.	.	Note=50%25	quinol	oxidase	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1309808;Dbxref=PMID:1309808
P0ABI8	UniProtKB	Mutagenesis	55	55	.	.	.	Note=No	effect.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9378723;Dbxref=PMID:9378723
P0ABI8	UniProtKB	Mutagenesis	71	71	.	.	.	Note=No	quinol	oxidase	activity.	R->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11017202,ECO:0000269|PubMed:12186553;Dbxref=PMID:11017202,PMID:12186553
P0ABI8	UniProtKB	Mutagenesis	71	71	.	.	.	Note=Abolishes	quinol	oxidase	activity.	R->Q%2CL;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11017202,ECO:0000269|PubMed:12186553;Dbxref=PMID:11017202,PMID:12186553
P0ABI8	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Very	similar	to	wild-type.	D->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11017202,ECO:0000269|PubMed:12186553,ECO:0000269|PubMed:17267395;Dbxref=PMID:11017202,PMID:12186553,PMID:17267395
P0ABI8	UniProtKB	Mutagenesis	75	75	.	.	.	Note=No	quinol	oxidase	activity%2C	alteredbinding	of	a	semiquinone	intermediate	at	the	QH	site.	D->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11017202,ECO:0000269|PubMed:12186553,ECO:0000269|PubMed:17267395;Dbxref=PMID:11017202,PMID:12186553,PMID:17267395
P0ABI8	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Abolishes	quinol	oxidase	activity.	D->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11017202,ECO:0000269|PubMed:12186553,ECO:0000269|PubMed:17267395;Dbxref=PMID:11017202,PMID:12186553,PMID:17267395
P0ABI8	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Abolishes	quinol	oxidase	activity.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9378723;Dbxref=PMID:9378723
P0ABI8	UniProtKB	Mutagenesis	98	98	.	.	.	Note=About	1%25	quinol	oxidase	activity.	H->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11017202,ECO:0000269|PubMed:12186553;Dbxref=PMID:11017202,PMID:12186553
P0ABI8	UniProtKB	Mutagenesis	98	98	.	.	.	Note=Abolishes	enzyme	activity.	H->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11017202,ECO:0000269|PubMed:12186553;Dbxref=PMID:11017202,PMID:12186553
P0ABI8	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Reduces	quinol	oxidase	activity	by	75%25%2C	decreased	affinity	for	ubiquinol-1.	Q->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11017202;Dbxref=PMID:11017202
P0ABI8	UniProtKB	Mutagenesis	102	102	.	.	.	Note=No	quinol	oxidase	activity.	I->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12186553;Dbxref=PMID:12186553
P0ABI8	UniProtKB	Mutagenesis	106	106	.	.	.	Note=2%25	quinol	oxidase	activity%2C	loss	of	heme	b%2C	loss	of	heme	o%2C	loss	of	Cu(B).	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1309808;Dbxref=PMID:1309808
P0ABI8	UniProtKB	Mutagenesis	135	135	.	.	.	Note=Abolishes	quinol	oxidase	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9378723;Dbxref=PMID:9378723
P0ABI8	UniProtKB	Mutagenesis	173	173	.	.	.	Note=No	effect.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9378723;Dbxref=PMID:9378723
P0ABI8	UniProtKB	Mutagenesis	188	188	.	.	.	Note=No	effect.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9378723;Dbxref=PMID:9378723
P0ABI8	UniProtKB	Mutagenesis	256	256	.	.	.	Note=No	effect.	D->N
P0ABI8	UniProtKB	Mutagenesis	257	257	.	.	.	Note=Abolishes	quinol	oxidase	activity.	R->Q
P0ABI8	UniProtKB	Mutagenesis	284	284	.	.	.	Note=1%25	quinol	oxidase	activity%2C	loss	of	heme	o.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1309808;Dbxref=PMID:1309808
P0ABI8	UniProtKB	Mutagenesis	286	286	.	.	.	Note=Great	decrease	in	quinol	oxidase	activity.	E->Q%2CD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9378723;Dbxref=PMID:9378723
P0ABI8	UniProtKB	Mutagenesis	288	288	.	.	.	Note=Great	decrease	in	activity%2C	100-fold	decrease	in	heme	b-to-heme	o	electron	transfer.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9378723;Dbxref=PMID:9378723
P0ABI8	UniProtKB	Mutagenesis	333	333	.	.	.	Note=2%25	quinol	oxidase	activity%2C	loss	of	Cu(B).	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1309808;Dbxref=PMID:1309808
P0ABI8	UniProtKB	Mutagenesis	334	334	.	.	.	Note=1%25	quinol	oxidase	activity%2C	loss	of	Cu(B).	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1309808;Dbxref=PMID:1309808
P0ABI8	UniProtKB	Mutagenesis	362	362	.	.	.	Note=Abolishes	quinol	oxidase	activity%2C	100-fold	decrease	in	heme	b-to-heme	o	electron	transfer.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9378723;Dbxref=PMID:9378723
P0ABI8	UniProtKB	Mutagenesis	407	407	.	.	.	Note=Abolishes	quinol	oxidase	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9378723;Dbxref=PMID:9378723
P0ABI8	UniProtKB	Mutagenesis	411	411	.	.	.	Note=50%25	quinol	oxidase	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1309808;Dbxref=PMID:1309808
P0ABI8	UniProtKB	Mutagenesis	419	419	.	.	.	Note=3%25	quinol	oxidase	activity%2C	loss	of	heme	o%2C	loss	of	Cu(B).	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1309808;Dbxref=PMID:1309808
P0ABI8	UniProtKB	Mutagenesis	421	421	.	.	.	Note=1%25	quinol	oxidase	activity%2C	loss	of	heme	b%2C	some	loss	of	Cu(B).	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1309808;Dbxref=PMID:1309808
P0ABI8	UniProtKB	Mutagenesis	481	481	.	.	.	Note=No	effect.	R->Q
P0ABI8	UniProtKB	Mutagenesis	482	482	.	.	.	Note=No	effect.	R->Q
P0ABI8	UniProtKB	Mutagenesis	540	540	.	.	.	Note=Abolishes	quinol	oxidase	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9378723;Dbxref=PMID:9378723
P08622	UniProtKB	Mutagenesis	19	20	.	.	.	Note=No	effect.	RE->AA
P08622	UniProtKB	Mutagenesis	25	25	.	.	.	Note=Loss	of	activity.	Y->A
P08622	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Loss	of	activity.	K->A
P08622	UniProtKB	Mutagenesis	27	27	.	.	.	Note=No	effect.	R->A
P08622	UniProtKB	Mutagenesis	28	28	.	.	.	Note=No	effect.	L->A
P08622	UniProtKB	Mutagenesis	29	29	.	.	.	Note=No	effect.	A->G
P08622	UniProtKB	Mutagenesis	30	31	.	.	.	Note=No	effect.	MK->AA
P08622	UniProtKB	Mutagenesis	32	32	.	.	.	Note=No	effect.	Y->A
P08622	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Loss	of	ability	to	stimulate	DnaK	ATPase	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8106526;Dbxref=PMID:8106526
P08622	UniProtKB	Mutagenesis	34	34	.	.	.	Note=Loss	of	function.	P->F
P08622	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Loss	of	ability	to	bind	DnaK.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9860950;Dbxref=PMID:9860950
P08622	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Decrease	in	chaperone	function.	R->A
P08622	UniProtKB	Mutagenesis	37	37	.	.	.	Note=Decrease	in	chaperone	function.	N->A
P08622	UniProtKB	Mutagenesis	38	38	.	.	.	Note=No	effect.	Q->A
P08622	UniProtKB	Mutagenesis	41	42	.	.	.	Note=No	effect.	KE->AA
P08622	UniProtKB	Mutagenesis	44	44	.	.	.	Note=No	effect.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12454054;Dbxref=PMID:12454054
P08622	UniProtKB	Mutagenesis	46	46	.	.	.	Note=No	effect.	K->A
P08622	UniProtKB	Mutagenesis	47	47	.	.	.	Note=Loss	of	function.	F->A
P08622	UniProtKB	Mutagenesis	48	49	.	.	.	Note=No	effect.	KE->AA
P08622	UniProtKB	Mutagenesis	51	52	.	.	.	Note=No	effect.	KE->AA
P08622	UniProtKB	Mutagenesis	54	54	.	.	.	Note=No	effect.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12454054;Dbxref=PMID:12454054
P08622	UniProtKB	Mutagenesis	55	55	.	.	.	Note=No	effect.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12454054;Dbxref=PMID:12454054
P08622	UniProtKB	Mutagenesis	58	59	.	.	.	Note=No	effect.	TD->AA
P08622	UniProtKB	Mutagenesis	60	61	.	.	.	Note=No	effect.	SQ->AA
P08622	UniProtKB	Mutagenesis	62	63	.	.	.	Note=No	effect.	KR->AA
P08622	UniProtKB	Mutagenesis	67	68	.	.	.	Note=No	effect.	DQ->AA
P08622	UniProtKB	Mutagenesis	144	144	.	.	.	Note=Loss	of	DnaK-independent	chaperone	activity%3B	when	associated	with	S-147%3B	S-197	and	S-200.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12941935;Dbxref=PMID:12941935
P08622	UniProtKB	Mutagenesis	147	147	.	.	.	Note=Loss	of	DnaK-independent	chaperone	activity%3B	when	associated	with	S-144%3B	S-197	and	S-200.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12941935;Dbxref=PMID:12941935
P08622	UniProtKB	Mutagenesis	161	161	.	.	.	Note=No	effect	on	chaperone	function%3B	when	associated	with	H-183.	C->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12941935,ECO:0000269|PubMed:15683252;Dbxref=PMID:12941935,PMID:15683252
P08622	UniProtKB	Mutagenesis	161	161	.	.	.	Note=Loss	of	function%3B	when	associated	with	S-164%3B	S-183	and	S-186.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12941935,ECO:0000269|PubMed:15683252;Dbxref=PMID:12941935,PMID:15683252
P08622	UniProtKB	Mutagenesis	164	164	.	.	.	Note=No	effect	on	chaperone	function%3B	when	associated	with	H-183.	C->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12941935,ECO:0000269|PubMed:15683252;Dbxref=PMID:12941935,PMID:15683252
P08622	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Loss	of	function%3B	when	associated	with	S-161%3B	S-183	and	S-186.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12941935,ECO:0000269|PubMed:15683252;Dbxref=PMID:12941935,PMID:15683252
P08622	UniProtKB	Mutagenesis	183	183	.	.	.	Note=No	effect	on	chaperone	function.	Same	effect%3B	when	associated	with	H-161	or	H-164.	C->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12941935,ECO:0000269|PubMed:15683252;Dbxref=PMID:12941935,PMID:15683252
P08622	UniProtKB	Mutagenesis	183	183	.	.	.	Note=Loss	of	function%3B	when	associated	with	S-161%3B	S-164	and	S-186.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12941935,ECO:0000269|PubMed:15683252;Dbxref=PMID:12941935,PMID:15683252
P08622	UniProtKB	Mutagenesis	186	186	.	.	.	Note=No	effect	on	chaperone	function.	C->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12941935,ECO:0000269|PubMed:15683252;Dbxref=PMID:12941935,PMID:15683252
P08622	UniProtKB	Mutagenesis	186	186	.	.	.	Note=Loss	of	function%3B	when	associated	with	S-161%3B	S-164	and	S-184.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12941935,ECO:0000269|PubMed:15683252;Dbxref=PMID:12941935,PMID:15683252
P08622	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Loss	of	DnaK-independent	chaperone	activity%3B	when	associated	with	S-144%3B	S-147	and	S-200.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12941935;Dbxref=PMID:12941935
P08622	UniProtKB	Mutagenesis	200	200	.	.	.	Note=Loss	of	DnaK-independent	chaperone	activity%3B	when	associated	with	S-144%3B	S-147	and	S-197.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12941935;Dbxref=PMID:12941935
P0ACF8	UniProtKB	Mutagenesis	2	69	.	.	.	Note=No	longer	complements	a	deletiomutant%2C	has	no	dominant-negative	effects	on	wild-type	protein%2C	does	not	oligomerize.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9398522;Dbxref=PMID:9398522
P0ACF8	UniProtKB	Mutagenesis	2	20	.	.	.	Note=No	longer	complements	a	deletiomutant%2C	has	dominant-negative	effects	on	wild-type	protein%2C	oligomerizes.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9398522;Dbxref=PMID:9398522
P0ACF8	UniProtKB	Mutagenesis	6	6	.	.	.	Note=No	effect	on	oligomerization	of	N-terminal	fragment	1-89.	K->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12460581;Dbxref=PMID:12460581
P0ACF8	UniProtKB	Mutagenesis	12	15	.	.	.	Note=Decreased	DNA-binding%2C	loss	of	preference	for	curved	DNA.	RTLR->ERLA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12592399;Dbxref=PMID:12592399
P0ACF8	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Derepression	of	proV	and	bgl	expression%2C	normal	DNA-binding%2C	normal	oligomerization.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8913298;Dbxref=PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Derepression	of	proV	and	bgl	expression%2C	normal	DNA-binding%2C	normal	oligomerization.	Fragments	1-46	and	1-64	no	longer	bind	Hha.	R->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16650431,ECO:0000269|PubMed:8913298;Dbxref=PMID:16650431,PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Abolishes	the	interaction	with	Hha.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21600204;Dbxref=PMID:21600204
P0ACF8	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Derepression	of	proV	and	bgl	expression.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8913298;Dbxref=PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Derepression	of	proV	and	bgl	expression.	Fragments	1-46	and	1-64	fold	incorrectly	but	still	bind	Hha.	R->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16650431,ECO:0000269|PubMed:8913298;Dbxref=PMID:16650431,PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Abolishes	oligomerization	of	N-terminal	fragment	1-89.	Q->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12460581;Dbxref=PMID:12460581
P0ACF8	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Partial	loss	of	repressor	function.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755860;Dbxref=PMID:8755860
P0ACF8	UniProtKB	Mutagenesis	30	30	.	.	.	Note=Wild-type	function.	L->A%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9398522;Dbxref=PMID:9398522
P0ACF8	UniProtKB	Mutagenesis	30	30	.	.	.	Note=Derepression	of	proV	and	partial	derepression	of	bgl	epxression%2C	does	not	dimerize%2C	anomalous	protein	mobility	on	gels.	L->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9398522;Dbxref=PMID:9398522
P0ACF8	UniProtKB	Mutagenesis	30	30	.	.	.	Note=Derepression	of	proV	and	bgl	epxression%2C	does	not	dimerize%2C	anomalous	protein	mobility	on	gels.	Protein	localizes	to	nucleoid	but	no	longer	forms	discreet	compact	clusters.	L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21903814,ECO:0000269|PubMed:9398522;Dbxref=PMID:21903814,PMID:9398522
P0ACF8	UniProtKB	Mutagenesis	32	32	.	.	.	Note=Loss	of	Hha	binding	by	fragment	1-64%2C	protein	folding	is	unaffected.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26085102;Dbxref=PMID:26085102
P0ACF8	UniProtKB	Mutagenesis	53	55	.	.	.	Note=Partial	loss	of	repressor	function.	ERT->GRP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755860;Dbxref=PMID:8755860
P0ACF8	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Derepression	of	proV	and	bgl	expression.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8913298;Dbxref=PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	64	137	.	.	.	Note=No	longer	complements	a	deletiomutant%2C	has	dominant-negative	effects	on	wild-type	protein%2C	oligomerizes.	Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:8755860,ECO:0000269|PubMed:9398522;Dbxref=PMID:8755860,PMID:9398522
P0ACF8	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Derepression	of	proV	expression.	R->C%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8913298;Dbxref=PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Derepression	of	proV	expression.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8913298;Dbxref=PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	92	137	.	.	.	Note=Derepression	of	proV	expression%2C	loss	of	DNA-binding%2C	increased	oligomerization.	No	longer	complements	a	deletiomutant%2C	has	dominant-negative	effects	on	wild-type	protein%2C	oligomerizes.	Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:8913298,ECO:0000269|PubMed:9398522;Dbxref=PMID:8913298,PMID:9398522
P0ACF8	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Derepression	of	proV	expression.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8913298;Dbxref=PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	94	94	.	.	.	Note=Derepression	of	proV	expression.	P->L%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8913298;Dbxref=PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	95	95	.	.	.	Note=Derepression	of	proV	expression.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8913298;Dbxref=PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Partial	loss	of	repressor	function.	Y->C%2CH%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755860;Dbxref=PMID:8755860
P0ACF8	UniProtKB	Mutagenesis	110	110	.	.	.	Note=Partial	loss	of	repressor	function.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755860;Dbxref=PMID:8755860
P0ACF8	UniProtKB	Mutagenesis	110	110	.	.	.	Note=Derepression	of	proV	expression.	T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8913298;Dbxref=PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	111	111	.	.	.	Note=Derepression	of	proV	expression.	G->D%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8913298;Dbxref=PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Derepression	of	proV	expression%2C	decreased	DNA-binding	but	still	prefers	curved	DNA%2C	increased	oligomerization.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8913298;Dbxref=PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Partial	loss	of	repressor	function.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755860;Dbxref=PMID:8755860
P0ACF8	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Derepression	of	proV	expression.	R->C%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8913298;Dbxref=PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Derepression	of	proV	expression.	T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8913298;Dbxref=PMID:8913298
P0ACF8	UniProtKB	Mutagenesis	116	116	.	.	.	Note=Partial	loss	of	repressor	function.	Protein	localizes	to	nucleoid	but	forms	about	20-fold	fewer	localization	points.P->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21903814,ECO:0000269|PubMed:8755860;Dbxref=PMID:21903814,PMID:8755860
P0ACF8	UniProtKB	Mutagenesis	119	119	.	.	.	Note=Partial	loss	of	repressor	function.	I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755860;Dbxref=PMID:8755860
P0ACF8	UniProtKB	Mutagenesis	122	137	.	.	.	Note=Partial	loss	of	repressor	function.	AMDEQGKSLDDFLIKQ->KQWMRKVNPSTIS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755860;Dbxref=PMID:8755860
P0ACF8	UniProtKB	Mutagenesis	133	133	.	.	.	Note=Partial	loss	of	repressor	function.	F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755860;Dbxref=PMID:8755860
P0AES6	UniProtKB	Mutagenesis	1	14	.	.	.	Note=No	dimerization	of	residues	15-393%2C	fragment	has	no	ATPase	activity.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10734094;Dbxref=PMID:10734094
P0AES6	UniProtKB	Mutagenesis	5	5	.	.	.	Note=5-	to	10-fold	reduced	dimerization	of	residues	2-393%2C	fragment	has	3-	to	5-fold	reduced	ATPase	activity.	Fragmendimerizes	upon	crystallization.	Y->F%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10734094;Dbxref=PMID:10734094
P0AES6	UniProtKB	Mutagenesis	10	10	.	.	.	Note=No	dimerization	of	residues	2-393%2C	fragment	has	significantly	decreased	ATPase	activity.	I->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10734094;Dbxref=PMID:10734094
P0AES6	UniProtKB	Mutagenesis	38	38	.	.	.	Note=0.2%25	supercoiling	activity%2C	7%25	DNA-dependent	ATPase	activity%2C	binds	ATP	normally%2C	complements	the	N4177	ts	mutant.H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8248233;Dbxref=PMID:8248233
P0AES6	UniProtKB	Mutagenesis	42	42	.	.	.	Note=No	supercoiling	or	DNA-dependent	ATPase	activity%2C	25%25	fluoroquinolone-induced	DNA	cleavage%2C	50%25	ATP-independent	DNA	relaxation%2C	binds	ATP	normally%2C	does	not	complement	the	N4177	ts	mutant.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8248233;Dbxref=PMID:8248233
P0AES6	UniProtKB	Mutagenesis	42	42	.	.	.	Note=7%25	supercoiling	activity%2C	16%25	DNA-dependent	ATPase	activity%2C	fluoroquinolone-induced	DNA	cleavage	normal%2C	40%25	ATP-independent	DNA	relaxation%2C	binds	ATP	normally%2C	complements	the	N4177	ts	mutant.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8248233;Dbxref=PMID:8248233
P0AES6	UniProtKB	Mutagenesis	42	42	.	.	.	Note=No	supercoiling	or	DNA-dependent	ATPase	activity%2C	binds	ATP	normally%2C	does	not	complement	the	N4177	ts	mutant.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8248233;Dbxref=PMID:8248233
P0AES6	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Retains	ATP-independent	DNA	relaxation	and	quinolone-induced	DNA	cleavage%3B	loss	of	supercoiling	activity%2C	loss	of	ATPase%2C	does	not	bind	ATP	analogs.	K->E%2CI%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8621650;Dbxref=PMID:8621650
P0AES6	UniProtKB	Mutagenesis	110	110	.	.	.	Note=Binds	about	50%25	ATP	analog%2C	2-	to	3-fold	decreased	ATPase%2C	retains	ATP-independent	DNA	relaxation%2C	quinolone-induced	DNA	cleavage	and	negative	supercoiling	activity.	K->E%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8621650;Dbxref=PMID:8621650
P0AES6	UniProtKB	Mutagenesis	136	136	.	.	.	Note=Resistance	to	coumarin	antibiotics%2C	decreased	ATPase	and	DNA	supercoiling.	R->C%2CH%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1323022;Dbxref=PMID:1323022
P0AES6	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Resistance	to	coumarin	antibiotics%2C	decreased	ATPase	and	DNA	supercoiling.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1323022;Dbxref=PMID:1323022
P0AES6	UniProtKB	Mutagenesis	335	335	.	.	.	Note=Wild-type	ATP	analog-binding	and	ATPase	activity	in	N-terminal	fragment	GyrB43	(residues	2-393)%2C	in	whole	proteinwild-type	DNA	supercoiling	and	ATP-independent	DNA	relaxation%2C	50%25	ATPase	activity	which	is	not	stimulated	by	DNA%2C	complements	the	N4177	ts	mutant.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9657678;Dbxref=PMID:9657678
P0AES6	UniProtKB	Mutagenesis	337	337	.	.	.	Note=Binds	about	60%25	ATP	analog	but	strongly	decreased	enzyme	turnover	for	ATPase	activity	in	N-terminal	fragmenGyrB43	(residues	2-393)%2C	in	whole	protein	<1%25	DNA	supercoiling	and	ATPase	activity	not	stimulated	by	DNA%2C	wild-type	ATP-independent	DNA	relaxation	and	quinolone-induced	DNA	cleavage%2C	does	not	complement	the	N4177	ts	mutant.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9657678;Dbxref=PMID:9657678
P0AES6	UniProtKB	Mutagenesis	424	424	.	.	.	Note=Strongly	reduced	DNA	supercoiling	and	relaxation	activity.	Reduces	ATP	hydrolysis	in	response	to	DNA	binding%2C	but	has	only	minor	effect	on	the	basal	rate	of	ATP	hydrolysis.	E->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12051843;Dbxref=PMID:12051843
P0AES6	UniProtKB	Mutagenesis	436	436	.	.	.	Note=Cannot	be	made%2C	suggesting	it	is	lethal.	This	is	temperature-sensitive	in	S.typhimurium%2C	but	not	lethal.	R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17400739;Dbxref=PMID:17400739
P0AES6	UniProtKB	Mutagenesis	498	498	.	.	.	Note=Strongly	reduced	DNA	supercoiling	and	relaxation	activity.	Reduces	ATP	hydrolysis	in	response	to	DNA	binding%2C	but	has	only	minor	effect	on	the	basal	rate	of	ATP	hydrolysis.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12051843;Dbxref=PMID:12051843
P0AES6	UniProtKB	Mutagenesis	500	500	.	.	.	Note=Strongly	reduced	DNA	supercoiling	and	relaxation	activity.	Reduces	ATP	hydrolysis	in	response	to	DNA	binding%2C	but	has	only	minor	effect	on	the	basal	rate	of	ATP	hydrolysis.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12051843;Dbxref=PMID:12051843
P0AES6	UniProtKB	Mutagenesis	500	500	.	.	.	Note=Alters	metal-dependency	of	ATP-independent	DNA	relaxation%2C	prefers	Mn(2+)	and	Co(2+)	over	wild-type	Mg(2+).	D->C%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12051843;Dbxref=PMID:12051843
P0AES6	UniProtKB	Mutagenesis	502	502	.	.	.	Note=Strongly	reduced	DNA	supercoiling	and	relaxation	activity.	Reduces	ATP	hydrolysis	in	response	to	DNA	binding%2C	but	has	only	minor	effect	on	the	basal	rate	of	ATP	hydrolysis.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12051843;Dbxref=PMID:12051843
P0AES6	UniProtKB	Mutagenesis	502	502	.	.	.	Note=Alters	metal-dependency	of	ATP-independent	DNA	relaxation%2C	prefers	Mn(2+)	and	Co(2+)	over	wild-type	Mg(2+).	D->C%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12051843;Dbxref=PMID:12051843
P05793	UniProtKB	Mutagenesis	68	68	.	.	.	Note=Inversion	of	cofactor	specificity	from	NADPH	to	NADH%3B	when	associated	with	L-69%2C	V-75	and	D-76.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9015391;Dbxref=PMID:9015391
P05793	UniProtKB	Mutagenesis	68	68	.	.	.	Note=18-fold	decrease	of	the	catalytic	efficiency	and	3-fold	decrease	of	the	affinity	for	NADPH.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9015391;Dbxref=PMID:9015391
P05793	UniProtKB	Mutagenesis	69	69	.	.	.	Note=Does	not	significantly	alter	the	affinity	for	NADPH.	Slight	increase	of	the	catalytic	efficiency.	Inversion	of	cofactor	specificity	from	NADPH	to	NADH%3B	when	associated	with	D-68%2C	V-75	and	D-76.	K->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9015391;Dbxref=PMID:9015391
P05793	UniProtKB	Mutagenesis	71	71	.	.	.	Note=7-	and	2.5-fold	increase	of	the	reductoisomerase	activity	with	NADH	and	NADPH%2C	respectively.	A->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21515217;Dbxref=PMID:21515217
P05793	UniProtKB	Mutagenesis	75	75	.	.	.	Note=13-fold	decrease	of	the	catalytic	efficiency	and	3-fold	increase	of	the	affinity	for	NADPH.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9015391;Dbxref=PMID:9015391
P05793	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Inversion	of	cofactor	specificity	from	NADPH	to	NADH%3B	when	associated	with	D-68%2C	L-69	and	D-76.	K->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9015391;Dbxref=PMID:9015391
P05793	UniProtKB	Mutagenesis	76	76	.	.	.	Note=3-fold	increase	of	the	reductoisomerase	activity	with	NADH	and	slight	decrease	of	the	reductoisomerase	activitwith	NADPH.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21515217;Dbxref=PMID:21515217
P05793	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Strong	increase	of	catalytic	efficiency	and	2.5-fold	increase	of	the	affinity	for	NADH.	4-fold	decreasof	the	catalytic	efficiency	and	strong	decrease	of	the	affinity	for	NADPH.	Inversion	of	cofactor	specificity	from	NADPH	to	NADH%3B	when	associated	with	D-68%2CL-69	and	V-75.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9015391;Dbxref=PMID:9015391
P05793	UniProtKB	Mutagenesis	76	76	.	.	.	Note=20-fold	decrease	of	the	catalytic	efficiency	and	5-fold	decrease	of	the	affinity	for	NADPH.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9015391;Dbxref=PMID:9015391
P05793	UniProtKB	Mutagenesis	78	78	.	.	.	Note=12-fold	increase	of	the	reductoisomerase	activity	with	NADH	and	slight	decrease	of	the	reductoisomerase	activitwith	NADPH.	S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21515217;Dbxref=PMID:21515217
P05793	UniProtKB	Mutagenesis	110	110	.	.	.	Note=12-	and	2-fold	increase	of	the	reductoisomerase	activity	with	NADH	and	NADPH%2C	respectively.	Q->V%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21515217;Dbxref=PMID:21515217
P05793	UniProtKB	Mutagenesis	132	132	.	.	.	Note=Loss	of	reductoisomerase	activity.	H->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15654896;Dbxref=PMID:15654896
P05793	UniProtKB	Mutagenesis	132	132	.	.	.	Note=Loss	of	reductoisomerase	activity.	The	reductase	activity	with	3-hydroxypyruvate	and	HMKB	is	nearly	normal%2C	and	the	isomerase	activity	decreases	24-fold.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15654896;Dbxref=PMID:15654896
P05793	UniProtKB	Mutagenesis	155	155	.	.	.	Note=Loss	of	reductoisomerase	activity.	K->E%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15654896;Dbxref=PMID:15654896
P05793	UniProtKB	Mutagenesis	155	155	.	.	.	Note=Loss	of	reductoisomerase	activity.	The	reductase	activity	with	3-hydroxypyruvate	and	HMKB	is	nearly	normal%2C	and	the	isomerase	activity	decreases	40-fold.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15654896;Dbxref=PMID:15654896
P05793	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Loss	of	reductoisomerase	activity.	1.5-fold	decrease	of	the	reductase	activity	with	3-hydroxypyruvate	and	the	isomerase	activity	decreases	48-fold.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15654896;Dbxref=PMID:15654896
P05793	UniProtKB	Mutagenesis	217	217	.	.	.	Note=Loss	of	reductoisomerase	activity.	D->E%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15654896;Dbxref=PMID:15654896
P05793	UniProtKB	Mutagenesis	221	221	.	.	.	Note=Loss	of	reductoisomerase	activity.	E->D%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15654896;Dbxref=PMID:15654896
P05793	UniProtKB	Mutagenesis	389	389	.	.	.	Note=Loss	of	reductoisomerase	activity.	1.5-fold	decrease	of	the	reductase	activity	with	3-hydroxypyruvate	and	the	isomerase	activity	decreases	4-fold.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15654896;Dbxref=PMID:15654896
P05793	UniProtKB	Mutagenesis	389	389	.	.	.	Note=Loss	of	reductoisomerase	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15654896;Dbxref=PMID:15654896
P05793	UniProtKB	Mutagenesis	393	393	.	.	.	Note=Loss	of	reductoisomerase	activity.	The	reductase	activity	with	HMKB	is	nearly	normal.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15654896;Dbxref=PMID:15654896
P05793	UniProtKB	Mutagenesis	414	414	.	.	.	Note=Loss	of	reductoisomerase	activity.	The	isomerase	activity	decreases	15-fold.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15654896;Dbxref=PMID:15654896
P05793	UniProtKB	Mutagenesis	414	414	.	.	.	Note=Loss	of	reductoisomerase	activity.	The	isomerase	activity	decreases	24-fold.	S->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15654896;Dbxref=PMID:15654896
P15042	UniProtKB	Mutagenesis	10	10	.	.	.	Note=No	effect.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781321;Dbxref=PMID:11781321
P15042	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Reduces	nick	joining	activity	by	99.9%25.	Y->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781321;Dbxref=PMID:11781321
P15042	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Reduces	nick	joining	activity	by	91%25.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781321;Dbxref=PMID:11781321
P15042	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Reduces	nick	joining	activity	by	90%25.	H->A%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781321;Dbxref=PMID:11781321
P15042	UniProtKB	Mutagenesis	32	32	.	.	.	Note=Reduces	nick	joining	activity	by	99%25.	D->A%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781321;Dbxref=PMID:11781321
P15042	UniProtKB	Mutagenesis	32	32	.	.	.	Note=Reduces	nick	joining	activity	by	91%25.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781321;Dbxref=PMID:11781321
P15042	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Reduces	nick	joining	activity	by	98%25.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781321;Dbxref=PMID:11781321
P15042	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Reduces	nick	joining	activity	by	77%25.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781321;Dbxref=PMID:11781321
P15042	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Reduces	nick	joining	activity	by	99.9%25.	Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781321;Dbxref=PMID:11781321
P15042	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Reduces	nick	joining	activity	by	99.8%25.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781321;Dbxref=PMID:11781321
P15042	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Reduces	nick	joining	activity	by	96%25.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781321;Dbxref=PMID:11781321
P15042	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Reduces	nick	joining	activity	by	88%25.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781321;Dbxref=PMID:11781321
P15042	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Reduces	nick	joining	activity	by	99.9%25.	K->Q%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	117	117	.	.	.	Note=Reduces	nick	joining	activity	by	97%25.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	117	117	.	.	.	Note=Reduces	nick	joining	activity	by	99.9%25.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Reduces	nick	joining	activity	by	99.9%25.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	138	138	.	.	.	Note=Reduces	nick	joining	activity	by	63%25.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	143	143	.	.	.	Note=Reduces	nick	joining	activity	by	48%25.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	172	172	.	.	.	Note=Reduces	nick	joining	activity	by	64%25.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	173	173	.	.	.	Note=Reduces	nick	joining	activity	by	99.9%25.	E->A%2CD%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	198	198	.	.	.	Note=Reduces	nick	joining	activity	by	74%25.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	200	200	.	.	.	Note=Reduces	nick	joining	activity	by	99.9%25.	R->A%2CK%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	208	208	.	.	.	Note=Reduces	nick	joining	activity	by	99%25.	R->A%2CK%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	277	277	.	.	.	Note=Reduces	nick	joining	activity	by	99%25.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	285	285	.	.	.	Note=Reduces	nick	joining	activity	by	96%25.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	285	285	.	.	.	Note=Reduces	nick	joining	activity	by	99%25.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	286	286	.	.	.	Note=Reduces	nick	joining	activity	by	86%25.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	288	288	.	.	.	Note=Reduces	nick	joining	activity	by	25%25.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	290	290	.	.	.	Note=Reduces	nick	joining	activity	by	87%25.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	314	314	.	.	.	Note=Reduces	nick	joining	activity	by	99%25.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	314	314	.	.	.	Note=Reduces	nick	joining	activity	by	95%25.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15671015;Dbxref=PMID:15671015
P15042	UniProtKB	Mutagenesis	333	333	.	.	.	Note=Reduces	nick	joining	activity	by	over	95%25.	Abolishes	nick	joining	activity%3B	when	associated	with	A-334.	R->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P15042	UniProtKB	Mutagenesis	334	334	.	.	.	Note=Abolishes	nick	joining	activity%3B	when	associated	with	A-333.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P15042	UniProtKB	Mutagenesis	342	342	.	.	.	Note=Reduces	nick	joining	activity	by	80%25.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P15042	UniProtKB	Mutagenesis	379	379	.	.	.	Note=Reduces	nick	joining	activity	by	over	95%25.	R->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P15042	UniProtKB	Mutagenesis	383	384	.	.	.	Note=Reduces	nick	joining	activity	by	95%25.	VI->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P15042	UniProtKB	Mutagenesis	446	447	.	.	.	Note=Reduces	nick	joining	activity	by	95%25.	RR->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P15042	UniProtKB	Mutagenesis	455	455	.	.	.	Note=Reduces	nick	joining	activity	by	50%25.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P15042	UniProtKB	Mutagenesis	455	455	.	.	.	Note=Reduces	nick	joining	activity	by	95%25.	G->D%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P15042	UniProtKB	Mutagenesis	487	487	.	.	.	Note=Reduces	nick	joining	activity	by	over	90%25.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P15042	UniProtKB	Mutagenesis	489	489	.	.	.	Note=Reduces	nick	joining	activity	by	95%25.	G->D%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P15042	UniProtKB	Mutagenesis	521	521	.	.	.	Note=Reduces	nick	joining	activity	by	95%25.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P15042	UniProtKB	Mutagenesis	521	521	.	.	.	Note=Loss	of	nick	joining	activity.	G->D%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P15042	UniProtKB	Mutagenesis	553	553	.	.	.	Note=Reduces	nick	joining	activity	by	95%25.	G->D%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P15042	UniProtKB	Mutagenesis	614	614	.	.	.	Note=Reduces	nick	joining	activity	by	85%25.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18515356;Dbxref=PMID:18515356
P60472	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Great	decrease	in	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11076526;Dbxref=PMID:11076526
P60472	UniProtKB	Mutagenesis	31	31	.	.	.	Note=Decrease	in	activity%3B	reducedaffinity	for	decaprenyl	diphosphate	substrate	analog.	W->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11744728;Dbxref=PMID:11744728
P60472	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Great	decreases	in	the	catalytic	efficiency	and	the	affinity	for	FPP	and	IPP.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12756244;Dbxref=PMID:12756244
P60472	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Formation	predominantly	of	C(60)	and	C(65)	polymers	rather	than	the	C(55)	polymer.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11581264;Dbxref=PMID:11581264
P60472	UniProtKB	Mutagenesis	69	69	.	.	.	Note=Produces	shorter	polymers.	A->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11581264;Dbxref=PMID:11581264
P60472	UniProtKB	Mutagenesis	71	71	.	.	.	Note=Decrease	in	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11581264;Dbxref=PMID:11581264
P60472	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Slight	decrease	in	activity.	E->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11076526,ECO:0000269|PubMed:11581264;Dbxref=PMID:11076526,PMID:11581264
P60472	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Decrease	in	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11581264;Dbxref=PMID:11581264
P60472	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Decrease	in	activity%3B	reducedaffinity	for	decaprenyl	diphosphate	substrate	analog.	W->A%2CF;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11581264,ECO:0000269|PubMed:11744728;Dbxref=PMID:11581264,PMID:11744728
P60472	UniProtKB	Mutagenesis	77	77	.	.	.	Note=Decrease	in	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11581264;Dbxref=PMID:11581264
P60472	UniProtKB	Mutagenesis	81	81	.	.	.	Note=Slight	decrease	in	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11581264;Dbxref=PMID:11581264
P60472	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Decrease	in	affinity	for	IPP.	W->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11744728;Dbxref=PMID:11744728
P60472	UniProtKB	Mutagenesis	103	103	.	.	.	Note=No	effect.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11581264;Dbxref=PMID:11581264
P60472	UniProtKB	Mutagenesis	105	105	.	.	.	Note=Formation	predominantly	of	C(60)%2C(65)	and	C(70)	polymers	rather	than	the	C(55)	polymer.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11581264;Dbxref=PMID:11581264
P60472	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Formation	predominantly	of	a	C(70)	polymer	rather	than	the	C(55)	polymer.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11581264;Dbxref=PMID:11581264
P60472	UniProtKB	Mutagenesis	143	143	.	.	.	Note=No	effect	on	polymer	length.	A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11581264;Dbxref=PMID:11581264
P60472	UniProtKB	Mutagenesis	149	149	.	.	.	Note=Decrease	in	affinity	for	IPP.	W->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11744728;Dbxref=PMID:11744728
P60472	UniProtKB	Mutagenesis	150	150	.	.	.	Note=Great	decrease	in	affinitfor	the	substrate.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11076526;Dbxref=PMID:11076526
P60472	UniProtKB	Mutagenesis	190	190	.	.	.	Note=No	effect.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11076526;Dbxref=PMID:11076526
P60472	UniProtKB	Mutagenesis	198	198	.	.	.	Note=No	effect.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11076526;Dbxref=PMID:11076526
P60472	UniProtKB	Mutagenesis	199	199	.	.	.	Note=Great	decreases	in	the	catalytic	efficiency	and	in	the	affinity	for	IPP%3B	when	associated	with	A-213.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12756244;Dbxref=PMID:12756244
P60472	UniProtKB	Mutagenesis	207	207	.	.	.	Note=Decrease	in	affinity	for	both	IPP	and	decaprenyl	diphosphate	substrate	analog.	W->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11744728;Dbxref=PMID:11744728
P60472	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Great	decrease	in	activity%3B	reduced	affinity	for	IPP.	Great	decreases	in	the	catalytic	efficiency	and	in	the	affinity	for	IPP%3B	when	associated	with	A-199.	E->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11076526,ECO:0000269|PubMed:12756244;Dbxref=PMID:11076526,PMID:12756244
P60472	UniProtKB	Mutagenesis	218	218	.	.	.	Note=Slight	decrease	in	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11076526;Dbxref=PMID:11076526
P60472	UniProtKB	Mutagenesis	221	221	.	.	.	Note=Decrease	in	affinity	for	IPP.	W->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11744728;Dbxref=PMID:11744728
P60472	UniProtKB	Mutagenesis	223	223	.	.	.	Note=No	effect.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11076526;Dbxref=PMID:11076526
P0ACJ8	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Decreased	transcription	activation	at	class	II	promoters%2C	decreased	interaction	with	RNAP%2C	binds	DNA.	H->A%2CL%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8978616;Dbxref=PMID:8978616
P0ACJ8	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Decreased	transcription	activation	at	class	II	promoters%2C	decreased	interaction	with	RNAP%2C	binds	DNA.	H->A%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8978616;Dbxref=PMID:8978616
P0ACJ8	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Increased	activation	at	class	II	promoters%2C	increased	interaction	with	RNAP.	K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8978616;Dbxref=PMID:8978616
P0ACJ8	UniProtKB	Mutagenesis	54	56	.	.	.	Note=80%25	reduction	in	activation	of	class	II	promoters%3B	95%25	loss	when	associated	with	A-59.	DEE->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10860739;Dbxref=PMID:10860739
P0ACJ8	UniProtKB	Mutagenesis	59	59	.	.	.	Note=45%25	reduction	in	activation	of	class	II	promoters%3B	95%25	loss	when	associated	with	AAA-54-56.	E->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10860739,ECO:0000269|PubMed:10860740;Dbxref=PMID:10860739,PMID:10860740
P0ACJ8	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Reduction	in	activation	of	class	II	promoters.	E->G%2CK;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10860739,ECO:0000269|PubMed:10860740;Dbxref=PMID:10860739,PMID:10860740
P0ACJ8	UniProtKB	Mutagenesis	63	63	.	.	.	Note=Enhanced	cAMP-binding%2C	enhanced	transcription.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2845936;Dbxref=PMID:2845936
P0ACJ8	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Loss	of	cAMP-binding.	R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2845936;Dbxref=PMID:2845936
P0ACJ8	UniProtKB	Mutagenesis	84	84	.	.	.	Note=No	modification	of	cAMP-binding.	S->A%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2845936;Dbxref=PMID:2845936
P0ACJ8	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Increased	transcription	activation	at	class	II	promoters%2C	binds	DNA.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8978616;Dbxref=PMID:8978616
P0ACJ8	UniProtKB	Mutagenesis	102	102	.	.	.	Note=Disrupts	AR2.	No	activation	of	class	II	promoters%2C	decreased	interaction	with	RNAP%2C	binds	DNA.	K->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15520470,ECO:0000269|PubMed:8978616;Dbxref=PMID:15520470,PMID:8978616
P0ACJ8	UniProtKB	Mutagenesis	128	129	.	.	.	Note=Constitutively	active	at	class	and	II	promoters	in	the	absence	of	cAMP%2C	binds	DNA	almost	as	well	in	the	absence	as	in	the	presence	of	cAMP.	Binds	cAMP	normally.	TS->LI;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16260780,ECO:0000269|PubMed:23644478;Dbxref=PMID:16260780,PMID:23644478
P0ACJ8	UniProtKB	Mutagenesis	128	128	.	.	.	Note=No	modification	of	cAMP-binding.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2845936;Dbxref=PMID:2845936
P0ACJ8	UniProtKB	Mutagenesis	129	129	.	.	.	Note=Reduced	DNA-binding%3B	no	modification	of	cAMP-binding.	S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:2845936,ECO:0000269|PubMed:3333845;Dbxref=PMID:2845936,PMID:3333845
P0ACJ8	UniProtKB	Mutagenesis	139	139	.	.	.	Note=Some	stabilization	of	an	inactive	(apo-)	form.	Decreased	affinity	for	DNA%2C	normal	subunit	association.	D->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15096034,ECO:0000269|PubMed:19805344,ECO:0000269|PubMed:8380500;Dbxref=PMID:15096034,PMID:19805344,PMID:8380500
P0ACJ8	UniProtKB	Mutagenesis	157	157	.	.	.	Note=Decreased	transcription	activation	(6-29%25)%2C	binds	DNA.	A->D%2CP;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7966284,ECO:0000269|PubMed:8392187;Dbxref=PMID:7966284,PMID:8392187
P0ACJ8	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Decreased	transcription	activation	(15-87%25)	at	class	I	and	II	promoters%2C	binds	DNA.	T->A%2CI%2CN%2CS%2CV;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7966284,ECO:0000269|PubMed:8392187,ECO:0000269|PubMed:8978616;Dbxref=PMID:7966284,PMID:8392187,PMID:8978616
P0ACJ8	UniProtKB	Mutagenesis	160	160	.	.	.	Note=Disrupts	AR1.	Decreased	transcription	activation	(3-45%25)	at	class	I	and	II	promoters%2C	binds	DNA.	H->A%2CK%2CL%2CN%2CP%2CQ%2CR%2CY;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15520470,ECO:0000269|PubMed:7966284,ECO:0000269|PubMed:8392187,ECO:0000269|PubMed:8978616;Dbxref=PMID:15520470,PMID:7966284,PMID:8392187,PMID:8978616
P0ACJ8	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Decreased	transcription	activation	(2-62%25)	at	class	I	and	II	promoters%2C	binds	DNA.	G->A%2CC%2CD%2CR%2CS%2CV;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7966284,ECO:0000269|PubMed:8392187,ECO:0000269|PubMed:8978616;Dbxref=PMID:7966284,PMID:8392187,PMID:8978616
P0ACJ8	UniProtKB	Mutagenesis	181	181	.	.	.	Note=Suppresses	DNA-binding.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3333845;Dbxref=PMID:3333845
P0ACJ8	UniProtKB	Mutagenesis	181	181	.	.	.	Note=Suppresses	DNA-binding.	R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3333845;Dbxref=PMID:3333845
P0ACJ8	UniProtKB	Mutagenesis	186	186	.	.	.	Note=No	modification	of	DNA-binding.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3333845;Dbxref=PMID:3333845
P0ACJ8	UniProtKB	Mutagenesis	186	186	.	.	.	Note=Marginally	reduced	DNA-binding.	R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3333845;Dbxref=PMID:3333845
P0AES0	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Loss	of	amidase	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9398217;Dbxref=PMID:9398217
P0AES0	UniProtKB	Mutagenesis	173	173	.	.	.	Note=No	effect	on	amidase	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9398217;Dbxref=PMID:9398217
P0AES0	UniProtKB	Mutagenesis	316	316	.	.	.	Note=Loss	of	synthetase	activity.	R->E
P0AES0	UniProtKB	Mutagenesis	335	335	.	.	.	Note=3.6-fold	decrease	in	GSH	affinity%2C	1.6-fold	decrease	in	spermidine	activity%2C	and	1.3-fold	decrease	in	synthetase	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17124497;Dbxref=PMID:17124497
P0AES0	UniProtKB	Mutagenesis	337	337	.	.	.	Note=No	effect	on	GSH	and	spermidine	affinity%2C	but	2-fold	decrease	in	synthetase	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17124497;Dbxref=PMID:17124497
P0AES0	UniProtKB	Mutagenesis	338	338	.	.	.	Note=10-fold	decrease	in	GSH	affinity%2C	5-fold	decrease	in	spermidine	activity%2C	but	no	effect	on	synthetase	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17124497;Dbxref=PMID:17124497
P0AES0	UniProtKB	Mutagenesis	391	391	.	.	.	Note=2-fold	decrease	in	GSH	affinity%2C	60-fold	decrease	in	spermidine	activity%2C	and	10-fold	decrease	in	synthetase	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17124497;Dbxref=PMID:17124497
P0AES0	UniProtKB	Mutagenesis	392	392	.	.	.	Note=33-fold	decrease	in	GSH	affinity%2C	13-fold	decrease	in	spermidine	activity%2C	and	6-fold	decrease	in	synthetase	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17124497;Dbxref=PMID:17124497
P0AES0	UniProtKB	Mutagenesis	441	441	.	.	.	Note=3-fold	decrease	in	GSH	affinity%2C	21-fold	decrease	in	spermidine	activity%2C	and	17-fold	decrease	in	synthetase	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17124497;Dbxref=PMID:17124497
P0AES0	UniProtKB	Mutagenesis	538	538	.	.	.	Note=6-fold	decrease	in	GSH	affinity%2C	2.4-fold	decrease	in	spermidine	activity%2C	and	4-fold	decrease	in	synthetase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17124497;Dbxref=PMID:17124497
P0AES0	UniProtKB	Mutagenesis	598	598	.	.	.	Note=10-fold	increase	in	GSH	affinity%2C	9-fold	decrease	in	spermidine	activity%2C	and	15-fold	decrease	in	synthetase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17124497;Dbxref=PMID:17124497
P0A817	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Loss	of	activity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10660564;Dbxref=PMID:10660564
P0A817	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Loss	of	activity.	D->N%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10551856;Dbxref=PMID:10551856
P0A817	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Misfolding	and	subject	to	proteolytic	degradation.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7629147;Dbxref=PMID:7629147
P0A817	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Nearly	abolishes	enzyme	activity.	Abolishes	stimulation	of	enzyme	activity	by	potassium.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7629147;Dbxref=PMID:7629147
P0A817	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Decrease	in	the	homotetramer	formation	capability.	Enhanced	thermal	stability.	C->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7629176;Dbxref=PMID:7629176
P0A817	UniProtKB	Mutagenesis	119	119	.	.	.	Note=Decrease	of	both	AdoMet	synthesis	and	AdoMet-activated	tripolyphosphate	hydrolysis.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10551856;Dbxref=PMID:10551856
P0A817	UniProtKB	Mutagenesis	166	166	.	.	.	Note=Decrease	in	AdoMet	synthesis.	K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10660564;Dbxref=PMID:10660564
P0A817	UniProtKB	Mutagenesis	239	239	.	.	.	Note=Decrease	in	AdoMet	synthesis.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10551856;Dbxref=PMID:10551856
P0A817	UniProtKB	Mutagenesis	240	240	.	.	.	Note=Decrease	in	AdoMet	synthesis.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7629176;Dbxref=PMID:7629176
P0A817	UniProtKB	Mutagenesis	245	245	.	.	.	Note=Loss	of	activity.	R->H%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9753435;Dbxref=PMID:9753435
P0A817	UniProtKB	Mutagenesis	246	246	.	.	.	Note=Loss	of	activity.	Modification	in	protein	conformation.	K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10660564;Dbxref=PMID:10660564
P0A817	UniProtKB	Mutagenesis	266	266	.	.	.	Note=Loss	of	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10660564;Dbxref=PMID:10660564
P0A817	UniProtKB	Mutagenesis	266	266	.	.	.	Note=Unstable%3B	trace	activity.	K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10660564;Dbxref=PMID:10660564
P0A817	UniProtKB	Mutagenesis	270	270	.	.	.	Note=Decrease	in	activity.	K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10660564;Dbxref=PMID:10660564
P0A817	UniProtKB	Mutagenesis	272	272	.	.	.	Note=Loss	of	activity.	D->N%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10551856;Dbxref=PMID:10551856
P0AES4	UniProtKB	Mutagenesis	32	32	.	.	.	Note=Nearly	abolishes	DNA	supercoiling.	Reduces	quinolone-induced	DNA	cleavage	and	relaxation.	R->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12051842;Dbxref=PMID:12051842
P0AES4	UniProtKB	Mutagenesis	47	47	.	.	.	Note=Nearly	abolishes	DNA	supercoiling.	Reduces	quinolone-induced	DNA	cleavage.	Slightly	reduces	DNA	relaxation.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12051842;Dbxref=PMID:12051842
P0AES4	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Nearly	abolishes	DNA	supercoiling.	Reduces	quinolone-induced	DNA	cleavage	and	DNA	relaxation.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12051842;Dbxref=PMID:12051842
P0AES4	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Reduces	DNA	supercoiling.	Slightlreduces	quinolone-induced	DNA	cleavage.	No	effect	on	DNA	relaxation.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12051842;Dbxref=PMID:12051842
P0AES4	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Resistant	to	fluoroquinolones.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1850970;Dbxref=PMID:1850970
P0AES4	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Resistant	to	fluoroquinolones.	Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1850970;Dbxref=PMID:1850970
P0AES4	UniProtKB	Mutagenesis	462	462	.	.	.	Note=In	gyrA462%3B	resistant	to	cytotoxic	protein	CcdB%2C	but	not	to	the	quinoline	antibiotic	enoxacin%2C	has	no	effect	on	DNA	supercoiling.	Does	not	interact	with	CcdB.	R->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1324324,ECO:0000269|PubMed:8254658;Dbxref=PMID:1324324,PMID:8254658
P0AES4	UniProtKB	Mutagenesis	560	566	.	.	.	Note=Loss	of	gyrase-mediated	DNA	wrapping%2C	nearly	complete	loss	of	DNA	supercoiling	activity%2C	no	change	in	DNA	supercoil	relaxation	or	DNA	decatenation	activity.	QRRGGKG->AAAAAAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16332690;Dbxref=PMID:16332690
P0AES4	UniProtKB	Mutagenesis	560	566	.	.	.	Note=Loss	of	gyrase-mediated	DNA	wrapping%2C	nearly	complete	loss	of	DNA	supercoiling	activity%2C	no	change	in	DNA	supercoil	relaxation	or	DNA	decatenation	activity.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16332690;Dbxref=PMID:16332690
P0AES4	UniProtKB	Mutagenesis	842	856	.	.	.	Note=Gains	ability	to	wrap	DNA	around	itself	in	the	absence	of	GyrB%3B	holoenzyme	gains	ability	to	wrap	DNA	in	the	absence	of	ATP	analogs%2C	but	reduces	ATP-dependent	supercoiling	activity	50-fold%2C	DNA	is	not	as	extensively	negatively	supercoiled%2C	has	10-fold	less	ATP-independent	negative	supercoiled	DNA	relaxation	activity%2C	no	change	in	ATPase	activity	of	holoenzyme%2C	no	change	in	decatenation	ability.	Isolated	CTD	gains	ability	to	wrap	DNA	around	itself	in	the	absence	of	GyrB%2C	binds	DNA	better	than	wild-type	CTD.	Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22457352,ECO:0000269|PubMed:22457353;Dbxref=PMID:22457352,PMID:22457353
P0AES4	UniProtKB	Mutagenesis	854	875	.	.	.	Note=Isolated	CTD	gains	ability	to	wrap	DNA	around	itself	in	the	absence	of	GyrB%2C	binds	DNA	better	than	wild-type	CTD.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22457353;Dbxref=PMID:22457353
P0A6F5	UniProtKB	Mutagenesis	2	2	.	.	.	Note=Complex	stability	is	significantly	decreased%3B	when	associated	with	S-76%2C	same	residues	as	in	M.tuberculosis.	A->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15327959;Dbxref=PMID:15327959
P0A6F5	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Complex	stability	is	significantly	decreased%3B	when	associated	with	S-2%2C	same	residues	as	in	M.tuberculosis.	E->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15327959;Dbxref=PMID:15327959
P0ABQ0	UniProtKB	Mutagenesis	11	11	.	.	.	Note=In	Dfp-707%3B	temperature-sensitive%2impairs	folding.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11358972;Dbxref=PMID:11358972
P0ABQ0	UniProtKB	Mutagenesis	14	14	.	.	.	Note=No	FMN	binding.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11358972;Dbxref=PMID:11358972
P0ABQ0	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Less	than	5%25	of	wild-type	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11358972;Dbxref=PMID:11358972
P0ABQ0	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Severely	reduced	activity.	I->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11358972;Dbxref=PMID:11358972
P0ABQ0	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Slightly	reduced	activity.	I->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11358972;Dbxref=PMID:11358972
P0ABQ0	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Less	than	5%25	of	wild-type	activity.	A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11358972;Dbxref=PMID:11358972
P0ABQ0	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Almost	wild-type	activity.	A->G%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11358972;Dbxref=PMID:11358972
P0ABQ0	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Almost	wild-type	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11358972;Dbxref=PMID:11358972
P0ABQ0	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Reduced	activity.	Y->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11358972;Dbxref=PMID:11358972
P0ABQ0	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Reduced	activity.	K->N%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11358972;Dbxref=PMID:11358972
P0ABQ0	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Almost	wild-type	activity.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11358972;Dbxref=PMID:11358972
P0ABQ0	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Reduced	activity.	F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10922366;Dbxref=PMID:10922366
P0ABQ0	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Loss	of	activity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10922366;Dbxref=PMID:10922366
P0ABQ0	UniProtKB	Mutagenesis	89	89	.	.	.	Note=Binds	FMN%2C	but	more	looselythan	wild-type.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10922366;Dbxref=PMID:10922366
P0ABQ0	UniProtKB	Mutagenesis	89	89	.	.	.	Note=No	FMN	binding.	P->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10922366;Dbxref=PMID:10922366
P0ABQ0	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Binds	FMN.	T->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10922366;Dbxref=PMID:10922366
P0ABQ0	UniProtKB	Mutagenesis	124	124	.	.	.	Note=No	effect.	M->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10922366;Dbxref=PMID:10922366
P0ABQ0	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Loss	of	activity.	N->D%2CQ;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10922366,ECO:0000269|PubMed:11358972;Dbxref=PMID:10922366,PMID:11358972
P0ABQ0	UniProtKB	Mutagenesis	128	128	.	.	.	Note=Severely	reduced	activity.	M->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10922366;Dbxref=PMID:10922366
P0ABQ0	UniProtKB	Mutagenesis	158	158	.	.	.	Note=Loss	of	activity.	C->A%2CS
P0ABQ0	UniProtKB	Mutagenesis	194	194	.	.	.	Note=Loss	of	dimerization.	T->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12140293;Dbxref=PMID:12140293
P0ABQ0	UniProtKB	Mutagenesis	198	198	.	.	.	Note=Loss	of	dimerization.	T->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12140293;Dbxref=PMID:12140293
P0ABQ0	UniProtKB	Mutagenesis	203	203	.	.	.	Note=Loss	of	dimerization.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12140293;Dbxref=PMID:12140293
P0ABQ0	UniProtKB	Mutagenesis	210	210	.	.	.	Note=Loss	of	activity%2C	reactiointermediate	detectable.	N->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12140293,ECO:0000269|PubMed:14686929;Dbxref=PMID:12140293,PMID:14686929
P0ABQ0	UniProtKB	Mutagenesis	210	210	.	.	.	Note=Loss	of	activity%2C	reactiointermediate	not	detectable.	N->H%2CK;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12140293,ECO:0000269|PubMed:14686929;Dbxref=PMID:12140293,PMID:14686929
P0ABQ0	UniProtKB	Mutagenesis	212	212	.	.	.	Note=Small	effect	on	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12140293;Dbxref=PMID:12140293
P0ABQ0	UniProtKB	Mutagenesis	215	215	.	.	.	Note=No	effect.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12140293;Dbxref=PMID:12140293
P0ABQ0	UniProtKB	Mutagenesis	275	275	.	.	.	Note=Loss	of	dimerization.	A->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12140293,ECO:0000269|PubMed:14686929;Dbxref=PMID:12140293,PMID:14686929
P0ABQ0	UniProtKB	Mutagenesis	289	289	.	.	.	Note=Loss	of	activity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12140293;Dbxref=PMID:12140293
P0ABQ0	UniProtKB	Mutagenesis	291	291	.	.	.	Note=Reduced	activity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12140293;Dbxref=PMID:12140293
P0ABQ0	UniProtKB	Mutagenesis	292	292	.	.	.	Note=Small	effect	on	activity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12140293;Dbxref=PMID:12140293
P0AC78	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Decrease	in	activity%3B	both	in	vivo	and	in	vitro.	D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11832520;Dbxref=PMID:11832520
P0AC78	UniProtKB	Mutagenesis	90	91	.	.	.	Note=Loss	of	activity	in	vivo.	Decrease	in	activity	in	vitro.	No	change	in	binding	to	tunicamycin.	DD->EE%2CGG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11832520;Dbxref=PMID:11832520
P0AC78	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Reduces	slightly	the	velocitand	shows	a	small	increase	of	the	affinity	for	the	transferase.	D->E%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17237164;Dbxref=PMID:17237164
P0AC78	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Reduces	slightly	the	velocitand	shows	a	small	increase	of	the	affinity	for	the	transferase.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17237164;Dbxref=PMID:17237164
P0AC78	UniProtKB	Mutagenesis	94	94	.	.	.	Note=No	loss	in	activity%3B	both	in	vivo	and	in	vitro.	D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11832520;Dbxref=PMID:11832520
P0AC78	UniProtKB	Mutagenesis	156	156	.	.	.	Note=Loss	of	activity.	D->E%2CN;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11832520,ECO:0000269|PubMed:17237164;Dbxref=PMID:11832520,PMID:17237164
P0AC78	UniProtKB	Mutagenesis	156	156	.	.	.	Note=Loss	of	activity%3B	both	in	vivo	and	in	vitro%3B	when	associated	with	E-159.	D->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11832520,ECO:0000269|PubMed:17237164;Dbxref=PMID:11832520,PMID:17237164
P0AC78	UniProtKB	Mutagenesis	156	156	.	.	.	Note=Loss	of	activity%3B	both	in	vivo	and	in	vitro.	No	binding	to	tunicamycin%3B	when	associated	with	G-159.	D->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11832520,ECO:0000269|PubMed:17237164;Dbxref=PMID:11832520,PMID:17237164
P0AC78	UniProtKB	Mutagenesis	159	159	.	.	.	Note=The	activity	is	detectable	but	drastically	reduced.	D->E%2CN;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11832520,ECO:0000269|PubMed:17237164;Dbxref=PMID:11832520,PMID:17237164
P0AC78	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Loss	of	activity%3B	both	in	vivo	and	in	vitro%3B	when	associated	with	E-156.	D->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11832520,ECO:0000269|PubMed:17237164;Dbxref=PMID:11832520,PMID:17237164
P0AC78	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Loss	of	activity%3B	both	in	vivo	and	in	vitro.	No	binding	to	tunicamycin%3B	when	associated	with	G-156.	D->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11832520,ECO:0000269|PubMed:17237164;Dbxref=PMID:11832520,PMID:17237164
P0AC78	UniProtKB	Mutagenesis	265	265	.	.	.	Note=Decrease	in	activity.	Reducesbinding	to	tunicamycin.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11700352;Dbxref=PMID:11700352
P0AC78	UniProtKB	Mutagenesis	276	276	.	.	.	Note=No	loss	of	activity%3B	both	in	vivo	and	in	vitro.	D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11832520;Dbxref=PMID:11832520
P0AC78	UniProtKB	Mutagenesis	279	282	.	.	.	Note=Loss	of	activity.	No	binding	to	tunicamycin.	HIHH->GGGG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11700352;Dbxref=PMID:11700352
P0AC78	UniProtKB	Mutagenesis	279	279	.	.	.	Note=Loss	of	activity.	No	binding	to	tunicamycin.	H->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11700352;Dbxref=PMID:11700352
P0AAI3	UniProtKB	Mutagenesis	201	201	.	.	.	Note=No	in	vivo	protease	activity%2C	no	in	vitro	ATPase	activity.	L->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10473576;Dbxref=PMID:10473576
P0AAI3	UniProtKB	Mutagenesis	225	225	.	.	.	Note=Does	not	complement	ftsH1	at	42	degrees	Celsius%2C	no	protease	activity	in	vivo.	F->A%2CD%2CE%2CG%2CN%2CQ%2CR%2CS%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14514680;Dbxref=PMID:14514680
P0AAI3	UniProtKB	Mutagenesis	225	225	.	.	.	Note=Partially	complements	ftsH1	at	42	degrees	Celsius%2C	some	protease	activity	in	vivo.	F->C%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14514680;Dbxref=PMID:14514680
P0AAI3	UniProtKB	Mutagenesis	225	225	.	.	.	Note=Complements	ftsH1	at	42	degrees	Celsius%2C	restores	protease	activity	in	vivo.	F->I%2CL%2CM%2CV%2CW%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14514680;Dbxref=PMID:14514680
P0AAI3	UniProtKB	Mutagenesis	227	227	.	.	.	Note=Does	not	complement	ftsH1	at	42	degrees	Celsius%2C	no	protease	activity	in	vivo.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14514680;Dbxref=PMID:14514680
P0AAI3	UniProtKB	Mutagenesis	297	297	.	.	.	Note=Low	protease	activity	in	vivo%2C	low	ATPase	activity	in	vitro%2C	complements	ftsH1	at	42	degrees	CelsiusT->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10473576;Dbxref=PMID:10473576
P0AAI3	UniProtKB	Mutagenesis	298	298	.	.	.	Note=No	in	vivo	protease	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10473576;Dbxref=PMID:10473576
P0AAI3	UniProtKB	Mutagenesis	304	304	.	.	.	Note=No	in	vivo	protease	activity%2C	no	in	vitro	ATPase	activity%3B	probably	still	binds	ATP.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10473576;Dbxref=PMID:10473576
P0AAI3	UniProtKB	Mutagenesis	304	304	.	.	.	Note=Low	protease	activity	in	vivo%2C	low	ATPase	activity	in	vitro%2C	complements	ftsH1	at	42	degrees	CelsiusD->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10473576;Dbxref=PMID:10473576
P0AAI3	UniProtKB	Mutagenesis	307	307	.	.	.	Note=Low	protease	activity	in	vivo.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10473576;Dbxref=PMID:10473576
P0AAI3	UniProtKB	Mutagenesis	309	309	.	.	.	Note=No	in	vivo	protease	activity%2C	no	ATPase	activity	in	vitro%3B	probably	still	binds	ATP.	R->A%2CL%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10473576;Dbxref=PMID:10473576
P0AAI3	UniProtKB	Mutagenesis	312	312	.	.	.	Note=No	in	vivo	protease	activity%2C	no	ATPase	activity	in	vitro%3B	probably	still	binds	ATP.	R->A%2CL%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10473576;Dbxref=PMID:10473576
P0AAI3	UniProtKB	Mutagenesis	414	418	.	.	.	Note=Loss	of	protease	function.	HEAGH->KEAGK
P0AAI3	UniProtKB	Mutagenesis	414	414	.	.	.	Note=Loss	of	protease	function.	H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11827531;Dbxref=PMID:11827531
P0AAI3	UniProtKB	Mutagenesis	415	415	.	.	.	Note=Loss	of	protease	activitin	vivo.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10473576;Dbxref=PMID:10473576
P0AAI3	UniProtKB	Mutagenesis	418	418	.	.	.	Note=In	tolZ21%3B	loss	of	proteasfunction	in	vivo%2C	retains	about	25%25	ATPase	activity%2C	temperature	sensitive.	H->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10473576,ECO:0000269|PubMed:11827531;Dbxref=PMID:10473576,PMID:11827531
P0AAI3	UniProtKB	Mutagenesis	463	463	.	.	.	Note=In	ftsH1%3B	a	temperature-sensitive	mutant	which	increases	the	frequency	of	lysogenization	of	phage	lambda%3B	when	associated	with	A-587.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8444796;Dbxref=PMID:8444796
P0AAI3	UniProtKB	Mutagenesis	476	476	.	.	.	Note=Severe	loss	of	protease	function	that	is	restored	by	excess	Zn.	E->D%2CK%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11827531;Dbxref=PMID:11827531
P0AAI3	UniProtKB	Mutagenesis	476	476	.	.	.	Note=Little	effect	on	protease	function.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11827531;Dbxref=PMID:11827531
P0AAI3	UniProtKB	Mutagenesis	536	536	.	.	.	Note=In	hflB29%3B	increases	the	frequency	of	lysogenization	of	phage	lambda.	H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8444796;Dbxref=PMID:8444796
P0AAI3	UniProtKB	Mutagenesis	582	582	.	.	.	Note=No	effect	on	protease	function.	E->D%2CK%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11827531;Dbxref=PMID:11827531
P0AAI3	UniProtKB	Mutagenesis	582	582	.	.	.	Note=Decreased	protease	function.	E->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11827531;Dbxref=PMID:11827531
P25522	UniProtKB	Mutagenesis	224	224	.	.	.	Note=1.5-fold	decrease	in	GTPase	activity	and	almost	no	change	in	affinity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983041;Dbxref=PMID:15983041
P25522	UniProtKB	Mutagenesis	226	226	.	.	.	Note=100-fold	decrease	in	GTPase	activity.	5-fold	decrease	of	affinity	for	GTP.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16763562;Dbxref=PMID:16763562
P25522	UniProtKB	Mutagenesis	226	226	.	.	.	Note=70-fold	decrease	in	GTPase	activity.	2-fold	decrease	of	affinity	for	GTP.	N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16763562;Dbxref=PMID:16763562
P25522	UniProtKB	Mutagenesis	228	228	.	.	.	Note=Loss	of	GTP	binding	and	hydrolase	activity.	Completely	impairs	tRNA	modifying	function.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12730230;Dbxref=PMID:12730230
P25522	UniProtKB	Mutagenesis	249	249	.	.	.	Note=22-fold	decrease	in	GTPase	activity	and	7-fold	increase	of	affinity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983041;Dbxref=PMID:15983041
P25522	UniProtKB	Mutagenesis	250	250	.	.	.	Note=4-fold	decrease	in	GTPase	activity	and	1.5-fold	increase	of	affinity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983041;Dbxref=PMID:15983041
P25522	UniProtKB	Mutagenesis	250	250	.	.	.	Note=1.8-fold	decrease	in	GTPase	activity	and	1.5-fold	increase	of	affinity.	T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983041;Dbxref=PMID:15983041
P25522	UniProtKB	Mutagenesis	251	251	.	.	.	Note=92-fold	decrease	in	GTPase	activity	and	59-fold	increase	of	affinity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983041;Dbxref=PMID:15983041
P25522	UniProtKB	Mutagenesis	251	251	.	.	.	Note=4-fold	decrease	in	GTPase	activity	and	1.2-fold	decrease	of	affinity.	T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983041;Dbxref=PMID:15983041
P25522	UniProtKB	Mutagenesis	252	252	.	.	.	Note=7-fold	decrease	in	GTPase	activity	and	6-fold	increase	of	affinity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983041;Dbxref=PMID:15983041
P25522	UniProtKB	Mutagenesis	252	252	.	.	.	Note=2-fold	decrease	in	GTPase	activity	and	no	change	in	affinity.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983041;Dbxref=PMID:15983041
P25522	UniProtKB	Mutagenesis	253	253	.	.	.	Note=9-fold	decrease	in	GTPase	activity	and	13-fold	increase	of	affinity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983041;Dbxref=PMID:15983041
P25522	UniProtKB	Mutagenesis	255	255	.	.	.	Note=1.5-fold	decrease	in	affinitfor	GTP.	L->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16763562;Dbxref=PMID:16763562
P25522	UniProtKB	Mutagenesis	256	256	.	.	.	Note=2-fold	decrease	in	GTPase	activity	and	almost	no	change	in	affinity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983041;Dbxref=PMID:15983041
P25522	UniProtKB	Mutagenesis	270	270	.	.	.	Note=Does	not	affect	GTP	binding%2C	but	impairs	hydrolase	activity.	Completely	impairs	tRNA	modifying	function.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12730230;Dbxref=PMID:12730230
P25522	UniProtKB	Mutagenesis	275	275	.	.	.	Note=6-fold	decrease	in	GTPase	activity	and	1.9-fold	increase	of	affinity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983041;Dbxref=PMID:15983041
P25522	UniProtKB	Mutagenesis	282	282	.	.	.	Note=1900-fold	decrease	in	GTPase	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16763562;Dbxref=PMID:16763562
P25522	UniProtKB	Mutagenesis	282	282	.	.	.	Note=370-fold	decrease	in	GTPase	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16763562;Dbxref=PMID:16763562
P25522	UniProtKB	Mutagenesis	288	288	.	.	.	Note=1.7-fold	decrease	in	GTPase	activity	and	1.5-fold	increase	of	affinity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983041;Dbxref=PMID:15983041
P25522	UniProtKB	Mutagenesis	338	338	.	.	.	Note=Strong	decrease	in	GTP	binding.	Does	not	affect	hydrolase	activity%2C	but	has	10-fold	higher	affinity	for	XTP	than	for	GTP.	Partially	impairs	tRNA	modifying	function.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12730230;Dbxref=PMID:12730230
P25522	UniProtKB	Mutagenesis	451	451	.	.	.	Note=No	change	in	GTP	binding	and	hydrolase	activity.	Does	not	affect	association	to	the	cell	inner	membrane.	Completely	impairs	tRNA	modifying	function.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12730230;Dbxref=PMID:12730230
P23837	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Shows	Mg(2+)-dependent	signaling	and	partial	gene	activation	activity%3B	when	associated	with	A-202.	V->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20404199;Dbxref=PMID:20404199
P23837	UniProtKB	Mutagenesis	30	30	.	.	.	Note=Shows	Mg(2+)-dependent	signaling	and	displays	higher	gene	activation	activity	than	wild-type%3B	when	associated	with	A-202.	L->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20404199;Dbxref=PMID:20404199
P23837	UniProtKB	Mutagenesis	47	47	.	.	.	Note=No	significant	effect	(with	or	without	MgCl(2)	or	CaCl(2)).	T->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16041131;Dbxref=PMID:16041131
P23837	UniProtKB	Mutagenesis	48	48	.	.	.	Note=No	significant	effect	(with	or	without	MgCl(2)	or	CaCl(2)).	T->A%2CC%2CE%2CM%2CN%2CQ%2CS%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12218035;Dbxref=PMID:12218035
P23837	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Confers	less	than	30%25	of	the	wild-type	levels	of	PhoP/PhoQ-signaling	cascade	in	absence	of	CaCl(2)	or	MgCl(2).	T->D%2CG%2CH%2CI%2CK%2CL%2CP%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12218035;Dbxref=PMID:12218035
P23837	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Decreased	sensitivity	to	repression	by	calcium	but	not	by	magnesium.	T->F%2CW;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12218035;Dbxref=PMID:12218035
P23837	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Higher	activity	than	wild-type	(with	or	without	MgCl(2)	or	CaCl(2)).	T->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12218035;Dbxref=PMID:12218035
P23837	UniProtKB	Mutagenesis	50	50	.	.	.	Note=Large	decrease	in	the	transcriptional	activation	of	PhoQ-dependent	genes.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18348979;Dbxref=PMID:18348979
P23837	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Very	large	decrease	in	the	transcriptional	activation	of	PhoQ-dependent	genes.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18348979;Dbxref=PMID:18348979
P23837	UniProtKB	Mutagenesis	68	68	.	.	.	Note=No	significant	effect	(with	or	without	MgCl(2)	or	CaCl(2)).	N->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16041131;Dbxref=PMID:16041131
P23837	UniProtKB	Mutagenesis	90	90	.	.	.	Note=No	significant	effect	(with	or	without	MgCl(2)	or	CaCl(2)).	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16041131;Dbxref=PMID:16041131
P23837	UniProtKB	Mutagenesis	148	154	.	.	.	Note=Unable	to	bind	divalent	cations	in	vitro	and	impaired	in	the	ability	to	respond	to	Mg(2+)	deprivation	in	vivo.	EDDDDAE->QNNNNAQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8900137;Dbxref=PMID:8900137
P23837	UniProtKB	Mutagenesis	149	149	.	.	.	Note=Wild-type	effect	concerning	mgrB	transcription.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16041131;Dbxref=PMID:16041131
P23837	UniProtKB	Mutagenesis	150	150	.	.	.	Note=Wild-type	effect	concerning	mgrB	transcription.	D->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16041131;Dbxref=PMID:16041131
P23837	UniProtKB	Mutagenesis	151	151	.	.	.	Note=Wild-type	effect	concerning	mgrB	transcription.	D->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16041131;Dbxref=PMID:16041131
P23837	UniProtKB	Mutagenesis	152	152	.	.	.	Note=Wild-type	effect	concerning	mgrB	transcription.	D->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16041131;Dbxref=PMID:16041131
P23837	UniProtKB	Mutagenesis	179	179	.	.	.	Note=Locked-on	mutant	defective	in	Mg(2+)-sensing	and	unable	to	control	its	phosphorylation	state	and	phosphotransfer	to	phoP.	D->L%2CA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16041131,ECO:0000269|PubMed:18348979;Dbxref=PMID:16041131,PMID:18348979
P23837	UniProtKB	Mutagenesis	179	179	.	.	.	Note=Very	large	decrease	in	the	transcriptional	activation	of	PhoQ-dependent	genes.	D->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16041131,ECO:0000269|PubMed:18348979;Dbxref=PMID:16041131,PMID:18348979
P23837	UniProtKB	Mutagenesis	199	199	.	.	.	Note=Shows	Mg(2+)-dependent	signaling	and	partial	gene	activation	activity%3B	when	associated	with	A-202.	L->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20404199;Dbxref=PMID:20404199
P23837	UniProtKB	Mutagenesis	202	202	.	.	.	Note=Is	blind	to	signal%2C	fails	to	activate	transcription	of	PhoQ-dependent	genes%2C	and	abrogates	transcription	when	coexpressed	with	wild-type	PhoQ.	Shows	no	detectable	autophosphorylation.	Still	displays	phosphatase	activity.	Recovers	Mg(2+)-dependent	signaling	and	partial	gene	activation	activity%3B	when	associated	with	N-27	or	N-199	or	N-203	or	N-205.	Recovers	Mg(2+)-dependent	signaling	and	displays	higher	gene	activation	activity	than	wild-type%3B	when	associated	with	N-30.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20404199;Dbxref=PMID:20404199
P23837	UniProtKB	Mutagenesis	202	202	.	.	.	Note=Is	blind	to	signal%2C	fails	to	activate	transcription	of	PhoQ-dependent	genes%2C	and	abrogates	transcription	when	coexpressed	with	wild-type	PhoQ.	N->I%2CL%2CM%2CF%2CW%2CY%2CV%2CC%2CG%2CP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20404199;Dbxref=PMID:20404199
P23837	UniProtKB	Mutagenesis	202	202	.	.	.	Note=Shows	similar	activity	profileto	wild-type.	N->R%2CD%2CQ%2CE%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20404199;Dbxref=PMID:20404199
P23837	UniProtKB	Mutagenesis	203	203	.	.	.	Note=Shows	Mg(2+)-dependent	signaling	and	partial	gene	activation	activity%3B	when	associated	with	A-202.	L->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20404199;Dbxref=PMID:20404199
P23837	UniProtKB	Mutagenesis	205	205	.	.	.	Note=Shows	Mg(2+)-dependent	signaling	and	partial	gene	activation	activity%3B	when	associated	with	A-202.	L->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20404199;Dbxref=PMID:20404199
P23837	UniProtKB	Mutagenesis	392	392	.	.	.	Note=44-fold	decrease	in	ATP	affinity	and	6-fold	decrease	in	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11493605;Dbxref=PMID:11493605
P23837	UniProtKB	Mutagenesis	434	434	.	.	.	Note=2-fold	decrease	in	ATP	affinity	and	51-fold	decrease	in	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11493605;Dbxref=PMID:11493605
P23837	UniProtKB	Mutagenesis	439	439	.	.	.	Note=3-fold	decrease	in	ATP	affinity	and	2-fold	increase	in	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11493605;Dbxref=PMID:11493605
Q46896	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Slightly	decreased	spacer	acquisition	in	vivo.	Y->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26478180,ECO:0000269|PubMed:26503043;Dbxref=PMID:26478180,PMID:26503043
Q46896	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Nearly	wild-type	spacer	acquisition	in	vivo.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26503043;Dbxref=PMID:26503043
Q46896	UniProtKB	Mutagenesis	41	41	.	.	.	Note=Dramatically	decreased	spacer	acquisition	in	vivo.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26503043;Dbxref=PMID:26503043
Q46896	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Loss	of	spacer	acquisition	in	vivo%2C	decreased	protospacer	binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26478180;Dbxref=PMID:26478180
Q46896	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Dramatically	decreased	spacer	acquisition	in	vitro%2C	250-fold	decreased	affinity	for	protospacer	DNA.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26503043;Dbxref=PMID:26503043
Q46896	UniProtKB	Mutagenesis	66	66	.	.	.	Note=Dramatically	decreased	spacer	acquisition	in	vitro%2C	250-fold	decreased	affinity	for	protospacer	DNA.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26503043;Dbxref=PMID:26503043
Q46896	UniProtKB	Mutagenesis	66	66	.	.	.	Note=Dramatically	decreased	spacer	acquisition	in	vivo.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26503043;Dbxref=PMID:26503043
Q46896	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Decreased	spacer	acquisition	in	vivo.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26478180;Dbxref=PMID:26478180
Q46896	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Dramatically	decreased	spacer	acquisition	in	vivo.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26503043;Dbxref=PMID:26503043
Q46896	UniProtKB	Mutagenesis	141	141	.	.	.	Note=No	cleavage	of	any	substrates%2C	no	restoration	of	UV	or	mitomycin	C	(MMC)	resistance	(PubMed:21219465).	Loss	of	spacer	acquisition	in	vivo	(PubMed:24793649).	E->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21219465,ECO:0000269|PubMed:24793649;Dbxref=PMID:21219465,PMID:24793649
Q46896	UniProtKB	Mutagenesis	149	149	.	.	.	Note=No	effect	on	in	vitro	protospacer	integration.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25707795;Dbxref=PMID:25707795
Q46896	UniProtKB	Mutagenesis	165	165	.	.	.	Note=No	effect	on	in	vitro	protospacer	integration	(PubMed:25707795).	Alone	significantly	decreased	protospacer	acquisition	in	vivo	(PubMed:26478180).	Loss	of	protospacer	acquisition%2C	decreased	protospacer	binding%3B	in	association	with	A-170%2C	significantly	decreased	protospacer	binding%3B	in	association	with	A-217	(PubMed:26478180).	Y->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:25707795,ECO:0000269|PubMed:26478180;Dbxref=PMID:25707795,PMID:26478180
Q46896	UniProtKB	Mutagenesis	170	170	.	.	.	Note=Alone	significantly	decreased	protospacer	acquisition	in	vivo	(PubMed:26478180).	Decreased	protospacer	binding%3B	in	association	with	A-170	(PubMed:26478180).	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26478180;Dbxref=PMID:26478180
Q46896	UniProtKB	Mutagenesis	184	184	.	.	.	Note=No	cleavage	of	any	substrates.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21219465;Dbxref=PMID:21219465
Q46896	UniProtKB	Mutagenesis	188	188	.	.	.	Note=Partial	inhibition	of	cleavag(PubMed:21219465).	No	effect	on	in	vitro	protospacer	integration	(PubMed:25707795).	Significantly	decreased	protospacer	acquisition	in	vivo	(PubMed:26478180).	Y->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21219465,ECO:0000269|PubMed:25707795,ECO:0000269|PubMed:26478180;Dbxref=PMID:21219465,PMID:25707795,PMID:26478180
Q46896	UniProtKB	Mutagenesis	208	208	.	.	.	Note=No	cleavage	of	any	substrates%2C	no	restoration	of	UV	or	MMC	resistance	(PubMed:21219465).	Loss	of	spacer	acquisition	in	vivo	(PubMed:24793649%2C	PubMed:25707795%2C	PubMed:26478180).	H->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21219465,ECO:0000269|PubMed:24793649,ECO:0000269|PubMed:25707795,ECO:0000269|PubMed:26478180;Dbxref=PMID:21219465,PMID:24793649,PMID:25707795,PMID:26478180
Q46896	UniProtKB	Mutagenesis	211	211	.	.	.	Note=No	cleavage	of	any	substrates.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21219465;Dbxref=PMID:21219465
Q46896	UniProtKB	Mutagenesis	217	217	.	.	.	Note=No	effect	on	in	vitro	protospacer	integration	(PubMed:25707795).	Alone	significantly	decreased	protospacer	acquisition	in	vivo	(PubMed:26478180).	Significantly	decreased	protospacer	binding%3B	in	association	with	A-165	(PubMed:26478180).	Y->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:25707795,ECO:0000269|PubMed:26478180;Dbxref=PMID:25707795,PMID:26478180
Q46896	UniProtKB	Mutagenesis	218	218	.	.	.	Note=No	cleavage	of	any	substrates%2C	no	restoration	of	UV	or	MMC	resistance	(PubMed:21219465).	Loss	of	spacer	acquisition	in	vivo	(PubMed:24793649).	D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21219465,ECO:0000269|PubMed:24793649;Dbxref=PMID:21219465,PMID:24793649
Q46896	UniProtKB	Mutagenesis	221	221	.	.	.	Note=No	cleavage	of	any	substrates	(PubMed:21219465).	Loss	of	spacer	acquisition	in	vivo	(PubMed:24793649%2C	PubMed:24920831%2C	PubMed:25707795).	No	cleavage	of	CRISPR	leader	in	preparation	for	spacer	integration	(PubMed:24920831).	D->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21219465,ECO:0000269|PubMed:24793649,ECO:0000269|PubMed:24920831,ECO:0000269|PubMed:25707795;Dbxref=PMID:21219465,PMID:24793649,PMID:24920831,PMID:25707795
Q46896	UniProtKB	Mutagenesis	224	224	.	.	.	Note=No	cleavage	of	any	substrates	(PubMed:21219465).	Loss	of	spacer	acquisition	in	vivo	(PubMed:24793649%2C	PubMed:25707795).	K->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21219465,ECO:0000269|PubMed:24793649,ECO:0000269|PubMed:25707795;Dbxref=PMID:21219465,PMID:24793649,PMID:25707795
Q46896	UniProtKB	Mutagenesis	245	248	.	.	.	Note=Loss	of	spacer	acquisition	in	vivo.	REVR->AEVA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26478180;Dbxref=PMID:26478180
Q46896	UniProtKB	Mutagenesis	245	245	.	.	.	Note=No	effect	on	spacer	acquisition.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
Q46896	UniProtKB	Mutagenesis	245	245	.	.	.	Note=Decreased	spacer	acquisition.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
Q46896	UniProtKB	Mutagenesis	245	245	.	.	.	Note=Dramatically	decreased	spacer	acquisition	in	vivo.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26503043;Dbxref=PMID:26503043
Q46896	UniProtKB	Mutagenesis	248	248	.	.	.	Note=Dramatically	decreased	spacer	acquisition	in	vivo.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26503043;Dbxref=PMID:26503043
Q46896	UniProtKB	Mutagenesis	252	252	.	.	.	Note=No	effect	on	spacer	acquisition.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
Q46896	UniProtKB	Mutagenesis	252	252	.	.	.	Note=Loss	of	spacer	acquisition%2C	no	Cas1-Cas2	complex	formation%2C	loss	of	CRISPR	DNA-binding	by	complex.	Protein	is	stable	and	dimerizes.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
Q46896	UniProtKB	Mutagenesis	256	259	.	.	.	Note=Loss	of	spacer	acquisition	in	vivo.	RSSK->ASSA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26478180;Dbxref=PMID:26478180
Q46896	UniProtKB	Mutagenesis	256	256	.	.	.	Note=No	effect	on	spacer	acquisition.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
Q46896	UniProtKB	Mutagenesis	256	256	.	.	.	Note=Loss	of	spacer	acquisition.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
Q46896	UniProtKB	Mutagenesis	282	305	.	.	.	Note=No	effect	on	spacer	acquisition%2C	Cas1-Cas2	complex	formation	or	CRISPR	DNA-binding	by	complex.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
Q46896	UniProtKB	Mutagenesis	291	291	.	.	.	Note=No	effect	on	spacer	acquisition.	I->G%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
P45563	UniProtKB	Mutagenesis	191	191	.	.	.	Note=No	detectable	activity	with	xanthosine	as	substrate%2C	but	largely	retains	its	activity	against	other	substrates%2C	namely	inosine	and	guanosine%2C	although	with	altered	affinities%2C	higher	and	lower	respectively%2C	and	clearly	reduced	maximal	velocities	for	both.	Y->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15808857;Dbxref=PMID:15808857
P45563	UniProtKB	Mutagenesis	239	239	.	.	.	Note=Catalyzes	the	phosphorolysis	of	adenosine	with	moderate	efficiency%2C	and	essentially	has	lost	all	activity	againstthe	6-oxo-purine	substrates	xanthosine%2C	inosine	and	guanosine.	N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15808857;Dbxref=PMID:15808857
P0CE47	UniProtKB	Mutagenesis	20	20	.	.	.	Note=No	change	in	binding	GDP	and	3-fold	reduction	in	binding	EF-Ts.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9468511;Dbxref=PMID:9468511
P0CE47	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Lowers	GTPase	activity	5	to	10-fold.	V->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2684669;Dbxref=PMID:2684669
P0CE47	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Loss	of	GTPase	activity	and	creation	of	an	autophosphorylation	site.	P->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2157708;Dbxref=PMID:2157708
P0CE47	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Weaker	binding	for	GDP	and	for	EF-Ts.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9468511;Dbxref=PMID:9468511
P0CE47	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Kirromycin	resistant.	Q->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2508560;Dbxref=PMID:2508560
P0CE47	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Reduces	affinity	for	GDP.	K->R%2CQ%2CE%2CI;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2498311;Dbxref=PMID:2498311
P0CE47	UniProtKB	Mutagenesis	139	139	.	.	.	Note=Reduces	affinity	for	GDP%3B	increases	affinity	for	XDP.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3308869;Dbxref=PMID:3308869
P0CE47	UniProtKB	Mutagenesis	223	223	.	.	.	Note=Inhibits	codon-induced	conformational	changes	leading	to	GTPase	activation	on	the	ribosome.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2508560;Dbxref=PMID:2508560
P0CE47	UniProtKB	Mutagenesis	231	231	.	.	.	Note=Pulvomycin	resistant.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2508560;Dbxref=PMID:2508560
P0CE47	UniProtKB	Mutagenesis	317	317	.	.	.	Note=Kirromycin	resistant.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2508560;Dbxref=PMID:2508560
P0CE47	UniProtKB	Mutagenesis	334	334	.	.	.	Note=Pulvomycin	resistant.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2508560;Dbxref=PMID:2508560
P0CE47	UniProtKB	Mutagenesis	335	335	.	.	.	Note=Pulvomycin	resistant.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2508560;Dbxref=PMID:2508560
P0CE47	UniProtKB	Mutagenesis	349	349	.	.	.	Note=No	change	in	binding	GDP	but	higher	binding	constant	for	EF-Ts.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9468511;Dbxref=PMID:9468511
P0CE47	UniProtKB	Mutagenesis	376	376	.	.	.	Note=Kirromycin	resistant.	A->T%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2508560;Dbxref=PMID:2508560
P0CE47	UniProtKB	Mutagenesis	383	383	.	.	.	Note=No	longer	phosphorylated	by	phage	protein	doc%2C	has	no	effect	on	translation.	T->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24141193;Dbxref=PMID:24141193
P0ADI4	UniProtKB	Mutagenesis	240	240	.	.	.	Note=The	catalytic	efficiency	slightly	increases%2C	but	a	8-fold	decrease	of	the	affinity	for	the	S-dihydroxybenzoyltransferase	EntE	is	observed.	D->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16632253;Dbxref=PMID:16632253
P0ADI4	UniProtKB	Mutagenesis	242	242	.	.	.	Note=Not	efficiently	phosphopantetheinylated	by	EntD.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16925399;Dbxref=PMID:16925399
P0ADI4	UniProtKB	Mutagenesis	244	244	.	.	.	Note=Efficiently	phosphopantetheinylatedby	EntD.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16925399;Dbxref=PMID:16925399
P0ADI4	UniProtKB	Mutagenesis	244	244	.	.	.	Note=Not	efficiently	phosphopantetheinylated	by	EntD.	D->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16925399;Dbxref=PMID:16925399
P0ADI4	UniProtKB	Mutagenesis	249	249	.	.	.	Note=Unable	to	recognize	EntE	and	EntF.	Exhibits	a	decrease	in	the	enterobactin	production	compared	to	the	wild-type.	Still	able	to	be	phosphopantetheinylated.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16567620;Dbxref=PMID:16567620
P0ADI4	UniProtKB	Mutagenesis	263	263	.	.	.	Note=The	catalytic	efficiency	is	the	same	as	the	wild-type%2C	but	a	3-fold	decrease	of	the	affinity	for	the	S-dihydroxybenzoyltransferase	EntE	is	observed.	D->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16632253;Dbxref=PMID:16632253
P0ADI4	UniProtKB	Mutagenesis	264	264	.	.	.	Note=The	affinity	for	EntE	and	catalytic	efficiency	of	the	S-dihydroxybenzoyltransferase	EntE	are	below	that	of	the	wild-type.	F->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16567620,ECO:0000269|PubMed:16632253;Dbxref=PMID:16567620,PMID:16632253
P0ADI4	UniProtKB	Mutagenesis	268	268	.	.	.	Note=Unable	to	recognize	EntE	and	EntF.	Exhibits	a	decrease	in	the	enterobactin	production	compared	to	the	wild-type.	Still	able	to	be	phosphopantetheinylated.	A->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16567620;Dbxref=PMID:16567620
P0ADI4	UniProtKB	Mutagenesis	269	269	.	.	.	Note=Behaves	similarly	to	the	wild-type.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16567620;Dbxref=PMID:16567620
P0A9E5	UniProtKB	Mutagenesis	16	16	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2226775;Dbxref=PMID:2226775
P0A9E5	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Loss	of	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2226775;Dbxref=PMID:2226775
P0A9E5	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Loss	of	regulation	by	O(2).	D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1898918;Dbxref=PMID:1898918
P0A9E5	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Loss	of	activity.	C->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2226775;Dbxref=PMID:2226775
P0A9E5	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Loss	of	regulation	by	O(2).	L->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1898918;Dbxref=PMID:1898918
P0A9E5	UniProtKB	Mutagenesis	29	29	.	.	.	Note=Loss	of	activity.	C->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2226775;Dbxref=PMID:2226775
P0A9E5	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9321653;Dbxref=PMID:9321653
P0A9E5	UniProtKB	Mutagenesis	64	64	.	.	.	Note=No	effect.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2226775;Dbxref=PMID:2226775
P0A9E5	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9321653;Dbxref=PMID:9321653
P0A9E5	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	S->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11115116,ECO:0000269|PubMed:9321653;Dbxref=PMID:11115116,PMID:9321653
P0A9E5	UniProtKB	Mutagenesis	81	81	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1762901;Dbxref=PMID:1762901
P0A9E5	UniProtKB	Mutagenesis	82	82	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1762901;Dbxref=PMID:1762901
P0A9E5	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	Trace	activity%3B	when	associated	with	P-187.	G->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11115116,ECO:0000269|PubMed:1762901;Dbxref=PMID:11115116,PMID:1762901
P0A9E5	UniProtKB	Mutagenesis	86	86	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1762901;Dbxref=PMID:1762901
P0A9E5	UniProtKB	Mutagenesis	87	87	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1762901;Dbxref=PMID:1762901
P0A9E5	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	Q->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1762901;Dbxref=PMID:1762901
P0A9E5	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Loss	of	regulation	by	O(2).	H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1898918;Dbxref=PMID:1898918
P0A9E5	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Loss	of	activity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2226775;Dbxref=PMID:2226775
P0A9E5	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	T->A%2CP;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11115116,ECO:0000269|PubMed:9321653;Dbxref=PMID:11115116,PMID:9321653
P0A9E5	UniProtKB	Mutagenesis	120	120	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	M->I%2CR%2CT%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9321653;Dbxref=PMID:9321653
P0A9E5	UniProtKB	Mutagenesis	122	122	.	.	.	Note=Loss	of	activity.	C->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2226775;Dbxref=PMID:2226775
P0A9E5	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Decrease	in	activity.	R->A
P0A9E5	UniProtKB	Mutagenesis	143	143	.	.	.	Note=Decrease	in	activity.	M->A
P0A9E5	UniProtKB	Mutagenesis	144	144	.	.	.	Note=Decrease	in	activity	due	to	faulty	dimerization.	M->A
P0A9E5	UniProtKB	Mutagenesis	145	145	.	.	.	Note=Decrease	in	activity.	R->A
P0A9E5	UniProtKB	Mutagenesis	146	146	.	.	.	Note=Decrease	in	activity.	L->A
P0A9E5	UniProtKB	Mutagenesis	147	147	.	.	.	Note=Decrease	in	activity	due	to	faulty	dimerization.	M->A
P0A9E5	UniProtKB	Mutagenesis	150	150	.	.	.	Note=Loss	of	regulation	by	O(2).	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1898918;Dbxref=PMID:1898918
P0A9E5	UniProtKB	Mutagenesis	151	151	.	.	.	Note=Decrease	in	activity	due	to	faulty	dimerization.	I->A
P0A9E5	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Loss	of	regulation	by	O(2).	D->A%2CG%2CV;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1898918,ECO:0000269|PubMed:8406003;Dbxref=PMID:1898918,PMID:8406003
P0A9E5	UniProtKB	Mutagenesis	158	158	.	.	.	Note=Decrease	in	activity	due	to	faulty	dimerization.	I->A
P0A9E5	UniProtKB	Mutagenesis	181	181	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9321653;Dbxref=PMID:9321653
P0A9E5	UniProtKB	Mutagenesis	186	186	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9321653;Dbxref=PMID:9321653
P0A9E5	UniProtKB	Mutagenesis	187	187	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	Trace	activity%3B	when	associated	with	A-85.	S->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11115116,ECO:0000269|PubMed:9321653;Dbxref=PMID:11115116,PMID:9321653
P0A9E5	UniProtKB	Mutagenesis	191	191	.	.	.	Note=Decrease	in	activity%3B	no	effect	on	DNA-binding.	F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9321653;Dbxref=PMID:9321653
P0A825	UniProtKB	Mutagenesis	55	55	.	.	.	Note=50	and	15-fold	increase	in	the	affinity	for	serine	and	tetrahydrofolate%2C	respectively%2C	and	4-fold	decrease	in	the	catalytic	efficiency.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19883126;Dbxref=PMID:19883126
P0A825	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Decrease	in	catalytic	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10858298;Dbxref=PMID:10858298
P0A825	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Alteration	of	the	dimer-monomer	equilibrium	accompanied	by	minor	changes	in	the	catalytic	properties	and	whitout	any	significant	change	of	tertiary	structure.	In	the	monomeric	state%3B	when	associated	with	A-276.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19019081;Dbxref=PMID:19019081
P0A825	UniProtKB	Mutagenesis	214	214	.	.	.	Note=No	significant	difference	in	catalytic	efficiency	and	affinity	compared	to	the	wild-type.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12773539;Dbxref=PMID:12773539
P0A825	UniProtKB	Mutagenesis	214	214	.	.	.	Note=No	significant	difference	in	catalytic	efficiency	and	affinity	compared	to	the	wild-type.	P->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12773539;Dbxref=PMID:12773539
P0A825	UniProtKB	Mutagenesis	216	216	.	.	.	Note=No	significant	difference	in	catalytic	efficiency	and	affinity	compared	to	the	wild-type.	Alteration	in	the	folding	rate.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12773539;Dbxref=PMID:12773539
P0A825	UniProtKB	Mutagenesis	216	216	.	.	.	Note=Important	decrease	in	affinitand	catalytic	efficiency.	Severely	compromised	in	folding	into	a	catalytically	competent	enzyme.	P->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12773539;Dbxref=PMID:12773539
P0A825	UniProtKB	Mutagenesis	218	218	.	.	.	Note=No	significant	difference	in	catalytic	efficiency	and	affinity	compared	to	the	wild-type.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12773539;Dbxref=PMID:12773539
P0A825	UniProtKB	Mutagenesis	218	218	.	.	.	Note=No	significant	difference	in	catalytic	efficiency	and	affinity	compared	to	the	wild-type.	P->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12773539;Dbxref=PMID:12773539
P0A825	UniProtKB	Mutagenesis	235	235	.	.	.	Note=1500-	and	20-fold	increase	in	the	affinity	for	serine	and	tetrahydrofolate%2C	respectively%2C	and	15-fold	decrease	in	the	catalytic	efficiency.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19883126;Dbxref=PMID:19883126
P0A825	UniProtKB	Mutagenesis	235	235	.	.	.	Note=450-	and	11-fold	increase	in	the	affinity	for	serine	and	tetrahydrofolate%2C	respectively%2C	and	60-fold	decrease	in	the	catalytic	efficiency.	R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19883126;Dbxref=PMID:19883126
P0A825	UniProtKB	Mutagenesis	235	235	.	.	.	Note=900-	and	17-fold	increase	in	the	affinity	for	serine	and	tetrahydrofolate%2C	respectively%2C	and	30-fold	decrease	in	the	catalytic	efficiency.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19883126;Dbxref=PMID:19883126
P0A825	UniProtKB	Mutagenesis	258	258	.	.	.	Note=Important	decrease	in	affinitand	catalytic	efficiency.	Reduced	thermal	stability.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12773539;Dbxref=PMID:12773539
P0A825	UniProtKB	Mutagenesis	258	258	.	.	.	Note=Important	decrease	in	affinitand	catalytic	efficiency.	P->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12773539;Dbxref=PMID:12773539
P0A825	UniProtKB	Mutagenesis	264	264	.	.	.	Note=Important	decrease	in	affinitand	catalytic	efficiency.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12773539;Dbxref=PMID:12773539
P0A825	UniProtKB	Mutagenesis	264	264	.	.	.	Note=Important	decrease	in	affinitand	catalytic	efficiency.	P->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12773539;Dbxref=PMID:12773539
P0A825	UniProtKB	Mutagenesis	276	276	.	.	.	Note=Alteration	of	the	dimer-monomer	equilibrium	accompanied	by	minor	changes	in	the	catalytic	properties	and	whitout	any	significant	change	of	tertiary	structure.	In	the	monomeric	state%3B	when	associated	with	A-85.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19019081;Dbxref=PMID:19019081
P0A825	UniProtKB	Mutagenesis	363	363	.	.	.	Note=It	does	not	bind	serine	and	glycine	and	shows	no	activity	with	serine	as	the	substrate.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7925461;Dbxref=PMID:7925461
P0A825	UniProtKB	Mutagenesis	363	363	.	.	.	Note=Exhibits	only	0.03%25	of	the	catalytic	activity	of	the	wild-type	and	a	15-fold	reduction	in	affinity	for	glycine	and	serine.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7925461;Dbxref=PMID:7925461
P0A825	UniProtKB	Mutagenesis	372	372	.	.	.	Note=No	significant	difference	compareto	the	wild-type.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7925461;Dbxref=PMID:7925461
P0A825	UniProtKB	Mutagenesis	372	372	.	.	.	Note=No	significant	difference	compareto	the	wild-type.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7925461;Dbxref=PMID:7925461
P0AEH1	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Loss	of	protease	activity.	H->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11689431,ECO:0000269|PubMed:11750129,ECO:0000269|PubMed:12183368,ECO:0000269|PubMed:15496982,ECO:0000269|PubMed:18268014,ECO:0000269|PubMed:21810987;Dbxref=PMID:11689431,PMID:11750129,PMID:12183368,PMID:15496982,PMID:18268014,PMID:21810987
P0AEH1	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Loss	of	protease	activitof	RseA	and	signal	peptides%2C	does	not	complement	deletion	mutant.	Binds	substrate.	H->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11689431,ECO:0000269|PubMed:11750129,ECO:0000269|PubMed:12183368,ECO:0000269|PubMed:15496982,ECO:0000269|PubMed:18268014,ECO:0000269|PubMed:21810987;Dbxref=PMID:11689431,PMID:11750129,PMID:12183368,PMID:15496982,PMID:18268014,PMID:21810987
P0AEH1	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Low	basal	sigma-E	activity%2C	sigma-E	not	induced.	No	proteolysis	of	RseA.	E->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11750129,ECO:0000269|PubMed:12183369,ECO:0000269|PubMed:18268014;Dbxref=PMID:11750129,PMID:12183369,PMID:18268014
P0AEH1	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Behaves	like	wild-type	in	vivo%2C	slight	reduction	in	RseA	cleavage	in	vitro.	E->D;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11750129,ECO:0000269|PubMed:12183369,ECO:0000269|PubMed:18268014;Dbxref=PMID:11750129,PMID:12183369,PMID:18268014
P0AEH1	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Does	not	complement	deletiomutant.	E->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11750129,ECO:0000269|PubMed:12183369,ECO:0000269|PubMed:18268014;Dbxref=PMID:11750129,PMID:12183369,PMID:18268014
P0AEH1	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Loss	of	protease	activity.	E->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11750129,ECO:0000269|PubMed:12183369,ECO:0000269|PubMed:18268014;Dbxref=PMID:11750129,PMID:12183369,PMID:18268014
P0AEH1	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Does	not	complement	deletiomutant.	H->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11750129;Dbxref=PMID:11750129
P0AEH1	UniProtKB	Mutagenesis	115	115	.	.	.	Note=No	effect.	Cleaves	RseA	without	previouDegS	cleavage%3B	when	associated	with	R-214.	A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18945679;Dbxref=PMID:18945679
P0AEH1	UniProtKB	Mutagenesis	145	145	.	.	.	Note=Cuts	RseA	without	previous	DegS	cleavage.	I->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18945679;Dbxref=PMID:18945679
P0AEH1	UniProtKB	Mutagenesis	151	151	.	.	.	Note=Cuts	RseA	without	previous	DegS	cleavage.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18945679;Dbxref=PMID:18945679
P0AEH1	UniProtKB	Mutagenesis	162	162	.	.	.	Note=Cuts	RseA	without	previous	DegS	cleavage.	W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18945679;Dbxref=PMID:18945679
P0AEH1	UniProtKB	Mutagenesis	169	169	.	.	.	Note=Cuts	RseA	without	previous	DegS	cleavage.	L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18945679;Dbxref=PMID:18945679
P0AEH1	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Cuts	RseA	without	previous	DegS	cleavage.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18945679;Dbxref=PMID:18945679
P0AEH1	UniProtKB	Mutagenesis	214	214	.	.	.	Note=Cuts	RseA	without	previous	DegS	cleavage.	G->E%2CQ;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14633997,ECO:0000269|PubMed:18945679;Dbxref=PMID:14633997,PMID:18945679
P0AEH1	UniProtKB	Mutagenesis	214	214	.	.	.	Note=Weakly	cuts	RseA	without	previouDegS	cleavage.	Stronger	cleavage%3B	when	associated	with	V-115.	G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14633997,ECO:0000269|PubMed:18945679;Dbxref=PMID:14633997,PMID:18945679
P0AEH1	UniProtKB	Mutagenesis	215	215	.	.	.	Note=No	cleavage	of	RseA	in	vitro	(PubMed:19706448)%2C	cleavage	of	RseA	(PubMed:23016873)	in	vivo.	I->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19706448,ECO:0000269|PubMed:23016873;Dbxref=PMID:19706448,PMID:23016873
P0AEH1	UniProtKB	Mutagenesis	234	235	.	.	.	Note=Cuts	RseA	without	previous	DegS	cleavage.	AA->KK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14633997;Dbxref=PMID:14633997
P0AEH1	UniProtKB	Mutagenesis	243	243	.	.	.	Note=Cuts	RseA	without	previous	DegS	cleavage.	G->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14633997;Dbxref=PMID:14633997
P0AEH1	UniProtKB	Mutagenesis	244	244	.	.	.	Note=Cuts	RseA	without	previous	DegS	cleavage.	D->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14633997;Dbxref=PMID:14633997
P0AEH1	UniProtKB	Mutagenesis	246	246	.	.	.	Note=Cuts	RseA	without	previous	DegS	cleavage.	I->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14633997;Dbxref=PMID:14633997
P0AEH1	UniProtKB	Mutagenesis	261	261	.	.	.	Note=Does	not	complement	deletiomutant.	V->VTDSYTQVASWTEPFPFSIQGDPRSDQETAFV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11750129;Dbxref=PMID:11750129
P0AEH1	UniProtKB	Mutagenesis	304	304	.	.	.	Note=No	cleavage	of	RseA	in	vitro	(PubMed:19706448)%2C	cleavage	of	RseA	(PubMed:23016873)	in	vivo.	I->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19706448,ECO:0000269|PubMed:23016873;Dbxref=PMID:19706448,PMID:23016873
P0AEH1	UniProtKB	Mutagenesis	389	389	.	.	.	Note=Decreased	substrate	binding%2C	retains	some	proteolytic	activity.	N->C%2CG%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18268014;Dbxref=PMID:18268014
P0AEH1	UniProtKB	Mutagenesis	389	389	.	.	.	Note=No	effect.	N->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18268014;Dbxref=PMID:18268014
P0AEH1	UniProtKB	Mutagenesis	394	394	.	.	.	Note=Decreased	substrate	binding%2C	retains	some	proteolytic	activity.	N->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18268014;Dbxref=PMID:18268014
P0AEH1	UniProtKB	Mutagenesis	397	397	.	.	.	Note=Decreased	substrate	binding%2C	retains	some	proteolytic	activity.	P->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18268014;Dbxref=PMID:18268014
P0AEH1	UniProtKB	Mutagenesis	399	399	.	.	.	Note=Decreased	substrate	binding%2C	retains	some	proteolytic	activity.	P->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18268014;Dbxref=PMID:18268014
P0AEH1	UniProtKB	Mutagenesis	402	402	.	.	.	Note=Does	not	complement	deletiomutant%2C	loss	of	protease	activity.	D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11750129,ECO:0000269|PubMed:12183368;Dbxref=PMID:11750129,PMID:12183368
P04395	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Methylmethane	sulfonate-resistant.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8706135;Dbxref=PMID:8706135
P04395	UniProtKB	Mutagenesis	218	218	.	.	.	Note=No	catalytic	activity%2C	methylmethane	sulfonate-sensitive.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8706135;Dbxref=PMID:8706135
P04395	UniProtKB	Mutagenesis	237	237	.	.	.	Note=More	than	30%25	catalytic	activity%2C	methylmethane	sulfonate-resistant.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8706135;Dbxref=PMID:8706135
P04395	UniProtKB	Mutagenesis	238	238	.	.	.	Note=No	catalytic	activity%2C	methylmethane	sulfonate-sensitive.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8706135;Dbxref=PMID:8706135
P11071	UniProtKB	Mutagenesis	336	336	.	.	.	Note=Inhibits	enzyme.	K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2557093;Dbxref=PMID:2557093
P11071	UniProtKB	Mutagenesis	371	371	.	.	.	Note=Loss	of	activity.	D->A%2CE%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11258918;Dbxref=PMID:11258918
P11071	UniProtKB	Mutagenesis	377	377	.	.	.	Note=No	loss	of	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11258918;Dbxref=PMID:11258918
P11071	UniProtKB	Mutagenesis	403	403	.	.	.	Note=No	loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11258918;Dbxref=PMID:11258918
P11071	UniProtKB	Mutagenesis	439	439	.	.	.	Note=No	loss	of	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11258918;Dbxref=PMID:11258918
P76491	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Shows	negligible	enzymatic	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353368;Dbxref=PMID:18353368
P76491	UniProtKB	Mutagenesis	30	30	.	.	.	Note=Shows	reduced	activity	and	affinity	compared	to	the	wild-type.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353368;Dbxref=PMID:18353368
P76491	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Shows	negligible	enzymatic	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353368;Dbxref=PMID:18353368
P76491	UniProtKB	Mutagenesis	68	68	.	.	.	Note=Shows	negligible	enzymatic	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353368;Dbxref=PMID:18353368
P76491	UniProtKB	Mutagenesis	69	69	.	.	.	Note=Shows	negligible	enzymatic	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353368;Dbxref=PMID:18353368
P76491	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Shows	negligible	enzymatic	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353368;Dbxref=PMID:18353368
P76491	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Shows	wild-type	activity	and	substrate	affinity.	E->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353368;Dbxref=PMID:18353368
P76491	UniProtKB	Mutagenesis	77	77	.	.	.	Note=Shows	negligible	enzymatic	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353368;Dbxref=PMID:18353368
P76491	UniProtKB	Mutagenesis	122	122	.	.	.	Note=Shows	reduced	activity	and	affinity	compared	to	the	wild-type.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353368;Dbxref=PMID:18353368
P76491	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Shows	negligible	enzymatic	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353368;Dbxref=PMID:18353368
P0AB65	UniProtKB	Mutagenesis	5	5	.	.	.	Note=No	change	in	secondary	structure.	Nearly	identical	enzymatic	properties.	Loss	of	activity	in	8.0	M	urea.	Reduced	thermodynamic	activity.	Inactivated	after	3	hours	of	incubation	at	90	degreesCelsius.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17134700;Dbxref=PMID:17134700
P36683	UniProtKB	Mutagenesis	769	769	.	.	.	Note=Inhibits	the	dimer	formation.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15882410;Dbxref=PMID:15882410
P0AE06	UniProtKB	Mutagenesis	1	25	.	.	.	Note=Fully	functional	(replaces	endogenous	signal	and	lipid	anchor	with	periplasmic	signal	for	OmpA).	MNKNRGFTPLAVVLMLSGSLALTGC->MKKTAIAIAVALAGFATVAQA
P0AE06	UniProtKB	Mutagenesis	223	224	.	.	.	Note=Wild-type	resistance	to	efflux	substrates.	Protein	unstable%3B	when	associated	with	287-M-M-288.	FL->MM;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16531241;Dbxref=PMID:16531241
P0AE06	UniProtKB	Mutagenesis	287	288	.	.	.	Note=Wild-type	resistance	to	efflux	substrates.	Protein	unstable%3B	when	associated	with	223-M-M-224.	LL->MM;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16531241;Dbxref=PMID:16531241
P31224	UniProtKB	Mutagenesis	526	526	.	.	.	Note=Partially	restores	chloramphenicolresistance	to	an	AcrZ	G30R	mutant.	H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23010927;Dbxref=PMID:23010927
P31119	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Loss	of	2-acyl-GPE	acyltransferase	activity%3B	retains	acyl-ACP	synthetase	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9515909;Dbxref=PMID:9515909
P24182	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Loss	of	homodimerization.	No	effect	on	ATP	binding.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16793549;Dbxref=PMID:16793549
P24182	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Loss	of	homodimerization.	No	effect	on	ATP	binding.	E->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16793549;Dbxref=PMID:16793549
P24182	UniProtKB	Mutagenesis	363	363	.	.	.	Note=Loss	of	homodimerization.	No	effect	on	ATP	binding.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16793549;Dbxref=PMID:16793549
P24182	UniProtKB	Mutagenesis	366	366	.	.	.	Note=Loss	of	homodimerization.	No	effect	on	ATP	binding.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16793549;Dbxref=PMID:16793549
P00509	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Slight	changes	in	activity.	Y->F%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1868057;Dbxref=PMID:1868057
P00509	UniProtKB	Mutagenesis	133	133	.	.	.	Note=Slight	increase	in	maximumvelocity	of	the	overall	transamination	reaction	between	aspartate	and	2-oxoglutarate.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2007566;Dbxref=PMID:2007566
P00509	UniProtKB	Mutagenesis	133	133	.	.	.	Note=Decreases	to	60%25	in	maximumrate	of	the	overall	reactions	in	both	directions.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2007566;Dbxref=PMID:2007566
P00509	UniProtKB	Mutagenesis	280	280	.	.	.	Note=Reduces	first-order	rate	constanover	25000-fold.	R->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10556573;Dbxref=PMID:10556573
P00509	UniProtKB	Mutagenesis	374	374	.	.	.	Note=Reduces	first-order	rate	constanabout	10000-fold.	R->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10556573,ECO:0000269|PubMed:1993208;Dbxref=PMID:10556573,PMID:1993208
P00509	UniProtKB	Mutagenesis	374	374	.	.	.	Note=Second-order	rate	constants	are	reduced	by	>5	orders	of	magnitude.	R->F%2CY;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10556573,ECO:0000269|PubMed:1993208;Dbxref=PMID:10556573,PMID:1993208
P0A9Q5	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Vmax	decreases	9-fold.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19965770;Dbxref=PMID:19965770
P0A9Q5	UniProtKB	Mutagenesis	30	30	.	.	.	Note=Vmax	decreases	140-fold.	Loss	of	nucleic	acid-binding.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19965770;Dbxref=PMID:19965770
P0A9Q5	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Vmax	decreases	11-fold.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19965770;Dbxref=PMID:19965770
P0A9Q5	UniProtKB	Mutagenesis	49	49	.	.	.	Note=Vmax	decreases	8-fold.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19965770;Dbxref=PMID:19965770
P08660	UniProtKB	Mutagenesis	8	8	.	.	.	Note=Reduces	activity	about	98%25.	Increases	KM	for	aspartate	about	40-fold%2C	enzyme	is	less	sensitive	to	lysine	inhibition.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14623187;Dbxref=PMID:14623187
P08660	UniProtKB	Mutagenesis	119	119	.	.	.	Note=Increases	KM	for	aspartate	about	3000-fold.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14623187;Dbxref=PMID:14623187
P08660	UniProtKB	Mutagenesis	198	198	.	.	.	Note=Increases	KM	for	aspartate	about	200-fold.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14623187;Dbxref=PMID:14623187
P08660	UniProtKB	Mutagenesis	202	202	.	.	.	Note=Reduces	activity	about	98%25.	Increases	KM	for	aspartate	about	40-fold%2C	enzyme	is	less	sensitive	to	lysine	inhibition.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14623187;Dbxref=PMID:14623187
P0A9G6	UniProtKB	Mutagenesis	195	195	.	.	.	Note=Large	decrease	in	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7826335;Dbxref=PMID:7826335
P0A9G6	UniProtKB	Mutagenesis	195	195	.	.	.	Note=Large	decrease	in	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7826335;Dbxref=PMID:7826335
P0A9G6	UniProtKB	Mutagenesis	219	219	.	.	.	Note=Isocitrate	lyase	activity	is	reduced	compared	to	the	wild-type.	A->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11526312;Dbxref=PMID:11526312
P0A6A8	UniProtKB	Mutagenesis	37	37	.	.	.	Note=Loss	of	phosphopantetheinylation%2C	and	inhibition	of	cell	growth.	S->A%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7673201;Dbxref=PMID:7673201
P33224	UniProtKB	Mutagenesis	437	437	.	.	.	Note=Does	not	affect	DNA	bindingaffinity.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18829440;Dbxref=PMID:18829440
P33224	UniProtKB	Mutagenesis	518	518	.	.	.	Note=Reduces	DNA	binding	affinity.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18829440;Dbxref=PMID:18829440
P24224	UniProtKB	Mutagenesis	5	5	.	.	.	Note=5-fold	reduction	in	catalytic	activity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10625633;Dbxref=PMID:10625633
P0AAP1	UniProtKB	Mutagenesis	291	292	.	.	.	Note=No	c-di-GMP	produced	in	an	overexpressing	strain.	DE->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19707751;Dbxref=PMID:19707751
P31466	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Almost	no	change	in	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Lack	of	activity.	T->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Almost	no	change	in	activity.	A->G%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	267	267	.	.	.	Note=Lack	of	activity.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	267	267	.	.	.	Note=Strong	decrease	in	activity.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	271	271	.	.	.	Note=Almost	no	change	in	activity.	T->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	271	271	.	.	.	Note=Lack	of	activity.	T->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	271	271	.	.	.	Note=Strong	decrease	in	activity.	T->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	298	298	.	.	.	Note=Almost	no	change	in	activity.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	298	298	.	.	.	Note=Lack	of	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	317	317	.	.	.	Note=Almost	no	change	in	activity.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	317	317	.	.	.	Note=Strong	decrease	in	activity.	I->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	318	318	.	.	.	Note=Strong	decrease	in	activity.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	318	318	.	.	.	Note=Lack	of	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P31466	UniProtKB	Mutagenesis	319	319	.	.	.	Note=Almost	no	change	in	activity.	S->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P32719	UniProtKB	Mutagenesis	196	196	.	.	.	Note=Shortens	the	substrate-binding	pocket.	Slightly	lower	activity	towards	allulose	6-phosphate	and	increased	activity	towards	ribulose	5-phosphate.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18700786;Dbxref=PMID:18700786
P32719	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Shortens	the	substrate-binding	pocket.	Slightly	lower	activity	towards	allulose	6-phosphate	and	increased	activity	towards	ribulose	5-phosphate.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18700786;Dbxref=PMID:18700786
P32719	UniProtKB	Mutagenesis	198	198	.	.	.	Note=Shortens	the	substrate-binding	pocket.	Slightly	lower	activity	towards	allulose	6-phosphate	and	increased	activity	towards	ribulose	5-phosphate.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18700786;Dbxref=PMID:18700786
P37685	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Less	than	10%25	of	wild-type	acetaldehyde	dehydrogenase	activity.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15659684;Dbxref=PMID:15659684
P05050	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Slighly	reduced	activity	towardssingle-stranded	DNA	containing	1-methyladenine.	Reduces	affinity	for	undamaged	DNA.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20084272;Dbxref=PMID:20084272
P05050	UniProtKB	Mutagenesis	69	69	.	.	.	Note=Abolishes	activity	towards	single-stranded	DNA	containing	1-methyladenine.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20084272;Dbxref=PMID:20084272
P05050	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Reduces	affinity	for	damagedDNA	and	activity	towards	single-stranded	DNA	containing	1-methyladenine.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20084272;Dbxref=PMID:20084272
P05050	UniProtKB	Mutagenesis	135	135	.	.	.	Note=Abolishes	activity	towards	single-stranded	DNA	containing	1-methyladenine.	Alters	substrate	specificity%2C	so	that	the	enzyme	gains	activity	towards	single-stranded	DNA	containing	1-methylguanine.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20084272;Dbxref=PMID:20084272
P05050	UniProtKB	Mutagenesis	161	161	.	.	.	Note=No	effect	on	enzyme	activity.	Decreases	affinity	for	damaged	DNA.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20084272;Dbxref=PMID:20084272
P23872	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Reduces	enzymatic	efficiency.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10431819;Dbxref=PMID:10431819
P23872	UniProtKB	Mutagenesis	128	128	.	.	.	Note=Reduces	enzymatic	efficiency.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10431819;Dbxref=PMID:10431819
P23872	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Diminishes	catalytic	efficiency.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10431819;Dbxref=PMID:10431819
P23872	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Strongly	reduces	enzymatic	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10431819;Dbxref=PMID:10431819
P23872	UniProtKB	Mutagenesis	165	165	.	.	.	Note=Abolishes	enzymatic	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10431819;Dbxref=PMID:10431819
P23872	UniProtKB	Mutagenesis	167	167	.	.	.	Note=Diminishes	substrate	affinity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10431819;Dbxref=PMID:10431819
P23872	UniProtKB	Mutagenesis	262	262	.	.	.	Note=Strongly	reduces	enzymatic	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10431819;Dbxref=PMID:10431819
P23872	UniProtKB	Mutagenesis	266	266	.	.	.	Note=Reduces	enzymatic	efficiency.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10431819;Dbxref=PMID:10431819
P23872	UniProtKB	Mutagenesis	292	292	.	.	.	Note=Abolishes	enzymatic	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10431819;Dbxref=PMID:10431819
P0AAW9	UniProtKB	Mutagenesis	30	30	.	.	.	Note=Loss	of	chloramphenicol	resistance%2C	does	not	bind	AcrB	(dominant-negative	to	wild-type).	Partially	suppressed	by	AcrB	H526Y.	G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23010927;Dbxref=PMID:23010927
P0AAW9	UniProtKB	Mutagenesis	46	49	.	.	.	Note=Loss	of	chloramphenicol	resistance%2C	still	binds	AcrB	(dominant-negative	to	wild-type).	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23010927;Dbxref=PMID:23010927
P0A991	UniProtKB	Mutagenesis	237	237	.	.	.	Note=Loss	of	activity.	K->A
P0A991	UniProtKB	Mutagenesis	239	239	.	.	.	Note=No	change	in	activity.	K->A
P0AB71	UniProtKB	Mutagenesis	36	36	.	.	.	Note=1.5%25	of	wild-type	activity.	5-fold	decrease	in	FBP	affinity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10712619;Dbxref=PMID:10712619
P0AB71	UniProtKB	Mutagenesis	60	60	.	.	.	Note=81%25	of	wild-type	activity.	1.3-fold	decrease	in	FBP	affinity.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10712619;Dbxref=PMID:10712619
P0AB71	UniProtKB	Mutagenesis	62	62	.	.	.	Note=8%25	of	wild-type	activity.	16-fold	decrease	in	FBP	affinity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10712619;Dbxref=PMID:10712619
P0AB71	UniProtKB	Mutagenesis	62	62	.	.	.	Note=60%25	of	wild-type	activity.	2.5-fold	decrease	in	FBP	affinity.	S->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10712619;Dbxref=PMID:10712619
P0AB71	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8436219;Dbxref=PMID:8436219
P0AB71	UniProtKB	Mutagenesis	111	111	.	.	.	Note=Loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8436219;Dbxref=PMID:8436219
P0AB71	UniProtKB	Mutagenesis	112	112	.	.	.	Note=Partial	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8436219;Dbxref=PMID:8436219
P0AB71	UniProtKB	Mutagenesis	326	326	.	.	.	Note=6%25	of	wild-type	activity.	2.2-fold	decrease	in	FBP	affinity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10712619;Dbxref=PMID:10712619
P0A955	UniProtKB	Mutagenesis	45	45	.	.	.	Note=50-fold	decrease	in	catalytic	efficiency	and	6-fold	decrease	of	binding	affinity.	E->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16403639,ECO:0000269|PubMed:17981470;Dbxref=PMID:16403639,PMID:17981470
P0A955	UniProtKB	Mutagenesis	133	133	.	.	.	Note=Absence	of	aldolase	activity.	Shows	a	markedly	altered	substrate	specificity	relative	to	the	wild-type%2C	with	an	enhanced	activity	against	pyridine	carboxaldehyde%2C	benzaldehyde%2C	and	alpha-ketobutyrate%3B	when	associated	with	k-161.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11342129;Dbxref=PMID:11342129
P0A955	UniProtKB	Mutagenesis	161	161	.	.	.	Note=Shows	activity	significantly	greater	than	wild-type.	Shows	a	markedly	altered	substrate	specificity	relative	to	the	wild-type%2C	with	an	enhanced	activity	against	pyridine	carboxaldehyde%2C	benzaldehyde%2C	and	alpha-ketobutyrate%3B	when	associated	with	Q-133.	T->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11342129,ECO:0000269|PubMed:17981470;Dbxref=PMID:11342129,PMID:17981470
P0A955	UniProtKB	Mutagenesis	161	161	.	.	.	Note=Little	stereoselectivity%2C	accepting	KDPG	and	KDPGal	as	substrate	with	roughly	equal	efficacy.	It	strongly	diminishes	the	activity	against	KDPG	and	slightly	increases	activity	against	KDPGal.	T->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11342129,ECO:0000269|PubMed:17981470;Dbxref=PMID:11342129,PMID:17981470
P0A955	UniProtKB	Mutagenesis	168	168	.	.	.	Note=Shows	activity	significantly	greater	than	wild-type.	N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11342129;Dbxref=PMID:11342129
P0A6B4	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Slightly	reduces	affinity	for	D-Ala	and	L-Ala.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18434499;Dbxref=PMID:18434499
P0A6B4	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Reduces	catalytic	activity.	Slightly	reduces	affinity	for	D-Ala	and	L-Ala.	D->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18434499;Dbxref=PMID:18434499
P0A6B4	UniProtKB	Mutagenesis	165	165	.	.	.	Note=Slightly	reduces	affinity	for	D-Ala	and	L-Ala.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18434499;Dbxref=PMID:18434499
P0A6B4	UniProtKB	Mutagenesis	165	165	.	.	.	Note=Reduces	catalytic	activity.	Slightly	reduces	affinity	for	D-Ala	and	L-Ala.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18434499;Dbxref=PMID:18434499
P0A6B4	UniProtKB	Mutagenesis	219	219	.	.	.	Note=No	effect	on	catalytic	activity.	No	effect	on	affinity	for	D-Ala	and	L-Ala.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18434499;Dbxref=PMID:18434499
P0A6B4	UniProtKB	Mutagenesis	221	221	.	.	.	Note=Slightly	increases	catalytic	activity.	Slightly	increases	affinity	for	D-Ala	and	L-Ala.	E->A%2CK%2CP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18434499;Dbxref=PMID:18434499
P32718	UniProtKB	Mutagenesis	73	73	.	.	.	Note=60-fold	increase	in	catalytic	efficiency	for	glucose	phosphorylation.	45-fold	increase	in	D-glucose	affinity.	No	change	in	catalytic	efficiency	for	D-allose	phosphorylation.	A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17979299;Dbxref=PMID:17979299
P32718	UniProtKB	Mutagenesis	145	145	.	.	.	Note=10-fold	increase	in	catalytic	efficiency	for	glucose	phosphorylation.	Slight	increase	in	catalytic	efficiency	for	D-allose	phosphorylation.	F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17979299;Dbxref=PMID:17979299
P0ACN4	UniProtKB	Mutagenesis	135	142	.	.	.	Note=Loss	of	repressor	activity.	Loss	of	DNA	binding.	Reduces	assembly	into	functionally	active	tetramers.	CKSMVRMC->APA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16546208;Dbxref=PMID:16546208
P0ACN4	UniProtKB	Mutagenesis	141	141	.	.	.	Note=No	effect	on	repressor	activity.	Loss	of	glyoxylate-triggered	dissociation	from	DNA.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16546208;Dbxref=PMID:16546208
P0ACN4	UniProtKB	Mutagenesis	142	142	.	.	.	Note=Strongly	reduced	repressor	activity.	Reduces	DNA	binding.	Prevents	assembly	into	functionally	active	tetramers.	C->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16546208;Dbxref=PMID:16546208
P0ACN4	UniProtKB	Mutagenesis	215	215	.	.	.	Note=Reduced	repressor	activity.	Loss	of	glyoxylate-triggered	dissociation	from	DNA.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16546208;Dbxref=PMID:16546208
P0ACN4	UniProtKB	Mutagenesis	217	217	.	.	.	Note=Slightly	reduced	repressor	activity.	Loss	of	glyoxylate-triggered	dissociation	from	DNA.	C->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16546208;Dbxref=PMID:16546208
P0ACN4	UniProtKB	Mutagenesis	234	234	.	.	.	Note=Reduced	repressor	activity.	Loss	of	glyoxylate-triggered	dissociation	from	DNA.	S->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16546208;Dbxref=PMID:16546208
P0ACN4	UniProtKB	Mutagenesis	236	236	.	.	.	Note=Slightly	reduced	repressor	activity.	Loss	of	glyoxylate-triggered	dissociation	from	DNA.	S->A%2CM;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16546208;Dbxref=PMID:16546208
P0A6C5	UniProtKB	Mutagenesis	15	15	.	.	.	Note=In	EE17.	H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9572954;Dbxref=PMID:9572954
P0A6C5	UniProtKB	Mutagenesis	19	19	.	.	.	Note=In	EE51.	Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9572954;Dbxref=PMID:9572954
P0A6C5	UniProtKB	Mutagenesis	54	54	.	.	.	Note=In	PT2M217.	S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9572954;Dbxref=PMID:9572954
P0A6C5	UniProtKB	Mutagenesis	58	58	.	.	.	Note=In	EE11.	R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9572954;Dbxref=PMID:9572954
P0A6C5	UniProtKB	Mutagenesis	287	287	.	.	.	Note=In	PT2M216.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9572954;Dbxref=PMID:9572954
P0A6C5	UniProtKB	Mutagenesis	432	432	.	.	.	Note=In	PT2M217.	Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9572954;Dbxref=PMID:9572954
P68767	UniProtKB	Mutagenesis	354	354	.	.	.	Note=Loss	of	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8057849;Dbxref=PMID:8057849
P00811	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Loss	of	activity.	S->D%2CE%2CG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12144785;Dbxref=PMID:12144785
P00811	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Lowers	activity	more	than	1000-fold	and	increases	protein	stability.	K->Q%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12144785;Dbxref=PMID:12144785
P00811	UniProtKB	Mutagenesis	166	166	.	.	.	Note=Lowers	activity	more	than	1000-fold.	Y->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12144785;Dbxref=PMID:12144785
P00811	UniProtKB	Mutagenesis	168	168	.	.	.	Note=Lowers	activity	more	than	1000-fold.	N->D%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12144785;Dbxref=PMID:12144785
P00811	UniProtKB	Mutagenesis	331	331	.	.	.	Note=Lowers	activity	more	than	1000-fold.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12144785;Dbxref=PMID:12144785
P0A6D0	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Increased	affinity	for	ARG	box	in	the	presence	of	arginine.	E->K
P0A6D0	UniProtKB	Mutagenesis	44	44	.	.	.	Note=Defective	binding	to	ARG	box.	S->F
P0A6D0	UniProtKB	Mutagenesis	47	47	.	.	.	Note=Defective	binding	to	ARG	box.	S->L
P0A6D0	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Increased	affinity	for	ARG	box	in	the	absence	of	arginine.	P->L
P0A6D0	UniProtKB	Mutagenesis	105	105	.	.	.	Note=Defective	binding	to	arginine	and	to	ARG	box.	A->V
P0A6D0	UniProtKB	Mutagenesis	123	123	.	.	.	Note=Defective	binding	to	arginine	and	to	ARG	box.	Forms	dimers	not	hexamers.	G->D
P0AEC3	UniProtKB	Mutagenesis	292	292	.	.	.	Note=Loss	of	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10851007;Dbxref=PMID:10851007
P0AEC3	UniProtKB	Mutagenesis	576	576	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10851007;Dbxref=PMID:10851007
P0AEC3	UniProtKB	Mutagenesis	717	717	.	.	.	Note=Loss	of	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10851007;Dbxref=PMID:10851007
P0AC38	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9230046;Dbxref=PMID:9230046
P0AC38	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Reduces	Kcal	by	80%25.	Increases	KM	for	aspartic	acid	3-fold.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9230046;Dbxref=PMID:9230046
P0AC38	UniProtKB	Mutagenesis	15	15	.	.	.	Note=No	effect	on	Kcat.	Increases	KM	for	aspartic	acid	2.5-fold.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9230046;Dbxref=PMID:9230046
P0AC38	UniProtKB	Mutagenesis	26	26	.	.	.	Note=No	effect	on	Kcat.	Increases	KM	for	aspartic	acid	3-fold.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9230046;Dbxref=PMID:9230046
P0AC38	UniProtKB	Mutagenesis	29	29	.	.	.	Note=No	effect	on	Kcat.	Increases	KM	for	aspartic	acid	40-fold.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9230046;Dbxref=PMID:9230046
P0AC38	UniProtKB	Mutagenesis	55	55	.	.	.	Note=Loss	of	activity.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8119980;Dbxref=PMID:8119980
P0AC38	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Reduces	activity	by	30%25.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8119980;Dbxref=PMID:8119980
P0AC38	UniProtKB	Mutagenesis	143	143	.	.	.	Note=Reduces	Kcat	by	90%25.	Increases	KM	for	aspartic	acid	4-fold.	S->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9230046;Dbxref=PMID:9230046
P0AC38	UniProtKB	Mutagenesis	143	143	.	.	.	Note=Reduces	Kcat	by	98.5%25.	Increases	KM	for	aspartic	acid	2-fold.	S->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9230046;Dbxref=PMID:9230046
P0AC38	UniProtKB	Mutagenesis	327	327	.	.	.	Note=Reduces	activity	by	99.7%25Increases	KM	for	aspartic	acid	5-fold.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8119980;Dbxref=PMID:8119980
P0A962	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Loss	of	enzyme	activity.	T->A%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17451745;Dbxref=PMID:17451745
P0A962	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Loss	of	enzyme	activity.	S->Q
P0A962	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Loss	of	enzyme	activity.	T->A%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17451745;Dbxref=PMID:17451745
P0A962	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Loss	of	enzyme	activity.	Q->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17451745;Dbxref=PMID:17451745
P0A962	UniProtKB	Mutagenesis	162	162	.	.	.	Note=No	effect	on	activity	at	saturating	substrate	concentration.	Abolishes	cooperativity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17451745;Dbxref=PMID:17451745
P0A962	UniProtKB	Mutagenesis	240	240	.	.	.	Note=No	effect	on	activity	at	saturating	substrate	concentration.	Reduced	activity	at	lower	substrate	concentrations.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17451745;Dbxref=PMID:17451745
P02924	UniProtKB	Mutagenesis	277	277	.	.	.	Note=Improves	binding	to	galactose.	P->G
P60844	UniProtKB	Mutagenesis	9	9	.	.	.	Note=No	effect.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10518952;Dbxref=PMID:10518952
P60844	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Loss	of	oligomerization%3B	no	alteration	of	water	permeability.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10518952;Dbxref=PMID:10518952
P60844	UniProtKB	Mutagenesis	183	183	.	.	.	Note=No	effect.	T->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10518952;Dbxref=PMID:10518952
P60844	UniProtKB	Mutagenesis	189	189	.	.	.	Note=Loss	of	function.	R->V%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10518952;Dbxref=PMID:10518952
P77398	UniProtKB	Mutagenesis	102	102	.	.	.	Note=No	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15807526;Dbxref=PMID:15807526
P77398	UniProtKB	Mutagenesis	104	104	.	.	.	Note=25-fold	lower	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15807526;Dbxref=PMID:15807526
P77398	UniProtKB	Mutagenesis	104	104	.	.	.	Note=Less	than	1%25	residual	activity.	H->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15807526;Dbxref=PMID:15807526
P77398	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Less	than	1%25	residual	activity.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15807526;Dbxref=PMID:15807526
P77398	UniProtKB	Mutagenesis	433	433	.	.	.	Note=40-fold	lower	specific	activity.	S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15809294,ECO:0000269|PubMed:15939024;Dbxref=PMID:15809294,PMID:15939024
P77398	UniProtKB	Mutagenesis	433	433	.	.	.	Note=No	activity.	S->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15809294,ECO:0000269|PubMed:15939024;Dbxref=PMID:15809294,PMID:15939024
P77398	UniProtKB	Mutagenesis	434	434	.	.	.	Note=100-fold	lower	specific	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15809294;Dbxref=PMID:15809294
P77398	UniProtKB	Mutagenesis	434	434	.	.	.	Note=No	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15809294;Dbxref=PMID:15809294
P77398	UniProtKB	Mutagenesis	619	619	.	.	.	Note=No	activity.	R->E%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15939024;Dbxref=PMID:15939024
P77398	UniProtKB	Mutagenesis	619	619	.	.	.	Note=400-fold	lower	activity.	R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15939024;Dbxref=PMID:15939024
P0A6D3	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Insensitive	to	glyphosate	with	unaltered	affinity	for	its	first	substrate	S3P%2C	but	displays	a	30-foldlower	affinity	for	its	second	substrate	PEP.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12430021;Dbxref=PMID:12430021
P0A6D3	UniProtKB	Mutagenesis	97	97	.	.	.	Note=This	mutant	is	sensitive	to	glyphosate	and	causes	a	substantial	decrease	in	the	affinity	for	PEP.	Insensitive	to	glyphosate	but	maintains	high	affinity	for	PEP.	It	causes	a	shift	of	residue	G96	toward	the	glyphosate	binding	site%2C	impairing	efficient	binding	of	glyphosate%2C	while	the	side	chain	of	I97	points	away	from	the	substrate	binding	site%2Cfacilitating	PEP	utilization%3B	when	associated	with	S-101.	T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19211556;Dbxref=PMID:19211556
P0A6D3	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Displays	a	slight	decrease	of	the	affinity	binding	for	both	S3P	and	PEP.	Decreases	the	binding	affinity	of	glyphosate%2C	reducing	the	potency	of	this	inhibitor.	P->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17855366,ECO:0000269|PubMed:19211556;Dbxref=PMID:17855366,PMID:19211556
P0A6D3	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Displays	a	slight	decrease	of	the	affinity	binding	for	both	S3P	and	PEP.	Decreases	the	binding	affinity	of	glyphosate%2C	reducing	the	potency	of	this	inhibitor.	P->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17855366,ECO:0000269|PubMed:19211556;Dbxref=PMID:17855366,PMID:19211556
P0A6D3	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Displays	a	2-fold	lower	affinitbinding	for	both	S3P	and	PEP.	Decreases	the	binding	affinity	of	glyphosate%2C	reducinthe	potency	of	this	inhibitor.	P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17855366,ECO:0000269|PubMed:19211556;Dbxref=PMID:17855366,PMID:19211556
P0A6D3	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Displays	a	slight	decrease	of	the	affinity	binding	for	both	S3P	and	PEP.	Decreases	the	binding	affinity	of	glyphosate%2C	reducing	the	potency	of	this	inhibitor.	Insensitive	to	glyphosate	but	maintains	high	affinity	for	PEP.	It	causes	a	shift	of	residue	G96	toward	the	glyphosate	binding	site%2C	impairing	efficient	binding	of	glyphosate%2C	while	the	side	chain	of	I97	points	away	from	the	substrate-binding	site%2C	facilitating	PEP	utilization%3B	when	associated	with	I-97.	P->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17855366,ECO:0000269|PubMed:19211556;Dbxref=PMID:17855366,PMID:19211556
P0A6D3	UniProtKB	Mutagenesis	313	313	.	.	.	Note=The	enolpyruvyl	transfer	reaction	is	halted	after	formation	of	the	tetrahedral	adduct	of	the	substrates.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:13129913;Dbxref=PMID:13129913
P36675	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Loss	of	activity.	Does	not	affect	binding	to	the	ribosome.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21062370;Dbxref=PMID:21062370
P40711	UniProtKB	Mutagenesis	26	27	.	.	.	Note=Strong	decrease	in	activity.	GG->VA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21051357;Dbxref=PMID:21051357
P40711	UniProtKB	Mutagenesis	27	28	.	.	.	Note=Strong	decrease	in	activity.	GQ->AE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21051357;Dbxref=PMID:21051357
P40711	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Decrease	in	activity.	G->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21051357,ECO:0000269|PubMed:21418110;Dbxref=PMID:21051357,PMID:21418110
P40711	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Decrease	in	activity.	Q->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21051357;Dbxref=PMID:21051357
P0AB98	UniProtKB	Mutagenesis	206	206	.	.	.	Note=Reduced	activity.	S->L
P0AB98	UniProtKB	Mutagenesis	207	207	.	.	.	Note=No	change	in	activity.	L->Y%2CF
P0AB98	UniProtKB	Mutagenesis	210	210	.	.	.	Note=Completely	defective.	R->K%2CI%2CV%2CE
P0AB98	UniProtKB	Mutagenesis	214	214	.	.	.	Note=Completely	defective.	N->H
P0AB98	UniProtKB	Mutagenesis	214	214	.	.	.	Note=Reduced	activity.	N->V
P0AB98	UniProtKB	Mutagenesis	217	217	.	.	.	Note=Reduced	activity.	A->H
P0AB98	UniProtKB	Mutagenesis	217	217	.	.	.	Note=Completely	defective.	A->R
P0AB98	UniProtKB	Mutagenesis	245	245	.	.	.	Note=Reduced	activity.	H->Y
P00805	UniProtKB	Mutagenesis	34	34	.	.	.	Note=Loss	of	enzyme	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1906013;Dbxref=PMID:1906013
P00805	UniProtKB	Mutagenesis	111	111	.	.	.	Note=Reduced	enzyme	activity.	T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8706862;Dbxref=PMID:8706862
P00805	UniProtKB	Mutagenesis	111	111	.	.	.	Note=Loss	of	enzyme	activity.	T->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8706862;Dbxref=PMID:8706862
P22106	UniProtKB	Mutagenesis	2	2	.	.	.	Note=Loss	of	glutamine-dependent	activity	but	no	effect	on	ammonia-dependent	asparagine	synthetase	activity.	C->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7907328;Dbxref=PMID:7907328
P22106	UniProtKB	Mutagenesis	30	30	.	.	.	Note=4%2C5-fold	decrease	in	glutamine	affinity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7907328;Dbxref=PMID:7907328
P22106	UniProtKB	Mutagenesis	34	34	.	.	.	Note=Little	effect	on	the	kineticproperties.	D->N%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7907328;Dbxref=PMID:7907328
P22106	UniProtKB	Mutagenesis	81	81	.	.	.	Note=5-fold	decrease	in	glutamine	affinity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7907328;Dbxref=PMID:7907328
P22106	UniProtKB	Mutagenesis	105	105	.	.	.	Note=Little	effect	on	the	kineticproperties.	A->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7907328;Dbxref=PMID:7907328
P22106	UniProtKB	Mutagenesis	349	349	.	.	.	Note=Loss	of	glutamine-	and	ammonia-dependent	synthetase	activity%2C	but	still	exhibits	glutaminase	activity.	E->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20853825;Dbxref=PMID:20853825
P22106	UniProtKB	Mutagenesis	349	349	.	.	.	Note=5-fold	increase	in	affinitfor	asparate	when	assaying	both	the	glutamine-	and	ammonia-dependent	synthetase	reactions%2C	and	2-fold	decrease	in	kcat	for	these	reactions.	Modifies	the	productglutamate/asparagine	stoichiometry.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20853825;Dbxref=PMID:20853825
P0A6C8	UniProtKB	Mutagenesis	8	8	.	.	.	Note=Reduces	activity	50-fold.	Increases	KM	for	N-acetyl-L-glutamate	and	ATP	about	10-fold.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14623187;Dbxref=PMID:14623187
P0A6C8	UniProtKB	Mutagenesis	66	66	.	.	.	Note=Increases	KM	for	N-acetyl-L-glutamate	over	1000-fold.	Increases	KM	for	ATP	nearly	20-fold.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14623187;Dbxref=PMID:14623187
P0A6C8	UniProtKB	Mutagenesis	158	158	.	.	.	Note=Increases	KM	for	N-acetyl-L-glutamate	over	1000-fold.	Increases	KM	for	ATP	over	20-fold.	N->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14623187;Dbxref=PMID:14623187
P0A6C8	UniProtKB	Mutagenesis	162	162	.	.	.	Note=Reduces	activity	over	99%25.	No	effect	on	KM	for	N-acetyl-L-glutamate	and	ATP.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14623187;Dbxref=PMID:14623187
P05194	UniProtKB	Mutagenesis	143	143	.	.	.	Note=Loss	of	dehydratase	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7592767;Dbxref=PMID:7592767
P05194	UniProtKB	Mutagenesis	146	146	.	.	.	Note=It	retains	full	catalytic	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7592767;Dbxref=PMID:7592767
P05194	UniProtKB	Mutagenesis	170	170	.	.	.	Note=Loss	of	dehydratase	activity%2C	but	it	is	still	able	to	bind	substrate.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7592767;Dbxref=PMID:7592767
P05194	UniProtKB	Mutagenesis	205	205	.	.	.	Note=It	has	little	effect	on	the	catalytic	efficiency	and	affinity	for	3-dehydroquinate.	M->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7592767;Dbxref=PMID:7592767
P0ABB4	UniProtKB	Mutagenesis	157	157	.	.	.	Note=Impairs	ATPase	activity.	T->A%2CC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1832155;Dbxref=PMID:1832155
P39333	UniProtKB	Mutagenesis	50	50	.	.	.	Note=Shows	higher	affinity	for	cyclic-di-GMP%2C	increases	swimming	motility	and	biofilm	dispersal.	Biofilm	formation	is	almost	completely	removed.	E->Q%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21059164;Dbxref=PMID:21059164
P76216	UniProtKB	Mutagenesis	365	365	.	.	.	Note=Large	decrease	in	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15703173;Dbxref=PMID:15703173
P68699	UniProtKB	Mutagenesis	23	23	.	.	.	Note=In	uncE429%3B	unable	to	assemblin	the	membrane.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:6309138;Dbxref=PMID:6309138
P68699	UniProtKB	Mutagenesis	28	28	.	.	.	Note=In	DC1%3B	has	a	functional	F0	as	well	as	F1	part.	However%2C	the	ATPase	activity	is	inhibited.	I->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:6446460;Dbxref=PMID:6446460
P68699	UniProtKB	Mutagenesis	31	31	.	.	.	Note=In	uncE408	and	uncE463%3B	unable	to	assemble	in	the	membrane.	L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:6309138;Dbxref=PMID:6309138
P68699	UniProtKB	Mutagenesis	61	61	.	.	.	Note=In	DG	7/1%3B	contains	an	enzymatically	active	F1	component%2C	but	no	functional	F0	component.	D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:6446460;Dbxref=PMID:6446460
P0A940	UniProtKB	Mutagenesis	435	435	.	.	.	Note=Very	minor	growth	defect.	Lethal%3B	when	associated	with	L-800.	E->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24619089;Dbxref=PMID:24619089
P0A940	UniProtKB	Mutagenesis	464	464	.	.	.	Note=Very	minor	growth	defect.	D->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24619089;Dbxref=PMID:24619089
P0A940	UniProtKB	Mutagenesis	500	500	.	.	.	Note=Very	minor	growth	defect.	D->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24619089;Dbxref=PMID:24619089
P0A940	UniProtKB	Mutagenesis	547	547	.	.	.	Note=Lethal.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24619089;Dbxref=PMID:24619089
P0A940	UniProtKB	Mutagenesis	554	562	.	.	.	Note=Loop	4	to	HA	epitope%3B	still	susceptible	to	CdiA-EC93.	EHPSTSDQD->VDYPYDVPDYA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23882017;Dbxref=PMID:23882017
P0A940	UniProtKB	Mutagenesis	556	563	.	.	.	Note=Delta	loop	4%3B	slight	increasin	resistance	to	CdiA-EC93%2C	forms	aggregates	with	CdiA-EC93	cells.	PSTSDQDN->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23882017;Dbxref=PMID:23882017
P0A940	UniProtKB	Mutagenesis	661	661	.	.	.	Note=Slow	growth	on	solid	and	liquid	media%2C	less	protein	accumulates	which	is	more	proteinase	sensitive.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24619089;Dbxref=PMID:24619089
P0A940	UniProtKB	Mutagenesis	673	702	.	.	.	Note=Lethal.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24619089;Dbxref=PMID:24619089
P0A940	UniProtKB	Mutagenesis	675	701	.	.	.	Note=Delta	loop	6%3B	fully	resistant	to	CdiA-EC93%2C	does	not	form	aggregates	with	CdiA-EC93	cells.	FPHQASNYDPDYDYECATQDGAKDLCK->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23882017;Dbxref=PMID:23882017
P0A940	UniProtKB	Mutagenesis	677	685	.	.	.	Note=Loop	6	to	HA	epitope%3B	still	susceptible	to	CdiA-EC93.	HQASNYDPD->VDYPYDVPDYA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23882017;Dbxref=PMID:23882017
P0A940	UniProtKB	Mutagenesis	740	740	.	.	.	Note=Slow	growth	on	solid	and	liquid	media%2C	less	protein	accumulates	which	is	more	proteinase	sensitive.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24619089;Dbxref=PMID:24619089
P0A940	UniProtKB	Mutagenesis	754	755	.	.	.	Note=Loop	7	to	HA	epitope%3B	fully	resistant	to	CdiA-EC93%2C	does	not	form	aggregates	with	CdiA-EC93	cells.	YS->VDYPYDVPDYA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23882017;Dbxref=PMID:23882017
P0A940	UniProtKB	Mutagenesis	800	800	.	.	.	Note=Very	minor	growth	defect.	Lethal%3B	when	associated	with	L-435.	E->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24619089;Dbxref=PMID:24619089
P66948	UniProtKB	Mutagenesis	136	136	.	.	.	Note=Lack	of	protease	activity.	Increases	sensitivity	to	erythromycin.	H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24003122;Dbxref=PMID:24003122
P66948	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Lack	of	protease	activity.	Increases	sensitivity	to	erythromycin.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24003122;Dbxref=PMID:24003122
P13000	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Strong	decreased	in	the	affinity	for	ATP%3B	essential	role	for	this	residue	in	the	steady-state	affinity	for	ATP.	T->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9125495;Dbxref=PMID:9125495
P13000	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Almost	no	change	in	activity.	E->A%2CD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9125495;Dbxref=PMID:9125495
P13000	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Complete	loss	of	activity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9125495;Dbxref=PMID:9125495
P13000	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Complete	loss	of	activity.	K->L%2CQ%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9125495;Dbxref=PMID:9125495
P13000	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Almost	no	change	in	activity.	S->A%2CC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9125495;Dbxref=PMID:9125495
P0AFP2	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Does	not	confer	alkyltransferasactivity.	W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16027108;Dbxref=PMID:16027108
P0ABB0	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Reduced	activity	and	reducedATP-binding.	K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2903146;Dbxref=PMID:2903146
P0ABB0	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Reduced	activity	and	loss	of	ATP-binding.	K->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2903146;Dbxref=PMID:2903146
P30847	UniProtKB	Mutagenesis	150	150	.	.	.	Note=Increased	expression	of	periplasmic	chaperone	Spy.	R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21317898;Dbxref=PMID:21317898
P30847	UniProtKB	Mutagenesis	192	192	.	.	.	Note=Increased	expression	of	periplasmic	chaperone	Spy.	P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21317898;Dbxref=PMID:21317898
P30847	UniProtKB	Mutagenesis	264	264	.	.	.	Note=Increased	expression	of	periplasmic	chaperone	Spy.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21317898;Dbxref=PMID:21317898
P30847	UniProtKB	Mutagenesis	268	268	.	.	.	Note=Increased	expression	of	periplasmic	chaperone	Spy.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21317898;Dbxref=PMID:21317898
P30847	UniProtKB	Mutagenesis	416	416	.	.	.	Note=Increased	expression	of	periplasmic	chaperone	Spy%2C	increased	mRNA	for	mdtA	and	acrD%2C	target	genes	of	the	BaeSR	envelope	stress	response.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21317898;Dbxref=PMID:21317898
P12995	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Severely	reduces	the	aminotransferasactivity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14756557;Dbxref=PMID:14756557
P12995	UniProtKB	Mutagenesis	144	144	.	.	.	Note=Severely	reduces	the	aminotransferasactivity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14756557;Dbxref=PMID:14756557
P12995	UniProtKB	Mutagenesis	147	147	.	.	.	Note=Loss	of	aminotransferase	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14756557;Dbxref=PMID:14756557
P12995	UniProtKB	Mutagenesis	253	253	.	.	.	Note=Has	only	a	small	effect	on	the	rate	of	reaction	with	DAPA.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14756557;Dbxref=PMID:14756557
P12995	UniProtKB	Mutagenesis	253	253	.	.	.	Note=Increases	aminotransferase	activittoward	SAM.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14756557;Dbxref=PMID:14756557
P12995	UniProtKB	Mutagenesis	253	253	.	.	.	Note=Loss	of	aminotransferase	activity.	R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14756557;Dbxref=PMID:14756557
P12995	UniProtKB	Mutagenesis	253	253	.	.	.	Note=Increases	aminotransferase	activittoward	SAM.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14756557;Dbxref=PMID:14756557
P12995	UniProtKB	Mutagenesis	391	391	.	.	.	Note=Reduces	aminotransferase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12379100;Dbxref=PMID:12379100
P12996	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Total	loss	of	activity.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11834738,ECO:0000269|PubMed:11862544;Dbxref=PMID:11834738,PMID:11862544
P12996	UniProtKB	Mutagenesis	57	57	.	.	.	Note=Total	loss	of	activity.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11834738,ECO:0000269|PubMed:11862544;Dbxref=PMID:11834738,PMID:11862544
P12996	UniProtKB	Mutagenesis	60	60	.	.	.	Note=Total	loss	of	activity.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11834738,ECO:0000269|PubMed:11862544;Dbxref=PMID:11834738,PMID:11862544
P12996	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Total	loss	of	activity.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11834738,ECO:0000269|PubMed:11862544;Dbxref=PMID:11834738,PMID:11862544
P12996	UniProtKB	Mutagenesis	128	128	.	.	.	Note=Total	loss	of	activity.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11834738,ECO:0000269|PubMed:11862544;Dbxref=PMID:11834738,PMID:11862544
P12996	UniProtKB	Mutagenesis	151	151	.	.	.	Note=Total	loss	of	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17014080;Dbxref=PMID:17014080
P12996	UniProtKB	Mutagenesis	152	152	.	.	.	Note=Weak	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17014080;Dbxref=PMID:17014080
P12996	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Total	loss	of	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17014080;Dbxref=PMID:17014080
P12996	UniProtKB	Mutagenesis	155	155	.	.	.	Note=Total	loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17014080;Dbxref=PMID:17014080
P12996	UniProtKB	Mutagenesis	188	188	.	.	.	Note=Total	loss	of	activity.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11834738,ECO:0000269|PubMed:11862544;Dbxref=PMID:11834738,PMID:11862544
P13001	UniProtKB	Mutagenesis	82	82	.	.	.	Note=No	effect	on	CoA-binding.	Loss	of	Carboxylesterase	activity.	S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11904168,ECO:0000269|PubMed:20693992;Dbxref=PMID:11904168,PMID:20693992
P0ABD3	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Highly	decreased	Fe(2+)	oxidation	activity.	Is	also	severely	restricted	in	its	ability	to	lay	down	an	iron	core.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14636073;Dbxref=PMID:14636073
P0ABD3	UniProtKB	Mutagenesis	31	31	.	.	.	Note=No	loss	of	heme	binding.	M->H%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7559480;Dbxref=PMID:7559480
P0ABD3	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Fe(2+)-binding	and	single	turnoveoxidation	at	the	ferroxidase	center	occur	normally	but	iron	mineralization	within	the	cavity	is	significantly	impaired.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19391621;Dbxref=PMID:19391621
P0ABD3	UniProtKB	Mutagenesis	50	50	.	.	.	Note=Fe(2+)-binding	and	single	turnoveoxidation	at	the	ferroxidase	center	occur	normally	but	iron	mineralization	within	the	cavity	is	significantly	impaired.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19391621;Dbxref=PMID:19391621
P0ABD3	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Loss	of	heme	binding.	Is	still	capable	of	accumulating	iron.	M->H%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7559480;Dbxref=PMID:7559480
P0ABD3	UniProtKB	Mutagenesis	86	86	.	.	.	Note=No	loss	of	heme	binding.	M->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7559480;Dbxref=PMID:7559480
P0ABD3	UniProtKB	Mutagenesis	127	127	.	.	.	Note=Decreased	Fe(2+)	oxidation	activity.	Is	also	affected	in	its	ability	to	lay	down	an	iron	core.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14636073;Dbxref=PMID:14636073
P0ABD3	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Decreased	Fe(2+)	oxidation	activity.	Is	also	severely	restricted	in	its	ability	to	lay	down	an	iron	core.	H->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14636073;Dbxref=PMID:14636073
P00722	UniProtKB	Mutagenesis	202	202	.	.	.	Note=Causes	a	significant	decreasin	binding	affinity	in	the	absence	of	monovalent	cations	or	in	the	presence	of	potassium	ions%2C	but	only	a	moderate	decrease	in	the	presence	of	sodium	ions.	D->E%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15060622;Dbxref=PMID:15060622
P00722	UniProtKB	Mutagenesis	202	202	.	.	.	Note=Obliterates	all	binding	and	catalysis.	D->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15060622;Dbxref=PMID:15060622
P00722	UniProtKB	Mutagenesis	358	358	.	.	.	Note=Less	stable	to	heat	than	wild-type.	Causes	significant	destabilizations	of	the	first	transition	state.	H->D%2CF%2CL%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9665715;Dbxref=PMID:9665715
P00722	UniProtKB	Mutagenesis	392	392	.	.	.	Note=Essentially	inactive	unless	very	rapid	purification.	Causes	very	large	destabilizations	of	the	transition	state.	H->E%2CF%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11310566;Dbxref=PMID:11310566
P00722	UniProtKB	Mutagenesis	462	462	.	.	.	Note=Slowly	inactivates	galactosidase	activity	by	reducing	the	binding	of	magnesium.	It	increases	binding	specificity.	E->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7577931;Dbxref=PMID:7577931
P00722	UniProtKB	Mutagenesis	538	538	.	.	.	Note=10000-fold	decrease	in	the	beta-galactosidase	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11732897;Dbxref=PMID:11732897
P00722	UniProtKB	Mutagenesis	541	541	.	.	.	Note=Poorly	reactive	with	galactosyl	substrates.	Less	stable	to	heat	than	wild-type.	H->E%2CF%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8662937;Dbxref=PMID:8662937
P00722	UniProtKB	Mutagenesis	602	602	.	.	.	Note=Decreases	the	stability	of	the	loop	794-804.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11732897;Dbxref=PMID:11732897
P00722	UniProtKB	Mutagenesis	795	795	.	.	.	Note=It	forces	the	apoenzyme	to	adopt	the	closed	rather	than	the	open	conformation.	Reduces	the	binding	affinity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14621996;Dbxref=PMID:14621996
P00722	UniProtKB	Mutagenesis	798	798	.	.	.	Note=The	catalytic	efficiency	is	not	increased%2C	when	the	sodium	concentration	increases.	E->A%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17126292;Dbxref=PMID:17126292
P00722	UniProtKB	Mutagenesis	798	798	.	.	.	Note=Small	increase	of	the	catalytic	efficiency%2C	when	the	sodium	concentration	increases.	E->D%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17126292;Dbxref=PMID:17126292
P00722	UniProtKB	Mutagenesis	1000	1000	.	.	.	Note=Decreases	affinity	for	substrate.	W->F%2CG%2CL%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12578395;Dbxref=PMID:12578395
P06709	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Does	not	affect	repressor	activity.	T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24189073;Dbxref=PMID:24189073
P06709	UniProtKB	Mutagenesis	52	52	.	.	.	Note=5-fold	increase	of	repressor	activity.	Increases	binding	to	DNA.	T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24189073;Dbxref=PMID:24189073
P06709	UniProtKB	Mutagenesis	57	57	.	.	.	Note=Lack	of	repressor	activity.	Does	not	bind	DNA.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24189073;Dbxref=PMID:24189073
P06709	UniProtKB	Mutagenesis	58	58	.	.	.	Note=Lack	of	repressor	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24189073;Dbxref=PMID:24189073
P06709	UniProtKB	Mutagenesis	58	58	.	.	.	Note=Does	not	affect	repressor	activity.	Y->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24189073;Dbxref=PMID:24189073
P23890	UniProtKB	Mutagenesis	120	124	.	.	.	Note=Significantly	reduced	dependence	on	EF-P	for	translation%2C	increased	levels	of	protein	in	an	efp-strain.	PPPIP->AAAIS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23239623;Dbxref=PMID:23239623
P23890	UniProtKB	Mutagenesis	121	121	.	.	.	Note=Reduced	dependence	on	EF-P	for	translation%2C	increased	levels	of	protein	in	an	efp-	strain.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23239623;Dbxref=PMID:23239623
P06129	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Inactivates	uptake.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11705387;Dbxref=PMID:11705387
P06129	UniProtKB	Mutagenesis	30	30	.	.	.	Note=Inactivates	uptake.	V->G%2CP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11705387;Dbxref=PMID:11705387
P75990	UniProtKB	Mutagenesis	193	195	.	.	.	Note=Does	not	confer	c-di-GMP	phosphodiesterase	activity.	IVQ->LVR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19240136;Dbxref=PMID:19240136
P06961	UniProtKB	Mutagenesis	21	21	.	.	.	Note=No	effect	on	phosphodiesterase	and	phosphatase	activities.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15210699;Dbxref=PMID:15210699
P06961	UniProtKB	Mutagenesis	23	23	.	.	.	Note=No	effect	on	phosphodiesterase	and	phosphatase	activities.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15210699;Dbxref=PMID:15210699
P06961	UniProtKB	Mutagenesis	70	70	.	.	.	Note=Lowered	AMP	incorporation.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3533927;Dbxref=PMID:3533927
P06961	UniProtKB	Mutagenesis	255	255	.	.	.	Note=Loss	of	phosphodiesterase	and	phosphatase	activities.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15210699;Dbxref=PMID:15210699
P06961	UniProtKB	Mutagenesis	256	256	.	.	.	Note=Loss	of	phosphodiesterase	and	phosphatase	activities.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15210699;Dbxref=PMID:15210699
P06961	UniProtKB	Mutagenesis	305	305	.	.	.	Note=Loss	of	phosphodiesterase	and	phosphatase	activities.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15210699;Dbxref=PMID:15210699
P06961	UniProtKB	Mutagenesis	306	306	.	.	.	Note=Still	possesses	phosphodiesterase	and	phosphatase	activities.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15210699;Dbxref=PMID:15210699
P00864	UniProtKB	Mutagenesis	138	138	.	.	.	Note=Loss	of	activity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1765093;Dbxref=PMID:1765093
P00864	UniProtKB	Mutagenesis	579	579	.	.	.	Note=29%25	of	wild-type	activity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2016273;Dbxref=PMID:2016273
P00864	UniProtKB	Mutagenesis	579	579	.	.	.	Note=5.4%25	of	wild-type	activity.	H->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2016273;Dbxref=PMID:2016273
P00864	UniProtKB	Mutagenesis	587	587	.	.	.	Note=Loss	of	activity.	R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7490260;Dbxref=PMID:7490260
P45956	UniProtKB	Mutagenesis	9	9	.	.	.	Note=No	effect	on	spacer	acquisition%2C	Cas1-Cas2	complex	formation	or	CRISPR	DNA-binding	by	complex.	E->A%2CR;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24793649,ECO:0000269|PubMed:25707795;Dbxref=PMID:24793649,PMID:25707795
P45956	UniProtKB	Mutagenesis	10	10	.	.	.	Note=No	effect	on	spacer	acquisition.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
P45956	UniProtKB	Mutagenesis	14	16	.	.	.	Note=No	in	vivspacer	acquisition%2C	significantly	decreased	protospacer	binding.	RLR->ALA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26478180;Dbxref=PMID:26478180
P45956	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Slight	decrease	in	spacer	acquisition.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
P45956	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Slight	decrease	in	spacer	acquisition.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
P45956	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Dramatically	decreased	spacer	acquisition	in	vivo.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26503043;Dbxref=PMID:26503043
P45956	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Very	little	spacer	acquisition.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
P45956	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Slight	decrease	in	spacer	acquisition.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
P45956	UniProtKB	Mutagenesis	38	40	.	.	.	Note=Very	little	in	vivo	spacer	acquisition.	KIR->AIA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26478180;Dbxref=PMID:26478180
P45956	UniProtKB	Mutagenesis	65	65	.	.	.	Note=No	effect	on	spacer	acquisition.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
P45956	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Slight	decrease	in	spacer	acquisition%2C	Cas1-Cas2	complex	formation	or	CRISPR	DNA-binding	by	complex.	Loss	of	spacer	acquisition%3B	when	associated	with	R-84.	E->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
P45956	UniProtKB	Mutagenesis	77	78	.	.	.	Note=No	spacer	acquisition%2C	significantly	decreased	protospacer	binding.	RR->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26478180;Dbxref=PMID:26478180
P45956	UniProtKB	Mutagenesis	77	77	.	.	.	Note=No	change	in	spacer	acquisition	in	vivo.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26503043;Dbxref=PMID:26503043
P45956	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Dramatically	decreased	spacer	acquisition	in	vivo.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26503043;Dbxref=PMID:26503043
P45956	UniProtKB	Mutagenesis	79	94	.	.	.	Note=Loss	of	spacer	acquisition%2C	no	Cas1-Cas2	complex	formation%2C	loss	of	CRISPR	DNA-binding	by	complex	(beta6-beta7	deletion).	Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24793649,ECO:0000269|PubMed:25707795;Dbxref=PMID:24793649,PMID:25707795
P45956	UniProtKB	Mutagenesis	84	84	.	.	.	Note=No	effect	on	spacer	acquisition.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
P45956	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Slight	decrease	in	spacer	acquisition.	Loss	of	spacer	acquisition%3B	when	associated	with	R-65.	D->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24793649;Dbxref=PMID:24793649
P38036	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Loss	of	CRISPR	immunity	to	lambda	DNA	and	of	CRISPR-mediated	plasmid	curing.	H->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21699496,ECO:0000269|PubMed:22521689;Dbxref=PMID:21699496,PMID:22521689
P38036	UniProtKB	Mutagenesis	74	74	.	.	.	Note=75%25	R-loop	formation.	H->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21699496,ECO:0000269|PubMed:22521689;Dbxref=PMID:21699496,PMID:22521689
P38036	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Loss	of	CRISPR	immunity	to	lambda	DNA	and	of	CRISPR-mediated	plasmid	curing.	D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21699496,ECO:0000269|PubMed:22521689;Dbxref=PMID:21699496,PMID:22521689
P38036	UniProtKB	Mutagenesis	75	75	.	.	.	Note=10%25	R-loop	formation.	D->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21699496,ECO:0000269|PubMed:22521689;Dbxref=PMID:21699496,PMID:22521689
P38036	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Loss	of	CRISPR	immunity	to	lambda	DNA	and	of	CRISPR-mediated	plasmid	curing.	K->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21699496,ECO:0000269|PubMed:22521689;Dbxref=PMID:21699496,PMID:22521689
P38036	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Less	than	5%25	R-loop	formation%2C	binds	DNA	normally.	100-fold	greater	senstivity	to	bacteriophage	lambda.	No	effect	on	R-loop	formation%3B	when	associated	with	L-320.	K->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21699496,ECO:0000269|PubMed:22521689;Dbxref=PMID:21699496,PMID:22521689
P38036	UniProtKB	Mutagenesis	317	318	.	.	.	Note=No	effect	on	R-loop	formation.	Impaired	R-loop	unwinding.	GS->SY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21699496;Dbxref=PMID:21699496
P38036	UniProtKB	Mutagenesis	320	320	.	.	.	Note=Double	R-loop	formation.	2-4	fold	decreased	ATPase.	No	effect	on	R-loop	formation%3B	when	associated	with	L-78.	K->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21699496,ECO:0000269|PubMed:22521689;Dbxref=PMID:21699496,PMID:22521689
P38036	UniProtKB	Mutagenesis	320	320	.	.	.	Note=Loss	of	CRISPR	immunity	to	lambda	DNA	and	of	CRISPR-mediated	plasmid	curing.	Nicks	target	plasmid	DNA	but	does	not	degrade	it.	K->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21699496,ECO:0000269|PubMed:22521689;Dbxref=PMID:21699496,PMID:22521689
P38036	UniProtKB	Mutagenesis	452	452	.	.	.	Note=Loss	of	CRISPR	immunity	to	lambda	DNA	and	of	CRISPR-mediated	plasmid	curing.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22521689;Dbxref=PMID:22521689
P38036	UniProtKB	Mutagenesis	455	455	.	.	.	Note=Loss	of	R-loop	unwinding.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21699496;Dbxref=PMID:21699496
P38036	UniProtKB	Mutagenesis	483	485	.	.	.	Note=Retains	CRISPR	immunity	to	lambda	DNA	and	CRISPR-mediated	plasmid	curing.	SAT->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22521689;Dbxref=PMID:22521689
P64524	UniProtKB	Mutagenesis	1	15	.	.	.	Note=No	longer	toxic%2C	cells	become	lemon-shaped	more	quickly	than	wild-type	on	overexpression.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21166897;Dbxref=PMID:21166897
P69490	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Abolishes	heme	binding.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12486054;Dbxref=PMID:12486054
P69490	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Can	still	form	a	covalenbond	with	heme%2C	but	blocks	heme	release	transfer	to	cytochrome	c.	H->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12486054;Dbxref=PMID:12486054
Q46897	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Loss	of	pre-crRNA	cleavage.	H->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18703739,ECO:0000269|PubMed:21255106;Dbxref=PMID:18703739,PMID:21255106
P0A9H9	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Gain	of	function%2C	increased	counterclockwise	rotation	of	flagella.	I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17998207;Dbxref=PMID:17998207
P0A9H9	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Loss	of	function%2C	fails	to	oligomerize.	A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10852888;Dbxref=PMID:10852888
P0A9H9	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Loss	of	localization	to	the	cell	pole.	Fails	to	oligomerize.	L->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10852888,ECO:0000269|PubMed:12644507;Dbxref=PMID:10852888,PMID:12644507
P0A9H9	UniProtKB	Mutagenesis	94	94	.	.	.	Note=Loss	of	localization	to	the	cell	pole.	W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12644507;Dbxref=PMID:12644507
P0A9H9	UniProtKB	Mutagenesis	117	117	.	.	.	Note=Loss	of	localization	to	the	cell	pole.	F->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10852888,ECO:0000269|PubMed:12644507;Dbxref=PMID:10852888,PMID:12644507
P0A9H9	UniProtKB	Mutagenesis	143	143	.	.	.	Note=Loss	of	function.	Fails	to	oligomerize.	D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10852888;Dbxref=PMID:10852888
P0A9H9	UniProtKB	Mutagenesis	147	147	.	.	.	Note=Severely	diminished	function%2C	exclusive	clockwise	flagellar	rotation.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12080332;Dbxref=PMID:12080332
P0A9H9	UniProtKB	Mutagenesis	188	188	.	.	.	Note=Diminished	ability	to	stimulate	dephosphorylation	of	CheY-P.	G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10852888;Dbxref=PMID:10852888
P0A9H9	UniProtKB	Mutagenesis	205	205	.	.	.	Note=Severely	impairs	the	interaction	the	interaction	with	CheY-P.	V->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10852888;Dbxref=PMID:10852888
P0AGE6	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Improves	chromate	reductase	activity	compared	to	the	wild-type	enzyme.	Y->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22558308;Dbxref=PMID:22558308
P0AGE6	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Improves	chromate	reductase	activity	compared	to	the	wild-type	enzyme.	R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22558308;Dbxref=PMID:22558308
P0AGE6	UniProtKB	Mutagenesis	128	128	.	.	.	Note=Improves	chromate	reductase	activity	compared	to	the	wild-type	enzyme.	Increase	of	the	affinity	binding	and	catalytic	efficiency	for	both	chromate	and	uranate.	Y->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17088379;Dbxref=PMID:17088379
P0AGE6	UniProtKB	Mutagenesis	146	146	.	.	.	Note=Improves	chromate	reductase	activity	compared	to	the	wild-type	enzyme.	E->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22558308;Dbxref=PMID:22558308
P37019	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Uncouples	chloride	transport	from	proton	transport.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16341087;Dbxref=PMID:16341087
P37019	UniProtKB	Mutagenesis	148	148	.	.	.	Note=Abolishes	proton	transport%2C	but	permits	the	transit	of	chloride	ions.	Abolishes	gating%2C	permitting	continuous	rapid	transit	of	chloride	ions%3B	when	associated	with	A-445.	E->A%2CQ;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12649487,ECO:0000269|PubMed:14985752,ECO:0000269|PubMed:16341087,ECO:0000269|PubMed:18678918;Dbxref=PMID:12649487,PMID:14985752,PMID:16341087,PMID:18678918
P37019	UniProtKB	Mutagenesis	203	203	.	.	.	Note=Abolishes	proton	transport%2C	and	reduces	chloride	transport.	E->A%2CG%2CQ%2CS%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19139174;Dbxref=PMID:19139174
P37019	UniProtKB	Mutagenesis	203	203	.	.	.	Note=Abolishes	proton	and	chloride	transport.	E->C%2CI%2CL%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19139174;Dbxref=PMID:19139174
P37019	UniProtKB	Mutagenesis	203	203	.	.	.	Note=No	effect	on	proton	and	chloridtransport.	E->D%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19139174;Dbxref=PMID:19139174
P37019	UniProtKB	Mutagenesis	203	203	.	.	.	Note=Decreased	proton	and	chloride	transport.	E->K%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19139174;Dbxref=PMID:19139174
P37019	UniProtKB	Mutagenesis	445	445	.	.	.	Note=Abolishes	gating%2C	permitting	continuous	rapid	transit	of	chloride	ions%3B	when	associated	with	A-148.	Y->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16341087,ECO:0000269|PubMed:16949616,ECO:0000269|PubMed:18678918;Dbxref=PMID:16341087,PMID:16949616,PMID:18678918
P37019	UniProtKB	Mutagenesis	445	445	.	.	.	Note=No	effect.	Y->F%2CW;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16341087,ECO:0000269|PubMed:16949616,ECO:0000269|PubMed:18678918;Dbxref=PMID:16341087,PMID:16949616,PMID:18678918
P37019	UniProtKB	Mutagenesis	445	445	.	.	.	Note=Alters	stoichiometry	of	proton/chloride	exchange.	Y->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16341087,ECO:0000269|PubMed:16949616,ECO:0000269|PubMed:18678918;Dbxref=PMID:16341087,PMID:16949616,PMID:18678918
P0A6G7	UniProtKB	Mutagenesis	17	17	.	.	.	Note=No	ClpA-ClpP%2C	little	ClpX-ClpP	complex	forms.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16406682;Dbxref=PMID:16406682
P0A6G7	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Reduced	processing%2C	no	ClpA-ClpP	complex	forms.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16406682;Dbxref=PMID:16406682
P0A6G7	UniProtKB	Mutagenesis	19	19	.	.	.	Note=No	ClpA-ClpP%2C	little	ClpX-ClpP	complex	forms.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16406682;Dbxref=PMID:16406682
P0A6G7	UniProtKB	Mutagenesis	20	20	.	.	.	Note=No	ClpA-ClpP	or	ClpX-ClpP	complex	forms.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16406682;Dbxref=PMID:16406682
P0A6G7	UniProtKB	Mutagenesis	21	21	.	.	.	Note=No	ClpA-ClpP	or	ClpX-ClpP	complex	forms.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16406682;Dbxref=PMID:16406682
P0A6G7	UniProtKB	Mutagenesis	24	24	.	.	.	Note=No	ClpA-ClpP%2C	little	ClpX-ClpP	complex	forms.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16406682;Dbxref=PMID:16406682
P0A6G7	UniProtKB	Mutagenesis	27	27	.	.	.	Note=No	ClpA-ClpP%2C	little	ClpX-ClpP	complex	forms.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16406682;Dbxref=PMID:16406682
P0A6G7	UniProtKB	Mutagenesis	32	32	.	.	.	Note=No	ClpA-ClpP	or	ClpX-ClpP	complex	forms.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16406682;Dbxref=PMID:16406682
P0A6G7	UniProtKB	Mutagenesis	33	33	.	.	.	Note=No	ClpA-ClpP	or	ClpX-ClpP	complex	forms.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16406682;Dbxref=PMID:16406682
P0A6G7	UniProtKB	Mutagenesis	34	34	.	.	.	Note=No	ClpA-ClpP	or	ClpX-ClpP	complex	forms.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16406682;Dbxref=PMID:16406682
P0A6G7	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Little	ClpA-ClpP	or	ClpX-ClpP	complex	forms.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16406682;Dbxref=PMID:16406682
P0A6G7	UniProtKB	Mutagenesis	185	185	.	.	.	Note=Loss	of	protease	activity%2C	forms	ClpA-ClpP	complex.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16406682;Dbxref=PMID:16406682
P76291	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Decreases	affinity	toward	Cx-SAM	and	increases	affinity	toward	SAM.	Lack	of	carboxymethyltransferase	activity%2C	but	can	still	produce	mho5U.	K->A
P76291	UniProtKB	Mutagenesis	200	200	.	.	.	Note=Slight	decrease	in	Cx-SAM	binding	affinity.	Does	not	affect	carboxymethyltransferase	activity.	Y->A
P76291	UniProtKB	Mutagenesis	315	315	.	.	.	Note=Slight	decrease	in	Cx-SAM	binding	affinity.	Does	not	affect	carboxymethyltransferase	activity.	R->A
P0AE67	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Abolishes	magnesium	binding.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11023787;Dbxref=PMID:11023787
P0AE67	UniProtKB	Mutagenesis	13	13	.	.	.	Note=No	effect	on	magnesium	bindingD->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11023787;Dbxref=PMID:11023787
P0AE67	UniProtKB	Mutagenesis	57	57	.	.	.	Note=Abolishes	magnesium	binding.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11023787;Dbxref=PMID:11023787
P0AE67	UniProtKB	Mutagenesis	87	87	.	.	.	Note=Impairs	chemotaxis%3B	when	associated	with	W-106.	T->I
P0AE67	UniProtKB	Mutagenesis	92	92	.	.	.	Note=No	effect	on	chemotaxis.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9560203;Dbxref=PMID:9560203
P0AE67	UniProtKB	Mutagenesis	95	95	.	.	.	Note=Enhanced	CW	flagellar	rotational	signaling	activity.	I->A%2CV
P0AE67	UniProtKB	Mutagenesis	95	95	.	.	.	Note=Loss	of	CW	flagellar	rotational	signaling	activity.	I->D%2CK%2CM
P0AE67	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Impairs	chemotaxis%3B	when	associated	with	I-87.	Y->W
P0ABH7	UniProtKB	Mutagenesis	207	207	.	.	.	Note=Weakened	NADH	binding	and	inhibition.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1939121;Dbxref=PMID:1939121
P0ABH7	UniProtKB	Mutagenesis	208	208	.	.	.	Note=Weakened	NADH	binding	and	inhibition.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1939121;Dbxref=PMID:1939121
P63284	UniProtKB	Mutagenesis	7	7	.	.	.	Note=Loss	of	chaperone	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12139937;Dbxref=PMID:12139937
P63284	UniProtKB	Mutagenesis	84	84	.	.	.	Note=No	effect.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12139937;Dbxref=PMID:12139937
P63284	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Loss	of	chaperone	activity.	Retains	ATPase	activity.	L->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12623019;Dbxref=PMID:12623019
P63284	UniProtKB	Mutagenesis	97	97	.	.	.	Note=75%25	decrease	in	chaperone	activity%3B	retains	ATPase	activity.	L->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12623019;Dbxref=PMID:12623019
P63284	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Loss	of	chaperone	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12139937;Dbxref=PMID:12139937
P63284	UniProtKB	Mutagenesis	109	109	.	.	.	Note=Loss	of	chaperone	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12139937;Dbxref=PMID:12139937
P63284	UniProtKB	Mutagenesis	110	110	.	.	.	Note=30%25	decrease	in	chaperone	activity%3B	retains	ATPase	activity.	L->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12623019;Dbxref=PMID:12623019
P63284	UniProtKB	Mutagenesis	212	212	.	.	.	Note=Loss	of	ability	to	form	oligomers	even	in	the	presence	of	ATP.	Loss	of	chaperone	activity.	K->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11061966,ECO:0000269|PubMed:12220194,ECO:0000269|PubMed:12624113;Dbxref=PMID:11061966,PMID:12220194,PMID:12624113
P63284	UniProtKB	Mutagenesis	251	251	.	.	.	Note=Decrease	in	ability	to	disaggregate	proteins	due	to	decreased	substrate-binding	activity.	Retains	hexameric	quaternary	structure	and	ATPase	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15208691;Dbxref=PMID:15208691
P63284	UniProtKB	Mutagenesis	254	254	.	.	.	Note=Decrease	in	ability	to	disaggregate	proteins	due	to	decreased	substrate-binding	activity.	Retains	hexameric	quaternary	structure	and	ATPase	activity%3B	when	associated	with	A-257.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15208691;Dbxref=PMID:15208691
P63284	UniProtKB	Mutagenesis	257	257	.	.	.	Note=Decrease	in	ability	to	disaggregate	proteins	due	to	decreased	substrate-binding	activity.	Retains	hexameric	quaternary	structure	and	ATPase	activity%3B	when	associated	with	A-254.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15208691;Dbxref=PMID:15208691
P63284	UniProtKB	Mutagenesis	279	279	.	.	.	Note=No	effect	on	oligomerization.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12624113;Dbxref=PMID:12624113
P63284	UniProtKB	Mutagenesis	332	332	.	.	.	Note=Loss	of	ability	to	form	oligomers.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12624113;Dbxref=PMID:12624113
P63284	UniProtKB	Mutagenesis	543	543	.	.	.	Note=No	effect	on	chaperone	activitor	ability	to	form	oligomers.	W->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12624113;Dbxref=PMID:12624113
P63284	UniProtKB	Mutagenesis	611	611	.	.	.	Note=No	effect	on	ability	to	form	oligomers.	Loss	of	chaperone	activity.	K->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11061966,ECO:0000269|PubMed:12220194,ECO:0000269|PubMed:12624113;Dbxref=PMID:11061966,PMID:12220194,PMID:12624113
P63284	UniProtKB	Mutagenesis	678	678	.	.	.	Note=No	effect	on	oligomerization.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12624113;Dbxref=PMID:12624113
P63284	UniProtKB	Mutagenesis	756	756	.	.	.	Note=No	effect	on	oligomerization.	Loss	of	ATPase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12624113;Dbxref=PMID:12624113
P63284	UniProtKB	Mutagenesis	797	797	.	.	.	Note=No	effect.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12220194;Dbxref=PMID:12220194
P63284	UniProtKB	Mutagenesis	813	815	.	.	.	Note=No	effect	on	oligomerization.	GAR->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12624113;Dbxref=PMID:12624113
P63284	UniProtKB	Mutagenesis	815	815	.	.	.	Note=Loss	of	ability	to	form	oligomers%3B	loss	of	chaperone	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12220194;Dbxref=PMID:12220194
P63284	UniProtKB	Mutagenesis	819	819	.	.	.	Note=Loss	of	ability	to	form	oligomers%3B	loss	of	chaperone	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12220194;Dbxref=PMID:12220194
P63284	UniProtKB	Mutagenesis	826	826	.	.	.	Note=No	effect.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12220194;Dbxref=PMID:12220194
P37794	UniProtKB	Mutagenesis	11	11	.	.	.	Note=Unable	to	induce	CnbR	and	to	grow	on	chitobiose.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22797760;Dbxref=PMID:22797760
P37794	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Unable	to	induce	CnbR	and	to	grow	on	chitobiose.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22797760;Dbxref=PMID:22797760
P37794	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Unable	to	induce	CnbR	and	to	grow	on	chitobiose.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22797760;Dbxref=PMID:22797760
P0A6H1	UniProtKB	Mutagenesis	185	185	.	.	.	Note=No	ATP	hydrolyis.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23622246;Dbxref=PMID:23622246
P0A6H1	UniProtKB	Mutagenesis	370	370	.	.	.	Note=No	ATP	hydrolyis.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23622246;Dbxref=PMID:23622246
P0A6H8	UniProtKB	Mutagenesis	2	60	.	.	.	Note=Remains	membrane	associated	and	retains	in	vitro	and	in	vivo	activity.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22988102;Dbxref=PMID:22988102
P0A6H8	UniProtKB	Mutagenesis	7	8	.	.	.	Note=Retains	in	vitro	activity%2C	but	loses	most	of	its	in	vivo	activity.	Higher	apparent	molecular	mass	than	wild-type	protein.	LV->SS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22988102;Dbxref=PMID:22988102
P0A6H8	UniProtKB	Mutagenesis	30	32	.	.	.	Note=Undergoes	altered	post-translational	processing	and	has	much	lower	in	vivo	and	in	vitro	activity.	KRR->TTT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22988102;Dbxref=PMID:22988102
P0A6H8	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Does	not	affect	CL	synthasprocessing	or	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22988102;Dbxref=PMID:22988102
P75919	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Lack	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22988102;Dbxref=PMID:22988102
P75919	UniProtKB	Mutagenesis	369	369	.	.	.	Note=Lack	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22988102;Dbxref=PMID:22988102
P64467	UniProtKB	Mutagenesis	44	44	.	.	.	Note=Abolishes	heterocomplex	formation	with	H-NS.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21600204;Dbxref=PMID:21600204
P76290	UniProtKB	Mutagenesis	89	89	.	.	.	Note=Lack	of	activity.	D->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23676670;Dbxref=PMID:23676670
P36566	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Lack	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26681692;Dbxref=PMID:26681692
P36566	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Lack	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26681692;Dbxref=PMID:26681692
P36566	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Lack	of	activity.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26681692;Dbxref=PMID:26681692
P36566	UniProtKB	Mutagenesis	150	150	.	.	.	Note=Lack	of	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26681692;Dbxref=PMID:26681692
P36566	UniProtKB	Mutagenesis	209	209	.	.	.	Note=Lack	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26681692;Dbxref=PMID:26681692
P36566	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Lack	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26681692;Dbxref=PMID:26681692
P36566	UniProtKB	Mutagenesis	246	246	.	.	.	Note=Lack	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26681692;Dbxref=PMID:26681692
P36566	UniProtKB	Mutagenesis	247	247	.	.	.	Note=Decrease	in	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26681692;Dbxref=PMID:26681692
P0DM85	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Interacts	with	beta	sliding	clamp.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23994470;Dbxref=PMID:23994470
P0DM85	UniProtKB	Mutagenesis	41	41	.	.	.	Note=No	longer	interacts	with	beta	sliding	clamp%2C	pattern	of	CrfC	foci	changes.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23994470;Dbxref=PMID:23994470
P0DM85	UniProtKB	Mutagenesis	734	734	.	.	.	Note=Interacts	with	beta	sliding	clamp.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23994470;Dbxref=PMID:23994470
Q59385	UniProtKB	Mutagenesis	8	150	.	.	.	Note=Loss	of	activity.	Missing
Q59385	UniProtKB	Mutagenesis	14	14	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11500054;Dbxref=PMID:11500054
Q59385	UniProtKB	Mutagenesis	17	17	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11500054;Dbxref=PMID:11500054
Q59385	UniProtKB	Mutagenesis	110	110	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11500054;Dbxref=PMID:11500054
Q59385	UniProtKB	Mutagenesis	113	113	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11500054;Dbxref=PMID:11500054
Q59385	UniProtKB	Mutagenesis	479	479	.	.	.	Note=Loss	of	copper	resistance%2C	transport	and	phosphoenzyme	formation.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12351646;Dbxref=PMID:12351646
Q59385	UniProtKB	Mutagenesis	481	481	.	.	.	Note=Loss	of	copper	resistance%2C	transport	and	phosphoenzyme	formation.	C->A%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12351646;Dbxref=PMID:12351646
P0AE82	UniProtKB	Mutagenesis	33	33	.	.	.	Note=In	cpxA104%3B	a	cpxA	gain	of	function	mutant%2C	constitutively	active.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9401031;Dbxref=PMID:9401031
P0AE82	UniProtKB	Mutagenesis	93	124	.	.	.	Note=In	cpxA24%3B	a	cpxA	gain	of	function	mutant%2C	constitutively	active%2C	up-regulation	of	the	Cpx	regulon	membersMissing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9401031;Dbxref=PMID:9401031
P0AE82	UniProtKB	Mutagenesis	185	185	.	.	.	Note=Nearly	complete	loss	of	response	to	excess	periplasmic	protein.	S->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24492262;Dbxref=PMID:24492262
P0AE82	UniProtKB	Mutagenesis	186	186	.	.	.	Note=30%25	decrease	in	responsto	excess	periplasmic	protein.	L->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24492262;Dbxref=PMID:24492262
P0AE82	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Slight	decrease	in	responsto	excess	periplasmic	protein.	A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24492262;Dbxref=PMID:24492262
P0AE82	UniProtKB	Mutagenesis	204	204	.	.	.	Note=80%25	decrease	in	responsto	excess	periplasmic	protein.	N->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24492262;Dbxref=PMID:24492262
P0AE82	UniProtKB	Mutagenesis	222	222	.	.	.	Note=90%25	decrease	in	responsto	excess	periplasmic	protein.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24492262;Dbxref=PMID:24492262
P0AE82	UniProtKB	Mutagenesis	222	222	.	.	.	Note=75%25	decrease	in	responsto	excess	periplasmic	protein.	G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24492262;Dbxref=PMID:24492262
P0AE82	UniProtKB	Mutagenesis	228	228	.	.	.	Note=No	response	to	excess	periplasmic	protein%2C	decreased	autophosphorylation%2C	no	phosphotransfer	to	CpxR%2C	no	tetramer	formation	of	the	C-terminal	domain	in	solution.	M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24492262;Dbxref=PMID:24492262
P0AE82	UniProtKB	Mutagenesis	252	252	.	.	.	Note=In	cpxA101%3B	a	cpxA	gain	of	function	mutant%2C	decreased	autophosphorylation%2C	decreased	phosphotransfer	to	CpxR%2Closs	of	phosphatase	activity%2C	responds	to	periplasmic	protein	overproduction.	T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9401031;Dbxref=PMID:9401031
P0AE82	UniProtKB	Mutagenesis	356	356	.	.	.	Note=Nearly	complete	loss	of	response	to	excess	periplasmic	protein.	N->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24492262;Dbxref=PMID:24492262
P0AE85	UniProtKB	Mutagenesis	55	55	.	.	.	Note=No	longer	inhibits	Cpx	pathway%2C	protein	more	susceptible	to	DegP.	Q->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16166523,ECO:0000269|PubMed:21317318;Dbxref=PMID:16166523,PMID:21317318
P0AE85	UniProtKB	Mutagenesis	56	56	.	.	.	Note=No	longer	interacts	with	CpxA.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25207645;Dbxref=PMID:25207645
P0AE85	UniProtKB	Mutagenesis	59	59	.	.	.	Note=No	longer	inhibits	Cpx	pathway%2C	protein	more	susceptible	to	DegP.	M->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16166523;Dbxref=PMID:16166523
P0AE85	UniProtKB	Mutagenesis	60	60	.	.	.	Note=No	longer	inhibits	Cpx	pathwayR->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16166523;Dbxref=PMID:16166523
P0AE85	UniProtKB	Mutagenesis	61	61	.	.	.	Note=No	longer	inhibits	Cpx	pathwayD->E%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16166523;Dbxref=PMID:16166523
P0AE85	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Decreased	protein	stability%2C	significantly	reduced	degradation	of	PapE.	A->D%2CG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21239493;Dbxref=PMID:21239493
P0AE85	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Decreased	protein	stability%2C	significantly	reduced	degradation	of	PapE.	I->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21239493;Dbxref=PMID:21239493
P0AE85	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Decreased	protein	stability%2C	wild-type	degradation	of	PapE.	I->G%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21239493;Dbxref=PMID:21239493
P0AE85	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Decreased	protein	stability%2C	significantly	reduced	degradation	of	PapE.	A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21239493;Dbxref=PMID:21239493
P0AE85	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Decreased	protein	stability%2C	wild-type	degradation	of	PapE.	A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21239493;Dbxref=PMID:21239493
P0AE85	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Decreased	protein	stability%2C	significantly	reduced	degradation	of	PapE%2C	retains	most	Cpx	inhibition	activity.	A->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21239493,ECO:0000269|PubMed:25207645;Dbxref=PMID:21239493,PMID:25207645
P0AE85	UniProtKB	Mutagenesis	128	128	.	.	.	Note=No	longer	inhibits	Cpx	pathwayin	wild-type	cells%2C	protein	more	susceptible	to	DegP%2C	in	the	absence	of	DegP	protease	partially	inhibits	Cpx.	Q->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16166523,ECO:0000269|PubMed:21317318;Dbxref=PMID:16166523,PMID:21317318
P25524	UniProtKB	Mutagenesis	157	157	.	.	.	Note=Less	than	0.01%25	of	wild-type	enzymatic	activity.	Q->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21545144;Dbxref=PMID:21545144
P25524	UniProtKB	Mutagenesis	218	218	.	.	.	Note=Less	than	0.01%25	of	wild-type	enzymatic	activity.	E->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21545144;Dbxref=PMID:21545144
P25524	UniProtKB	Mutagenesis	247	247	.	.	.	Note=Less	than	0.01%25	of	wild-type	enzymatic	activity.	H->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21545144;Dbxref=PMID:21545144
P25524	UniProtKB	Mutagenesis	247	247	.	.	.	Note=200-fold	decrease	in	catalytic	efficiency.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21545144;Dbxref=PMID:21545144
P25524	UniProtKB	Mutagenesis	314	314	.	.	.	Note=17-fold	decrease	in	catalytic	efficiency	with	cytosine	as	substrate	and	2-fold	increase	in	that	with	5FC	as	substrate.	Shows	increased	sensitivity	to	5FC.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15381761;Dbxref=PMID:15381761
P25524	UniProtKB	Mutagenesis	314	314	.	.	.	Note=Less	than	0.01%25	of	wild-type	enzymatic	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21545144;Dbxref=PMID:21545144
P25524	UniProtKB	Mutagenesis	314	314	.	.	.	Note=Still	active	towards	cytosine.	Shows	increased	sensitivity	to	5FC.	D->G%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15381761;Dbxref=PMID:15381761
P25524	UniProtKB	Mutagenesis	314	314	.	.	.	Note=Loss	of	enzymatic	activity.	D->K%2CR%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15381761;Dbxref=PMID:15381761
P25524	UniProtKB	Mutagenesis	314	314	.	.	.	Note=35000-fold	decrease	in	catalytic	efficiency.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21545144;Dbxref=PMID:21545144
P45955	UniProtKB	Mutagenesis	173	173	.	.	.	Note=Decreases	self-association.	Y->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20455268;Dbxref=PMID:20455268
P45955	UniProtKB	Mutagenesis	211	211	.	.	.	Note=Does	not	affect	oligomerizationP->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20455268;Dbxref=PMID:20455268
P45955	UniProtKB	Mutagenesis	247	247	.	.	.	Note=Forms	dimers	instead	of	trimersY->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20455268;Dbxref=PMID:20455268
Q46925	UniProtKB	Mutagenesis	100	100	.	.	.	Note=No	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9278392;Dbxref=PMID:9278392
Q46925	UniProtKB	Mutagenesis	176	176	.	.	.	Note=No	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9278392;Dbxref=PMID:9278392
Q46925	UniProtKB	Mutagenesis	323	323	.	.	.	Note=No	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9278392;Dbxref=PMID:9278392
Q46925	UniProtKB	Mutagenesis	358	358	.	.	.	Note=Loss	of	cysteine	desulfurization.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10739946;Dbxref=PMID:10739946
Q46901	UniProtKB	Mutagenesis	129	129	.	.	.	Note=80%25	increase	in	phage	sensitivity%3B	500-fold	decrease	in	affinity	for	target	dsDNA.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22521690;Dbxref=PMID:22521690
Q46901	UniProtKB	Mutagenesis	130	130	.	.	.	Note=20%25	increase	in	phage	sensitivity%3B	no	change	in	binding	of	target	dsDNA.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22521690;Dbxref=PMID:22521690
Q46901	UniProtKB	Mutagenesis	131	131	.	.	.	Note=45%25	increase	in	phage	sensitivity%3B	60-fold	decrease	in	affinity	for	target	dsDNA.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22521690;Dbxref=PMID:22521690
P13518	UniProtKB	Mutagenesis	584	584	.	.	.	Note=Decreased	transcription	of	csrB.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16980588;Dbxref=PMID:16980588
P0A9G4	UniProtKB	Mutagenesis	112	112	.	.	.	Note=Loss	of	sensitivity	to	copper.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12446701,ECO:0000269|PubMed:14518983;Dbxref=PMID:12446701,PMID:14518983
P0A9G4	UniProtKB	Mutagenesis	120	120	.	.	.	Note=Loss	of	sensitivity	to	copper.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12446701,ECO:0000269|PubMed:14518983;Dbxref=PMID:12446701,PMID:14518983
P0A9G4	UniProtKB	Mutagenesis	129	129	.	.	.	Note=No	effect	on	response	to	copper.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12446701,ECO:0000269|PubMed:14518983;Dbxref=PMID:12446701,PMID:14518983
P0A9G4	UniProtKB	Mutagenesis	130	130	.	.	.	Note=No	effect	on	response	to	copper.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12446701,ECO:0000269|PubMed:14518983;Dbxref=PMID:12446701,PMID:14518983
P0ABK2	UniProtKB	Mutagenesis	56	56	.	.	.	Note=No	effect.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2656671;Dbxref=PMID:2656671
P0ABK2	UniProtKB	Mutagenesis	197	197	.	.	.	Note=No	effect.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2656671;Dbxref=PMID:2656671
P0ABK2	UniProtKB	Mutagenesis	237	237	.	.	.	Note=No	effect.	H->L%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2656671;Dbxref=PMID:2656671
P0ABK2	UniProtKB	Mutagenesis	376	376	.	.	.	Note=No	effect.	H->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2656671;Dbxref=PMID:2656671
P0AEA8	UniProtKB	Mutagenesis	21	21	.	.	.	Note=It	has	methyltransferase	and	ferrochelatase	activities	but	a	greatly	reduced	dehydrogenase	activity.	It	is	able	to	bind	AdoMet.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9461500;Dbxref=PMID:9461500
P0AEA8	UniProtKB	Mutagenesis	224	224	.	.	.	Note=It	abolishes	methyltransferase	activity%2C	but	has	dehydrogenase	and	ferrochelatase	activities.	It	is	unable	to	bind	AdoMet.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9461500;Dbxref=PMID:9461500
P0AEA8	UniProtKB	Mutagenesis	227	227	.	.	.	Note=It	has	all	activities	of	CysG.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9461500;Dbxref=PMID:9461500
P0AEA8	UniProtKB	Mutagenesis	248	248	.	.	.	Note=It	abolishes	methyltransferase	activity%2C	but	has	dehydrogenase	and	ferrochelatase	activities.	It	is	able	to	bind	AdoMet.	D->A
P0AEA8	UniProtKB	Mutagenesis	270	270	.	.	.	Note=It	has	all	activities	of	CysG.	It	is	able	to	bind	AdoMet.	K->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9461500;Dbxref=PMID:9461500
P0AEA8	UniProtKB	Mutagenesis	298	298	.	.	.	Note=It	abolishes	methyltransferase	activity%2C	but	has	dehydrogenase	and	ferrochelatase	activities.	It	is	unable	to	bind	AdoMet.	R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9461500;Dbxref=PMID:9461500
P0AEA8	UniProtKB	Mutagenesis	303	303	.	.	.	Note=It	has	all	activities	of	CysG.	It	is	able	to	bind	AdoMet.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9461500;Dbxref=PMID:9461500
P0AEA8	UniProtKB	Mutagenesis	309	309	.	.	.	Note=It	abolishes	methyltransferase	activity%2C	but	has	dehydrogenase	and	ferrochelatase	activities.	It	is	able	to	bind	AdoMet.	R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9461500;Dbxref=PMID:9461500
P0A6L2	UniProtKB	Mutagenesis	44	44	.	.	.	Note=8%25	of	wild-type	activity.	4-fold	decrease	in	affinity	for	pyruvate%2C	but	nearly	no	change	in	that	for	(S)-ASA.	T->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15066435,ECO:0000269|PubMed:19505526;Dbxref=PMID:15066435,PMID:19505526
P0A6L2	UniProtKB	Mutagenesis	44	44	.	.	.	Note=Reduced	kcat	by	99.9%25.	T->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15066435,ECO:0000269|PubMed:19505526;Dbxref=PMID:15066435,PMID:19505526
P0A6L2	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Reduced	kcat	by	90%25.	Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15066435,ECO:0000269|PubMed:18937497;Dbxref=PMID:15066435,PMID:18937497
P0A6L2	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Reduced	activity	by	95%25.	Reduced	affinity	for	both	substrates.	Exists	as	a	mixture	of	monomer%2C	dimer	and	tetramer	in	solution.	Has	significantly	lower	thermal	stability	than	the	wild-type	enzyme.Y->W;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15066435,ECO:0000269|PubMed:18937497;Dbxref=PMID:15066435,PMID:18937497
P0A6L2	UniProtKB	Mutagenesis	133	133	.	.	.	Note=Reduced	kcat	by	99.7%25.	Reduced	affinity	for	both	substrates.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15066435;Dbxref=PMID:15066435
P0A6L2	UniProtKB	Mutagenesis	138	138	.	.	.	Note=Strongly	increased	KM	for	L-aspartate	4-semialdehyde.	No	effect	on	KM	for	pyruvate.	Reduced	activity	by	99.7%25R->A%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16185069;Dbxref=PMID:16185069
P0A6L2	UniProtKB	Mutagenesis	161	161	.	.	.	Note=0.1%25	of	wild-type	activity.	3-fold	decrease	in	affinity	for	pyruvate%2C	and	2-fold	decrease	in	that	for	(S)-ASA.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20353808;Dbxref=PMID:20353808
P0A6L2	UniProtKB	Mutagenesis	161	161	.	.	.	Note=0.35%25	of	wild-type	activity.	3-fold	decrease	in	affinity	for	pyruvate%2C	but	nearly	no	change	in	that	for	(S)-ASA.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20353808;Dbxref=PMID:20353808
P0A6L2	UniProtKB	Mutagenesis	197	197	.	.	.	Note=1.4	to	2.5%25	of	wild-type	activity.	Decrease	in	affinity	for	pyruvate%2C	but	nearly	no	change	in	that	for	(S)-ASA.	Exists	as	a	dimer	in	solution.	L->Y%2CD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18556019;Dbxref=PMID:18556019
P76113	UniProtKB	Mutagenesis	247	247	.	.	.	Note=Exhibits	a	reduction	of	about	50%25	in	activity%2C	but	is	not	inhibited	by	5%2C5'-dithio-bis-2-nitrobenzoate.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21467222;Dbxref=PMID:21467222
P36649	UniProtKB	Mutagenesis	500	501	.	.	.	Note=Residual	activity	and	loss	of	resistance	to	copper.	CH->SR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11527384;Dbxref=PMID:11527384
P38054	UniProtKB	Mutagenesis	399	399	.	.	.	Note=Strong	decrease	in	copper	resistance.	A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P38054	UniProtKB	Mutagenesis	405	405	.	.	.	Note=Loss	of	copper	resistance.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P38054	UniProtKB	Mutagenesis	412	412	.	.	.	Note=Slight	decrease	in	copper	resistance.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P38054	UniProtKB	Mutagenesis	412	412	.	.	.	Note=Loss	of	copper	resistance.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P38054	UniProtKB	Mutagenesis	573	573	.	.	.	Note=Loss	of	copper	resistance.	M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P38054	UniProtKB	Mutagenesis	623	623	.	.	.	Note=Loss	of	copper	resistance.	M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P38054	UniProtKB	Mutagenesis	640	640	.	.	.	Note=No	change	in	copper	resistance.	M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P38054	UniProtKB	Mutagenesis	672	672	.	.	.	Note=Loss	of	copper	resistance.	M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P38054	UniProtKB	Mutagenesis	738	738	.	.	.	Note=No	change	in	copper	resistance.	M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P38054	UniProtKB	Mutagenesis	755	755	.	.	.	Note=Slight	decrease	in	copper	resistance.	M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P38054	UniProtKB	Mutagenesis	792	792	.	.	.	Note=No	change	in	copper	resistance.	M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P38054	UniProtKB	Mutagenesis	812	812	.	.	.	Note=Slight	decrease	in	copper	resistance.	M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P38054	UniProtKB	Mutagenesis	833	833	.	.	.	Note=Slight	decrease	in	copper	resistance.	M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P77214	UniProtKB	Mutagenesis	25	27	.	.	.	Note=No	change	in	copper	resistance.	HHH->QQQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P77214	UniProtKB	Mutagenesis	48	48	.	.	.	Note=No	change	in	copper	resistance.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P77214	UniProtKB	Mutagenesis	57	58	.	.	.	Note=Slight	decrease	in	copper	resistance.	HH->QQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P77214	UniProtKB	Mutagenesis	69	69	.	.	.	Note=Loss	of	copper	resistance	and	strong	decrease	in	copper	binding%3B	when	associated	with	I-71.	M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P77214	UniProtKB	Mutagenesis	71	71	.	.	.	Note=Loss	of	copper	resistance	and	strong	decrease	in	copper	binding%3B	when	associated	with	I-69.	M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P77214	UniProtKB	Mutagenesis	73	73	.	.	.	Note=No	change	in	copper	resistance.	F->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813074;Dbxref=PMID:12813074
P56100	UniProtKB	Mutagenesis	1	1	.	.	.	Note=Does	not	restore	reductant	(beta-mercapoethanol)	resistance.	M->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23749980;Dbxref=PMID:23749980
P56100	UniProtKB	Mutagenesis	4	4	.	.	.	Note=Does	not	restore	reductant	(beta-mercapoethanol)	resistance.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23749980;Dbxref=PMID:23749980
P56100	UniProtKB	Mutagenesis	7	7	.	.	.	Note=Does	not	restore	reductant	(beta-mercapoethanol)	resistance.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23749980;Dbxref=PMID:23749980
P56100	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Does	not	restore	reductant	(beta-mercapoethanol)	resistance.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23749980;Dbxref=PMID:23749980
P56100	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Restores	reductant	(beta-mercapoethanol)	resistance.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23749980;Dbxref=PMID:23749980
P56100	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Does	not	restore	reductant	(beta-mercapoethanol)	resistance.	A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23749980;Dbxref=PMID:23749980
P0AGF2	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Unable	to	exert	a	stimulatory	effect	on	the	cysteine	desulfurase	activity	of	CsdA	and	to	accept	sulfur.Retains	the	ability	to	interact	with	CsdA.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15901727;Dbxref=PMID:15901727
P0ABJ9	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Loss	of	cytochrome	b595	and	heme	d%2C	no	aerobic	growth%2C	complex	assembles.	H->L%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2656671;Dbxref=PMID:2656671
P0ABJ9	UniProtKB	Mutagenesis	86	86	.	.	.	Note=No	effect.	H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2656671;Dbxref=PMID:2656671
P0ABJ9	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Loss	of	all	cofactors%2C	no	aerobic	growth%2C	complex	assembles.	H->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2656671;Dbxref=PMID:2656671
P0ABJ9	UniProtKB	Mutagenesis	126	126	.	.	.	Note=No	effect.	H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2656671;Dbxref=PMID:2656671
P0ABJ9	UniProtKB	Mutagenesis	186	186	.	.	.	Note=Loss	of	cytochrome	b558%2Cno	aerobic	growth%2C	complex	assembles%2C	this	subunit	is	more	susceptible	to	proteolysis.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2656671;Dbxref=PMID:2656671
P0ABJ9	UniProtKB	Mutagenesis	314	314	.	.	.	Note=Grows	aerobically%2C	has	alteredcytochrome	b/d	ratio%2C	complex	assembles.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2656671;Dbxref=PMID:2656671
P0ABJ9	UniProtKB	Mutagenesis	314	314	.	.	.	Note=Loss	of	cytochrome	b595	and	heme	d%2C	no	aerobic	growth%2C	loss	of	complex.	H->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2656671;Dbxref=PMID:2656671
P0ABJ9	UniProtKB	Mutagenesis	393	393	.	.	.	Note=Cytochrome	b558	shifts	to	a	high	spin	configuration%2C	complex	assembles.	Retains	about	1%25	quinol	oxidoreductase	activity	after	purification.	M->L
P0ABJ9	UniProtKB	Mutagenesis	510	510	.	.	.	Note=No	effect.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2656671;Dbxref=PMID:2656671
P04036	UniProtKB	Mutagenesis	159	159	.	.	.	Note=135	to	200-fold	reduction	in	catalytic	activity.	H->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9398235;Dbxref=PMID:9398235
P04036	UniProtKB	Mutagenesis	163	163	.	.	.	Note=625	to	830-fold	reduction	in	catalytic	activity.	K->A%2CC%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9398235;Dbxref=PMID:9398235
P17854	UniProtKB	Mutagenesis	209	209	.	.	.	Note=Reduction	in	Vmax.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7588765;Dbxref=PMID:7588765
P17854	UniProtKB	Mutagenesis	239	239	.	.	.	Note=5-fold	reduction	in	Vmax.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7588765;Dbxref=PMID:7588765
P11557	UniProtKB	Mutagenesis	351	351	.	.	.	Note=Eliminates	septal	localization.	Q->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23290046;Dbxref=PMID:23290046
P11557	UniProtKB	Mutagenesis	354	354	.	.	.	Note=Impairs	septal	localization.	S->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23290046;Dbxref=PMID:23290046
P11557	UniProtKB	Mutagenesis	416	416	.	.	.	Note=Impairs	septal	localization.	W->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23290046;Dbxref=PMID:23290046
P0ACF4	UniProtKB	Mutagenesis	30	30	.	.	.	Note=No	effect.	A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2265752;Dbxref=PMID:2265752
P0ACF4	UniProtKB	Mutagenesis	37	37	.	.	.	Note=No	effect.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2265752;Dbxref=PMID:2265752
P0ACF4	UniProtKB	Mutagenesis	47	47	.	.	.	Note=Reduced	DNA-binding.	F->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2265752;Dbxref=PMID:2265752
P0ACF4	UniProtKB	Mutagenesis	58	61	.	.	.	Note=Reduced	DNA-binding.	RTGR->GTGG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2265752;Dbxref=PMID:2265752
P0A9P6	UniProtKB	Mutagenesis	157	157	.	.	.	Note=Abolishes	ATPase	activity%2C	drastically	reduces	helicase	activity.	In	vivo	acts	as	a	dominant	negative	mutatioin	the	presence	of	the	wild-type	protein	at	low	temperature.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17259309;Dbxref=PMID:17259309
P0A9Q9	UniProtKB	Mutagenesis	135	135	.	.	.	Note=Complete	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1350921;Dbxref=PMID:1350921
P0A9Q9	UniProtKB	Mutagenesis	135	135	.	.	.	Note=99.7%25	loss	of	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1350921;Dbxref=PMID:1350921
P39099	UniProtKB	Mutagenesis	187	187	.	.	.	Note=Loss	of	peptidase	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21685389;Dbxref=PMID:21685389
P39099	UniProtKB	Mutagenesis	191	191	.	.	.	Note=Reduces	the	peptidase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21685389;Dbxref=PMID:21685389
P39099	UniProtKB	Mutagenesis	329	329	.	.	.	Note=Reduces	the	peptidase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21685389;Dbxref=PMID:21685389
P0AEC8	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Abolishes	the	stimulation	by	fumarate	to	the	same	extent	as	complete	deletion	of	the	dcuS	gene.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12907689;Dbxref=PMID:12907689
P0AEC8	UniProtKB	Mutagenesis	110	110	.	.	.	Note=Abolishes	the	stimulation	by	fumarate	to	the	same	extent	as	complete	deletion	of	the	dcuS	gene.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12907689;Dbxref=PMID:12907689
P0AEC8	UniProtKB	Mutagenesis	147	147	.	.	.	Note=Abolishes	the	stimulation	by	fumarate	to	the	same	extent	as	complete	deletion	of	the	dcuS	gene.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12907689;Dbxref=PMID:12907689
P0AEC8	UniProtKB	Mutagenesis	248	248	.	.	.	Note=Causes	constitutive	active	state	of	the	kinase%2C	leading	to	constitutive	expression	of	a	target	gene%2C	without	additioof	C4-dicarboxylates.	N->A%2CD%2CG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18820688;Dbxref=PMID:18820688
P0AEC8	UniProtKB	Mutagenesis	304	304	.	.	.	Note=Causes	constitutive	active	state	of	the	kinase%2C	leading	to	constitutive	expression	of	a	target	gene%2C	without	additioof	C4-dicarboxylates.	N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18820688;Dbxref=PMID:18820688
P0AEE5	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Improductive	interaction	with	trg.	G->D
Q6BF17	UniProtKB	Mutagenesis		185	185	.	.	.	Note=Loss	of	activity.	H->N%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.7
Q6BF17	UniProtKB	Mutagenesis	285	285	.	.	.	Note=Loss	of	activity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.7
Q6BF17	UniProtKB	Mutagenesis	310	310	.	.	.	Note=Loss	of	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.7
P0ABS1	UniProtKB	Mutagenesis	71	71	.	.	.	Note=Does	not	increase	ppGpp-dependent	inhibition	of	transcription%2C	but	retains	its	ability	to	bind	to	RNAP%3B	when	associated	with	N-74.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15294156;Dbxref=PMID:15294156
P0ABS1	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Does	not	increase	ppGpp-dependent	inhibition	of	transcription%2C	but	retains	its	ability	to	bind	to	RNAP%3B	when	associated	with	N-71.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15294156;Dbxref=PMID:15294156
P77510	UniProtKB	Mutagenesis	138	138	.	.	.	Note=Reduces	strongly	citrate	bindingG->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11889485;Dbxref=PMID:11889485
P77510	UniProtKB	Mutagenesis	478	478	.	.	.	Note=Loss	of	autophosphorylation.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19202292;Dbxref=PMID:19202292
P77510	UniProtKB	Mutagenesis	517	517	.	.	.	Note=Decrease	in	autophosphorylation.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19202292;Dbxref=PMID:19202292
P77510	UniProtKB	Mutagenesis	529	529	.	.	.	Note=Constitutively	active.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19202292;Dbxref=PMID:19202292
Q6BF16	UniProtKB	Mutagenesis	37	37	.	.	.	Note=50-fold	decrease	in	catalytic	efficiency	and	6-fold	decrease	of	binding	affinity.	E->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17981470;Dbxref=PMID:17981470
Q6BF16	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Little	stereoselectivity%2C	accepting	KDPG	and	KDPGal	as	substrate	with	roughly	equal	efficacy.	Reduced	the	preference	for	KDPGal.	It	diminishes	the	activity	against	KDPGal	and	increases	activity	againstKDPG.	V->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17981470;Dbxref=PMID:17981470
P37349	UniProtKB	Mutagenesis	9	9	.	.	.	Note=Loss	of	phosphotransfer	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350937;Dbxref=PMID:11350937
P37349	UniProtKB	Mutagenesis	169	169	.	.	.	Note=Loss	of	phosphotransfer	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350937;Dbxref=PMID:11350937
P37349	UniProtKB	Mutagenesis	200	200	.	.	.	Note=Loss	of	lysine	deacetylase	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26716769;Dbxref=PMID:26716769
P37349	UniProtKB	Mutagenesis	430	430	.	.	.	Note=Loss	of	phosphotransfer	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350937;Dbxref=PMID:11350937
P66817	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Abolishes	stimulation	of	DnaA-dependent	DNA	synthesis.	S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17699754;Dbxref=PMID:17699754
P66817	UniProtKB	Mutagenesis	71	71	.	.	.	Note=Reduces	affinity	for	DnaA.	Strongly	reduces	DnaA-dependent	DNA	synthesis.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17699754;Dbxref=PMID:17699754
P66817	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Strongly	reduces	affinity	for	DnaA.	Reduces	DnaA-dependent	DNA	synthesis.	P->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17699754;Dbxref=PMID:17699754
P66817	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Abolishes	association	of	homodimers	into	homotetramers.	Reduces	affinity	for	DnaA.	Strongly	reduces	DnaA-dependent	DNA	synthesis.	N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17699754;Dbxref=PMID:17699754
P66817	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Abolishes	association	of	homodimers	into	homotetramers.	Strongly	reduces	DnaA-dependent	DNA	synthesis.	K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17699754;Dbxref=PMID:17699754
P66817	UniProtKB	Mutagenesis	190	190	.	.	.	Note=Abolishes	interaction	with	DnaA.	Strongly	reduces	DnaA-dependent	DNA	synthesis.	L->A%2CP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17699754;Dbxref=PMID:17699754
P66817	UniProtKB	Mutagenesis	191	191	.	.	.	Note=Abolishes	interaction	with	DnaA.	Strongly	reduces	DnaA-dependent	DNA	synthesis.	F->L%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17699754;Dbxref=PMID:17699754
P69853	UniProtKB	Mutagenesis	72	75	.	.	.	Note=1.5-fold	increased	binding	to	DmsA	signal	sequence.	WQRL->HQRY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20169075;Dbxref=PMID:20169075
P69910	UniProtKB	Mutagenesis	276	276	.	.	.	Note=Strongly	reduces	pyridoxal	phosphate	binding	and	increases	stability	of	the	polypeptide.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12383249;Dbxref=PMID:12383249
P69910	UniProtKB	Mutagenesis	276	276	.	.	.	Note=Abolishes	pyridoxal	phosphate	binding.	K->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12383249;Dbxref=PMID:12383249
P76129	UniProtKB	Mutagenesis	69	69	.	.	.	Note=Loss	of	heme	binding.	H->A%2CG;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11970957,ECO:0000269|PubMed:14551206;Dbxref=PMID:11970957,PMID:14551206
P76129	UniProtKB	Mutagenesis	75	75	.	.	.	Note=No	loss	of	heme	binding.	H->A%2CG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11970957;Dbxref=PMID:11970957
P76129	UniProtKB	Mutagenesis	87	87	.	.	.	Note=Ferrous	heme	iron	changes	from	an	exclusively	hexacoordinate	low-spin	form	to	an	exclusively	pentacoordinate	high-spin	form.	Ferric	heme	iron	remains	hexacoordinate	but	becomes	a	mixture	of	high	and	low	spin.	Increases	c-di-GMP	PDE	activity	7-fold	in	absence	of	O(2)%2C	CO	or	NO%2C	no	additional	increase	upon	addition	of	gases	(M-A	only).	M->A%2CI;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12080073,ECO:0000269|PubMed:12081490,ECO:0000269|PubMed:17535805;Dbxref=PMID:12080073,PMID:12081490,PMID:17535805
P76129	UniProtKB	Mutagenesis	87	87	.	.	.	Note=No	change	in	heme	coordination%3Bincreases	c-di-GMP	PDE	activity	2-fold	in	absence	of	O(2)%2C	CO	or	NO%2C	and	2-fold	more	upon	addition	of	gases.	M->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12080073,ECO:0000269|PubMed:12081490,ECO:0000269|PubMed:17535805;Dbxref=PMID:12080073,PMID:12081490,PMID:17535805
P76129	UniProtKB	Mutagenesis	89	89	.	.	.	Note=The	Fe(2+)-O(2)	form	loses	c-di-GMP	PDE	activity%2C	due	to	reduced	O(2)	affinity	and/or	increased	auto-oxidation.	NO	and	CO	forms	are	less	affected.	R->A%2CE%2CI;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12081490,ECO:0000269|PubMed:17535805;Dbxref=PMID:12081490,PMID:17535805
P76129	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Alters	O(2)	binding%2C	increases	auto-oxidation.	L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16519686;Dbxref=PMID:16519686
P76129	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Increases	auto-oxidation.	L->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16519686;Dbxref=PMID:16519686
P76129	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Significantly	reduces	heme-binding	affinity%3B	increases	auto-oxidation.	L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16519686;Dbxref=PMID:16519686
P76129	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Increases	auto-oxidation.	L->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16519686;Dbxref=PMID:16519686
P76129	UniProtKB	Mutagenesis	582	582	.	.	.	Note=Loss	of	cAMP	PDE	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14551206;Dbxref=PMID:14551206
P76129	UniProtKB	Mutagenesis	586	586	.	.	.	Note=Loss	of	cAMP	PDE	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14551206;Dbxref=PMID:14551206
P0ABK5	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Still	stimulates	tRNase	activitof	CdiA-CT	in	vitro	and	in	vivo.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22333533;Dbxref=PMID:22333533
P0AEB2	UniProtKB	Mutagenesis	101	121	.	.	.	Note=Complete	loss	of	enzyme	activity.	No	effect	on	penicillin	binding.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14555648;Dbxref=PMID:14555648
P0AEB2	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Complete	loss	of	enzyme	activity.	No	effect	on	penicillin	binding.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1597468;Dbxref=PMID:1597468
P0AEB2	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Complete	loss	of	activity.	K->X;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1597468;Dbxref=PMID:1597468
P21693	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Shows	accumulation	of	partially-assembled	45S	particles.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19734347;Dbxref=PMID:19734347
P21693	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Shows	accumulation	of	partially-assembled	45S	particles.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19734347;Dbxref=PMID:19734347
P21693	UniProtKB	Mutagenesis	331	331	.	.	.	Note=Shows	accumulation	of	partially-assembled	45S	particles.	Binds	rRNA	normally	but	is	severely	impaired	in	ATPase	and	helicase	activities.	Overexpression	confers	a	dominant	slow	growth	and	cold-sensitive	phenotype.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19734347;Dbxref=PMID:19734347
P00370	UniProtKB	Mutagenesis	92	92	.	.	.	Note=Complete	loss	of	dehydrogenase	activity.	K->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8355660;Dbxref=PMID:8355660
P00370	UniProtKB	Mutagenesis	128	128	.	.	.	Note=Reduces	catalytic	activity	and	increases	pH	optima	for	activity.	Increases	relative	activity	with	amino	acid	substrates	other	than	glutamate%2C	especially	L-norvaline.	K->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3149742;Dbxref=PMID:3149742
P00370	UniProtKB	Mutagenesis	128	128	.	.	.	Note=Reduced	catalytic	activity	and	increases	pH	optima	for	activity.	NADP-specific	glutamate	dehydrogenase.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3149742;Dbxref=PMID:3149742
P76015	UniProtKB	Mutagenesis	218	218	.	.	.	Note=Loss	of	kinase	activity.	H->A%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12813127;Dbxref=PMID:12813127
P27296	UniProtKB	Mutagenesis	120	120	.	.	.	Note=Abolishes	iron-sulfur-binding.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19074432;Dbxref=PMID:19074432
P27296	UniProtKB	Mutagenesis	194	194	.	.	.	Note=Abolishes	iron-sulfur-binding.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19074432;Dbxref=PMID:19074432
P27296	UniProtKB	Mutagenesis	199	199	.	.	.	Note=Abolishes	iron-sulfur-binding.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19074432;Dbxref=PMID:19074432
P27296	UniProtKB	Mutagenesis	205	205	.	.	.	Note=Abolishes	iron-sulfur-binding.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19074432;Dbxref=PMID:19074432
P0AEE3	UniProtKB	Mutagenesis	122	122	.	.	.	Note=Causes	substantial	reduction	of	peptidase	activity.	Binds	activator	peptides.	D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17938245,ECO:0000269|PubMed:17981123;Dbxref=PMID:17938245,PMID:17981123
P0AEE3	UniProtKB	Mutagenesis	162	162	.	.	.	Note=Loss	of	peptidase	activity.	Binds	activator	peptides.	Y->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15137941,ECO:0000269|PubMed:17938245,ECO:0000269|PubMed:17981123,ECO:0000269|PubMed:20739286;Dbxref=PMID:15137941,PMID:17938245,PMID:17981123,PMID:20739286
P0AEE3	UniProtKB	Mutagenesis	162	162	.	.	.	Note=Loss	of	60%25	of	peptidase	activity.	Y->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15137941,ECO:0000269|PubMed:17938245,ECO:0000269|PubMed:17981123,ECO:0000269|PubMed:20739286;Dbxref=PMID:15137941,PMID:17938245,PMID:17981123,PMID:20739286
P0AEE3	UniProtKB	Mutagenesis	178	178	.	.	.	Note=Causes	substantial	reduction	of	peptidase	activity.	R->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17981123,ECO:0000269|PubMed:20739286;Dbxref=PMID:17981123,PMID:20739286
P0AEE3	UniProtKB	Mutagenesis	183	183	.	.	.	Note=Loss	of	peptidase	activity.	Also	affects	an	interface	contact	between	the	PDZ	and	protease	domains.	P->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15137941,ECO:0000269|PubMed:17981123;Dbxref=PMID:15137941,PMID:17981123
P0AEE3	UniProtKB	Mutagenesis	191	191	.	.	.	Note=Loss	of	peptidase	activity.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20739286;Dbxref=PMID:20739286
P0AEE3	UniProtKB	Mutagenesis	198	198	.	.	.	Note=Behaves	like	wild-type.	H->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19836340,ECO:0000269|PubMed:20739286,ECO:0000269|PubMed:21245315;Dbxref=PMID:19836340,PMID:20739286,PMID:21245315
P0AEE3	UniProtKB	Mutagenesis	198	198	.	.	.	Note=Partially	bypasses	the	requirement	for	peptide	activation%2C	acts	synergistically	with	mutations	that	disrupt	contacts	betweenthe	protease	and	PDZ	domains	and	with	an	rseB	disruption.	H->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19836340,ECO:0000269|PubMed:20739286,ECO:0000269|PubMed:21245315;Dbxref=PMID:19836340,PMID:20739286,PMID:21245315
P0AEE3	UniProtKB	Mutagenesis	201	201	.	.	.	Note=Does	not	restore	RseA	degradation	in	a	degS	disruption.	Loss	of	RseA	degradation.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10500101;Dbxref=PMID:10500101
P0AEE3	UniProtKB	Mutagenesis	227	227	.	.	.	Note=Loss	of	peptidase	activity.	E->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15137941,ECO:0000269|PubMed:17981123;Dbxref=PMID:15137941,PMID:17981123
P0AEE3	UniProtKB	Mutagenesis	243	243	.	.	.	Note=Increases	the	basal	rate	of	RseA	cleavage	3-fold%2C	acts	synergistically	with	an	rseB	disruption.	K->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17981123,ECO:0000269|PubMed:21245315;Dbxref=PMID:17981123,PMID:21245315
P0AEE3	UniProtKB	Mutagenesis	256	256	.	.	.	Note=Dramatically	increases	the	basal	rate	of	RseA	cleavage.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17981123;Dbxref=PMID:17981123
P0AEE3	UniProtKB	Mutagenesis	256	256	.	.	.	Note=Dramatically	increases	the	basal	rate	of	RseA	cleavage.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17981123;Dbxref=PMID:17981123
P0AEE3	UniProtKB	Mutagenesis	320	320	.	.	.	Note=Dramatically	increases	the	basal	rate	of	RseA	cleavage.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17981123;Dbxref=PMID:17981123
P0A6P5	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Complements	a	disruption	mutant%2C	KM	for	GTP	695	uM.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16963571;Dbxref=PMID:16963571
P0A6P5	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Does	not	complement	a	disruption	mutant%2C	KM	for	GTP	4.9	mM.	Decreased	GTPase	activity%2C	no	stimulation	by	YihI.	S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16963571,ECO:0000269|PubMed:20434458;Dbxref=PMID:16963571,PMID:20434458
P0A6P5	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Complements	a	disruption	mutant	at	42	degrees	Celsius%2C	very	poor	complementation	at	30	degrees	Celsius.	Reducesaffinity	for	the	50S	ribosomal	subunit	at	30	degrees	Celsius.	RelA	suppresses	this	point	mutation	at	30	degrees	Celsius.	N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16930151;Dbxref=PMID:16930151
P0A6P5	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Does	not	complement	a	disruption	mutant	at	42	degrees	Celsius%2C	diminished	association	with	50S	ribosomal	subunits%3B	when	associated	with	D-321.	N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16930151;Dbxref=PMID:16930151
P0A6P5	UniProtKB	Mutagenesis	215	215	.	.	.	Note=Does	not	complement	a	disruption	mutant%2C	KM	for	GTP	6.7	mM.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16963571;Dbxref=PMID:16963571
P0A6P5	UniProtKB	Mutagenesis	216	216	.	.	.	Note=Does	not	complement	a	disruption	mutant%2C	considerably	decreased	GTPase	activity%2C	KM	for	GTP	4.8	mM%2C	no	stimulation	by	YihI.	S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16963571,ECO:0000269|PubMed:20434458;Dbxref=PMID:16963571,PMID:20434458
P0A6P5	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Complements	a	disruption	mutant	at	42	degrees	Celsius%2C	no	complementation	at	30	degrees	Celsius.	Greatly	reducesaffinity	for	the	50S	ribosomal	subunit	at	30	degrees	Celsius.	RelA	suppresses	this	point	mutation	at	30	degrees	Celsius.	N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16930151;Dbxref=PMID:16930151
P0A6P5	UniProtKB	Mutagenesis	414	414	.	.	.	Note=Does	not	complement	rrmJ	deletion%2C	complements	der	disruption	at	42	degrees	Celsius.	G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20172997;Dbxref=PMID:20172997
P0A6P5	UniProtKB	Mutagenesis	424	424	.	.	.	Note=Does	not	complement	rrmJ	deletion%2C	nor	the	der	disruption	at	42	degrees	Celsius.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20172997;Dbxref=PMID:20172997
P0A6P5	UniProtKB	Mutagenesis	469	469	.	.	.	Note=Does	not	complement	rrmJ	deletion%2C	complements	der	disruption	at	42	degrees	Celsius.	N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20172997;Dbxref=PMID:20172997
P0A6P5	UniProtKB	Mutagenesis	472	472	.	.	.	Note=Does	not	complement	rrmJ	deletion%2C	complements	der	disruption	at	42	degrees	Celsius.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20172997;Dbxref=PMID:20172997
P18775	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Not	targeted	to	the	membrane%2C	does	not	support	anaerobic	growth.	R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10801884;Dbxref=PMID:10801884
P18775	UniProtKB	Mutagenesis	57	57	.	.	.	Note=No	alteration	of	the	growth%2C	expression%2C	or	catalytic	activities.	K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8125918;Dbxref=PMID:8125918
P18775	UniProtKB	Mutagenesis	67	67	.	.	.	Note=Electron	transfer	from	the	4Fe-4S	clusters	of	DmsB	to	the	Mo-bisMGD	of	DmsA	is	blocked.	Little	effect	on	the	coordination	sphere	of	the	molybdenum	and	only	minor	effects	on	its	redox	chemistry.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10224050,ECO:0000269|PubMed:8125918;Dbxref=PMID:10224050,PMID:8125918
P18775	UniProtKB	Mutagenesis	71	71	.	.	.	Note=Cannot	support	growth.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8125918;Dbxref=PMID:8125918
P18775	UniProtKB	Mutagenesis	104	104	.	.	.	Note=No	alteration	of	the	growth%2C	expression%2C	or	catalytic	activities.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8125918;Dbxref=PMID:8125918
P18775	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Electron	transfer	from	the	4Fe-4S	clusters	of	DmsB	to	the	Mo-bisMGD	of	DmsA	is	blocked.	Little	effect	on	the	coordination	sphere	of	the	molybdenum	and	only	minor	effects	on	its	redox	chemistry.	R->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10224050,ECO:0000269|PubMed:8125918;Dbxref=PMID:10224050,PMID:8125918
P18776	UniProtKB	Mutagenesis	102	102	.	.	.	Note=Loss	of	electron	transfefrom	menaquinol	to	DMSO.	C->F%2CS%2CW%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1653010;Dbxref=PMID:1653010
P0C0V0	UniProtKB	Mutagenesis	131	131	.	.	.	Note=Loss	of	peptidase	activitwith	no	detectable	changes	in	secondary	structure.	H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7557477;Dbxref=PMID:7557477
P0C0V0	UniProtKB	Mutagenesis	236	236	.	.	.	Note=Loss	of	peptidase	activitwith	no	detectable	changes	in	secondary	structure.	S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12730160,ECO:0000269|PubMed:7557477;Dbxref=PMID:12730160,PMID:7557477
P0C0V0	UniProtKB	Mutagenesis	254	254	.	.	.	Note=It	does	not	affect	the	proteolytic	activity.	I->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20515644;Dbxref=PMID:20515644
P0C0V0	UniProtKB	Mutagenesis	255	255	.	.	.	Note=Loss	of	proteolytic	activity.	L->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20515644;Dbxref=PMID:20515644
P0C0V0	UniProtKB	Mutagenesis	258	258	.	.	.	Note=Increases	the	proteolytic	activity.	D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20515644;Dbxref=PMID:20515644
P0C0V0	UniProtKB	Mutagenesis	261	261	.	.	.	Note=Loss	of	proteolytic	activity.	N->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20515644;Dbxref=PMID:20515644
P0C0V0	UniProtKB	Mutagenesis	262	262	.	.	.	Note=Stimulates	the	proteolytic	activitat	low	temperatures	(20-30	degrees	Celsius)%2C	whereas	at	higher	temperatures	(above	35	degreesCelsius)%2C	the	proteolytic	activity	is	less	efficient.	I->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20515644;Dbxref=PMID:20515644
P0C0V0	UniProtKB	Mutagenesis	264	264	.	.	.	Note=Loss	of	proteolytic	activity.	I->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20515644;Dbxref=PMID:20515644
P0AA86	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Drastic	decrease	in	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9537397;Dbxref=PMID:9537397
P0AA86	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Drastic	decrease	in	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9537397;Dbxref=PMID:9537397
P66899	UniProtKB	Mutagenesis	77	77	.	.	.	Note=No	longer	binds	cofactor%2C	loss	of	enzymatic	activity.	K->H%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22505717;Dbxref=PMID:22505717
P66899	UniProtKB	Mutagenesis	120	120	.	.	.	Note=No	activity	on	D-DAP%2C	150-fold	reduced	catalytic	efficiency	for	L-DAP%3B	alters	substrate	stereospecificity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22505717;Dbxref=PMID:22505717
P66899	UniProtKB	Mutagenesis	189	189	.	.	.	Note=10000-fold	reduced	catalytic	efficiency	for	both	D-	and	L-DAP.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22505717;Dbxref=PMID:22505717
P0AA89	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Same	biofilm	formation	activitas	wild-type.	Large	decrease	in	O(2)	affinity.	Y->A%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21067162;Dbxref=PMID:21067162
P0AA89	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Same	biofilm	formation	activitas	wild-type.	Markedly	enhanced	O(2)	dissociation	but	not	association	rate	constants.	Highly	enhanced	autoxidation	rate	constant.	Y->F%2CW;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21067162;Dbxref=PMID:21067162
P0AA89	UniProtKB	Mutagenesis	60	60	.	.	.	Note=Same	biofilm	formation	activitas	wild-type.	Enhanced	O(2)	dissociation	but	not	association	rate	constants.	Enhanceautoxidation	rate	constant.	Q->A%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21067162;Dbxref=PMID:21067162
P0AA89	UniProtKB	Mutagenesis	60	60	.	.	.	Note=Same	biofilm	formation	activitas	wild-type.	5-fold	reduction	in	O(2)	dissociation	rate	constant.	Significant	decreasin	the	autoxidation	rate	constant.	Q->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21067162;Dbxref=PMID:21067162
P0AA89	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Enhanced	autoxidation	rate	constant.	Markedly	enhanced	O(2)	association	rate	constant.	L->G%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22005448;Dbxref=PMID:22005448
P0AA89	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Enhanced	autoxidation	rate	constant.	Decrease	in	O(2)	association	rate	constant.	L->M%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22005448;Dbxref=PMID:22005448
P0AA89	UniProtKB	Mutagenesis	98	98	.	.	.	Note=Same	biofilm	formation	activitas	wild-type.	Loss	of	heme-binding	ability.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21067162;Dbxref=PMID:21067162
P0AA89	UniProtKB	Mutagenesis	223	223	.	.	.	Note=Same	biofilm	formation	activitas	wild-type.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21067162;Dbxref=PMID:21067162
P0AA89	UniProtKB	Mutagenesis	365	365	.	.	.	Note=Same	biofilm	formation	activitas	wild-type.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21067162;Dbxref=PMID:21067162
P0AA89	UniProtKB	Mutagenesis	368	368	.	.	.	Note=Lacks	biofilm	formation	activity%2C	and	thus	is	probably	devoid	of	diguanylate	cyclase	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21067162;Dbxref=PMID:21067162
P0AA89	UniProtKB	Mutagenesis	376	377	.	.	.	Note=Loss	of	DGC	activity.	Stimulation	of	PNAG	production	and	activation	of	pgaABCD	expression	are	abolished.	DE->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20576684;Dbxref=PMID:20576684
P0AA89	UniProtKB	Mutagenesis	376	376	.	.	.	Note=Lacks	biofilm	formation	activity%2C	and	thus	is	probably	devoid	of	diguanylate	cyclase	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21067162;Dbxref=PMID:21067162
P0AA89	UniProtKB	Mutagenesis	377	377	.	.	.	Note=Lacks	biofilm	formation	activity%2C	and	thus	is	probably	devoid	of	diguanylate	cyclase	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21067162;Dbxref=PMID:21067162
Q47155	UniProtKB	Mutagenesis	8	8	.	.	.	Note=Loss	of	function.	D->A%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10488344;Dbxref=PMID:10488344
Q47155	UniProtKB	Mutagenesis	49	49	.	.	.	Note=Loss	of	function.	R->A%2CF;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10488344;Dbxref=PMID:10488344
Q47155	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Loss	of	function.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10488344;Dbxref=PMID:10488344
Q47155	UniProtKB	Mutagenesis	104	104	.	.	.	Note=Loss	of	function.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10488344;Dbxref=PMID:10488344
P33371	UniProtKB	Mutagenesis	98	98	.	.	.	Note=Loss	of	enzymatic	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25902496;Dbxref=PMID:25902496
P0ABQ4	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Increases	catalytic	rate	about	2-fold.	M->F%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16510443;Dbxref=PMID:16510443
P0ABQ4	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Increases	catalytic	rate	about	2-fold.	Increases	catalytic	rate	about	7-fold%3B	when	associated	with	L-20%3B	Y-42%3B	F-92%3BA-85	and	S-152.	M->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16510443;Dbxref=PMID:16510443
P0ABQ4	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Increases	catalytic	rate	2-fold.M->I%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16510443;Dbxref=PMID:16510443
P0ABQ4	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Increases	catalytic	rate	2.5-fold.	Increases	catalytic	rate	about	7-fold%3B	when	associated	with	N-16%3B	Y-42%3B	F-92%3BA-85	and	S-152.	M->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16510443;Dbxref=PMID:16510443
P0ABQ4	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Increases	catalytic	rate	almost	2-fold.	M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16510443;Dbxref=PMID:16510443
P0ABQ4	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Increases	catalytic	rate	almost	2-fold.	Increases	catalytic	rate	about	7-fold%3B	when	associated	with	N-16%3B	L-20%3B	A-85%3BF-92	and	S-152.	M->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16510443;Dbxref=PMID:16510443
P0ABQ4	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Decreases	catalytic	rate	by	one	third.	Increases	catalytic	rate	about	7-fold%3B	when	associated	with	N-16%3B	L-20%3BY-42%3B	F-92	and	S-152.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16510443;Dbxref=PMID:16510443
P0ABQ4	UniProtKB	Mutagenesis	92	92	.	.	.	Note=No	effect.	Increases	catalytic	rate	about	7-fold%3B	when	associated	with	N-16%3B	L-20%3B	Y-42%3B	A-85	and	S-152.	M->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16510443;Dbxref=PMID:16510443
P0ABQ4	UniProtKB	Mutagenesis	92	92	.	.	.	Note=No	effect.	M->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16510443;Dbxref=PMID:16510443
P0ABQ4	UniProtKB	Mutagenesis	152	152	.	.	.	Note=Increases	catalytic	rate	1.5-fold.	Increases	catalytic	rate	about	7-fold%3B	when	associated	with	N-16%3B	L-20%3B	Y-42%3BA-85	and	F-92.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16510443;Dbxref=PMID:16510443
P0A6Y8	UniProtKB	Mutagenesis	32	32	.	.	.	Note=In	SEG-1	and	dnaK756(TS)%3B	conferstemperature	sensitivity.	G->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1592823,ECO:0000269|PubMed:2674651;Dbxref=PMID:1592823,PMID:2674651
P0A6Y8	UniProtKB	Mutagenesis	436	436	.	.	.	Note=In	SEG-2%3B	confers	temperature	sensitivity.	V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2674651;Dbxref=PMID:2674651
P0A6Y8	UniProtKB	Mutagenesis	455	455	.	.	.	Note=In	dnaK756(TS)%3B	confers	temperature	sensitivity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1592823;Dbxref=PMID:1592823
P0A6Y8	UniProtKB	Mutagenesis	468	468	.	.	.	Note=In	dnaK756(TS)%3B	confers	temperature	sensitivity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1592823;Dbxref=PMID:1592823
P0A988	UniProtKB	Mutagenesis	66	66	.	.	.	Note=In	dnaN159%3B	a	temperature-	and	UV-sensitive	mutation%2C	displays	altered	DNA	polymerase	usage%2C	chronically	inducedSOS	response%3B	when	associated	with	A-174.	G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15466025;Dbxref=PMID:15466025
P0A988	UniProtKB	Mutagenesis	174	174	.	.	.	Note=In	dnaN159%3B	a	temperature-	and	UV-sensitive	mutation%2C	displays	altered	DNA	polymerase	usage%2C	chronically	inducedSOS	response%3B	when	associated	with	A-66.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15466025;Dbxref=PMID:15466025
P32695	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Loss	of	enzymatic	activity%3B	when	associated	with	Ala-153.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22123979;Dbxref=PMID:22123979
P32695	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Loss	of	the	ability	to	bind	FMN.	Loss	of	enzymatic	activity%3B	when	associated	with	Ala-114.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22123979;Dbxref=PMID:22123979
P45568	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Loss	of	solubility	and	activity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10787409;Dbxref=PMID:10787409
P45568	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Increase	in	KM	for	substrate.	Reduces	activity	35-fold.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10787409;Dbxref=PMID:10787409
P45568	UniProtKB	Mutagenesis	209	209	.	.	.	Note=Increase	in	KM	for	substrate.	Reduces	activity	5000-fold.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10787409;Dbxref=PMID:10787409
P45568	UniProtKB	Mutagenesis	231	231	.	.	.	Note=No	effect	on	KM	for	substrate.	Reduces	activity	by	over	99.9%25.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10787409;Dbxref=PMID:10787409
P45568	UniProtKB	Mutagenesis	257	257	.	.	.	Note=Strong	increase	in	KM	for	substrate.	Loss	of	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10787409;Dbxref=PMID:10787409
P31680	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Loss	of	activation	of	rcs.	L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9364918;Dbxref=PMID:9364918
P31680	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Only	partial	activation	of	rcs.	M->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9364918;Dbxref=PMID:9364918
P31680	UniProtKB	Mutagenesis	233	233	.	.	.	Note=Loss	of	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9364917;Dbxref=PMID:9364917
P0ABS5	UniProtKB	Mutagenesis	165	165	.	.	.	Note=Abolishes	DNA-binding	and	primer	synthesis.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18193061;Dbxref=PMID:18193061
P0ABS5	UniProtKB	Mutagenesis	199	199	.	.	.	Note=Abolishes	primer	synthesis	but	can	still	bind	DNA.	Abolishes	DNA-binding%3B	when	associated	with	A-201.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18193061;Dbxref=PMID:18193061
P0ABS5	UniProtKB	Mutagenesis	201	201	.	.	.	Note=Abolishes	primer	synthesis	but	can	still	bind	DNA.	Abolishes	DNA-binding%3B	when	associated	with	A-199.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18193061;Dbxref=PMID:18193061
P0ABS5	UniProtKB	Mutagenesis	576	576	.	.	.	Note=Decreases	interaction	with	DnaB	and	primase	activity.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8917517;Dbxref=PMID:8917517
P0AEG6	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Loss	of	activity.	C->T%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8168498;Dbxref=PMID:8168498
P0AEG6	UniProtKB	Mutagenesis	121	121	.	.	.	Note=Partial	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8168498;Dbxref=PMID:8168498
P0AEG6	UniProtKB	Mutagenesis	121	121	.	.	.	Note=Loss	of	activity.	C->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8168498;Dbxref=PMID:8168498
P0AEG6	UniProtKB	Mutagenesis	161	161	.	.	.	Note=Destabilization	of	protein.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8168498;Dbxref=PMID:8168498
P0AEG6	UniProtKB	Mutagenesis	183	183	.	.	.	Note=Destabilization	of	protein.	C->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8168498;Dbxref=PMID:8168498
P36655	UniProtKB	Mutagenesis	13	13	.	.	.	Note=No	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10545108;Dbxref=PMID:10545108
P36655	UniProtKB	Mutagenesis	122	122	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10545108,ECO:0000269|PubMed:10712691,ECO:0000269|PubMed:10760137;Dbxref=PMID:10545108,PMID:10712691,PMID:10760137
P36655	UniProtKB	Mutagenesis	128	128	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10545108,ECO:0000269|PubMed:10712691,ECO:0000269|PubMed:10760137;Dbxref=PMID:10545108,PMID:10712691,PMID:10760137
P36655	UniProtKB	Mutagenesis	182	182	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10545108,ECO:0000269|PubMed:10712691,ECO:0000269|PubMed:10760137;Dbxref=PMID:10545108,PMID:10712691,PMID:10760137
P36655	UniProtKB	Mutagenesis	301	301	.	.	.	Note=No	loss	of	activity.	C->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10545108,ECO:0000269|PubMed:10712691,ECO:0000269|PubMed:10760137;Dbxref=PMID:10545108,PMID:10712691,PMID:10760137
P36655	UniProtKB	Mutagenesis	304	304	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10545108,ECO:0000269|PubMed:10712691,ECO:0000269|PubMed:10760137;Dbxref=PMID:10545108,PMID:10712691,PMID:10760137
P36655	UniProtKB	Mutagenesis	480	480	.	.	.	Note=Loss	of	activity%3B	when	associated	with	A-483.	C->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10545108,ECO:0000269|PubMed:10712691,ECO:0000269|PubMed:10760137;Dbxref=PMID:10545108,PMID:10712691,PMID:10760137
P36655	UniProtKB	Mutagenesis	483	483	.	.	.	Note=Loss	of	activity%3B	when	associated	with	A-480.	C->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10545108,ECO:0000269|PubMed:10712691,ECO:0000269|PubMed:10760137;Dbxref=PMID:10545108,PMID:10712691,PMID:10760137
P77202	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Complete	loss	of	redox	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10788443;Dbxref=PMID:10788443
P77202	UniProtKB	Mutagenesis	126	126	.	.	.	Note=No	loss	of	chaperone	activity%3B	when	associated	with	S-129.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10788443;Dbxref=PMID:10788443
P77202	UniProtKB	Mutagenesis	129	129	.	.	.	Note=Partial	loss	of	redox	activity.	Traps	the	protein	in	complex	with	ErfK%2C	YbiS	and	YnhG.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10788443,ECO:0000269|PubMed:19965429;Dbxref=PMID:10788443,PMID:19965429
P77202	UniProtKB	Mutagenesis	129	129	.	.	.	Note=No	loss	of	chaperone	activity%3B	when	associated	with	S-126.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10788443,ECO:0000269|PubMed:19965429;Dbxref=PMID:10788443,PMID:19965429
P18956	UniProtKB	Mutagenesis	391	391	.	.	.	Note=Abolishes	autocatalytic	cleavage.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17135273;Dbxref=PMID:17135273
P18956	UniProtKB	Mutagenesis	513	513	.	.	.	Note=Not	processed	into	its	subunits.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1360205;Dbxref=PMID:1360205
P18956	UniProtKB	Mutagenesis	571	571	.	.	.	Note=Not	processed	into	its	subunits.	R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1360205;Dbxref=PMID:1360205
P0AD68	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Impairs	septal	localization.	R->C%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14702319;Dbxref=PMID:14702319
P0AD68	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Impairs	septal	localization.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14702319;Dbxref=PMID:14702319
P0AD68	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Impairs	septal	localization.	Q->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14702319;Dbxref=PMID:14702319
P0AD68	UniProtKB	Mutagenesis	57	57	.	.	.	Note=Impairs	recruitment	of	FtsN	to	the	septal	ring.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14702319;Dbxref=PMID:14702319
P0AD68	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Impairs	recruitment	of	FtsN	to	the	septal	ring.	S->F%2CP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14702319;Dbxref=PMID:14702319
P0AD68	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Impairs	recruitment	of	FtsN	to	the	septal	ring.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14702319;Dbxref=PMID:14702319
P0AD68	UniProtKB	Mutagenesis	210	210	.	.	.	Note=Impairs	recruitment	of	FtsN	to	the	septal	ring.	R->C%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14702319;Dbxref=PMID:14702319
P0AD68	UniProtKB	Mutagenesis	307	307	.	.	.	Note=Unable	to	bind	penicillin.	S->A%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3911028;Dbxref=PMID:3911028
P0AD68	UniProtKB	Mutagenesis	307	307	.	.	.	Note=Still	able	to	bind	penicillin.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3911028;Dbxref=PMID:3911028
P0AD68	UniProtKB	Mutagenesis	361	361	.	.	.	Note=In	PBPBR1%3B	obtained	after	selection	for	increased	resistance	to	cephalexin%2C	causes	a	change	in	the	shape	of	the	cell:	The	polar	caps	are	pointed.	N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3049550;Dbxref=PMID:3049550
P0AEN4	UniProtKB	Mutagenesis	70	70	.	.	.	Note=Impairs	both	localization	and	function%2C	and	reduces	the	efficiency	of	dimerization.	L->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10613870;Dbxref=PMID:10613870
P0AEN4	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Impairs	both	localization	and	function%2C	and	reduces	the	efficiency	of	dimerization.	L->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10613870;Dbxref=PMID:10613870
P0AF61	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Still	digests	ghoT	RNA.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22941047;Dbxref=PMID:22941047
P0AF61	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Still	digests	ghoT	RNA.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22941047;Dbxref=PMID:22941047
P0AF61	UniProtKB	Mutagenesis	25	25	.	.	.	Note=Protein	becomes	toxic	upon	overexpression.	Becomes	classic	type	II	TA	toxin	protein%2C	increased	cell	persistence	to	ampicillin%3B	when	associated	with	L-31.	L->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24797297;Dbxref=PMID:24797297
P0AF61	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Slightly	impaired	digestion	of	ghoT	RNA.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22941047;Dbxref=PMID:22941047
P0AF61	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Reduced	digestion	of	ghoT	RNA%2C	less	efficient	neutralization	of	GhoT	in	vivo.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22941047;Dbxref=PMID:22941047
P0AF61	UniProtKB	Mutagenesis	31	31	.	.	.	Note=Protein	becomes	toxic	upon	overexpression.	Becomes	classic	type	II	TA	toxin	protein%2C	increased	cell	persistence	to	ampicillin%3B	when	associated	with	I-25.	M->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24797297;Dbxref=PMID:24797297
P0AF61	UniProtKB	Mutagenesis	55	55	.	.	.	Note=Reduced	digestion	of	ghoT	RNA.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22941047;Dbxref=PMID:22941047
P0A9R7	UniProtKB	Mutagenesis	41	41	.	.	.	Note=Does	not	bind	ATP.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10048040;Dbxref=PMID:10048040
P0A9R7	UniProtKB	Mutagenesis	49	49	.	.	.	Note=Prevents	dimer	formation.	Does	not	alter	ATP-binding.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10048040;Dbxref=PMID:10048040
P09148	UniProtKB	Mutagenesis	160	160	.	.	.	Note=Slight	inhibition	of	enzymatic	activity.	C->S%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10820011;Dbxref=PMID:10820011
P09148	UniProtKB	Mutagenesis	161	161	.	.	.	Note=7000-fold	reduction	in	specifiactivity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10820011;Dbxref=PMID:10820011
P09148	UniProtKB	Mutagenesis	166	166	.	.	.	Note=Abolishes	enzymatic	activity.	H->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9063869;Dbxref=PMID:9063869
P09147	UniProtKB	Mutagenesis	124	124	.	.	.	Note=No	major	structural	changes.	Catalytic	efficiency	is	very	low	and	affinity	binding	is	21%25	of	the	wild-type	enzyme.	S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9271498,ECO:0000269|PubMed:9271499,ECO:0000269|PubMed:9708982;Dbxref=PMID:9271498,PMID:9271499,PMID:9708982
P09147	UniProtKB	Mutagenesis	124	124	.	.	.	Note=No	major	structural	changes.	Catalytic	efficiency	is	about	30%25	of	that	of	the	wild-type	enzyme%2C	and	affinity	binding	is	similar	to	that	of	the	native	enzyme.	S->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9271498,ECO:0000269|PubMed:9271499,ECO:0000269|PubMed:9708982;Dbxref=PMID:9271498,PMID:9271499,PMID:9708982
P09147	UniProtKB	Mutagenesis	149	149	.	.	.	Note=No	major	structural	changes.	Catalytic	efficiency	is	very	low	and	affinity	binding	is	12%25	of	the	wild-type	enzyme.	Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9271498,ECO:0000269|PubMed:9708982;Dbxref=PMID:9271498,PMID:9708982
P09147	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Decreases	the	catalytic	activity.	Not	reduced	by	sugars	in	the	presence	or	absence	of	UMP.	It	contains	very	little	NADH.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8241178;Dbxref=PMID:8241178
P09147	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Decreases	the	catalytic	activity.	Not	reduced	by	sugars	in	the	presence	or	absence	of	UMP.	It	contains	very	little	NADH.	K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8241178;Dbxref=PMID:8241178
P09147	UniProtKB	Mutagenesis	299	299	.	.	.	Note=Loss	of	epimerase	activitwith	UDP-Gal	by	almost	5-fold%2C	but	it	results	in	a	gain	of	epimerase	activitwith	uridine	diphosphate	N-acetylglucosamine	(UDP-GlcNAc)	by	230-fold	with	minimal	changes	in	its	three-dimensional	structure.	Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12019271;Dbxref=PMID:12019271
P05042	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Reduces	enzyme	activity	10-foldR->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14990798;Dbxref=PMID:14990798
P05042	UniProtKB	Mutagenesis	127	127	.	.	.	Note=No	effect.	K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14990798;Dbxref=PMID:14990798
P05042	UniProtKB	Mutagenesis	129	129	.	.	.	Note=No	effect	on	activity%2C	but	the	carboxyamide	group	from	Asn129	swings	into	the	B	site	and	replaces	S-malate	by	forming	a	bifurcated	hydrogen	bond	with	Asn131	and	Asp132.	H->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14990798,ECO:0000269|PubMed:9098893;Dbxref=PMID:14990798,PMID:9098893
P05042	UniProtKB	Mutagenesis	188	188	.	.	.	Note=Reduces	activity	200-fold.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9098893;Dbxref=PMID:9098893
P05042	UniProtKB	Mutagenesis	315	315	.	.	.	Note=Reduces	activity	10-fold.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12021453;Dbxref=PMID:12021453
P0A6T3	UniProtKB	Mutagenesis	371	371	.	.	.	Note=Displays	relaxed	substrate	specificity	since	it	gains	kinase	activity	toward	sugars	as	diverse	as	D-galacturonic	acid%2C	D-talose%2C	L-altrose%2C	and	L-glucose.	Also	shows	enhanced	turnover	of	the	small	pool	of	sugars	converted	by	the	wild-type	enzyme.	Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14612558;Dbxref=PMID:14612558
P0ACC7	UniProtKB	Mutagenesis	14	14	.	.	.	Note=8-fold	decrease	in	uridyltransferase	activity.	Creates	steric	conflict	and	decreases	affinity	for	UTP.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10428949;Dbxref=PMID:10428949
P0ACC7	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Dramatically	impairs	the	uridyltransferase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10428949;Dbxref=PMID:10428949
P0ACC7	UniProtKB	Mutagenesis	25	25	.	.	.	Note=8-fold	decrease	in	uridyltransferase	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10428949;Dbxref=PMID:10428949
P0ACC7	UniProtKB	Mutagenesis	296	296	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9733680;Dbxref=PMID:9733680
P0ACC7	UniProtKB	Mutagenesis	307	307	.	.	.	Note=1350-fold	decrease	in	acetyltransferase	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9733680;Dbxref=PMID:9733680
P0ACC7	UniProtKB	Mutagenesis	324	324	.	.	.	Note=8-fold	decrease	in	acetyltransferase	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9733680;Dbxref=PMID:9733680
P0ACC7	UniProtKB	Mutagenesis	385	385	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9733680;Dbxref=PMID:9733680
P31120	UniProtKB	Mutagenesis	100	100	.	.	.	Note=2%25	of	wild-type	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10231382;Dbxref=PMID:10231382
P31120	UniProtKB	Mutagenesis	100	100	.	.	.	Note=20-fold	increase	in	the	non-specific	phosphoglucomutase	activity	towards	glucose-phosphate	substrates	(non	aminated).	S->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10231382;Dbxref=PMID:10231382
P31120	UniProtKB	Mutagenesis	102	102	.	.	.	Note=Loss	of	activity	in	the	absence	or	presence	of	glucosamine-1%2C6-diP.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10231382;Dbxref=PMID:10231382
P77454	UniProtKB	Mutagenesis	69	69	.	.	.	Note=Loss	of	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18459799;Dbxref=PMID:18459799
P77454	UniProtKB	Mutagenesis	117	117	.	.	.	Note=Loss	of	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18459799;Dbxref=PMID:18459799
P77454	UniProtKB	Mutagenesis	160	160	.	.	.	Note=Loss	of	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18459799;Dbxref=PMID:18459799
P77454	UniProtKB	Mutagenesis	161	161	.	.	.	Note=Strongly	reduced	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18459799;Dbxref=PMID:18459799
P77454	UniProtKB	Mutagenesis	162	162	.	.	.	Note=No	effect.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18459799;Dbxref=PMID:18459799
P77454	UniProtKB	Mutagenesis	168	168	.	.	.	Note=Loss	of	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18459799;Dbxref=PMID:18459799
P77454	UniProtKB	Mutagenesis	192	192	.	.	.	Note=Loss	of	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18459799;Dbxref=PMID:18459799
P77454	UniProtKB	Mutagenesis	244	244	.	.	.	Note=Loss	of	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18459799;Dbxref=PMID:18459799
P77454	UniProtKB	Mutagenesis	260	260	.	.	.	Note=Reduced	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18459799;Dbxref=PMID:18459799
P64646	UniProtKB	Mutagenesis	1	1	.	.	.	Note=Not	toxic	in	a	disrupted	ghoS	strain	as	no	protein	produced.	M->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24373067;Dbxref=PMID:24373067
P64646	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Protein	remains	toxic.	I->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24373067;Dbxref=PMID:24373067
P64646	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Not	toxic%2C	protein	still	targeted	to	cell	pole.	No	change	in	intracellular	ATP	levels%2C	no	dissipation	of	the	membrane	potential.	F->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24373067;Dbxref=PMID:24373067
P0AF52	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Almost	no	change	in	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P0AF52	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Lack	of	activity.	T->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P0AF52	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Almost	no	change	in	activity.	A->G%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P0AF52	UniProtKB	Mutagenesis	271	271	.	.	.	Note=Strong	decrease	in	activity.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P0AF52	UniProtKB	Mutagenesis	271	271	.	.	.	Note=Lack	of	activity.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P0AF52	UniProtKB	Mutagenesis	275	275	.	.	.	Note=Lack	of	activity.	T->A%2CD%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P0AF52	UniProtKB	Mutagenesis	275	275	.	.	.	Note=Strong	decrease	in	activity.	T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P0AF52	UniProtKB	Mutagenesis	302	302	.	.	.	Note=Lack	of	activity.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P0AF52	UniProtKB	Mutagenesis	302	302	.	.	.	Note=Almost	no	change	in	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P0AF52	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Lack	of	activity.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P0AF52	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Almost	no	change	in	activity.	I->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P0AF52	UniProtKB	Mutagenesis	322	322	.	.	.	Note=Strong	decrease	in	activity.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P0AF52	UniProtKB	Mutagenesis	322	322	.	.	.	Note=Lack	of	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P0AF52	UniProtKB	Mutagenesis	323	323	.	.	.	Note=Lack	of	activity.	S->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24214977;Dbxref=PMID:24214977
P37747	UniProtKB	Mutagenesis	151	151	.	.	.	Note=3-fold	decrease	in	the	mutase	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11573090;Dbxref=PMID:11573090
P37747	UniProtKB	Mutagenesis	156	156	.	.	.	Note=Loss	of	mutase	activity.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11573090;Dbxref=PMID:11573090
P37747	UniProtKB	Mutagenesis	156	156	.	.	.	Note=2-fold	decrease	in	the	mutase	activity.	W->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11573090;Dbxref=PMID:11573090
P37747	UniProtKB	Mutagenesis	181	181	.	.	.	Note=Increase	in	the	mutase	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11573090;Dbxref=PMID:11573090
P37747	UniProtKB	Mutagenesis	311	311	.	.	.	Note=Loss	of	mutase	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11573090;Dbxref=PMID:11573090
P37747	UniProtKB	Mutagenesis	346	346	.	.	.	Note=Loss	of	mutase	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11573090;Dbxref=PMID:11573090
P0A6V1	UniProtKB	Mutagenesis	195	195	.	.	.	Note=No	loss	in	enzyme	activity.	K->E%2CI%2CH%2CQ%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1648099;Dbxref=PMID:1648099
P63224	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Almost	no	effect.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18056714;Dbxref=PMID:18056714
P63224	UniProtKB	Mutagenesis	65	65	.	.	.	Note=No	activity.	E->N%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18056714;Dbxref=PMID:18056714
P63224	UniProtKB	Mutagenesis	69	69	.	.	.	Note=Almost	no	effect.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18056714;Dbxref=PMID:18056714
P63224	UniProtKB	Mutagenesis	94	94	.	.	.	Note=No	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18056714;Dbxref=PMID:18056714
P63224	UniProtKB	Mutagenesis	120	120	.	.	.	Note=No	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18056714;Dbxref=PMID:18056714
P63224	UniProtKB	Mutagenesis	169	169	.	.	.	Note=No	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18056714;Dbxref=PMID:18056714
P63224	UniProtKB	Mutagenesis	172	172	.	.	.	Note=No	activity.	Q->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18056714;Dbxref=PMID:18056714
P63224	UniProtKB	Mutagenesis	180	180	.	.	.	Note=No	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18056714;Dbxref=PMID:18056714
P0A6F3	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Abolishes	inhibition	of	GK	by	FBP	via	disruption	of	the	dimer-tetramer	assembly	reaction.	Inhibition	by	EIIA-Glc	is	unchanged	compared	to	wild	type.	The	activity	of	this	mutant	is	significantly	higher	than	wild-type%2C	and	the	Michaelis	constants	are	increased	slightlcompared	to	wild-type.	S->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10090737;Dbxref=PMID:10090737
P0A6F3	UniProtKB	Mutagenesis	66	66	.	.	.	Note=Although	it	completely	abolishes	FBP	regulation	and	disruptes	dimer-tetramer	equilibrium%2C	the	crystal	structure	is	essentially	identical	to	the	symmetric	tetramer	found	in	the	FBP-bound	form	of	the	enzyme.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9817843;Dbxref=PMID:9817843
P0A6F3	UniProtKB	Mutagenesis	231	231	.	.	.	Note=Displays	an	increased	enzymatic	activity	and	a	decreased	allosteric	regulation	by	FBP	compared	to	wild-type.	It	displays	a	dimer	form	and	is	resistant	to	tetramer	formation	in	the	presence	of	FBP%2C	whereas	wild-type	dimers	are	converted	into	inactivtetramers	in	the	presence	of	FBP.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17441732;Dbxref=PMID:17441732
P0A6F3	UniProtKB	Mutagenesis	237	237	.	.	.	Note=Drastically	reduces	inhibition	of	GK	by	FBP	and	lowers%2C	but	did	not	eliminate%2C	the	ability	of	FBP	to	promote	tetramer	association.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9843423;Dbxref=PMID:9843423
P0A6F3	UniProtKB	Mutagenesis	305	305	.	.	.	Note=In	glpK22%3B	abolishes	glucosecontrol	of	glycerol	utilization.	G->S
P0A6F3	UniProtKB	Mutagenesis	475	475	.	.	.	Note=It	decreases	Vmax	to	about	10%25	of	the	wild-type	value	and	the	affinity	for	substrate	is	increased	about	two-	to	fourfold.	This	mutation	decreases	the	catalytic	activity	in	manner	that	is	analogous	to	that	obtained	upon	EIIA-Glc	binding.	It	increases	the	affinity	for	FBP	about	fivefold.	I->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9817843;Dbxref=PMID:9817843
P0A6F3	UniProtKB	Mutagenesis	480	480	.	.	.	Note=It	decreases	Vmax	to	about	10%25	of	the	wild-type	value	and	the	affinity	for	substrate	is	increased	about	two-	to	fourfold.	This	mutation	decreases	the	catalytic	activity	in	manner	that	is	analogous	to	that	obtained	upon	EIIA-Glc	binding.	Regulation	by	FBP	is	not	affected	by	this	substitution.	No	inhibition	by	EIIA-Glc	is	observed%2C	which	is	consistent	with	a	decrease	in	affinity	for	EIIA-Glof	about	250-fold.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9817843;Dbxref=PMID:9817843
P63228	UniProtKB	Mutagenesis	11	11	.	.	.	Note=Inactive.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20050699;Dbxref=PMID:20050699
P63228	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Inactive.	D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20050614,ECO:0000269|PubMed:20050699;Dbxref=PMID:20050614,PMID:20050699
P63228	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Inactive.	D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20050614,ECO:0000269|PubMed:20050699;Dbxref=PMID:20050614,PMID:20050699
P63228	UniProtKB	Mutagenesis	92	92	.	.	.	Note=Reduces	the	catalytic	efficiencies	towards	the	alpha	and	beta-anomers	of	HBP.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20050614;Dbxref=PMID:20050614
P63228	UniProtKB	Mutagenesis	107	107	.	.	.	Note=More	than	3-fold	reduction	in	the	affinity	binding	of	HBP.	Reduces	the	catalytic	efficiencies	towards	the	alpha	and	beta-anomers	of	HBP.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20050614,ECO:0000269|PubMed:20050699;Dbxref=PMID:20050614,PMID:20050699
P63228	UniProtKB	Mutagenesis	109	109	.	.	.	Note=Reduces	the	catalytic	efficiencies	towards	the	alpha	and	beta-anomers	of	HBP.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20050614;Dbxref=PMID:20050614
P63228	UniProtKB	Mutagenesis	110	110	.	.	.	Note=Significant	reduction	in	the	catalytic	efficiency	of	hydrolysis	of	the	physiological	substrate	HBP.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20050614;Dbxref=PMID:20050614
P63228	UniProtKB	Mutagenesis	111	111	.	.	.	Note=Inactive.	K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20050699;Dbxref=PMID:20050699
P63228	UniProtKB	Mutagenesis	137	137	.	.	.	Note=8-fold	reduction	in	the	affinity	binding	of	HBP.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20050614;Dbxref=PMID:20050614
P69931	UniProtKB	Mutagenesis	6	6	.	.	.	Note=Severely	impaired	in	beta	clamp	binding	and	DnaA-ATP	hydrolysis%2C	very	poor	growth	at	30	degrees	Celsius.	Q->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15611053,ECO:0000269|PubMed:22716942;Dbxref=PMID:15611053,PMID:22716942
P69931	UniProtKB	Mutagenesis	7	11	.	.	.	Note=Decreased	binding	to	beta	clamp.	LSLPL->ASAPA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15150238;Dbxref=PMID:15150238
P69931	UniProtKB	Mutagenesis	9	10	.	.	.	Note=Decreased	binding	to	beta	clamp.	LP->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15150238;Dbxref=PMID:15150238
P69931	UniProtKB	Mutagenesis	9	9	.	.	.	Note=Impaired	in	beta	clamp	bindingand	DnaA-ATP	hydrolysis%2C	very	poor	growth	at	30	degrees	Celsius.	L->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15611053,ECO:0000269|PubMed:22716942;Dbxref=PMID:15611053,PMID:22716942
P69931	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Severely	impaired	in	ADP-binding	but	still	has	beta	clamp-binding	activity	in	vitro%2C	defective	in	DnaA-AThydrolysis	in	vivo%3B	when	associated	with	102-A-A-103.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18977760;Dbxref=PMID:18977760
P69931	UniProtKB	Mutagenesis	98	98	.	.	.	Note=No	growth	at	30	degrees	Celsius%2C	impaired	RIDA.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22716942;Dbxref=PMID:22716942
P69931	UniProtKB	Mutagenesis	102	103	.	.	.	Note=Impaired	in	ADP-binding%2C	has	beta	clamp-binding	activity	in	vitro.	DN->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18977760;Dbxref=PMID:18977760
P69931	UniProtKB	Mutagenesis	136	136	.	.	.	Note=No	growth	at	30	degrees	Celsius%2C	impaired	RIDA.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22716942;Dbxref=PMID:22716942
P69931	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Defective	in	DnaA-ATP	hydrolysis%2C	binds	beta	clamp	normally%2C	no	growth	at	30	degrees	Celsius.	R->A%2CM;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15611053,ECO:0000269|PubMed:22716942;Dbxref=PMID:15611053,PMID:22716942
P69931	UniProtKB	Mutagenesis	157	157	.	.	.	Note=Grows	at	30	degrees	Celsius%2C	impaired	RIDA.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22716942;Dbxref=PMID:22716942
P69931	UniProtKB	Mutagenesis	167	167	.	.	.	Note=Grows	at	30	degrees	Celsius%2C	impaired	RIDA.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22716942;Dbxref=PMID:22716942
P69931	UniProtKB	Mutagenesis	196	196	.	.	.	Note=Grows	at	30	degrees	Celsius%2C	impaired	RIDA.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22716942;Dbxref=PMID:22716942
P69931	UniProtKB	Mutagenesis	208	210	.	.	.	Note=No	growth	at	30	degrees	Celsius%2C	impaired	RIDA.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22716942;Dbxref=PMID:22716942
P69931	UniProtKB	Mutagenesis	210	210	.	.	.	Note=No	growth	at	30	degrees	Celsius%2C	impaired	RIDA.	Q->QLDQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22716942;Dbxref=PMID:22716942
P69931	UniProtKB	Mutagenesis	212	212	.	.	.	Note=Grows	at	30	degrees	Celsius%2C	impaired	RIDA.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22716942;Dbxref=PMID:22716942
P69931	UniProtKB	Mutagenesis	233	233	.	.	.	Note=No	growth	at	30	degrees	Celsius%2C	impaired	RIDA.	L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22716942;Dbxref=PMID:22716942
P36553	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Complete	loss	of	oxidase	activitand	absence	of	manganese	ions.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12975365;Dbxref=PMID:12975365
P36553	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Complete	loss	of	oxidase	activitand	absence	of	manganese	ions.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12975365;Dbxref=PMID:12975365
P36553	UniProtKB	Mutagenesis	145	145	.	.	.	Note=Complete	loss	of	oxidase	activitand	absence	of	manganese	ions.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12975365;Dbxref=PMID:12975365
P36553	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Complete	loss	of	oxidase	activitand	absence	of	manganese	ions.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12975365;Dbxref=PMID:12975365
P36553	UniProtKB	Mutagenesis	274	274	.	.	.	Note=Complete	loss	of	oxidase	activity.	W->L
P32131	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Loss	of	activity.	Y->A%2CL;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12114526,ECO:0000269|PubMed:15967800;Dbxref=PMID:12114526,PMID:15967800
P32131	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Decreases	activity	by	50%25.	Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12114526,ECO:0000269|PubMed:15967800;Dbxref=PMID:12114526,PMID:15967800
P32131	UniProtKB	Mutagenesis	58	58	.	.	.	Note=Results	in	loss	of	iron-sulfur	cluster	and	activity.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12114526;Dbxref=PMID:12114526
P32131	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Results	in	loss	of	iron-sulfur	cluster	and	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12114526;Dbxref=PMID:12114526
P32131	UniProtKB	Mutagenesis	66	66	.	.	.	Note=Results	in	loss	of	iron-sulfur	cluster	and	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12114526;Dbxref=PMID:12114526
P32131	UniProtKB	Mutagenesis	68	68	.	.	.	Note=No	effect.	F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12114526;Dbxref=PMID:12114526
P32131	UniProtKB	Mutagenesis	69	69	.	.	.	Note=Results	in	loss	of	iron-sulfur	cluster	and	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12114526;Dbxref=PMID:12114526
P32131	UniProtKB	Mutagenesis	71	71	.	.	.	Note=No	effect	on	iron-sulfur	cluster%2C	but	results	in	activity	loss.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12114526;Dbxref=PMID:12114526
P32131	UniProtKB	Mutagenesis	111	111	.	.	.	Note=Loss	of	activity	and	much	less	iron-sulfur	cluster	formed%3B	when	associated	with	V-113.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12114526;Dbxref=PMID:12114526
P32131	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Loss	of	activity	and	much	less	iron-sulfur	cluster	formed%3B	when	associated	with	V-111.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12114526;Dbxref=PMID:12114526
P32131	UniProtKB	Mutagenesis	145	145	.	.	.	Note=Loss	of	activity.	Iron	content	reduced	by	about	80%25.	E->A%2CI;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15967800;Dbxref=PMID:15967800
P32131	UniProtKB	Mutagenesis	310	310	.	.	.	Note=Loss	of	activity.	Iron	content	reduced	by	about	50%25.	Can	cleave	up	to	one	molecule	of	S-adenosyl-L-methionine(in	vitro).	F->A%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15967800;Dbxref=PMID:15967800
P32131	UniProtKB	Mutagenesis	311	311	.	.	.	Note=Loss	of	activity.	No	change	in	iron	content.	Can	cleave	up	to	one	molecule	of	S-adenosyl-L-methionine(in	vitro).	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15967800;Dbxref=PMID:15967800
P32131	UniProtKB	Mutagenesis	329	329	.	.	.	Note=Loss	of	activity.	No	change	in	iron	content.	Can	cleave	up	to	one	molecule	of	S-adenosyl-L-methionine(in	vitro).	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15967800;Dbxref=PMID:15967800
P09372	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Great	decrease	in	abilityto	interact	with	DnaK.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15136046;Dbxref=PMID:15136046
P09372	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Great	decrease	in	abilityto	interact	with	DnaK.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15136046;Dbxref=PMID:15136046
P09372	UniProtKB	Mutagenesis	82	82	.	.	.	Note=Great	decrease	in	abilityto	interact	with	DnaK.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15136046;Dbxref=PMID:15136046
P09372	UniProtKB	Mutagenesis	86	86	.	.	.	Note=No	effect	in	ability	to	interacwith	DnaK.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12885238;Dbxref=PMID:12885238
P09372	UniProtKB	Mutagenesis	104	104	.	.	.	Note=No	effect	in	ability	to	interacwith	DnaK.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15136046;Dbxref=PMID:15136046
P09372	UniProtKB	Mutagenesis	107	107	.	.	.	Note=No	effect	in	ability	to	interacwith	DnaK.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15136046;Dbxref=PMID:15136046
P09372	UniProtKB	Mutagenesis	108	108	.	.	.	Note=No	effect	in	ability	to	interacwith	DnaK.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15136046;Dbxref=PMID:15136046
P09372	UniProtKB	Mutagenesis	122	122	.	.	.	Note=Temperature-sensitive	phenotype.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9103205;Dbxref=PMID:9103205
P09372	UniProtKB	Mutagenesis	149	149	.	.	.	Note=No	effect	in	ability	to	interacwith	DnaK.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15136046;Dbxref=PMID:15136046
P09372	UniProtKB	Mutagenesis	151	151	.	.	.	Note=No	effect	in	ability	to	interacwith	DnaK.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15136046;Dbxref=PMID:15136046
P09372	UniProtKB	Mutagenesis	155	155	.	.	.	Note=No	effect	in	ability	to	interacwith	DnaK.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15136046;Dbxref=PMID:15136046
P09372	UniProtKB	Mutagenesis	157	157	.	.	.	Note=No	effect	in	ability	to	interacwith	DnaK.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15136046;Dbxref=PMID:15136046
P09372	UniProtKB	Mutagenesis	159	159	.	.	.	Note=No	effect	in	ability	to	interacwith	DnaK.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15136046;Dbxref=PMID:15136046
P09372	UniProtKB	Mutagenesis	174	174	.	.	.	Note=No	effect	in	ability	to	interacwith	DnaK.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15136046;Dbxref=PMID:15136046
P09372	UniProtKB	Mutagenesis	183	183	.	.	.	Note=Loss	of	ability	to	interacwith	DnaK.	R->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12885238,ECO:0000269|PubMed:15136046;Dbxref=PMID:12885238,PMID:15136046
P09372	UniProtKB	Mutagenesis	186	186	.	.	.	Note=No	effect	in	ability	to	interacwith	DnaK.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8890154;Dbxref=PMID:8890154
P09372	UniProtKB	Mutagenesis	189	189	.	.	.	Note=No	effect	in	ability	to	interacwith	DnaK.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8890154;Dbxref=PMID:8890154
P09372	UniProtKB	Mutagenesis	192	192	.	.	.	Note=Loss	of	ability	to	interacwith	DnaK.	V->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12885238,ECO:0000269|PubMed:15136046;Dbxref=PMID:12885238,PMID:15136046
P04425	UniProtKB	Mutagenesis	122	122	.	.	.	Note=No	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3042775;Dbxref=PMID:3042775
P04425	UniProtKB	Mutagenesis	195	195	.	.	.	Note=No	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3042775;Dbxref=PMID:3042775
P04425	UniProtKB	Mutagenesis	222	222	.	.	.	Note=No	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3042775;Dbxref=PMID:3042775
P04425	UniProtKB	Mutagenesis	227	227	.	.	.	Note=Loss	of	activity.	P->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8241129;Dbxref=PMID:8241129
P04425	UniProtKB	Mutagenesis	233	233	.	.	.	Note=Loss	of	activity.	R->A%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1540581;Dbxref=PMID:1540581
P04425	UniProtKB	Mutagenesis	240	240	.	.	.	Note=Loss	of	activity.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8241129;Dbxref=PMID:8241129
P04425	UniProtKB	Mutagenesis	241	241	.	.	.	Note=No	loss	of	activity.	R->A%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1540581;Dbxref=PMID:1540581
P04425	UniProtKB	Mutagenesis	289	289	.	.	.	Note=No	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3042775;Dbxref=PMID:3042775
P0AES2	UniProtKB	Mutagenesis	150	150	.	.	.	Note=Reduces	activity	100-fold.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10769114;Dbxref=PMID:10769114
P0AES2	UniProtKB	Mutagenesis	207	207	.	.	.	Note=Reduces	activity	1000-fold.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10769114;Dbxref=PMID:10769114
P0AES2	UniProtKB	Mutagenesis	207	207	.	.	.	Note=Reduces	activity	10000-fold.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10769114;Dbxref=PMID:10769114
P0AES2	UniProtKB	Mutagenesis	339	339	.	.	.	Note=Loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10769114;Dbxref=PMID:10769114
P0AES2	UniProtKB	Mutagenesis	339	339	.	.	.	Note=Reduces	activity	10000-fold.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10769114;Dbxref=PMID:10769114
P0AES2	UniProtKB	Mutagenesis	339	339	.	.	.	Note=Reduces	activity	1000-fold.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10769114;Dbxref=PMID:10769114
P0AES2	UniProtKB	Mutagenesis	366	366	.	.	.	Note=Reduces	activity	over	100-fold.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10769114;Dbxref=PMID:10769114
P0A6X1	UniProtKB	Mutagenesis	7	7	.	.	.	Note=Loss	of	activity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12370189;Dbxref=PMID:12370189
P0A6X1	UniProtKB	Mutagenesis	49	49	.	.	.	Note=10%25	and	5%25	of	wild-type	reductase	and	esterase	activity%2C	respectively.	T->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17697121;Dbxref=PMID:17697121
P0A6X1	UniProtKB	Mutagenesis	50	50	.	.	.	Note=Loss	of	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12370189;Dbxref=PMID:12370189
P0A6X1	UniProtKB	Mutagenesis	52	52	.	.	.	Note=5%25	and	4%25	of	wild-type	reductase	and	esterase	activity%2C	respectively.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17697121;Dbxref=PMID:17697121
P0A6X1	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Loss	of	activity.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17697121;Dbxref=PMID:17697121
P0A6X1	UniProtKB	Mutagenesis	54	54	.	.	.	Note=6%25	and	2%25	of	wild-type	reductase	and	esterase	activity%2C	respectively.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17697121;Dbxref=PMID:17697121
P0A6X1	UniProtKB	Mutagenesis	74	74	.	.	.	Note=No	effect.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12370189;Dbxref=PMID:12370189
P0A6X1	UniProtKB	Mutagenesis	99	99	.	.	.	Note=5%25	and	4%25	of	wild-type	reductase	and	esterase	activity%2C	respectively.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17697121;Dbxref=PMID:17697121
P0A6X1	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Loss	of	activity.	G->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12370189;Dbxref=PMID:12370189
P0A6X1	UniProtKB	Mutagenesis	109	109	.	.	.	Note=28%25	and	25%25	of	wild-type	reductase	and	esterase	activity%2C	respectively.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17697121;Dbxref=PMID:17697121
P0A6X1	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Loss	of	activity.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12370189;Dbxref=PMID:12370189
P0A6X1	UniProtKB	Mutagenesis	116	116	.	.	.	Note=Loss	of	reductase	activity.	30%25	of	wild-type	esterase	activity.	Q->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17697121;Dbxref=PMID:17697121
P0A6X1	UniProtKB	Mutagenesis	145	145	.	.	.	Note=Loss	of	activity.	S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12370189;Dbxref=PMID:12370189
P0A6X1	UniProtKB	Mutagenesis	170	170	.	.	.	Note=No	effect.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12370189;Dbxref=PMID:12370189
P0A6X1	UniProtKB	Mutagenesis	191	191	.	.	.	Note=Loss	of	reductase	activity.	Retains	esterase	activity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12370189;Dbxref=PMID:12370189
P0A6X1	UniProtKB	Mutagenesis	314	314	.	.	.	Note=Loss	of	activity.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12370189;Dbxref=PMID:12370189
P32099	UniProtKB	Mutagenesis	73	73	.	.	.	Note=20-fold	decrease	in	affinitfor	ATP.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16043486;Dbxref=PMID:16043486
P32099	UniProtKB	Mutagenesis	141	141	.	.	.	Note=More	than	10-fold	reduction	in	Vmax.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16043486;Dbxref=PMID:16043486
P69776	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Localizes	to	the	inner	membrane%2C	where	it	associates	with	peptidoglycan%2C	thereby	preventing	separation	of	the	two	membranes.	Prolonged	expression	is	lethal	for	the	cell.	S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139900;Dbxref=PMID:9139900
P69776	UniProtKB	Mutagenesis	70	70	.	.	.	Note=Does	not	affect	the	formation	of	murein-bound	lipoprotein.	D->E%2CG%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1527073;Dbxref=PMID:1527073
P69776	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Does	not	affect	the	formation	of	murein-bound	lipoprotein.	K->S%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1527073;Dbxref=PMID:1527073
P69776	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Reduces	the	formation	of	murein-bound	lipoprotein.	Y->C%2CD%2CE%2CG%2CN%2CP%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1527073;Dbxref=PMID:1527073
P69776	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Does	not	affect	the	formation	of	murein-bound	lipoprotein.	Y->F%2CH%2CI%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1527073;Dbxref=PMID:1527073
P69776	UniProtKB	Mutagenesis	77	77	.	.	.	Note=Reduces	the	formation	of	murein-bound	lipoprotein.	R->D%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1527073;Dbxref=PMID:1527073
P69776	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Abolishes	the	formation	of	murein-bound	lipoprotein.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1527073;Dbxref=PMID:1527073
P60955	UniProtKB	Mutagenesis	7	7	.	.	.	Note=No	effect.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P60955	UniProtKB	Mutagenesis	24	24	.	.	.	Note=No	effect.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P60955	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Loss	of	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22287519;Dbxref=PMID:22287519
P60955	UniProtKB	Mutagenesis	26	26	.	.	.	Note=No	effect.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P60955	UniProtKB	Mutagenesis	62	62	.	.	.	Note=No	effect.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P60955	UniProtKB	Mutagenesis	76	76	.	.	.	Note=No	effect.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P60955	UniProtKB	Mutagenesis	98	98	.	.	.	Note=No	effect.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22287519;Dbxref=PMID:22287519
P60955	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Loss	of	activity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P60955	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Loss	of	activity	(PubMed:9139912).	No	effect	(PubMed:22287519).	H->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22287519,ECO:0000269|PubMed:9139912;Dbxref=PMID:22287519,PMID:9139912
P60955	UniProtKB	Mutagenesis	104	104	.	.	.	Note=No	effect.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22287519;Dbxref=PMID:22287519
P60955	UniProtKB	Mutagenesis	129	129	.	.	.	Note=No	effect.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22287519;Dbxref=PMID:22287519
P60955	UniProtKB	Mutagenesis	143	143	.	.	.	Note=Decrease	in	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22287519;Dbxref=PMID:22287519
P60955	UniProtKB	Mutagenesis	146	146	.	.	.	Note=Loss	of	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22287519;Dbxref=PMID:22287519
P60955	UniProtKB	Mutagenesis	151	151	.	.	.	Note=Decrease	in	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22287519;Dbxref=PMID:22287519
P60955	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Loss	of	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22287519;Dbxref=PMID:22287519
P60955	UniProtKB	Mutagenesis	190	190	.	.	.	Note=No	effect.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P60955	UniProtKB	Mutagenesis	196	196	.	.	.	Note=No	effect.	H->N%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P60955	UniProtKB	Mutagenesis	196	196	.	.	.	Note=50%25	decrease	in	activity.	H->Q%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P60955	UniProtKB	Mutagenesis	201	201	.	.	.	Note=No	effect.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P60955	UniProtKB	Mutagenesis	235	235	.	.	.	Note=Loss	of	activity.	Y->F%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P60955	UniProtKB	Mutagenesis	235	235	.	.	.	Note=37%25	decrease	in	activity.	Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P60955	UniProtKB	Mutagenesis	239	239	.	.	.	Note=Decrease	in	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22287519;Dbxref=PMID:22287519
P60955	UniProtKB	Mutagenesis	243	243	.	.	.	Note=Decrease	in	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22287519;Dbxref=PMID:22287519
P60955	UniProtKB	Mutagenesis	282	282	.	.	.	Note=No	effect.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P60955	UniProtKB	Mutagenesis	289	289	.	.	.	Note=No	effect.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9139912;Dbxref=PMID:9139912
P75957	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Loss	of	lipoprotein	releasewhen	overexpressed.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10783239;Dbxref=PMID:10783239
P0A725	UniProtKB	Mutagenesis	19	19	.	.	.	Note=1400-fold	decrease	in	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11148046;Dbxref=PMID:11148046
P0A725	UniProtKB	Mutagenesis	19	19	.	.	.	Note=90-fold	decrease	in	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11148046;Dbxref=PMID:11148046
P0A725	UniProtKB	Mutagenesis	19	19	.	.	.	Note=200-fold	decrease	in	activity.	H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11148046;Dbxref=PMID:11148046
P0A725	UniProtKB	Mutagenesis	63	63	.	.	.	Note=Reduces	level	of	inhibition	by	metal	ions.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20136146;Dbxref=PMID:20136146
P0A725	UniProtKB	Mutagenesis	78	78	.	.	.	Note=700-fold	decrease	in	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11148046;Dbxref=PMID:11148046
P0A725	UniProtKB	Mutagenesis	78	78	.	.	.	Note=3000-fold	decrease	in	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11148046;Dbxref=PMID:11148046
P0A725	UniProtKB	Mutagenesis	79	79	.	.	.	Note=2300-fold	decrease	in	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11148046;Dbxref=PMID:11148046
P0A725	UniProtKB	Mutagenesis	79	79	.	.	.	Note=1200-fold	decrease	in	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11148046;Dbxref=PMID:11148046
P0A725	UniProtKB	Mutagenesis	238	238	.	.	.	Note=1100-fold	decrease	in	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11148046;Dbxref=PMID:11148046
P0A725	UniProtKB	Mutagenesis	242	242	.	.	.	Note=10-fold	decrease	in	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11148046;Dbxref=PMID:11148046
P0A725	UniProtKB	Mutagenesis	242	242	.	.	.	Note=2300-fold	decrease	in	activity.	D->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11148046;Dbxref=PMID:11148046
P0A725	UniProtKB	Mutagenesis	246	246	.	.	.	Note=1800-fold	decrease	in	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11148046;Dbxref=PMID:11148046
P0A725	UniProtKB	Mutagenesis	265	265	.	.	.	Note=3800-fold	decrease	in	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11148046;Dbxref=PMID:11148046
P0A725	UniProtKB	Mutagenesis	265	265	.	.	.	Note=5600-fold	decrease	in	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11148046;Dbxref=PMID:11148046
P25772	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Loss	of	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11812821;Dbxref=PMID:11812821
P00803	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Indifferent.	E->V
P00803	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Indifferent.	R->E%2CN%2CL
P00803	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Loss	of	activity.	S->A
P00803	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Indifferent.	H->N
P00803	UniProtKB	Mutagenesis	128	128	.	.	.	Note=Small	effect.	R->Q
P00803	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Indifferent.	D->A
P00803	UniProtKB	Mutagenesis	144	144	.	.	.	Note=Indifferent.	Y->F
P00803	UniProtKB	Mutagenesis	146	146	.	.	.	Note=Loss	of	activity.	K->M%2CD%2CG%2CS
P00803	UniProtKB	Mutagenesis	147	147	.	.	.	Note=Small	effect.	R->Q
P00803	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Loss	of	activity.	D->A
P00803	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Indifferent.	D->N
P00803	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Small	effect.	D->N
P00803	UniProtKB	Mutagenesis	171	171	.	.	.	Note=Indifferent.	C->A
P00803	UniProtKB	Mutagenesis	177	177	.	.	.	Note=Indifferent.	C->A
P00803	UniProtKB	Mutagenesis	236	236	.	.	.	Note=Indifferent.	H->N
P00803	UniProtKB	Mutagenesis	269	269	.	.	.	Note=Indifferent.	Y->F
P00803	UniProtKB	Mutagenesis	274	274	.	.	.	Note=Indifferent.	D->A
P00803	UniProtKB	Mutagenesis	276	276	.	.	.	Note=Small	effect.	R->Q
P00803	UniProtKB	Mutagenesis	281	281	.	.	.	Note=Indifferent.	D->A
P00803	UniProtKB	Mutagenesis	283	283	.	.	.	Note=Small	effect.	R->Q
P60720	UniProtKB	Mutagenesis	137	137	.	.	.	Note=No	effect	on	activity.	C->A
P60720	UniProtKB	Mutagenesis	147	147	.	.	.	Note=No	effect	on	activity.	C->A
P60720	UniProtKB	Mutagenesis	169	169	.	.	.	Note=1%25	of	wild-type	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16342964;Dbxref=PMID:16342964
P60720	UniProtKB	Mutagenesis	169	169	.	.	.	Note=Loss	of	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16342964;Dbxref=PMID:16342964
P21645	UniProtKB	Mutagenesis	41	41	.	.	.	Note=30-fold	decrease	in	affinitfor	UDP-3-O-((3R)-hydroxytetradecanoyl)-GlcN	and	5-fold	decrease	in	catalytic	activity.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18422345;Dbxref=PMID:18422345
P21645	UniProtKB	Mutagenesis	165	165	.	.	.	Note=In	firA200%3B	confers	temperature	sensitivity	and	reverses	the	rifampicin	resistance	of	rpoB	mutants.	Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1987124;Dbxref=PMID:1987124
P21645	UniProtKB	Mutagenesis	172	172	.	.	.	Note=In	firA201%3B	confers	temperature	sensitivity.	I->F
P21645	UniProtKB	Mutagenesis	228	228	.	.	.	Note=In	firA200	and	firA201%3B	conferstemperature	sensitivity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1987124;Dbxref=PMID:1987124
P21645	UniProtKB	Mutagenesis	239	239	.	.	.	Note=1000-fold	reduction	in	catalytic	activity	with	very	little	effect	on	substrate	affinity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18422345;Dbxref=PMID:18422345
P21645	UniProtKB	Mutagenesis	252	252	.	.	.	Note=In	firA200	and	firA201%3B	conferstemperature	sensitivity.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1987124;Dbxref=PMID:1987124
P21645	UniProtKB	Mutagenesis	271	271	.	.	.	Note=In	omsA%3B	confers	temperature	sensitivity.	S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1429432;Dbxref=PMID:1429432
P21645	UniProtKB	Mutagenesis	276	276	.	.	.	Note=30-fold	reduction	in	catalytic	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18422345;Dbxref=PMID:18422345
P21645	UniProtKB	Mutagenesis	290	290	.	.	.	Note=Change	in	the	acyl	donor	selectivity%2C	showing	a	preference	for	3-hydroxypalmitoyl-ACP	over	3-hydroxytetradecanoyl-ACP	as	substrate.	Produces	a	lipid	A	with	longer	acyl	chains.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19655786;Dbxref=PMID:19655786
P21645	UniProtKB	Mutagenesis	292	292	.	.	.	Note=No	change	in	the	acyl	donor	selectivity.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19655786;Dbxref=PMID:19655786
P03023	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Broadening	of	specificity.	Y->H
P03023	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Recognizes	an	operator	variantR->N
P69451	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Loss	of	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12034706;Dbxref=PMID:12034706
P69451	UniProtKB	Mutagenesis	214	214	.	.	.	Note=10%25	of	wild-type	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12034706;Dbxref=PMID:12034706
P69451	UniProtKB	Mutagenesis	216	216	.	.	.	Note=Decreases	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12034706;Dbxref=PMID:12034706
P69451	UniProtKB	Mutagenesis	217	217	.	.	.	Note=Decreases	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12034706;Dbxref=PMID:12034706
P69451	UniProtKB	Mutagenesis	219	219	.	.	.	Note=Decreases	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12034706;Dbxref=PMID:12034706
P69451	UniProtKB	Mutagenesis	222	222	.	.	.	Note=Decreases	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12034706;Dbxref=PMID:12034706
P69451	UniProtKB	Mutagenesis	361	361	.	.	.	Note=Loss	of	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12034706;Dbxref=PMID:12034706
P60716	UniProtKB	Mutagenesis	68	79	.	.	.	Note=Loss	of	1	4Fe-4S	clusterbinding.	Loss	of	activity.	CEEASCPNLAEC->AEEASAPNLAEA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15362861;Dbxref=PMID:15362861
P60716	UniProtKB	Mutagenesis	94	101	.	.	.	Note=Loss	of	1	4Fe-4S	clusterbinding.	Loss	of	activity.	CTRRCPFC->ATRRAPFA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15362861;Dbxref=PMID:15362861
P30749	UniProtKB	Mutagenesis	34	34	.	.	.	Note=4-fold	lower	activity	than	wild-type.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12571226;Dbxref=PMID:12571226
P30749	UniProtKB	Mutagenesis	39	39	.	.	.	Note=24-fold	lower	activity	than	wild-type.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12571226;Dbxref=PMID:12571226
P30749	UniProtKB	Mutagenesis	115	115	.	.	.	Note=4-fold	lower	activity	than	wild-type.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12571226;Dbxref=PMID:12571226
P30749	UniProtKB	Mutagenesis	119	119	.	.	.	Note=No	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12571226;Dbxref=PMID:12571226
P30749	UniProtKB	Mutagenesis	126	126	.	.	.	Note=58-fold	lower	activity	than	wild-type.	Accumulates	large	quantities	of	reaction	intermediate.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12571226;Dbxref=PMID:12571226
P30749	UniProtKB	Mutagenesis	128	128	.	.	.	Note=17-fold	lower	activity	than	wild-type.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12571226;Dbxref=PMID:12571226
P30749	UniProtKB	Mutagenesis	140	140	.	.	.	Note=2-fold	lower	activity	than	wild-type.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12571226;Dbxref=PMID:12571226
P0AF03	UniProtKB	Mutagenesis	49	49	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10636880;Dbxref=PMID:10636880
P0AF03	UniProtKB	Mutagenesis	82	82	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10636880;Dbxref=PMID:10636880
P0AF06	UniProtKB	Mutagenesis	31	31	.	.	.	Note=Complete	loss	of	motility.	A->T
P0AF06	UniProtKB	Mutagenesis	32	32	.	.	.	Note=Complete	loss	of	motility.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061285;Dbxref=PMID:2061285
P0AF06	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Complete	loss	of	motility.	A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061285;Dbxref=PMID:2061285
P0AF06	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Decreased	motility%2C	subnormal	torque%2C	tethered	strains	rotate	very	slowly.	P->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061285;Dbxref=PMID:2061285
P0AF06	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Complete	loss	of	motility.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061285;Dbxref=PMID:2061285
P0AF06	UniProtKB	Mutagenesis	196	196	.	.	.	Note=Complete	loss	of	motility.	T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061285;Dbxref=PMID:2061285
P0AF06	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Complete	loss	of	motility.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061285;Dbxref=PMID:2061285
P0AF06	UniProtKB	Mutagenesis	205	205	.	.	.	Note=Decreased	motility%2C	subnormal	torque%2C	tethered	strains	rotate	very	slowly%2C	maybe	reduced	affinity	for	the	motor.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061285;Dbxref=PMID:2061285
P0AF06	UniProtKB	Mutagenesis	214	214	.	.	.	Note=Complete	loss	of	motility.	S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061285;Dbxref=PMID:2061285
P0AF06	UniProtKB	Mutagenesis	217	217	.	.	.	Note=Complete	loss	of	motility.	R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061285;Dbxref=PMID:2061285
P0AF06	UniProtKB	Mutagenesis	222	222	.	.	.	Note=Complete	loss	of	motility.	R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061285;Dbxref=PMID:2061285
P0AF06	UniProtKB	Mutagenesis	240	240	.	.	.	Note=Decreased	motility%2C	subnormal	torque%2C	tethered	strains	rotate	very	slowly.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061285;Dbxref=PMID:2061285
P0AF06	UniProtKB	Mutagenesis	242	242	.	.	.	Note=Complete	loss	of	motility.	A->T%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061285;Dbxref=PMID:2061285
P0AF06	UniProtKB	Mutagenesis	258	258	.	.	.	Note=Complete	loss	of	motility.	R->C%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061285;Dbxref=PMID:2061285
P77338	UniProtKB	Mutagenesis	922	922	.	.	.	Note=Prevents	growth	in	medium	containing	high	levels	of	potassium	in	the	presence	of	betaine.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11985727;Dbxref=PMID:11985727
P0A744	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Loss	of	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964927;Dbxref=PMID:10964927
P0A744	UniProtKB	Mutagenesis	87	87	.	.	.	Note=No	effect.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964927;Dbxref=PMID:10964927
P0A744	UniProtKB	Mutagenesis	199	199	.	.	.	Note=Decrease	in	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964927;Dbxref=PMID:10964927
P0A744	UniProtKB	Mutagenesis	207	207	.	.	.	Note=Decrease	in	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964927;Dbxref=PMID:10964927
P0A746	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Loss	of	activity%3B	when	associated	with	S-49%3B	S-95	and	S-98.	C->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16251365;Dbxref=PMID:16251365
P0A746	UniProtKB	Mutagenesis	49	49	.	.	.	Note=Loss	of	activity%3B	when	associated	with	S-46%3B	S-95	and	S-98.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16251365;Dbxref=PMID:16251365
P0A746	UniProtKB	Mutagenesis	95	95	.	.	.	Note=Loss	of	activity%3B	when	associated	with	S-46%3B	S-49	and	S-98.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16251365;Dbxref=PMID:16251365
P0A746	UniProtKB	Mutagenesis	98	98	.	.	.	Note=Loss	of	activity%3B	when	associated	with	S-46%3B	S-49	and	S-95.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16251365;Dbxref=PMID:16251365
P0A738	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Reduced	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10903949;Dbxref=PMID:10903949
P0A738	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Reduced	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10903949;Dbxref=PMID:10903949
P0A738	UniProtKB	Mutagenesis	67	67	.	.	.	Note=Reduced	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10903949;Dbxref=PMID:10903949
P0A738	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Reduced	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10903949;Dbxref=PMID:10903949
P0A738	UniProtKB	Mutagenesis	77	77	.	.	.	Note=Reduced	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10903949;Dbxref=PMID:10903949
P0A738	UniProtKB	Mutagenesis	110	110	.	.	.	Note=Reduced	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10903949;Dbxref=PMID:10903949
P0A738	UniProtKB	Mutagenesis	112	112	.	.	.	Note=Reduced	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10903949;Dbxref=PMID:10903949
P0A738	UniProtKB	Mutagenesis	117	117	.	.	.	Note=Strongly	reduced	activity.	T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10903949;Dbxref=PMID:10903949
P0A738	UniProtKB	Mutagenesis	128	128	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10903949;Dbxref=PMID:10903949
P0A738	UniProtKB	Mutagenesis	131	131	.	.	.	Note=Reduced	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10903949;Dbxref=PMID:10903949
P0C0S1	UniProtKB	Mutagenesis	40	40	.	.	.	Note=No	detectable	phenotype.	V->C%2CG%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12015316;Dbxref=PMID:12015316
P0C0S1	UniProtKB	Mutagenesis	40	40	.	.	.	Note=Normal	growth	stops%2C	withoutcell	death%2C	due	to	increased	membrane	permeability	to	potassium	ions	and	protons	(permeability	tested	only	for	D	substitutions).	V->D%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12015316;Dbxref=PMID:12015316
P0C0S1	UniProtKB	Mutagenesis	58	58	.	.	.	Note=Readily	forms	disulfide	bonds	with	cross-linkers%2C	suggesting	that	individual	S-58	are	only	3	Angstroms	apart	in	the	closed	state%2C	versus	33	Angstroms	apart	in	the	open	state	crystal	structure.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12767977;Dbxref=PMID:12767977
P0C0S1	UniProtKB	Mutagenesis	266	286	.	.	.	Note=Normal	levels	of	channels	are	expressed%3B	they	recover	more	slowly	than	wild-type	cells	after	desensitization.	ISFPYPQMDVNFKRVKEDKAA->HHHHHHLE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15665866;Dbxref=PMID:15665866
P0C0S1	UniProtKB	Mutagenesis	266	286	.	.	.	Note=Fewer	channels	present	in	the	membrane%2C	they	require	slightly	more	pressure	to	open	and	do	not	recoverafter	desensitization.	ISFPYPQMDVNFKRVKEDKAA->LE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15665866;Dbxref=PMID:15665866
P0C0S1	UniProtKB	Mutagenesis	267	267	.	.	.	Note=Provides	biochemical	evidence	for	heptameric	structure	upon	cross-linking.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12767977;Dbxref=PMID:12767977
P76342	UniProtKB	Mutagenesis	146	146	.	.	.	Note=Loss	of	enzymatic	activity.	Enhances	binding	to	MsrQ	and	targeting	to	the	inner	membrane.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16042411;Dbxref=PMID:16042411
P22523	UniProtKB	Mutagenesis	33	33	.	.	.	Note=In	mukB106%3B	no	effect.	S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10545099;Dbxref=PMID:10545099
P22523	UniProtKB	Mutagenesis	40	40	.	.	.	Note=No	effect.	K->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10545099;Dbxref=PMID:10545099
P22523	UniProtKB	Mutagenesis	688	688	.	.	.	Note=Does	not	rescue	a	ts-mutant	of	MukB.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20921377;Dbxref=PMID:20921377
P22523	UniProtKB	Mutagenesis	692	692	.	.	.	Note=Does	not	rescue	a	ts-mutant	of	MukB%3B	less	binding	of	ParC.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20921377;Dbxref=PMID:20921377
P22523	UniProtKB	Mutagenesis	1201	1201	.	.	.	Note=In	mukB33%3B	no	effect.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10545099;Dbxref=PMID:10545099
P22523	UniProtKB	Mutagenesis	1381	1381	.	.	.	Note=Abolishes	DNA-binding%2C	but	remainsassociated	with	MukE	and	MukF.	V->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10545099;Dbxref=PMID:10545099
P22523	UniProtKB	Mutagenesis	1403	1403	.	.	.	Note=Abolishes	association	with	MukE	and	MukF%2C	but	still	binds	DNA.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10545099;Dbxref=PMID:10545099
P22523	UniProtKB	Mutagenesis	1404	1404	.	.	.	Note=No	effect.	F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10545099;Dbxref=PMID:10545099
P22523	UniProtKB	Mutagenesis	1406	1406	.	.	.	Note=No	effect.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10545099;Dbxref=PMID:10545099
P22523	UniProtKB	Mutagenesis	1428	1428	.	.	.	Note=No	effect.	M->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10545099;Dbxref=PMID:10545099
P22523	UniProtKB	Mutagenesis	1429	1429	.	.	.	Note=Abolishes	association	with	MukE	and	MukF%2C	but	still	binds	DNA.	Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10545099;Dbxref=PMID:10545099
P60293	UniProtKB	Mutagenesis	233	233	.	.	.	Note=Abolishes	function.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8602138;Dbxref=PMID:8602138
P60752	UniProtKB	Mutagenesis	270	270	.	.	.	Note=Loss	of	lipid	export.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11278265;Dbxref=PMID:11278265
P60752	UniProtKB	Mutagenesis	511	511	.	.	.	Note=Loss	of	ATPase	activity%3B	ATP	is	still	bound.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8809774;Dbxref=PMID:8809774
P60752	UniProtKB	Mutagenesis	512	512	.	.	.	Note=Loss	of	ATPase	activity%3B	ATP	is	still	bound.	D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8809774;Dbxref=PMID:8809774
P0AF16	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Lack	of	activity.	R->A%2CC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23935042;Dbxref=PMID:23935042
P0AF16	UniProtKB	Mutagenesis	24	24	.	.	.	Note=Lack	of	activity.	R->A%2CC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23935042;Dbxref=PMID:23935042
P0AF16	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Lack	of	activity.	D->A%2CC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23935042;Dbxref=PMID:23935042
P0AF16	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Decrease	in	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23935042;Dbxref=PMID:23935042
P0AF16	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Lack	of	activity.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23935042;Dbxref=PMID:23935042
P0AF16	UniProtKB	Mutagenesis	270	270	.	.	.	Note=Lack	of	activity.	R->A%2CC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23935042;Dbxref=PMID:23935042
P76535	UniProtKB	Mutagenesis	83	83	.	.	.	Note=10000-fold	reduction	in	catalytic	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18837509;Dbxref=PMID:18837509
P76535	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Loss	of	catalytic	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18837509;Dbxref=PMID:18837509
P76535	UniProtKB	Mutagenesis	114	114	.	.	.	Note=2000-fold	reduction	in	catalytic	activity	and	4-fold	increase	in	substrate	affinity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18837509;Dbxref=PMID:18837509
P76535	UniProtKB	Mutagenesis	115	115	.	.	.	Note=7-fold	reduction	in	catalytic	activity	and	1.5-fold	increase	in	substrate	affinity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18837509;Dbxref=PMID:18837509
P0AF12	UniProtKB	Mutagenesis	9	9	.	.	.	Note=13-19%25	of	wild-type	catalytic	efficiency.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16101288;Dbxref=PMID:16101288
P0AF12	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Loss	of	catalytic	activity.	E->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16101288;Dbxref=PMID:16101288
P0AF12	UniProtKB	Mutagenesis	50	50	.	.	.	Note=12-23%25	of	wild-type	catalytic	efficiency.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16101288;Dbxref=PMID:16101288
P0AF12	UniProtKB	Mutagenesis	76	76	.	.	.	Note=13-23%25	of	wild-type	catalytic	efficiency.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16101288;Dbxref=PMID:16101288
P0AF12	UniProtKB	Mutagenesis	151	151	.	.	.	Note=0.5%25	of	wild-type	catalytic	efficiency.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16101288;Dbxref=PMID:16101288
P0AF12	UniProtKB	Mutagenesis	173	173	.	.	.	Note=0.5%25	of	wild-type	catalytic	efficiency.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16101288;Dbxref=PMID:16101288
P0AF12	UniProtKB	Mutagenesis	174	174	.	.	.	Note=Loss	of	catalytic	activity.	E->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16101288;Dbxref=PMID:16101288
P0AF12	UniProtKB	Mutagenesis	193	193	.	.	.	Note=13-28%25	of	wild-type	catalytic	efficiency.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16101288;Dbxref=PMID:16101288
P0AF12	UniProtKB	Mutagenesis	196	196	.	.	.	Note=2-4%25	of	wild-type	catalytic	efficiency.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16101288;Dbxref=PMID:16101288
P0AF12	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Loss	of	catalytic	activity.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16101288;Dbxref=PMID:16101288
P0AF12	UniProtKB	Mutagenesis	207	207	.	.	.	Note=2%25	of	wild-type	catalytic	efficiency.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16101288;Dbxref=PMID:16101288
P77788	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Increases	enzyme	activity	with	2-hydroxy-ATP.	Decreases	enzyme	activity	with	dCTP%2C	5-methyl-dCTP	and	8-hydroxy-ATP.	E->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15823026;Dbxref=PMID:15823026
P77788	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Decreases	enzyme	activity	with	2-hydroxy-ATP%2C	dCTP%2C	5-dmethyl-CTP	and	8-hydroxy-ATP.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15823026;Dbxref=PMID:15823026
P77788	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Abolishes	enzyme	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15381107;Dbxref=PMID:15381107
P77788	UniProtKB	Mutagenesis	37	37	.	.	.	Note=Abolishes	enzyme	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15381107;Dbxref=PMID:15381107
P77788	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Strongly	reduces	enzyme	activity	with	dCTP%2C	and	to	a	lesser	degree	with	5-methyl-dCTP.	K->A%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15381107;Dbxref=PMID:15381107
P77788	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Abolishes	enzyme	activity	with	dCTP	and	reduces	enzyme	activity	with	5-methyl-dCTP.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15381107;Dbxref=PMID:15381107
P77788	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Abolishes	enzyme	activity	with	dCTP.	Nearly	abolishes	enzyme	activity	with	5-methyl-dCTP.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15381107;Dbxref=PMID:15381107
P77788	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Abolishes	enzyme	activity.	E->A%2CD%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15381107;Dbxref=PMID:15381107
P77788	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Reduces	enzyme	activity.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15381107;Dbxref=PMID:15381107
P77788	UniProtKB	Mutagenesis	55	55	.	.	.	Note=Abolishes	enzyme	activity	with	dCTP	and	reduces	enzyme	activity	with	5-methyl-dCTP.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15381107;Dbxref=PMID:15381107
P77788	UniProtKB	Mutagenesis	55	55	.	.	.	Note=Abolishes	enzyme	activity	with	dCTP	and	reduces	enzyme	activity	with	5-methyl-dCTP.	E->D%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15381107;Dbxref=PMID:15381107
P77788	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Abolishes	enzyme	activity.	E->A%2CD%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15381107;Dbxref=PMID:15381107
P77788	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Strongly	decreases	the	activitwith	2-hydroxy-ATP.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15823026;Dbxref=PMID:15823026
P77788	UniProtKB	Mutagenesis	77	77	.	.	.	Note=No	effect.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15823026;Dbxref=PMID:15823026
P77788	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Abolishes	enzyme	activity	with	2-hydroxy-ATP.	No	effect	on	activity	with	dCTP%2C	5-methyl-dCTP	and	8-hydroxy-ATP.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15823026;Dbxref=PMID:15823026
P77788	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Abolishes	enzyme	activity	with	dCTP	and	2-hydroxy-ATP	and	decreases	activity	with	5-methyl-dCTP.	Increases	activity	with	8-hydroxy-ATP.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15823026;Dbxref=PMID:15823026
P77788	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Increases	the	activity	with	2-hydroxy-ATP.	Strongly	decreases	activity	with	8-hydroxy-ATP.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15823026;Dbxref=PMID:15823026
P09169	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11576541;Dbxref=PMID:11576541
P09169	UniProtKB	Mutagenesis	105	105	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11576541;Dbxref=PMID:11576541
P09169	UniProtKB	Mutagenesis	230	230	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11576541;Dbxref=PMID:11576541
P09169	UniProtKB	Mutagenesis	236	237	.	.	.	Note=70%25	of	wild-type	enzymatic	activity.	GK->KG
P09169	UniProtKB	Mutagenesis	237	237	.	.	.	Note=40%25	of	wild-type	enzymatic	activity.	K->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10651827;Dbxref=PMID:10651827
P09169	UniProtKB	Mutagenesis	238	238	.	.	.	Note=Loss	of	activity.	R->L
P42641	UniProtKB	Mutagenesis	27	31	.	.	.	Note=Almost	abolishes	50S	subunitbinding.	KYIPK->EYIPE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24844575;Dbxref=PMID:24844575
P42641	UniProtKB	Mutagenesis	76	82	.	.	.	Note=Slight	reduction	in	50S	subunit	binding.	RDCTGKR->GDCTGKG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24844575;Dbxref=PMID:24844575
P42641	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Temperature-sensitive	for	growth	at	42	degrees	Celsius%2C	defects	in	chromosome	partitioning%3B	when	associated	with	N-85.	G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11555285;Dbxref=PMID:11555285
P42641	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Temperature-sensitive	for	growth	at	42	degrees	Celsius%2C	defects	in	chromosome	partitioning%3B	when	associated	with	E-80.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11555285;Dbxref=PMID:11555285
P42641	UniProtKB	Mutagenesis	93	93	.	.	.	Note=No	effect	on	persister	cell	formation	upon	overexpression.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26051177;Dbxref=PMID:26051177
P42641	UniProtKB	Mutagenesis	136	139	.	.	.	Note=Almost	abolishes	50S	subunitbinding.	RTPR->GTPG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24844575;Dbxref=PMID:24844575
P42641	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Increased	sensitivity	to	HU	upon	overexpression%2C	supports	normal	growth%2C	no	effect	in	mazEF/relBE	or	tonB	deletions.	L->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22863262;Dbxref=PMID:22863262
P42641	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Increased	sensitivity	to	HU	upon	overexpression%2C	supports	normal	growth%2C	no	effect	in	mazEF/relBE	or	tonB	deletions.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22863262;Dbxref=PMID:22863262
P42641	UniProtKB	Mutagenesis	166	166	.	.	.	Note=No	increase	in	persister	cells	upon	overexpression%2C	does	not	induce	hokB	expression%2C	supports	normal	growth.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26051177;Dbxref=PMID:26051177
P42641	UniProtKB	Mutagenesis	168	168	.	.	.	Note=Increased	sensitivity	to	HU	upon	overexpression%2C	supports	normal	growth%2C	no	effect	in	mazEF/relBE	or	tonB	deletions.	No	effect	on	persister	cell	formation	upon	overexpression.	P->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15721258,ECO:0000269|PubMed:22863262,ECO:0000269|PubMed:26051177;Dbxref=PMID:15721258,PMID:22863262,PMID:26051177
P42641	UniProtKB	Mutagenesis	173	173	.	.	.	Note=No	effect	on	persister	cell	formation	upon	overexpression.	S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26051177;Dbxref=PMID:26051177
P42641	UniProtKB	Mutagenesis	193	193	.	.	.	Note=No	effect	on	persister	cell	formation	upon	overexpression.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26051177;Dbxref=PMID:26051177
P42641	UniProtKB	Mutagenesis	216	216	.	.	.	Note=Increased	sensitivity	to	HU	upon	overexpression%2C	supports	normal	growth%2C	no	effect	in	mazEF/relBE	or	tonB	deletions.	No	effect	on	persister	cell	formation	upon	overexpression.	G->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22863262,ECO:0000269|PubMed:26051177;Dbxref=PMID:22863262,PMID:26051177
P42641	UniProtKB	Mutagenesis	237	237	.	.	.	Note=Increased	sensitivity	to	HU	upon	overexpression%2C	supports	normal	growth%2C	no	effect	in	mazEF/relBE	or	tonB	deletions.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22863262;Dbxref=PMID:22863262
P42641	UniProtKB	Mutagenesis	314	314	.	.	.	Note=Severe	growth	defect	at	42	degrees	Celsius.	Decreased	levels	of	some	ribosomal	proteins%2C	altered	PTMs	of	others.S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15836769;Dbxref=PMID:15836769
P0AFF6	UniProtKB	Mutagenesis	104	104	.	.	.	Note=In	nusA10-1.	R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1847365;Dbxref=PMID:1847365
P0AFF6	UniProtKB	Mutagenesis	181	181	.	.	.	Note=In	nusa11%3B	inability	to	terminate	transcription	normally	at	termination	sites.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1847365;Dbxref=PMID:1847365
P0AFF6	UniProtKB	Mutagenesis	183	183	.	.	.	Note=In	nusA1%3B	restricts	lambda	growth	by	preventing	antitermination	activity	of	lambda	N	protein.	L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1847365;Dbxref=PMID:1847365
P0AFF6	UniProtKB	Mutagenesis	212	212	.	.	.	Note=In	nusA10-2.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1847365;Dbxref=PMID:1847365
P00914	UniProtKB	Mutagenesis	278	278	.	.	.	Note=Reduces	DNA-binding	affinity.	W->X;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2200511;Dbxref=PMID:2200511
P00914	UniProtKB	Mutagenesis	383	383	.	.	.	Note=Abolishes	photolyase	activity.	W->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12835419;Dbxref=PMID:12835419
P05055	UniProtKB	Mutagenesis	79	80	.	.	.	Note=Strongly	reduces	RNA	binding.	Reduces	RNA	degradation.	RR->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18812438;Dbxref=PMID:18812438
P05055	UniProtKB	Mutagenesis	83	83	.	.	.	Note=No	effect	on	RNA-binding.	No	effect	on	degradation	of	long	RNA	molecules.	Impairs	degradation	of	short	RNA	molecules.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18812438;Dbxref=PMID:18812438
P05055	UniProtKB	Mutagenesis	100	100	.	.	.	Note=Abolishes	enzyme	activity.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12162954;Dbxref=PMID:12162954
P05055	UniProtKB	Mutagenesis	319	319	.	.	.	Note=Abolishes	enzyme	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12162954;Dbxref=PMID:12162954
P05055	UniProtKB	Mutagenesis	398	399	.	.	.	Note=Abolishes	enzyme	activity.	RR->DD
P05055	UniProtKB	Mutagenesis	428	428	.	.	.	Note=Abolishes	enzyme	activity.	V->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12162954;Dbxref=PMID:12162954
P05055	UniProtKB	Mutagenesis	444	444	.	.	.	Note=Abolishes	enzyme	activity.	C->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12162954;Dbxref=PMID:12162954
P05055	UniProtKB	Mutagenesis	492	492	.	.	.	Note=Abolishes	enzyme	activity.	D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12162954;Dbxref=PMID:12162954
P0A7A7	UniProtKB	Mutagenesis	306	306	.	.	.	Note=Abolishes	acyltransferase	activity.	H->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10231527,ECO:0000269|PubMed:9515909;Dbxref=PMID:10231527,PMID:9515909
P0A7A7	UniProtKB	Mutagenesis	306	306	.	.	.	Note=Reduced	acyltransferase	activity.	H->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10231527,ECO:0000269|PubMed:9515909;Dbxref=PMID:10231527,PMID:9515909
P0A7A7	UniProtKB	Mutagenesis	308	308	.	.	.	Note=No	effect.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10231527;Dbxref=PMID:10231527
P0A7A7	UniProtKB	Mutagenesis	311	311	.	.	.	Note=Prevents	assembly	into	the	membrane%2C	suggesting	that	it	paticipates	to	folding.	D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10231527,ECO:0000269|PubMed:9515909;Dbxref=PMID:10231527,PMID:9515909
P0A7A7	UniProtKB	Mutagenesis	311	311	.	.	.	Note=Strongly	reduced	acyltransferase	activity.	D->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10231527,ECO:0000269|PubMed:9515909;Dbxref=PMID:10231527,PMID:9515909
P0A7A7	UniProtKB	Mutagenesis	349	349	.	.	.	Note=In	plsB26%3B	results	in	high	KM	for	glycerol-3-phosphate	and	reduced	specific	activity.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10074094;Dbxref=PMID:10074094
P0A7A7	UniProtKB	Mutagenesis	351	351	.	.	.	Note=Strongly	reduced	acyltransferase	activity.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10231527;Dbxref=PMID:10231527
P0A7A7	UniProtKB	Mutagenesis	352	352	.	.	.	Note=Reduced	acyltransferase	activity.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10231527;Dbxref=PMID:10231527
P0A7A7	UniProtKB	Mutagenesis	354	354	.	.	.	Note=Reduced	acyltransferase	activity.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10231527;Dbxref=PMID:10231527
P0A7A7	UniProtKB	Mutagenesis	354	354	.	.	.	Note=No	effect.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10231527;Dbxref=PMID:10231527
P0A7A7	UniProtKB	Mutagenesis	385	385	.	.	.	Note=Strongly	reduced	acyltransferase	activity.	E->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10231527;Dbxref=PMID:10231527
P0A7A7	UniProtKB	Mutagenesis	386	386	.	.	.	Note=No	effect.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10231527;Dbxref=PMID:10231527
P0A7A7	UniProtKB	Mutagenesis	386	386	.	.	.	Note=Reduced	acyltransferase	activity.	G->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10231527;Dbxref=PMID:10231527
P0A7A7	UniProtKB	Mutagenesis	389	389	.	.	.	Note=No	effect.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10231527;Dbxref=PMID:10231527
P0A7A7	UniProtKB	Mutagenesis	421	421	.	.	.	Note=Reduced	acyltransferase	activity.	P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10231527;Dbxref=PMID:10231527
P69874	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Lower	ATPase	activity	and	transport	efficiency.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7592703;Dbxref=PMID:7592703
P69874	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Lower	ATPase	activity	and	transport	efficiency.	F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11976340;Dbxref=PMID:11976340
P69874	UniProtKB	Mutagenesis	45	45	.	.	.	Note=Lower	ATPase	activity	and	transport	efficiency.	F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11976340;Dbxref=PMID:11976340
P69874	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Loss	of	ATPase	activity	and	transport.	C->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7592703;Dbxref=PMID:7592703
P69874	UniProtKB	Mutagenesis	60	60	.	.	.	Note=Lower	ATPase	activity	and	transport	efficiency.	L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11976340;Dbxref=PMID:11976340
P69874	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Lower	ATPase	activity	and	transport	efficiency.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11976340;Dbxref=PMID:11976340
P69874	UniProtKB	Mutagenesis	135	135	.	.	.	Note=Loss	of	ATPase	activity	and	transport.	V->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11976340,ECO:0000269|PubMed:8366082;Dbxref=PMID:11976340,PMID:8366082
P69874	UniProtKB	Mutagenesis	172	172	.	.	.	Note=Loss	of	ATPase	activity	and	transport.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11976340;Dbxref=PMID:11976340
P69874	UniProtKB	Mutagenesis	276	276	.	.	.	Note=Lower	ATPase	activity	and	transport	efficiency.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7592703;Dbxref=PMID:7592703
P69874	UniProtKB	Mutagenesis	297	297	.	.	.	Note=Lower	ATPase	activity	and	transport	efficiency.	E->K%2CD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11976340;Dbxref=PMID:11976340
P69874	UniProtKB	Mutagenesis	297	297	.	.	.	Note=Loss	of	ATPase	activity	and	transport.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11976340;Dbxref=PMID:11976340
P0AAF1	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Strong	decrease	in	both	uptake	and	excretion	activities.	C->A%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Moderate	decrease	in	both	uptake	and	excretion	activities.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	68	68	.	.	.	Note=Slight	decrease	in	both	uptake	and	excretion	activities.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	77	77	.	.	.	Note=Strong	decrease	in	both	uptake	and	excretion	activities.	E->A%2CD%2CN%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9045651;Dbxref=PMID:9045651
P0AAF1	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Uptake	activity	decreases	more	than	excretion	activity.	Y->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	82	82	.	.	.	Note=Slight	decrease	in	both	uptake	and	excretion	activities.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Uptake	activity	decreases	more	than	excretion	activity.	Y->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	92	92	.	.	.	Note=Moderate	decrease	in	both	uptake	and	excretion	activities.	Y->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	201	201	.	.	.	Note=Strong	decrease	in	both	uptake	and	excretion	activities.	W->F%2CL%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	207	207	.	.	.	Note=Lack	of	both	uptake	and	excretion	activities.	E->A%2CD%2CN%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9045651;Dbxref=PMID:9045651
P0AAF1	UniProtKB	Mutagenesis	210	210	.	.	.	Note=Moderate	decrease	in	both	uptake	and	excretion	activities.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	285	285	.	.	.	Note=Moderate	decrease	in	both	uptake	and	excretion	activities.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	286	286	.	.	.	Note=Moderate	decrease	in	both	uptake	and	excretion	activities.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	292	292	.	.	.	Note=Strong	decrease	in	both	uptake	and	excretion	activities.	W->F%2CL%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	301	301	.	.	.	Note=Excretion	activity	decreases	more	than	uptake	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	308	308	.	.	.	Note=Excretion	activity	decreases	more	than	uptake	activity.	Y->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	422	422	.	.	.	Note=Uptake	activity	decreases	more	than	excretion	activity.	W->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	425	425	.	.	.	Note=Moderate	decrease	in	both	uptake	and	excretion	activities.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	425	425	.	.	.	Note=Strong	decrease	in	both	uptake	and	excretion	activities.	Y->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10964926;Dbxref=PMID:10964926
P0AAF1	UniProtKB	Mutagenesis	433	433	.	.	.	Note=Strong	decrease	in	both	uptake	and	excretion	activities.	E->A%2CD%2CN%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9045651;Dbxref=PMID:9045651
P07003	UniProtKB	Mutagenesis	533	533	.	.	.	Note=In	poxB11.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2663858;Dbxref=PMID:2663858
P07003	UniProtKB	Mutagenesis	549	572	.	.	.	Note=In	poxB6.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2663858;Dbxref=PMID:2663858
P07003	UniProtKB	Mutagenesis	553	553	.	.	.	Note=In	poxB14.	A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2663858;Dbxref=PMID:2663858
P07003	UniProtKB	Mutagenesis	560	560	.	.	.	Note=In	poxB15%3B	normal	activity.	D->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2663858;Dbxref=PMID:2663858
P07003	UniProtKB	Mutagenesis	564	572	.	.	.	Note=In	poxB7.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2663858;Dbxref=PMID:2663858
P07003	UniProtKB	Mutagenesis	564	564	.	.	.	Note=In	poxB16%3B	loss	of	activity.	E->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2663858;Dbxref=PMID:2663858
P07003	UniProtKB	Mutagenesis	570	572	.	.	.	Note=In	poxB8.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2663858;Dbxref=PMID:2663858
P07003	UniProtKB	Mutagenesis	572	572	.	.	.	Note=In	poxB10%3B	reduced	activity%3B	may	interact	less	with	membranes.	R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2663858;Dbxref=PMID:2663858
P76038	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Lacks	the	PuuD	activity.	The	expression	level	is	similar	to	that	of	the	wild-type.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16499623;Dbxref=PMID:16499623
P0A7E5	UniProtKB	Mutagenesis	349	349	.	.	.	Note=30%25	increase	in	both	glutamine-dependent	and	ammonia-dependent	activities.	V->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3298209;Dbxref=PMID:3298209
P0A7E5	UniProtKB	Mutagenesis	352	352	.	.	.	Note=Loss	of	glutamine-dependent	activity%2C	but	no	change	in	ammonia-dependent	activity.	G->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3298209;Dbxref=PMID:3298209
P0A7E5	UniProtKB	Mutagenesis	379	379	.	.	.	Note=Loss	of	glutamine-dependent	activity%2C	but	no	change	in	ammonia-dependent	activity.	C->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11336655;Dbxref=PMID:11336655
P07117	UniProtKB	Mutagenesis	257	257	.	.	.	Note=Sodium-independent	binding	affinity	for	proline.	R->C
P07117	UniProtKB	Mutagenesis	376	376	.	.	.	Note=No	change	in	activity.	R->E%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8119910;Dbxref=PMID:8119910
P07117	UniProtKB	Mutagenesis	376	376	.	.	.	Note=Loss	of	activity.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8119910;Dbxref=PMID:8119910
P78061	UniProtKB	Mutagenesis	282	282	.	.	.	Note=Activity	is	impaired	to	9%25	of	wild-type.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18495664;Dbxref=PMID:18495664
P78061	UniProtKB	Mutagenesis	357	357	.	.	.	Note=Activity	is	impaired	to	3%25	of	wild-type.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18495664;Dbxref=PMID:18495664
P76037	UniProtKB	Mutagenesis	110	110	.	.	.	Note=The	uptake	activity	is	reduced	to	one-eighth	of	that	of	wild-type.	Y->X;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19181795;Dbxref=PMID:19181795
P39315	UniProtKB	Mutagenesis	139	139	.	.	.	Note=3-fold	increase	in	the	Km	for	methyl-1%2C4-benzoquinone.	W->A%2CI;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18455185;Dbxref=PMID:18455185
P39315	UniProtKB	Mutagenesis	139	139	.	.	.	Note=Almost	no	change	in	the	Km	for	methyl-1%2C4-benzoquinone.	W->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18455185;Dbxref=PMID:18455185
P39315	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Almost	complete	loss	of	catalytic	activity.	Y->A%2CI;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18455185;Dbxref=PMID:18455185
P39315	UniProtKB	Mutagenesis	140	140	.	.	.	Note=No	change.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18455185;Dbxref=PMID:18455185
P39315	UniProtKB	Mutagenesis	143	143	.	.	.	Note=6-fold	increase	in	the	Km	for	methyl-1%2C4-benzoquinone.	No	change	in	affinity	for	NADPH.	N->A%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18455185;Dbxref=PMID:18455185
Q46920	UniProtKB	Mutagenesis	89	89	.	.	.	Note=Drastic	decrease	in	activity.	E->A%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23595998;Dbxref=PMID:23595998
Q46920	UniProtKB	Mutagenesis	90	90	.	.	.	Note=9-fold	decrease	in	specifiactivity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23595998;Dbxref=PMID:23595998
Q46920	UniProtKB	Mutagenesis	190	190	.	.	.	Note=Loss	of	catalytic	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23595998;Dbxref=PMID:23595998
Q46920	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Loss	of	catalytic	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23595998;Dbxref=PMID:23595998
Q46920	UniProtKB	Mutagenesis	228	228	.	.	.	Note=11-fold	decrease	in	specifiactivity.	F->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23595998;Dbxref=PMID:23595998
Q46920	UniProtKB	Mutagenesis	229	229	.	.	.	Note=6.5-fold	decrease	in	specifiactivity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23595998;Dbxref=PMID:23595998
Q46920	UniProtKB	Mutagenesis	230	230	.	.	.	Note=26-fold	decrease	in	specifiactivity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23595998;Dbxref=PMID:23595998
P60240	UniProtKB	Mutagenesis	183	183	.	.	.	Note=Loss	of	function.	Still	interacts	with	RNAP.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11751638;Dbxref=PMID:11751638
P60240	UniProtKB	Mutagenesis	280	281	.	.	.	Note=Loss	of	function.	Still	interacts	with	RNAP.	DE->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11751638;Dbxref=PMID:11751638
P50457	UniProtKB	Mutagenesis	267	267	.	.	.	Note=No	GABA-AT	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20639325;Dbxref=PMID:20639325
P0A7E1	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Almost	no	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10074342;Dbxref=PMID:10074342
P0A7E1	UniProtKB	Mutagenesis	175	175	.	.	.	Note=500-fold	reduction	in	activity.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10074342;Dbxref=PMID:10074342
P0A7D4	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Significant	reduction	in	activity.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1733940;Dbxref=PMID:1733940
P0A7D4	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Significant	reduction	in	activity.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1733940;Dbxref=PMID:1733940
P0A7D4	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Reduces	catalytic	efficiency	by	50%25.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1733940;Dbxref=PMID:1733940
P0A7D4	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Significant	reduction	in	activity.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1733940;Dbxref=PMID:1733940
P0A7D4	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Significant	reduction	in	activity.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1733940;Dbxref=PMID:1733940
P0A7D4	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Significant	reduction	in	activity.	I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1733940;Dbxref=PMID:1733940
P0A7D4	UniProtKB	Mutagenesis	141	141	.	.	.	Note=Total	loss	of	activity.	K->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1733940;Dbxref=PMID:1733940
P0A7D4	UniProtKB	Mutagenesis	144	144	.	.	.	Note=Does	not	reduce	catalytic	efficiency.	R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1733940;Dbxref=PMID:1733940
P0A7D4	UniProtKB	Mutagenesis	148	148	.	.	.	Note=Reduced	activity.	R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2061308;Dbxref=PMID:2061308
P0A7D4	UniProtKB	Mutagenesis	304	304	.	.	.	Note=Reduces	catalytic	efficiency	by	87%25.	R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1733940;Dbxref=PMID:1733940
P0A7E9	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Loss	of	activation	by	GTP	and	decreased	affinity	for	UTP.	R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9457846;Dbxref=PMID:9457846
P0A7E9	UniProtKB	Mutagenesis	77	77	.	.	.	Note=Loss	of	activation	by	GTP	and	decreased	affinity	for	UTP.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9457846;Dbxref=PMID:9457846
P0A7E9	UniProtKB	Mutagenesis	138	138	.	.	.	Note=Loss	of	activation	by	GTP.	Moderate	loss	of	sensitivity	to	UTP	inhibition.	4-fold	and	2-fold	decrease	in	affinity	for	UMP	and	ATP%2C	respectively.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15857829;Dbxref=PMID:15857829
P0A7E9	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Loss	of	activation	by	GTP.	Moderate	loss	of	sensitivity	to	UTP	inhibition.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15857829;Dbxref=PMID:15857829
P0A7E9	UniProtKB	Mutagenesis	146	146	.	.	.	Note=Drastically	reduced	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9457846;Dbxref=PMID:9457846
P0A7E9	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Increased	solubility	at	neutralpH.	Nearly	no	change	in	kinetic	properties	and	stability.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9457846;Dbxref=PMID:9457846
P0A7E9	UniProtKB	Mutagenesis	174	174	.	.	.	Note=Reduced	UMP-binding	affinity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9457846;Dbxref=PMID:9457846
P0A7E9	UniProtKB	Mutagenesis	201	201	.	.	.	Note=Loss	of	activation	by	GTP.	D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7711027,ECO:0000269|PubMed:9457846;Dbxref=PMID:7711027,PMID:9457846
P0A7D1	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Pth(ts)	mutants	synthesize	thermosensitive	PTH	and	die	at	42	degrees	Celsius	from	a	defect	in	protein	synthesis.	G->D
P0A7D1	UniProtKB	Mutagenesis	134	134	.	.	.	Note=Rap	mutants	do	not	supportvegetative	growth	of	bacteriophage	lambda	and	die	upon	transcription	of	lambda	DNA	bar	sites.	R->H
P69791	UniProtKB	Mutagenesis	92	92	.	.	.	Note=Eliminates	the	need	for	a	metal	cation	at	the	homotrimer	interface	by	substituting	hydrophobic	methyl-methyl	interactions	in	place	of	the	metal	cation.	D->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15654077;Dbxref=PMID:15654077
P0DMC9	UniProtKB	Mutagenesis	145	145	.	.	.	Note=In	rcsA*%3B	increases	stability	and	capsule	synthesis.	M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1999391;Dbxref=PMID:1999391
P0DMC7	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Increases	heterodimer	formation	with	RcsA.	Does	not	affect	heterodimer	formation	with	BglJ.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20952573;Dbxref=PMID:20952573
P0DMC7	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Decreases	heterodimer	formation	with	RcsA.	Does	not	affect	heterodimer	formation	with	BglJ.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20952573;Dbxref=PMID:20952573
P24554	UniProtKB	Mutagenesis	28	28	.	.	.	Note=In	radA100%3B	rich	medium-grown	cells	are	sensitive	to	gamma%2C	X-ray	and	UV	radiation	as	well	as	methyl	methanesulfonate	and	hydroxyurea%2C	impaired	in	repair	of	dsDNA	breaks.	Decreased	resistance	to	ciprofloxacin	(CFX).	C->Y;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12446634,ECO:0000269|PubMed:25484163,ECO:0000269|PubMed:6754650,ECO:0000269|PubMed:8759876;Dbxref=PMID:12446634,PMID:25484163,PMID:6754650,PMID:8759876
P24554	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Decreased	resistance	to	CFX%2C	semi-dominant	to	wild-type.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25484163;Dbxref=PMID:25484163
P24554	UniProtKB	Mutagenesis	228	460	.	.	.	Note=Decreased	resistance	to	CFX.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25484163;Dbxref=PMID:25484163
P24554	UniProtKB	Mutagenesis	258	258	.	.	.	Note=Decreased	resistance	to	CFX%2C	semi-dominant	to	wild-type.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25484163;Dbxref=PMID:25484163
P24554	UniProtKB	Mutagenesis	275	460	.	.	.	Note=Decreased	resistance	to	CFX.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25484163;Dbxref=PMID:25484163
P24554	UniProtKB	Mutagenesis	372	372	.	.	.	Note=Wild-type	resistance	to	CFX%3B	equivalent	to	the	active	site	Ser	of	Lon	protease.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25484163;Dbxref=PMID:25484163
P33919	UniProtKB	Mutagenesis	37	37	.	.	.	Note=Partially	complements	a	radD	deletion	mutant	for	survival	of	ionizing	radiation	(possible	loss	of	ATPase	activity)%2C	increases	sensitivity	to	UV	of	a	double	radA-radD	deletion.	Has	a	dominant	negative	effect	on	survival	of	UV	in	the	presence	of	wild-type	enzyme	or	ciprofloxacin	survival.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25425430;Dbxref=PMID:25425430
P33919	UniProtKB	Mutagenesis	356	586	.	.	.	Note=Does	not	complement	sensitivity	of	a	double	radA-radD	deletion	to	dsDNA	breaks.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25425430;Dbxref=PMID:25425430
P33919	UniProtKB	Mutagenesis	437	437	.	.	.	Note=Does	not	complement	sensitivity	of	a	double	radA-radD	deletion	to	dsDNA	breaks.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25425430;Dbxref=PMID:25425430
P77379	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Does	not	induce	expression	of	target	genes	in	response	to	HOCl.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24078635;Dbxref=PMID:24078635
P77379	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Increases	expression	of	the	target	genes	in	the	absence	of	HOCl.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24078635;Dbxref=PMID:24078635
P77379	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Increases	expression	of	the	target	genes	in	the	absence	of	HOCl.	In	vitro%2C	increases	DNA	binding	under	reducinconditions.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24078635;Dbxref=PMID:24078635
P77379	UniProtKB	Mutagenesis	89	89	.	.	.	Note=Does	not	induce	expression	of	target	genes	in	response	to	HOCl.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24078635;Dbxref=PMID:24078635
P0DMC5	UniProtKB	Mutagenesis	479	479	.	.	.	Note=Does	not	induce	cps	operon	expression.	Retains	phosphatase	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11807084;Dbxref=PMID:11807084
P0DMC5	UniProtKB	Mutagenesis	875	875	.	.	.	Note=Does	not	induce	cps	operon	expression.	Lack	of	phosphatase	activity.	D->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11807084;Dbxref=PMID:11807084
P39838	UniProtKB	Mutagenesis	842	842	.	.	.	Note=Lack	of	activity.	H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11309126;Dbxref=PMID:11309126
P07648	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Acts	at	variant	Chi	sequences.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22603794;Dbxref=PMID:22603794
P07648	UniProtKB	Mutagenesis	64	64	.	.	.	Note=Does	not	act	at	Chi.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22603794;Dbxref=PMID:22603794
P07648	UniProtKB	Mutagenesis	70	70	.	.	.	Note=Does	not	act	at	Chi.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22603794;Dbxref=PMID:22603794
P07648	UniProtKB	Mutagenesis	133	133	.	.	.	Note=Does	not	act	at	Chi.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22603794;Dbxref=PMID:22603794
P07648	UniProtKB	Mutagenesis	134	134	.	.	.	Note=Acts	at	variant	Chi	sequences.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22603794;Dbxref=PMID:22603794
P07648	UniProtKB	Mutagenesis	136	136	.	.	.	Note=Does	not	act	at	Chi.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22603794;Dbxref=PMID:22603794
P07648	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Acts	at	variant	Chi	sequences.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22603794;Dbxref=PMID:22603794
P07648	UniProtKB	Mutagenesis	142	142	.	.	.	Note=Acts	at	variant	Chi	sequences.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22603794;Dbxref=PMID:22603794
P07648	UniProtKB	Mutagenesis	186	186	.	.	.	Note=Does	not	act	at	Chi.	R->A%2CC%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22603794;Dbxref=PMID:22603794
P07648	UniProtKB	Mutagenesis	705	705	.	.	.	Note=Acts	at	variant	Chi	sequences.	D->A%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22603794;Dbxref=PMID:22603794
P04983	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Loss	of	transport.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8762140;Dbxref=PMID:8762140
P0AAZ4	UniProtKB	Mutagenesis	156	156	.	.	.	Note=Lack	of	ATPase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21297161;Dbxref=PMID:21297161
P33229	UniProtKB	Mutagenesis	43	46	.	.	.	Note=No	longer	inhibits	growth.	EKEA->AIAE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24748661;Dbxref=PMID:24748661
P33229	UniProtKB	Mutagenesis	52	52	.	.	.	Note=No	longer	inhibits	growth%2C	has	no	DNase	activity.	K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24748661;Dbxref=PMID:24748661
P24230	UniProtKB	Mutagenesis	411	693	.	.	.	Note=In	radC102%3B	causes	mild	UV	and	X-ray	sensitivity.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11053371;Dbxref=PMID:11053371
P0A7K2	UniProtKB	Mutagenesis	66	66	.	.	.	Note=EF-Tu-binding	and	EF-Tu-promoted	GTP	hydrolysis	reduced.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15989950;Dbxref=PMID:15989950
P0A7K2	UniProtKB	Mutagenesis	67	67	.	.	.	Note=EF-Tu-binding	and	EF-Tu-promoted	GTP	hydrolysis	reduced.	V->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15989950;Dbxref=PMID:15989950
P0A7K2	UniProtKB	Mutagenesis	70	70	.	.	.	Note=EF-Tu-binding	and	EF-Tu-promoted	GTP	hydrolysis	reduced.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15989950;Dbxref=PMID:15989950
P0A7K2	UniProtKB	Mutagenesis	71	71	.	.	.	Note=EF-Tu-binding	and	EF-Tu-promoted	GTP	hydrolysis	reduced.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15989950;Dbxref=PMID:15989950
P0A7K2	UniProtKB	Mutagenesis	74	74	.	.	.	Note=EF-Tu-binding	and	EF-Tu-promoted	GTP	hydrolysis	reduced.	R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15989950;Dbxref=PMID:15989950
P0A7K2	UniProtKB	Mutagenesis	85	85	.	.	.	Note=EF-Tu-binding	and	EF-Tu-promoted	GTP	hydrolysis	reduced.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15989950;Dbxref=PMID:15989950
P60723	UniProtKB	Mutagenesis	40	88	.	.	.	Note=Regulates	the	S10	operon	normally.	Assembles	into	ribosomes	in	vivo.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8846294;Dbxref=PMID:8846294
P60723	UniProtKB	Mutagenesis	67	103	.	.	.	Note=Regulates	the	S10	operon	normally.	Does	not	assemble	into	ribosomes	in	vivo.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8846294;Dbxref=PMID:8846294
P60723	UniProtKB	Mutagenesis	93	101	.	.	.	Note=Regulates	the	S10	operon	normally.	Not	stably	associated	with	the	ribosome	in	vivo.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8846294;Dbxref=PMID:8846294
P60723	UniProtKB	Mutagenesis	131	131	.	.	.	Note=Does	not	regulate	the	S10	operon%3B	assembles	into	ribosomes	in	vivo.	T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8846294;Dbxref=PMID:8846294
P60723	UniProtKB	Mutagenesis	134	134	.	.	.	Note=Does	not	regulate	the	S10	operon	in	vivo.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8846294;Dbxref=PMID:8846294
P60723	UniProtKB	Mutagenesis	160	160	.	.	.	Note=Does	not	regulate	the	S10	operon%3B	assembles	into	ribosomes	in	vivo.	A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8846294;Dbxref=PMID:8846294
P60723	UniProtKB	Mutagenesis	167	167	.	.	.	Note=Does	not	regulate	the	S10	operon	in	vivo.	V->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8846294;Dbxref=PMID:8846294
P60723	UniProtKB	Mutagenesis	171	201	.	.	.	Note=Loss	of	S10	operon	regulation.	Assembles	into	ribosomes	in	vivo.	DATGIDPVSLIAFDKVVMTADAVKQVEEMLA->RRSK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8846294;Dbxref=PMID:8846294
P0ADZ0	UniProtKB	Mutagenesis	16	18	.	.	.	Note=Strongly	reduces	trigger	factor	bindingVSE->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12226666;Dbxref=PMID:12226666
P0ADZ0	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Binds	normally	to	ribosomes%3B	strongly	reduces	trigger	factor	binding.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12226666;Dbxref=PMID:12226666
P0ADZ0	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Strongly	reduces	trigger	factor	bindingE->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12226666;Dbxref=PMID:12226666
P0ADZ0	UniProtKB	Mutagenesis	51	53	.	.	.	Note=No	effect	on	trigger	factor	bindingFEV->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12226666;Dbxref=PMID:12226666
P0ADZ0	UniProtKB	Mutagenesis	52	52	.	.	.	Note=No	effect	on	trigger	factor	bindingE->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12226666;Dbxref=PMID:12226666
P61175	UniProtKB	Mutagenesis	82	99	.	.	.	Note=Incorporated	into	ribosomes	in	vivo%2C	but	is	easily	removed	by	a	salt	wash.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:13130133;Dbxref=PMID:13130133
P61175	UniProtKB	Mutagenesis	85	95	.	.	.	Note=Incorporates	into	ribosomes	in	vivo.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:13130133;Dbxref=PMID:13130133
P61175	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Abolishes	translation	elongation	arrest	of	SecM.	G->A%2CD%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11893334;Dbxref=PMID:11893334
P61175	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Abolishes	translation	elongation	arrest	of	SecM.	A->S%2CT%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11893334;Dbxref=PMID:11893334
P60422	UniProtKB	Mutagenesis	230	230	.	.	.	Note=Loss	of	peptidyltransferase	activity	in	reconstituted	ribosomes.	No	change	in	rRNA	binding	or	assembly	into	ribosomes.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8722025;Dbxref=PMID:8722025
P0A7M9	UniProtKB	Mutagenesis	16	16	.	.	.	Note=No	Zn(2+)	binding.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22196016;Dbxref=PMID:22196016
P0A7M9	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Binds	Zn(2+)	normally.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22196016;Dbxref=PMID:22196016
P0A7M9	UniProtKB	Mutagenesis	37	40	.	.	.	Note=Binds	Zn(2+)	normally.	CSKC->SSKS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22196016;Dbxref=PMID:22196016
P0C0R7	UniProtKB	Mutagenesis	20	20	.	.	.	Note=2-fold	decrease	in	activity.	Increase	in	Km	for	50S	subunit.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15375145;Dbxref=PMID:15375145
P0C0R7	UniProtKB	Mutagenesis	22	22	.	.	.	Note=No	change	in	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15375145;Dbxref=PMID:15375145
P0C0R7	UniProtKB	Mutagenesis	32	32	.	.	.	Note=4-fold	decrease	in	activitand	increase	in	Km	for	50S	subunit%3B	when	associated	with	A-34.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15375145;Dbxref=PMID:15375145
P0C0R7	UniProtKB	Mutagenesis	34	34	.	.	.	Note=4-fold	decrease	in	activitand	increase	in	Km	for	50S	subunit%3B	when	associated	with	A-32.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15375145;Dbxref=PMID:15375145
P0C0R7	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Loss	of	activity.	Almost	no	change	in	S-adenosyl-L-methionine	binding.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12181314;Dbxref=PMID:12181314
P0C0R7	UniProtKB	Mutagenesis	83	83	.	.	.	Note=5-fold	decrease	in	activity.	Increase	in	Km	for	50S	subunit	and	for	S-adenosyl-L-methionine.	Loss	of	S-adenosyl-L-methionine	binding.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12181314;Dbxref=PMID:12181314
P0C0R7	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Loss	of	activity.	Loss	of	S-adenosyl-L-methionine	binding.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12181314;Dbxref=PMID:12181314
P0C0R7	UniProtKB	Mutagenesis	136	136	.	.	.	Note=2-fold	decrease	in	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15375145;Dbxref=PMID:15375145
P0C0R7	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Loss	of	activity.	No	change	in	S-adenosyl-L-methionine	binding.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12181314;Dbxref=PMID:12181314
P0C0R7	UniProtKB	Mutagenesis	189	189	.	.	.	Note=9-fold	decrease	in	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15375145;Dbxref=PMID:15375145
P0C0R7	UniProtKB	Mutagenesis	194	194	.	.	.	Note=No	change	in	activity.	Increasin	Km	for	50S	subunit.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15375145;Dbxref=PMID:15375145
P0C0R7	UniProtKB	Mutagenesis	197	197	.	.	.	Note=No	change	in	activity.	Increasin	Km	for	50S	subunit.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15375145;Dbxref=PMID:15375145
P0C0R7	UniProtKB	Mutagenesis	199	199	.	.	.	Note=16-fold	decrease	in	activity.	No	change	in	S-adenosyl-L-methionine	binding.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12181314;Dbxref=PMID:12181314
P0C0R7	UniProtKB	Mutagenesis	201	201	.	.	.	Note=5-fold	decrease	in	activity.	Almost	no	change	in	S-adenosyl-L-methionine	binding.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12181314;Dbxref=PMID:12181314
P75864	UniProtKB	Mutagenesis	195	195	.	.	.	Note=Does	not	affect	methyltransferase	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22210896;Dbxref=PMID:22210896
P75864	UniProtKB	Mutagenesis	309	309	.	.	.	Note=Impairs	m2G2445	formation%2C	but	does	not	affect	m7G2069	formation.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22210896;Dbxref=PMID:22210896
P75864	UniProtKB	Mutagenesis	397	397	.	.	.	Note=Impairs	m2G2445	formation%2C	but	does	not	affect	m7G2069	formation.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22210896;Dbxref=PMID:22210896
P75864	UniProtKB	Mutagenesis	530	530	.	.	.	Note=Does	not	affect	methyltransferase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22210896;Dbxref=PMID:22210896
P75864	UniProtKB	Mutagenesis	568	568	.	.	.	Note=Impairs	m7G2069	formation%2C	but	does	not	affect	m2G2445	formation.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22210896;Dbxref=PMID:22210896
P75864	UniProtKB	Mutagenesis	597	597	.	.	.	Note=Does	not	affect	methyltransferase	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22210896;Dbxref=PMID:22210896
P36979	UniProtKB	Mutagenesis	118	118	.	.	.	Note=No	change	in	iron-sulfur	clustercontent.	No	effect	on	methylation	of	Cys-355.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21916495;Dbxref=PMID:21916495
P36979	UniProtKB	Mutagenesis	125	132	.	.	.	Note=Loss	of	iron-sulfur	clusterbinding.	No	methylation	of	Cys-355.	CALECKFC->AALEAKFA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21916495;Dbxref=PMID:21916495
P36979	UniProtKB	Mutagenesis	355	355	.	.	.	Note=No	change	in	iron-sulfur	clustercontent.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21916495;Dbxref=PMID:21916495
P37765	UniProtKB	Mutagenesis	110	110	.	.	.	Note=Loss	of	activity.	D->N%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11720289;Dbxref=PMID:11720289
P0A7Y4	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Loss	of	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1689729;Dbxref=PMID:1689729
P0A7Y4	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Loss	of	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1689729;Dbxref=PMID:1689729
P0A7Y4	UniProtKB	Mutagenesis	70	70	.	.	.	Note=Loss	of	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1689729;Dbxref=PMID:1689729
P0A7Y4	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Reduces	activity.	H->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1689729,ECO:0000269|PubMed:8931125,ECO:0000269|PubMed:9852071;Dbxref=PMID:1689729,PMID:8931125,PMID:9852071
P0A7Y4	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Reduces	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1689729;Dbxref=PMID:1689729
P0A7Y4	UniProtKB	Mutagenesis	134	134	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1689729,ECO:0000269|PubMed:8931125,ECO:0000269|PubMed:9852071;Dbxref=PMID:1689729,PMID:8931125,PMID:9852071
P0A7Y4	UniProtKB	Mutagenesis	134	134	.	.	.	Note=Slight	decrease	of	activity.	D->H%2CN;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1689729,ECO:0000269|PubMed:8931125,ECO:0000269|PubMed:9852071;Dbxref=PMID:1689729,PMID:8931125,PMID:9852071
P21499	UniProtKB	Mutagenesis	272	272	.	.	.	Note=Loss	of	RNase	activity%2C	but	exhibits	helicase	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20023028;Dbxref=PMID:20023028
P21499	UniProtKB	Mutagenesis	280	280	.	.	.	Note=Loss	of	RNase	activity%2C	but	exhibits	helicase	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20023028;Dbxref=PMID:20023028
P21499	UniProtKB	Mutagenesis	544	544	.	.	.	Note=Lack	of	acetylation.	Maintains	protein's	instability	in	exponential	phase.	Becomes	unstable	in	stationary	phase.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21981926;Dbxref=PMID:21981926
P21499	UniProtKB	Mutagenesis	544	544	.	.	.	Note=Lack	of	acetylation.	Stabilizes	exponential	phase	RNase	R.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21981926;Dbxref=PMID:21981926
P21499	UniProtKB	Mutagenesis	764	764	.	.	.	Note=Becomes	unstable	in	stationary	phase%3B	when	associated	with	A-766.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21981926;Dbxref=PMID:21981926
P21499	UniProtKB	Mutagenesis	766	766	.	.	.	Note=Becomes	unstable	in	stationary	phase%3B	when	associated	with	A-764.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21981926;Dbxref=PMID:21981926
P0AA37	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Forms	inclusion	bodies%2C	indicating	precipitation	even	within	the	cell.	K->M%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10924141;Dbxref=PMID:10924141
P0AA37	UniProtKB	Mutagenesis	29	29	.	.	.	Note=Reduced	structural	stability	and	decrease	in	activity.	P->G%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10924141;Dbxref=PMID:10924141
P0AA37	UniProtKB	Mutagenesis	64	64	.	.	.	Note=Loss	of	activity.	D->N%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383384;Dbxref=PMID:10383384
P0AA37	UniProtKB	Mutagenesis	117	117	.	.	.	Note=No	change	in	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10529181;Dbxref=PMID:10529181
P0AA37	UniProtKB	Mutagenesis	128	128	.	.	.	Note=No	change	in	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10529181;Dbxref=PMID:10529181
P37634	UniProtKB	Mutagenesis	4	4	.	.	.	Note=Loss	of	catalytic	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23945937;Dbxref=PMID:23945937
P37634	UniProtKB	Mutagenesis	4	4	.	.	.	Note=40-fold	reduction	in	catalytic	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23945937;Dbxref=PMID:23945937
P37634	UniProtKB	Mutagenesis	6	6	.	.	.	Note=Loss	of	catalytic	activity.	H->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23945937;Dbxref=PMID:23945937
P37634	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Loss	of	catalytic	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23945937;Dbxref=PMID:23945937
P37634	UniProtKB	Mutagenesis	18	18	.	.	.	Note=10-fold	reduction	in	catalytic	activity.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23945937;Dbxref=PMID:23945937
P37634	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Loss	of	catalytic	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23945937;Dbxref=PMID:23945937
P75966	UniProtKB	Mutagenesis	79	79	.	.	.	Note=Loss	of	activity.	D->N%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11720289;Dbxref=PMID:11720289
P32684	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Loss	of	activity.	D->N%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11720289;Dbxref=PMID:11720289
P33643	UniProtKB	Mutagenesis	139	139	.	.	.	Note=Loss	of	activity.	D->N%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11453071;Dbxref=PMID:11453071
P30014	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Strongly	reduces	affinity	for	RNA.	Nearly	abolishes	enzyme	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12364334;Dbxref=PMID:12364334
P30014	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Strongly	reduces	affinity	for	RNA.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12364334;Dbxref=PMID:12364334
P30014	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Nearly	abolishes	enzyme	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12364334;Dbxref=PMID:12364334
P30014	UniProtKB	Mutagenesis	25	25	.	.	.	Note=Nearly	abolishes	enzyme	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12364334;Dbxref=PMID:12364334
P30014	UniProtKB	Mutagenesis	29	29	.	.	.	Note=Abolishes	enzyme	activity%3B	when	associated	with	A-73	and	A-77.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21317904;Dbxref=PMID:21317904
P30014	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Reduces	enzyme	activity.	Abolishes	enzyme	activity%3B	when	associated	with	A-29	and	A-77.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21317904;Dbxref=PMID:21317904
P30014	UniProtKB	Mutagenesis	77	77	.	.	.	Note=Abolishes	enzyme	activity%3B	when	associated	with	A-29	and	A-73.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21317904;Dbxref=PMID:21317904
P30014	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Strongly	reduces	affinity	for	RNA.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12364334;Dbxref=PMID:12364334
P30014	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Strongly	reduces	affinity	for	RNA.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12364334;Dbxref=PMID:12364334
P30014	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Abolishes	enzyme	activity%3B	when	associated	with	A-146.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21317904;Dbxref=PMID:21317904
P30014	UniProtKB	Mutagenesis	139	139	.	.	.	Note=Reduces	affinity	for	RNA.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12364334;Dbxref=PMID:12364334
P30014	UniProtKB	Mutagenesis	146	146	.	.	.	Note=Abolishes	enzyme	activity%3B	when	associated	with	A-124.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21317904;Dbxref=PMID:21317904
P30014	UniProtKB	Mutagenesis	150	150	.	.	.	Note=Nearly	abolishes	enzyme	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12364334;Dbxref=PMID:12364334
P30014	UniProtKB	Mutagenesis	181	181	.	.	.	Note=Nearly	abolishes	enzyme	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12364334;Dbxref=PMID:12364334
P30014	UniProtKB	Mutagenesis	186	186	.	.	.	Note=Nearly	abolishes	enzyme	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12364334;Dbxref=PMID:12364334
P27431	UniProtKB	Mutagenesis	116	116	.	.	.	Note=Loss	of	binding	of	2-oxoglutarate.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24530688;Dbxref=PMID:24530688
P27431	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Loss	of	binding	of	2-oxoglutarate.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24530688;Dbxref=PMID:24530688
P27431	UniProtKB	Mutagenesis	211	211	.	.	.	Note=Blocks	dimerization.	Loss	of	activity.	I->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24814345;Dbxref=PMID:24814345
P0AGB3	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Decrease	in	activity.	Exhibitreduced	affinity	for	core	RNAP.	Q->N%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9144163;Dbxref=PMID:9144163
P0A7Z0	UniProtKB	Mutagenesis	81	81	.	.	.	Note=Catalytic	efficiency	decreases	by	10%2C000-fold%2C	with	no	measurable	effect	on	affinity	binding.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12517338;Dbxref=PMID:12517338
P0A7Z0	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Activity	decreases	by	250-fold%2C	with	little	change	on	affinity	binding.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12517338;Dbxref=PMID:12517338
P0A7Z0	UniProtKB	Mutagenesis	94	94	.	.	.	Note=Has	a	1500-fold	lower	Catalytic	efficiency	than	the	wild-type%2C	but	affinity	binding	is	increased	by	factor	of	seven.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12517338;Dbxref=PMID:12517338
P21513	UniProtKB	Mutagenesis	57	57	.	.	.	Note=Reduces	RNA	cleavage	by	over	98%25.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16237448;Dbxref=PMID:16237448
P21513	UniProtKB	Mutagenesis	66	66	.	.	.	Note=Disrupts	folding	of	the	S1	motif.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15312761;Dbxref=PMID:15312761
P21513	UniProtKB	Mutagenesis	67	67	.	.	.	Note=Reduces	RNA	cleavage	by	over	98%25.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16237448;Dbxref=PMID:16237448
P21513	UniProtKB	Mutagenesis	112	112	.	.	.	Note=Reduces	RNA	cleavage	by	98%25.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16237448;Dbxref=PMID:16237448
P21513	UniProtKB	Mutagenesis	170	170	.	.	.	Note=Abolishes	enzyme	activity	toward	RNA	substrates	with	a	5'	monophosphate	(PubMed:16237448).	Strongly	reduces	enzyme	activittoward	cspA	mRNA	(PubMed:19889093).	T->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16237448,ECO:0000269|PubMed:19889093;Dbxref=PMID:16237448,PMID:19889093
P21513	UniProtKB	Mutagenesis	303	303	.	.	.	Note=Reduces	RNA	cleavage	by	over	96%25.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16237448;Dbxref=PMID:16237448
P21513	UniProtKB	Mutagenesis	305	305	.	.	.	Note=Reduces	RNA	cleavage	by	over	96%25.	N->D%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16237448;Dbxref=PMID:16237448
P21513	UniProtKB	Mutagenesis	346	346	.	.	.	Note=Reduces	RNA	cleavage	by	over	96%25.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16237448;Dbxref=PMID:16237448
P21513	UniProtKB	Mutagenesis	373	373	.	.	.	Note=Reduces	RNA	cleavage	by	89%25.	R->A%2CD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16237448;Dbxref=PMID:16237448
P21513	UniProtKB	Mutagenesis	404	404	.	.	.	Note=Reduces	zinc-binding.	Abolishes	homotetramerization	and	enzyme	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15779893;Dbxref=PMID:15779893
P21513	UniProtKB	Mutagenesis	407	407	.	.	.	Note=Reduces	zinc-binding.	Abolishes	homotetramerization	and	enzyme	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15779893;Dbxref=PMID:15779893
P0AGB6	UniProtKB	Mutagenesis	25	25	.	.	.	Note=In	SR1576%3B	loss	of	sigma	factor	activity.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7889935;Dbxref=PMID:7889935
P0AGB6	UniProtKB	Mutagenesis	165	165	.	.	.	Note=Binds	RNAP	and	RseA	normally.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12016219;Dbxref=PMID:12016219
P0AGB6	UniProtKB	Mutagenesis	172	172	.	.	.	Note=In	SR1723%3B	loss	of	sigma	factor	activity.	S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7889935;Dbxref=PMID:7889935
P0AGB6	UniProtKB	Mutagenesis	178	178	.	.	.	Note=In	SR1502%3B	decreased	sigma	factor	activity.	Does	not	bind	RseA%2C	still	binds	RNAP.	R->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12016219,ECO:0000269|PubMed:7889935;Dbxref=PMID:12016219,PMID:7889935
P0AGB6	UniProtKB	Mutagenesis	181	181	.	.	.	Note=In	SR1503%3B	decreased	sigma	factor	activity.	Does	not	bind	RseA%2C	still	binds	RNAP.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12016219;Dbxref=PMID:12016219
P0AGB6	UniProtKB	Mutagenesis	185	185	.	.	.	Note=In	SR1504%3B	decreased	sigma	factor	activity.	Does	not	bind	RseA%2C	still	binds	RNAP.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12016219;Dbxref=PMID:12016219
P37351	UniProtKB	Mutagenesis	99	99	.	.	.	Note=Strongly	reduced	enzyme	activity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18640127;Dbxref=PMID:18640127
P0A7Z4	UniProtKB	Mutagenesis	45	45	.	.	.	Note=In	rpoA112%3B	temperature-sensitive%2blocks	RNA	polymerase	assembly.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2235479;Dbxref=PMID:2235479
P0A7Z4	UniProtKB	Mutagenesis	162	165	.	.	.	Note=5-fold	decrease	in	CRP-class	II	promoter-dependent	transcription.	EEDE->AAAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8978616;Dbxref=PMID:8978616
P0A7Z4	UniProtKB	Mutagenesis	165	165	.	.	.	Note=5-fold	decrease	in	CRP-class	II	promoter-dependent	transcription.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8978616;Dbxref=PMID:8978616
P0A7Z4	UniProtKB	Mutagenesis	191	191	.	.	.	Note=In	rpoA101%3B	temperature-sensitive.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2235479;Dbxref=PMID:2235479
P0A7S3	UniProtKB	Mutagenesis	57	57	.	.	.	Note=Protein	is	not	incorporated	into	ribosomes.	L->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10209746;Dbxref=PMID:10209746
P0A7S3	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Confers	low-level	resistance	to	streptomycin	and	a	15%25	decrease	in	the	translational	elongation	rate.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10209746;Dbxref=PMID:10209746
P0A7Y0	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Reduced	affinity	for	Mg(2+)%2C	no	catalytic	defect	at	10	mM	Mg(2+).	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15476399;Dbxref=PMID:15476399
P0A7Y0	UniProtKB	Mutagenesis	40	40	.	.	.	Note=Loss	of	activity.	L->G%2CD%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11738048;Dbxref=PMID:11738048
P0A7Y0	UniProtKB	Mutagenesis	40	40	.	.	.	Note=No	effect.	L->M%2CW;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11738048;Dbxref=PMID:11738048
P0A7Y0	UniProtKB	Mutagenesis	41	41	.	.	.	Note=Reduced	affinity	for	Mg(2+)%2C	catalytic	defect.	85-fold	reduced	affinity	for	Mg(2+)%3B	when	associated	with	A-114.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15476399;Dbxref=PMID:15476399
P0A7Y0	UniProtKB	Mutagenesis	44	44	.	.	.	Note=In	rnc-105%3B	slower	growth%2C	loss	of	RNase	activity.	G->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:3903434,ECO:0000269|PubMed:9632264;Dbxref=PMID:3903434,PMID:9632264
P0A7Y0	UniProtKB	Mutagenesis	45	45	.	.	.	Note=30000-fold	reduction	in	catalytic	efficiency%2C	binds	RNA	normally.	Partially	rescued	by	Mn(2+).	D->A%2CE%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15476399;Dbxref=PMID:15476399
P0A7Y0	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Reduced	affinity	for	Mg(2+)%2C	no	catalytic	defect	at	10	mM	Mg(2+).	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15476399;Dbxref=PMID:15476399
P0A7Y0	UniProtKB	Mutagenesis	100	100	.	.	.	Note=Reduced	affinity	for	Mg(2+)	and	RNA.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15476399;Dbxref=PMID:15476399
P0A7Y0	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Reduced	affinity	for	Mg(2+)%2C	no	catalytic	defect	at	10	mM	Mg(2+).	85-fold	reduced	affinity	for	Mg(2+)%3B	when	associated	with	A-41.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15476399;Dbxref=PMID:15476399
P0A7Y0	UniProtKB	Mutagenesis	117	117	.	.	.	Note=Nearly	complete	loss	of	RNase	activity%2C	still	binds	RNA.	Partially	rescued	by	Mn(2+).	E->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11305928,ECO:0000269|PubMed:9632264;Dbxref=PMID:11305928,PMID:9632264
P0A7Y0	UniProtKB	Mutagenesis	117	117	.	.	.	Note=In	rnc70%3B	slower	growth%2C	loss	of	RNase	activity.	Dominant	over	wild-type.	Binds	ds-RNA.	E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11305928,ECO:0000269|PubMed:9632264;Dbxref=PMID:11305928,PMID:9632264
P0A7Y0	UniProtKB	Mutagenesis	117	117	.	.	.	Note=Loss	of	RNase	activity%2C	still	binds	RNA.	E->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11305928,ECO:0000269|PubMed:9632264;Dbxref=PMID:11305928,PMID:9632264
P52129	UniProtKB	Mutagenesis	188	196	.	.	.	Note=In	rnlA5%3B	strongly	reducesRNase	LS	activity.	EKVLIRQED->KKVLIRQEN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15677746;Dbxref=PMID:15677746
P46850	UniProtKB	Mutagenesis	337	337	.	.	.	Note=Loss	of	function.	Abolishes	formation	of	guanylylated	RtcB	intermediate.	H->A%2CN%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22474365;Dbxref=PMID:22474365
P06992	UniProtKB	Mutagenesis	66	66	.	.	.	Note=Loss	of	activity.	Overexpression	of	the	mutant	has	a	negative	effect	on	cell	growth%2C	probably	becauseit	sequesters	the	small	subunits	in	the	free	form	and	limits	their	participation	in	the	translation	cycle.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18990185;Dbxref=PMID:18990185
P0AC98	UniProtKB	Mutagenesis	131	131	.	.	.	Note=Acquires	ability	to	transport	lactic	acid.	L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23844911;Dbxref=PMID:23844911
P0AC98	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Acquires	ability	to	transport	lactic	acid.	A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23844911;Dbxref=PMID:23844911
P62395	UniProtKB	Mutagenesis	1	1	.	.	.	Note=Protein	is	not	produced%2C	(and	therefore	neither	is	SecA)	indicating	this	is	the	start	codon.	M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10986266;Dbxref=PMID:10986266
P62395	UniProtKB	Mutagenesis	24	24	.	.	.	Note=Protein	is	produced%3B	this	is	not	the	start	codon.	M->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11948148;Dbxref=PMID:11948148
P62395	UniProtKB	Mutagenesis	29	33	.	.	.	Note=Loss	of	the	ability	to	repress	SecA-LacZ	fusion	proteins%2C	translational	pausing	is	very	long%2C	with	almost	no	secretion.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9748461;Dbxref=PMID:9748461
P62395	UniProtKB	Mutagenesis	31	34	.	.	.	Note=Loss	of	the	ability	to	repress	SecA-LacZ	fusion	proteins.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9748461;Dbxref=PMID:9748461
P62395	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Abolishes	translation	arrest.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10986266;Dbxref=PMID:10986266
P62395	UniProtKB	Mutagenesis	166	170	.	.	.	Note=Abolishes	translation	arrest.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10986266;Dbxref=PMID:10986266
P62395	UniProtKB	Mutagenesis	166	166	.	.	.	Note=Abolishes	translation	arrest.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10986266;Dbxref=PMID:10986266
P0AG74	UniProtKB	Mutagenesis	16	16	.	.	.	Note=No	effect	on	ability	to	promoteDNA	repair.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11080453;Dbxref=PMID:11080453
P0AG74	UniProtKB	Mutagenesis	17	17	.	.	.	Note=No	effect	on	ability	to	promoteDNA	repair.	Y->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11080453;Dbxref=PMID:11080453
P0AG74	UniProtKB	Mutagenesis	19	19	.	.	.	Note=No	effect	on	ability	to	promoteDNA	repair.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11080453;Dbxref=PMID:11080453
P0AG74	UniProtKB	Mutagenesis	58	58	.	.	.	Note=No	effect	on	ability	to	promoteDNA	repair.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11080453;Dbxref=PMID:11080453
P0AG74	UniProtKB	Mutagenesis	68	68	.	.	.	Note=No	effect	on	ability	to	promoteDNA	repair.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11080453;Dbxref=PMID:11080453
P0AG74	UniProtKB	Mutagenesis	69	69	.	.	.	Note=Loss	of	ability	to	promoteDNA	repair.	Great	loss	of	Holliday	junction	resolvase	activity.	No	effect	on	DNA	binding.	R->Q%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11080453;Dbxref=PMID:11080453
P0AG74	UniProtKB	Mutagenesis	70	70	.	.	.	Note=Reduces	junction	resolution	80-fold.	No	effect	on	DNA	binding.	D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9571038,ECO:0000269|PubMed:9973560;Dbxref=PMID:9571038,PMID:9973560
P0AG74	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Loss	of	ability	to	resolvejunctions.	No	effect	on	DNA	binding.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9973560;Dbxref=PMID:9973560
P0AG74	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Slight	reduction	in	abilityto	promote	DNA	repair.	Great	reduction	in	Holliday	junction	resolution	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11080453;Dbxref=PMID:11080453
P0AG74	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Loss	of	ability	to	promoteDNA	repair.	Loss	of	Holliday	junction	resolvase	activity.	No	effect	on	DNA	binding.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11080453;Dbxref=PMID:11080453
P0AG74	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Loss	of	ability	to	promoteDNA	repair.	Less	than	2%25	activity	of	Holliday	junction	resolvase.	No	effect	on	DNA	binding.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11080453;Dbxref=PMID:11080453
P0AG74	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Slight	reduction	in	abilityto	resolve	junctions.	No	effect	on	DNA	binding.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9973560;Dbxref=PMID:9973560
P0AG74	UniProtKB	Mutagenesis	87	87	.	.	.	Note=No	effect	on	ability	to	promoteDNA	repair.	F->Y%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11080453;Dbxref=PMID:11080453
P0AG74	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Slight	reduction	in	abilityto	resolve	junctions.	No	effect	on	DNA	binding.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9973560;Dbxref=PMID:9973560
P0AG74	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Loss	of	ability	to	resolvejunctions.	No	effect	on	DNA	binding.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9973560;Dbxref=PMID:9973560
P0AG74	UniProtKB	Mutagenesis	101	101	.	.	.	Note=No	effect	on	ability	to	promoteDNA	repair.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11080453;Dbxref=PMID:11080453
P0AG74	UniProtKB	Mutagenesis	111	111	.	.	.	Note=No	effect	on	resolvase	activitor	DNA	binding.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9973560;Dbxref=PMID:9973560
P0AG74	UniProtKB	Mutagenesis	116	116	.	.	.	Note=No	effect	on	resolvase	activitor	DNA	binding.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9973560;Dbxref=PMID:9973560
P0AG96	UniProtKB	Mutagenesis	120	120	.	.	.	Note=Massive	ion	flux	when	cross-linked	to	SecY	C-67	mutation.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17531809;Dbxref=PMID:17531809
P0AGA2	UniProtKB	Mutagenesis	40	40	.	.	.	Note=In	secY100%3B	temperature-sensitive.	P->S
P0AGA2	UniProtKB	Mutagenesis	60	74	.	.	.	Note=Some	loss	of	viability%2C	supports	protein	translocation%3B	strongly	suppresses	defective	and	missing	signal	sequences%3B	transient	transmembrane	channels	open.	Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17531809,ECO:0000269|PubMed:17531810;Dbxref=PMID:17531809,PMID:17531810
P0AGA2	UniProtKB	Mutagenesis	65	70	.	.	.	Note=Grows	almost	as	well	as	wild-type%2C	supports	protein	translocation%3B	strongly	suppresses	defective	and	missingsignal	sequences%3B	transient	transmembrane	channels	open.	Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17531809,ECO:0000269|PubMed:17531810;Dbxref=PMID:17531809,PMID:17531810
P0AGA2	UniProtKB	Mutagenesis	67	67	.	.	.	Note=In	prlA3%3B	altered	signal	sequencinteraction%2C	transient	channel	opening	and	closing	in	presence	of	oxidant%3B	massive	ion	flux	when	cross-linked	to	SecE	C-120	mutation.	F->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17531809;Dbxref=PMID:17531809
P0AGA2	UniProtKB	Mutagenesis	167	167	.	.	.	Note=In	secY100%3B	temperature-sensitive.	G->E
P0AGA2	UniProtKB	Mutagenesis	240	240	.	.	.	Note=In	secY24%3B	temperature-sensitive	at	42	degrees	Celsius%2C	impairs	interaction	with	SecE	even	at	30	degrees	in	vitro.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8183945;Dbxref=PMID:8183945
P0AGA2	UniProtKB	Mutagenesis	282	282	.	.	.	Note=In	prlA401%3B	altered	signal	sequencinteraction%2C	transient	transmembrane	channels	open.	S->R
P0AGA2	UniProtKB	Mutagenesis	286	286	.	.	.	Note=In	prlA4-1%3B	altered	signal	sequencinteraction.	F->Y
P0AGA2	UniProtKB	Mutagenesis	287	287	.	.	.	Note=In	secY161%3B	altered	signal	sequencinteraction.	P->L
P0AGA2	UniProtKB	Mutagenesis	290	290	.	.	.	Note=In	secY121%3B	altered	signal	sequencinteraction.	I->T
P0AGA2	UniProtKB	Mutagenesis	357	357	.	.	.	Note=In	secY39%3B	cold-sensitive.	R->H
P0AGA2	UniProtKB	Mutagenesis	363	363	.	.	.	Note=In	secY40%3B	cold-sensitive.	A->S
P0AGA2	UniProtKB	Mutagenesis	408	408	.	.	.	Note=In	prlA4-2%3B	altered	signal	sequencinteraction.	I->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17531809;Dbxref=PMID:17531809
P0AGA2	UniProtKB	Mutagenesis	424	443	.	.	.	Note=No	longer	complements	secY24%2C	temperature-sensitive	secY	mutation.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20855604;Dbxref=PMID:20855604
P33667	UniProtKB	Mutagenesis	96	96	.	.	.	Note=No	change	in	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14594807;Dbxref=PMID:14594807
P33667	UniProtKB	Mutagenesis	97	97	.	.	.	Note=In	vivo%2C	abolishes	2-selenouridinesynthase	activity.	In	vitro%2C	reduces	activity	by	only	50%25.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14594807;Dbxref=PMID:14594807
P0AG99	UniProtKB	Mutagenesis	41	41	.	.	.	Note=Affects	activity.	T->P
P0AG99	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Affects	activity.	L->P
P0AG99	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Affects	activity.	F->S%2CY
P16456	UniProtKB	Mutagenesis	13	13	.	.	.	Note=No	loss	of	activity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8262938;Dbxref=PMID:8262938
P16456	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Complete	loss	of	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1527085;Dbxref=PMID:1527085
P16456	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Partial	loss	of	activity.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8262938;Dbxref=PMID:8262938
P16456	UniProtKB	Mutagenesis	19	19	.	.	.	Note=No	loss	of	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1527085;Dbxref=PMID:1527085
P16456	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Complete	loss	of	activity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8262938;Dbxref=PMID:8262938
P16456	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Marked	loss	of	activity.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8262938;Dbxref=PMID:8262938
P0AFY8	UniProtKB	Mutagenesis	116	116	.	.	.	Note=Strongly	reduced	DNA	binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14704346;Dbxref=PMID:14704346
P0AFY8	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Strongly	reduced	DNA	binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14704346;Dbxref=PMID:14704346
P0AFY8	UniProtKB	Mutagenesis	149	149	.	.	.	Note=Strongly	reduced	DNA	binding.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14704346;Dbxref=PMID:14704346
P0AFY8	UniProtKB	Mutagenesis	150	150	.	.	.	Note=Strongly	reduced	DNA	binding.	N->A%2CD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14704346;Dbxref=PMID:14704346
P0AFY8	UniProtKB	Mutagenesis	151	151	.	.	.	Note=Reduced	DNA	binding.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14704346;Dbxref=PMID:14704346
P0AFY8	UniProtKB	Mutagenesis	152	152	.	.	.	Note=Strongly	reduced	DNA	binding.	N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14704346;Dbxref=PMID:14704346
P0AFY8	UniProtKB	Mutagenesis	155	155	.	.	.	Note=Strongly	reduced	DNA	binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14704346;Dbxref=PMID:14704346
P0AFY8	UniProtKB	Mutagenesis	156	156	.	.	.	Note=Strongly	reduced	DNA	binding.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14704346;Dbxref=PMID:14704346
P33018	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Reduces	catalytic	efficiency%2C	but	has	no	effect	on	affinity	for	substrate.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16567800;Dbxref=PMID:16567800
P33018	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Reduces	affinity	for	substrate	and	catalytic	efficiency.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16567800;Dbxref=PMID:16567800
P33018	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Increases	affinity	for	substrate%2C	but	reduces	catalytic	efficiency.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16567800;Dbxref=PMID:16567800
P33018	UniProtKB	Mutagenesis	145	145	.	.	.	Note=Loss	of	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16567800;Dbxref=PMID:16567800
P33018	UniProtKB	Mutagenesis	199	199	.	.	.	Note=Reduces	catalytic	efficiency%2C	but	has	no	effect	on	affinity	for	substrate.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16567800;Dbxref=PMID:16567800
P33018	UniProtKB	Mutagenesis	218	218	.	.	.	Note=Reduces	affinity	for	substrate	and	catalytic	efficiency.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16567800;Dbxref=PMID:16567800
P33018	UniProtKB	Mutagenesis	223	223	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16567800;Dbxref=PMID:16567800
P33018	UniProtKB	Mutagenesis	255	255	.	.	.	Note=Increases	affinity	for	substrate%2C	but	reduces	catalytic	efficiency.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16567800;Dbxref=PMID:16567800
P33018	UniProtKB	Mutagenesis	256	256	.	.	.	Note=Loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16567800;Dbxref=PMID:16567800
P0A9K9	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Decrease	in	PPIase	activity%2C	but	has	little	impact	on	chaperone	activity	and	interaction	with	HypB.	Almost	completloss	of	PPIase	activity%3B	when	associated	with	Y-132.	I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17720786;Dbxref=PMID:17720786
P0A9K9	UniProtKB	Mutagenesis	132	132	.	.	.	Note=Almost	complete	loss	of	PPIase	activity%2C	but	has	little	impact	on	chaperone	activity	and	interaction	with	HypB%3B	when	associated	with	S-42.	F->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17720786;Dbxref=PMID:17720786
P0A9K9	UniProtKB	Mutagenesis	167	168	.	.	.	Note=Reduces	nickel-binding	capacity.	CC->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19947632;Dbxref=PMID:19947632
P0A9K9	UniProtKB	Mutagenesis	184	185	.	.	.	Note=Reduces	nickel-binding	capacity.	CC->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19947632;Dbxref=PMID:19947632
P0AGC3	UniProtKB	Mutagenesis	505	505	.	.	.	Note=Inactivates	the	enzyme.	E->Q
P0AG90	UniProtKB	Mutagenesis	519	519	.	.	.	Note=Abolishes	protein	translocation.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21562494;Dbxref=PMID:21562494
P0A821	UniProtKB	Mutagenesis	224	224	.	.	.	Note=Still	binds	PLP.	K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9688279;Dbxref=PMID:9688279
P0A821	UniProtKB	Mutagenesis	295	295	.	.	.	Note=Loss	of	activity	and	PLP	binding.	K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9688279;Dbxref=PMID:9688279
P0A821	UniProtKB	Mutagenesis	328	328	.	.	.	Note=Loss	of	PLP	binding.	K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9688279;Dbxref=PMID:9688279
P0AG93	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Abolishes	protein	translocation.	D->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21562494;Dbxref=PMID:21562494
P0AG93	UniProtKB	Mutagenesis	247	247	.	.	.	Note=Abolishes	protein	translocation.	R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21562494;Dbxref=PMID:21562494
P0C093	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Does	not	associate	with	DNA%2C	but	can	inhibit	division	when	overproduced.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21321206;Dbxref=PMID:21321206
P0C093	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Loss	of	activity.	Binds	DNA%2C	but	does	not	associate	with	FtsZ	polymers.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21321206;Dbxref=PMID:21321206
P08395	UniProtKB	Mutagenesis	209	209	.	.	.	Note=Loss	of	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18476724;Dbxref=PMID:18476724
P08395	UniProtKB	Mutagenesis	366	366	.	.	.	Note=Reduced	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18476724;Dbxref=PMID:18476724
P08395	UniProtKB	Mutagenesis	409	409	.	.	.	Note=Loss	of	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18476724;Dbxref=PMID:18476724
P08395	UniProtKB	Mutagenesis	410	410	.	.	.	Note=Reduced	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18476724;Dbxref=PMID:18476724
P08395	UniProtKB	Mutagenesis	412	412	.	.	.	Note=No	effect	on	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18476724;Dbxref=PMID:18476724
P08395	UniProtKB	Mutagenesis	510	510	.	.	.	Note=Reduced	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18476724;Dbxref=PMID:18476724
P08395	UniProtKB	Mutagenesis	524	524	.	.	.	Note=Increased	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18476724;Dbxref=PMID:18476724
P32140	UniProtKB	Mutagenesis	55	55	.	.	.	Note=Loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18328504;Dbxref=PMID:18328504
P32140	UniProtKB	Mutagenesis	176	176	.	.	.	Note=Loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18328504;Dbxref=PMID:18328504
P32140	UniProtKB	Mutagenesis	248	248	.	.	.	Note=Loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18328504;Dbxref=PMID:18328504
P32140	UniProtKB	Mutagenesis	251	251	.	.	.	Note=Strong	decrease	in	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18328504;Dbxref=PMID:18328504
P32140	UniProtKB	Mutagenesis	320	320	.	.	.	Note=Loss	of	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18328504;Dbxref=PMID:18328504
P32140	UniProtKB	Mutagenesis	383	383	.	.	.	Note=Loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18328504;Dbxref=PMID:18328504
P16659	UniProtKB	Mutagenesis	257	257	.	.	.	Note=Reduces	the	posttransfer	editingactivity	5-fold%2C	with	little	change	in	both	the	aminoacylation	and	the	pretransfer	editingactivities.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12033945;Dbxref=PMID:12033945
P16659	UniProtKB	Mutagenesis	279	279	.	.	.	Note=Severely	affects	the	posttransfer	editing	activity%2C	with	little	change	in	both	the	aminoacylation	and	the	pretransfer	editingactivities.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12033945;Dbxref=PMID:12033945
P16659	UniProtKB	Mutagenesis	350	350	.	.	.	Note=Abolishes	the	pretransfer	editingactivity	and	reduces	the	aminoacylation	activity	20-fold	and	the	posttransfer	editing	activity	5-fold.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12033945;Dbxref=PMID:12033945
P16659	UniProtKB	Mutagenesis	369	369	.	.	.	Note=Reduces	both	the	aminoacylation	and	the	pretransfer	editing	activities	2.5-fold%2C	and	the	posttransfer	editing	activity	5-fold.	Loss	of	specificity	in	deacylation.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12033945;Dbxref=PMID:12033945
P16659	UniProtKB	Mutagenesis	378	378	.	.	.	Note=Little	change	in	both	the	aminoacylation	and	the	editing	activities.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12033945;Dbxref=PMID:12033945
P16659	UniProtKB	Mutagenesis	386	386	.	.	.	Note=Reduces	the	posttransfer	editingactivity	approximately	2-fold%2C	with	little	change	in	both	the	aminoacylation	and	the	pretransfer	editing	activities.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12033945;Dbxref=PMID:12033945
P16659	UniProtKB	Mutagenesis	394	394	.	.	.	Note=Reduces	the	posttransfer	editingactivity	approximately	2-fold%2C	with	little	change	in	both	the	aminoacylation	and	the	pretransfer	editing	activities.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12033945;Dbxref=PMID:12033945
P16659	UniProtKB	Mutagenesis	443	443	.	.	.	Note=150-fold	decrease	in	posttransfer	editing	activity	against	alanine%2C	without	change	neither	in	pretransfer	editing	nor	in	aminoacylation.	C->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10922054;Dbxref=PMID:10922054
P07118	UniProtKB	Mutagenesis	222	222	.	.	.	Note=Produces	mischarged	Thr-tRNA(Val)	and	Cys-tRNA(Val).	T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11313495;Dbxref=PMID:11313495
P07118	UniProtKB	Mutagenesis	277	277	.	.	.	Note=Reduces	posttransfer	Thr-tRNA(Val)	editing	rate	significantly	and	alters	amino	acid	discrimination	in	the	editing	site%2C	resulting	in	hydrolysis	of	the	correctly	charged	cognate	product.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12475234;Dbxref=PMID:12475234
P0AGJ9	UniProtKB	Mutagenesis	37	37	.	.	.	Note=Confers	specificity	for	the	non-natural	amino	acid	3-iodo-tyrosine%3B	when	associated	with	C-195.	Y->V
P0AGJ9	UniProtKB	Mutagenesis	195	195	.	.	.	Note=Confers	specificity	for	the	non-natural	amino	acid	3-iodo-tyrosine%3B	when	associated	with	V-37.	Q->C
P0A8M3	UniProtKB	Mutagenesis	334	334	.	.	.	Note=Activity	very	strongly	affected.	C->S
P0A8M3	UniProtKB	Mutagenesis	385	385	.	.	.	Note=Activity	very	strongly	affected.	H->A%2CN
P0A8M3	UniProtKB	Mutagenesis	511	511	.	.	.	Note=Activity	very	strongly	affected.	H->A%2CN
P00957	UniProtKB	Mutagenesis	179	179	.	.	.	Note=Inactivates	the	enzyme.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1712632;Dbxref=PMID:1712632
P00957	UniProtKB	Mutagenesis	182	182	.	.	.	Note=No	inactivation.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1712632;Dbxref=PMID:1712632
P00957	UniProtKB	Mutagenesis	184	184	.	.	.	Note=No	inactivation.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1712632;Dbxref=PMID:1712632
P00957	UniProtKB	Mutagenesis	188	188	.	.	.	Note=No	inactivation.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1712632;Dbxref=PMID:1712632
P00957	UniProtKB	Mutagenesis	189	189	.	.	.	Note=Inactivates	the	enzyme.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1712632;Dbxref=PMID:1712632
P00957	UniProtKB	Mutagenesis	191	191	.	.	.	Note=No	inactivation.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1712632;Dbxref=PMID:1712632
P00957	UniProtKB	Mutagenesis	192	192	.	.	.	Note=Inactivates	the	enzyme.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1712632;Dbxref=PMID:1712632
P00957	UniProtKB	Mutagenesis	236	236	.	.	.	Note=Decreases	affinity	for	alaninewithout	improving	discrimination	against	serine.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20010690;Dbxref=PMID:20010690
P00957	UniProtKB	Mutagenesis	238	238	.	.	.	Note=Greatly	decreases	affinity	for	alanine	with	only	small	changes	in	affinity	for	serine	and	glycine%2C	in	a	2-442	residue	construct.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20010690;Dbxref=PMID:20010690
P00957	UniProtKB	Mutagenesis	564	564	.	.	.	Note=No	effect	on	tRNA	editing.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12554667;Dbxref=PMID:12554667
P00957	UniProtKB	Mutagenesis	568	568	.	.	.	Note=No	effect	on	tRNA	editing.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12554667;Dbxref=PMID:12554667
P00957	UniProtKB	Mutagenesis	584	584	.	.	.	Note=Loss	of	mischarged	tRNA	editing	activity%3B	when	associated	with	A-666.	Q->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12554667,ECO:0000269|PubMed:18723508;Dbxref=PMID:12554667,PMID:18723508
P00957	UniProtKB	Mutagenesis	666	666	.	.	.	Note=Loss	of	mischarged	tRNA	editing	activity%3B	when	associated	with	H-584	the	effect	is	more	pronounced.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12554667,ECO:0000269|PubMed:18723508;Dbxref=PMID:12554667,PMID:18723508
P00957	UniProtKB	Mutagenesis	670	670	.	.	.	Note=No	effect	on	tRNA	editing.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12554667;Dbxref=PMID:12554667
P00957	UniProtKB	Mutagenesis	693	693	.	.	.	Note=Reduces	specificity	of	editingactivity	for	tRNA(Ala)%2C	allows	editing	of	tRNA(Thr).	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18172502;Dbxref=PMID:18172502
P0A8M0	UniProtKB	Mutagenesis	426	426	.	.	.	Note=No	effect.	Y->F
P0A8M0	UniProtKB	Mutagenesis	426	426	.	.	.	Note=15-fold	increase	in	Km	for	ATP.	Y->S
P0A8L1	UniProtKB	Mutagenesis	355	355	.	.	.	Note=Loss	of	serine	activation	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7537870;Dbxref=PMID:7537870
P69423	UniProtKB	Mutagenesis	17	17	.	.	.	Note=No	anaerobic	growth	and	no	TorA	export.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781311;Dbxref=PMID:11781311
P69423	UniProtKB	Mutagenesis	20	22	.	.	.	Note=No	anaerobic	growth	and	75%25	decrease	in	TorA	export.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781311;Dbxref=PMID:11781311
P69423	UniProtKB	Mutagenesis	20	20	.	.	.	Note=25%25	decrease	in	anaerobic	growth	and	75%25	decrease	in	TorA	export.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781311;Dbxref=PMID:11781311
P69423	UniProtKB	Mutagenesis	94	94	.	.	.	Note=Loss	of	function.	F->A%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11952898;Dbxref=PMID:11952898
P69423	UniProtKB	Mutagenesis	94	94	.	.	.	Note=Export	of	TorA	restored%3B	when	associated	with	A-211.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11952898;Dbxref=PMID:11952898
P69423	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Loss	of	function.	E->A%2CD%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11952898;Dbxref=PMID:11952898
P69423	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Export	of	TorA	restored%3B	when	associated	with	A-211.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11952898;Dbxref=PMID:11952898
P69423	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Severely	retard	but	does	not	abolish	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11952898;Dbxref=PMID:11952898
P69423	UniProtKB	Mutagenesis	211	211	.	.	.	Note=Export	activity	of	TorA	blocked.	Export	of	TorA	restored%3B	when	associated	with	A-94	or	A-103.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11952898;Dbxref=PMID:11952898
P69423	UniProtKB	Mutagenesis	211	211	.	.	.	Note=Decrease	in	TorA	export	activity.	D->E%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11952898;Dbxref=PMID:11952898
P68398	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Resistance	to	the	cell-killing	function	encoded	by	the	gef	gene	family.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1602968;Dbxref=PMID:1602968
P0A847	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Slight	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7893665;Dbxref=PMID:7893665
P0A847	UniProtKB	Mutagenesis	89	89	.	.	.	Note=Reduces	catalytic	activity	by	51%25.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11714265;Dbxref=PMID:11714265
P0A847	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Loss	of	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8003468;Dbxref=PMID:8003468
P0A847	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Loss	of	activity.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8003468;Dbxref=PMID:8003468
P0A847	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Loss	of	activity.	S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8003468;Dbxref=PMID:8003468
P0A847	UniProtKB	Mutagenesis	145	145	.	.	.	Note=No	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7893665;Dbxref=PMID:7893665
P0A847	UniProtKB	Mutagenesis	232	232	.	.	.	Note=Slight	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7893665;Dbxref=PMID:7893665
P0A847	UniProtKB	Mutagenesis	264	264	.	.	.	Note=Loss	of	catalytic	activity.	D->A%2CN%2CQ%2CK%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12909636;Dbxref=PMID:12909636
P0A847	UniProtKB	Mutagenesis	264	264	.	.	.	Note=Reduces	catalytic	activity	by	88%25.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12909636;Dbxref=PMID:12909636
P0A847	UniProtKB	Mutagenesis	265	265	.	.	.	Note=Significant	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7893665;Dbxref=PMID:7893665
P0A847	UniProtKB	Mutagenesis	302	302	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7893665;Dbxref=PMID:7893665
P0A847	UniProtKB	Mutagenesis	304	304	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7893665;Dbxref=PMID:7893665
P0A847	UniProtKB	Mutagenesis	307	307	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7893665;Dbxref=PMID:7893665
P0A847	UniProtKB	Mutagenesis	316	316	.	.	.	Note=Slight	loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7893665;Dbxref=PMID:7893665
P0A847	UniProtKB	Mutagenesis	317	317	.	.	.	Note=Loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7893665;Dbxref=PMID:7893665
P0A847	UniProtKB	Mutagenesis	321	321	.	.	.	Note=No	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7893665;Dbxref=PMID:7893665
P30138	UniProtKB	Mutagenesis	174	174	.	.	.	Note=No	adenylation	of	ThiS.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15896804;Dbxref=PMID:15896804
P30138	UniProtKB	Mutagenesis	184	184	.	.	.	Note=No	cross-link	formed	with	ThiS.	No	effect	on	ThiS	thiocarboxylate	formation	in	vitro.	Does	not	support	growth.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11438688;Dbxref=PMID:11438688
P69428	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Homooligomerizes	more	efficiently	than	wt%2C	blocks	translocation.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20169075;Dbxref=PMID:20169075
P27859	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Significant	decrease	in	nuclease	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25114049;Dbxref=PMID:25114049
P27859	UniProtKB	Mutagenesis	64	64	.	.	.	Note=No	change	in	nuclease	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25114049;Dbxref=PMID:25114049
P27859	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Lack	of	nuclease	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25114049;Dbxref=PMID:25114049
P27859	UniProtKB	Mutagenesis	127	127	.	.	.	Note=No	change	in	nuclease	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25114049;Dbxref=PMID:25114049
P27859	UniProtKB	Mutagenesis	152	152	.	.	.	Note=No	change	in	nuclease	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25114049;Dbxref=PMID:25114049
P27859	UniProtKB	Mutagenesis	201	201	.	.	.	Note=Lack	of	nuclease	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25114049;Dbxref=PMID:25114049
P27859	UniProtKB	Mutagenesis	203	203	.	.	.	Note=Lack	of	nuclease	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25114049;Dbxref=PMID:25114049
P0ADA1	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Reduces	activity	by	over	99%25.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16515533;Dbxref=PMID:16515533
P0ADA1	UniProtKB	Mutagenesis	70	70	.	.	.	Note=Reduces	activity	by	over	75%25.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16515533;Dbxref=PMID:16515533
P0ADA1	UniProtKB	Mutagenesis	99	99	.	.	.	Note=Reduces	activity	by	over	60%25.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16515533;Dbxref=PMID:16515533
P0ADA1	UniProtKB	Mutagenesis	135	135	.	.	.	Note=Lowers	activity	towards	substrates	with	long	acyl	chains.	L->P
P0ADA1	UniProtKB	Mutagenesis	180	180	.	.	.	Note=Reduces	activity	by	over	70%25.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16515533;Dbxref=PMID:16515533
P0ADA1	UniProtKB	Mutagenesis	183	183	.	.	.	Note=Reduces	activity	by	over	99%25.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16515533;Dbxref=PMID:16515533
P77718	UniProtKB	Mutagenesis	108	108	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11443125;Dbxref=PMID:11443125
P77718	UniProtKB	Mutagenesis	189	189	.	.	.	Note=No	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10595545;Dbxref=PMID:10595545
P77718	UniProtKB	Mutagenesis	202	202	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11443125;Dbxref=PMID:11443125
P77718	UniProtKB	Mutagenesis	207	207	.	.	.	Note=Enables	partial	functional	complementation	in	vivo.	Four-fold	reduction	in	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11443125;Dbxref=PMID:11443125
P77718	UniProtKB	Mutagenesis	321	321	.	.	.	Note=No	activity.	K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10595545;Dbxref=PMID:10595545
P77718	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Approximately	half	of	wild-type	activity.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10595545;Dbxref=PMID:10595545
P77718	UniProtKB	Mutagenesis	344	344	.	.	.	Note=Cannot	functionally	complement	for	wild-type	enzyme	in	vivo.	2700-fold	reduction	in	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11443125;Dbxref=PMID:11443125
P77718	UniProtKB	Mutagenesis	456	456	.	.	.	Note=No	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10722656;Dbxref=PMID:10722656
P25397	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Loss	of	tellurite	resistance.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11053398;Dbxref=PMID:11053398
P25397	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Loss	of	tellurite	resistance.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11053398;Dbxref=PMID:11053398
P25397	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Decrease	in	tellurite	resistance.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11053398;Dbxref=PMID:11053398
P25397	UniProtKB	Mutagenesis	97	97	.	.	.	Note=No	effect	on	tellurite	resistance.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11053398;Dbxref=PMID:11053398
P25397	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Decrease	in	tellurite	resistance.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11053398;Dbxref=PMID:11053398
P25397	UniProtKB	Mutagenesis	98	98	.	.	.	Note=Loss	of	tellurite	resistance.	F->A%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11053398;Dbxref=PMID:11053398
P25397	UniProtKB	Mutagenesis	176	176	.	.	.	Note=95%25	of	wild-type	methyltransferase	activity	on	tellurite.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21244361;Dbxref=PMID:21244361
P25397	UniProtKB	Mutagenesis	177	177	.	.	.	Note=35%25	of	wild-type	methyltransferase	activity	on	tellurite.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21244361;Dbxref=PMID:21244361
P25397	UniProtKB	Mutagenesis	184	184	.	.	.	Note=74%25	of	wild-type	methyltransferase	activity	on	tellurite.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21244361;Dbxref=PMID:21244361
P31142	UniProtKB	Mutagenesis	240	240	.	.	.	Note=Decrease	in	3-mercaptopyruvate	cyanide	sulfurtransferase	activity%3B	abolition	of	thiosulfate	binding.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11445076;Dbxref=PMID:11445076
P31142	UniProtKB	Mutagenesis	240	240	.	.	.	Note=Decrease	in	3-mercaptopyruvate	cyanide	sulfurtransferase	activity%3B	increased	affinity	for	thiosulfate.	S->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11445076;Dbxref=PMID:11445076
P06612	UniProtKB	Mutagenesis	9	9	.	.	.	Note=Abolishes	enzyme	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9497321;Dbxref=PMID:9497321
P06612	UniProtKB	Mutagenesis	9	9	.	.	.	Note=No	effect	on	DNA	cleavage	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9497321;Dbxref=PMID:9497321
P06612	UniProtKB	Mutagenesis	111	111	.	.	.	Note=Abolishes	both	magnesium	bindingand	enzyme	activity%3B	when	associated	with	A-113	and	A-115.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10681504;Dbxref=PMID:10681504
P06612	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Abolishes	both	magnesium	bindingand	enzyme	activity%3B	when	associated	with	A-111	and	A-115.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10681504;Dbxref=PMID:10681504
P06612	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Abolishes	both	magnesium	bindingand	enzyme	activity%3B	when	associated	with	A-111	and	A-113.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10681504;Dbxref=PMID:10681504
P06612	UniProtKB	Mutagenesis	168	168	.	.	.	Note=Abolishes	enzyme	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21482796;Dbxref=PMID:21482796
P06612	UniProtKB	Mutagenesis	172	172	.	.	.	Note=Abolishes	enzyme	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21482796;Dbxref=PMID:21482796
P06612	UniProtKB	Mutagenesis	319	319	.	.	.	Note=Abolishes	enzyme	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9497321;Dbxref=PMID:9497321
P06612	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Abolishes	enzyme	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9497321;Dbxref=PMID:9497321
P06612	UniProtKB	Mutagenesis	321	321	.	.	.	Note=No	effect.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9497321;Dbxref=PMID:9497321
P06612	UniProtKB	Mutagenesis	365	365	.	.	.	Note=No	effect.	H->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14604525,ECO:0000269|PubMed:9497321;Dbxref=PMID:14604525,PMID:9497321
P06612	UniProtKB	Mutagenesis	365	365	.	.	.	Note=Increases	DNA	binding	affinity.	H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14604525,ECO:0000269|PubMed:9497321;Dbxref=PMID:14604525,PMID:9497321
P06612	UniProtKB	Mutagenesis	496	496	.	.	.	Note=No	effect.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9497321;Dbxref=PMID:9497321
P38684	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Loss	of	phosphorylation.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9135110;Dbxref=PMID:9135110
P07913	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Shows	only	1%25	of	wild-type	catalytic	activity.	This	mutant	can	be	stimulated	to	the	wild-type	activitlevel	after	incubation	with	Zn(+).	C->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9784233;Dbxref=PMID:9784233
P07913	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Loss	of	catalytic	activity.	This	mutant	cannot	be	stimulated	to	the	wild-type	activity	level	after	incubation	with	Zn(+).	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9784233;Dbxref=PMID:9784233
P0A850	UniProtKB	Mutagenesis	44	46	.	.	.	Note=Decreases	association	with	ribosomes.	FRK->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12226666;Dbxref=PMID:12226666
P0A850	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Significantly	decreases	antiaggregation	activity.	M->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24812405;Dbxref=PMID:24812405
P0A850	UniProtKB	Mutagenesis	374	387	.	.	.	Note=Significantly	decreased	affinitfor	substrate	PhoA%2C	significantly	decreases	antiaggregation	activity.	MASAYEDPKEVIEF->AASAAEDPKEAIEA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24812405;Dbxref=PMID:24812405
P37025	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Lack	of	CPDase	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25239919;Dbxref=PMID:25239919
P37025	UniProtKB	Mutagenesis	45	45	.	.	.	Note=Lack	of	CPDase	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25239919;Dbxref=PMID:25239919
P37025	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Decreases	CPDase	activity.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25239919;Dbxref=PMID:25239919
P37025	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Lack	of	CPDase	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25239919;Dbxref=PMID:25239919
P37025	UniProtKB	Mutagenesis	127	127	.	.	.	Note=Does	not	affect	CPDase	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25239919;Dbxref=PMID:25239919
P37025	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Lack	of	CPDase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25239919;Dbxref=PMID:25239919
P0A884	UniProtKB	Mutagenesis	50	50	.	.	.	Note=Shows	0.2%25	of	wild-type	catalytic	activity%2C	but	substrate	affinity	is	not	affected.	C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3286637;Dbxref=PMID:3286637
P0A884	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Shows	2000-fold	decrease	in	catalytic	activity	and	600-fold	decrease	in	affinity	for	dUMP.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9416600;Dbxref=PMID:9416600
P0A884	UniProtKB	Mutagenesis	177	177	.	.	.	Note=Shows	200-fold	decrease	in	catalytic	activity%2C	20-fold	decrease	in	affinity	for	dUMP%2C	and	10-fold	decreasin	affinity	for	mTHF.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9826509;Dbxref=PMID:9826509
P0AGA6	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Lack	of	phosphorylation.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8999880;Dbxref=PMID:8999880
P0AGM7	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Slightly	decreased	uracil	uptake.F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21423164;Dbxref=PMID:21423164
P0AGM7	UniProtKB	Mutagenesis	241	241	.	.	.	Note=Abolishes	uracil	uptake.	Abolishes	uracil	binding.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21423164;Dbxref=PMID:21423164
P0AGM7	UniProtKB	Mutagenesis	245	245	.	.	.	Note=Abolishes	uracil	uptake.	Abolishes	uracil	binding.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21423164;Dbxref=PMID:21423164
P0AGM7	UniProtKB	Mutagenesis	288	288	.	.	.	Note=No	effect	on	uracil	uptake.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21423164;Dbxref=PMID:21423164
P0AGM7	UniProtKB	Mutagenesis	290	290	.	.	.	Note=Abolishes	uracil	uptake.	Abolishes	uracil	binding.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21423164;Dbxref=PMID:21423164
P0AGM7	UniProtKB	Mutagenesis	291	291	.	.	.	Note=Slightly	decreased	uracil	uptake.N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21423164;Dbxref=PMID:21423164
P0AGM7	UniProtKB	Mutagenesis	342	342	.	.	.	Note=Slightly	decreased	uracil	uptake.Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21423164;Dbxref=PMID:21423164
P25535	UniProtKB	Mutagenesis	301	303	.	.	.	Note=Leads	to	the	same	phenotype	as	the	ubiI	deletion	mutant%2C	indicating	a	strongly	impaired	catalytic	activity.	GVN->AVD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23709220;Dbxref=PMID:23709220
P04152	UniProtKB	Mutagenesis	75	75	.	.	.	Note=In	umuC36%3B	non-mutable.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1320188;Dbxref=PMID:1320188
P04152	UniProtKB	Mutagenesis	101	101	.	.	.	Note=In	umuC104%3B	non-mutable.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1320188;Dbxref=PMID:1320188
P04152	UniProtKB	Mutagenesis	290	290	.	.	.	Note=In	umuC25%3B	non-mutable.	T->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1320188;Dbxref=PMID:1320188
P0AG11	UniProtKB	Mutagenesis	27	27	.	.	.	Note=In	umuD1%3B	non-cleavable.	P->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1320188;Dbxref=PMID:1320188
P0AG11	UniProtKB	Mutagenesis	65	65	.	.	.	Note=In	umuD44%3B	non-cleavable.	G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1320188;Dbxref=PMID:1320188
P0AG11	UniProtKB	Mutagenesis	92	92	.	.	.	Note=In	umuD77%3B	non-cleavable.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1320188;Dbxref=PMID:1320188
P12758	UniProtKB	Mutagenesis	5	5	.	.	.	Note=No	change	in	activity.	D->A%2CE%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9661793;Dbxref=PMID:9661793
P09835	UniProtKB	Mutagenesis	313	313	.	.	.	Note=Lack	of	autokinase	activity.	H->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11053370;Dbxref=PMID:11053370
P0AGC0	UniProtKB	Mutagenesis	108	108	.	.	.	Note=No	change	in	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8402899;Dbxref=PMID:8402899
P0AGC0	UniProtKB	Mutagenesis	143	143	.	.	.	Note=30%25	of	wild-type	sugar	phosphate	transport	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8402899;Dbxref=PMID:8402899
P0AGC0	UniProtKB	Mutagenesis	265	265	.	.	.	Note=No	change	in	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8402899;Dbxref=PMID:8402899
P0AGC0	UniProtKB	Mutagenesis	331	331	.	.	.	Note=No	change	in	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8402899;Dbxref=PMID:8402899
P0AGC0	UniProtKB	Mutagenesis	436	436	.	.	.	Note=No	change	in	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8402899;Dbxref=PMID:8402899
P0AGC0	UniProtKB	Mutagenesis	438	438	.	.	.	Note=No	change	in	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8402899;Dbxref=PMID:8402899
P0A698	UniProtKB	Mutagenesis	253	253	.	.	.	Note=Reduced	activity.	C->A%2CH%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2550431;Dbxref=PMID:2550431
P0A8G0	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Defective	in	3'	incision	but	not	in	5'	incision.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10671556;Dbxref=PMID:10671556
P0A8G0	UniProtKB	Mutagenesis	399	399	.	.	.	Note=Defective	in	5'	incision	but	not	in	3'	incision.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1387639;Dbxref=PMID:1387639
P0A8G0	UniProtKB	Mutagenesis	438	438	.	.	.	Note=Defective	in	5'	incision	but	not	in	3'	incision.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1387639;Dbxref=PMID:1387639
P0A8G0	UniProtKB	Mutagenesis	466	466	.	.	.	Note=Defective	in	5'	incision	but	not	in	3'	incision.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1387639;Dbxref=PMID:1387639
P0A8G0	UniProtKB	Mutagenesis	538	538	.	.	.	Note=Defective	in	5'	incision	but	not	in	3'	incision.	H->F%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1387639;Dbxref=PMID:1387639
P03018	UniProtKB	Mutagenesis	30	30	.	.	.	Note=In	uvrD252%2C	UV	sensitive%2C	significant	loss	of	DNA-dependent	ATPase%2C	helicase	activity	requires	higher	ATP	and	MgCl(2)%2C	nearly	inactive	on	96	bp	dsDNA.	KM	for	ATP	rises	to	1.2	mM.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8419285;Dbxref=PMID:8419285
P0A8F0	UniProtKB	Mutagenesis	131	131	.	.	.	Note=60-fold	reduction	of	the	catalytic	rate%2C	and	large	decrease	in	uracil-binding	affinity.	P->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10079076;Dbxref=PMID:10079076
P0A8F8	UniProtKB	Mutagenesis	95	96	.	.	.	Note=Defective	in	DNA-unwinding	activity.	YY->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11689453;Dbxref=PMID:11689453
P0A8F8	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Defective	in	DNA-unwinding	activity%3B	when	associated	with	A-108.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11689453;Dbxref=PMID:11689453
P0A8F8	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Defective	in	DNA-unwinding	activity%3B	when	associated	with	A-101.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11689453;Dbxref=PMID:11689453
P31434	UniProtKB	Mutagenesis	307	308	.	.	.	Note=Converts	the	enzyme	to	have	alpha-glucosidase	activity.	CF->ID;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16631751;Dbxref=PMID:16631751
P0A8P8	UniProtKB	Mutagenesis	148	148	.	.	.	Note=Abolishes	DNA	cleavage	activity.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9268326;Dbxref=PMID:9268326
P0A8P8	UniProtKB	Mutagenesis	244	244	.	.	.	Note=Abolishes	DNA	religation	activity.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9268326;Dbxref=PMID:9268326
P0A8P8	UniProtKB	Mutagenesis	247	247	.	.	.	Note=Abolishes	DNA	cleavage	activity.	R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:8402918,ECO:0000269|PubMed:9268326;Dbxref=PMID:8402918,PMID:9268326
P0A8P8	UniProtKB	Mutagenesis	256	258	.	.	.	Note=Abolishes	plasmid	resolution	but	not	chromosomal	recombination.	NHG->ESS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10635320;Dbxref=PMID:10635320
P0A8P8	UniProtKB	Mutagenesis	279	279	.	.	.	Note=Abolishes	DNA	cleavage	activity.	Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7744017,ECO:0000269|PubMed:9268326;Dbxref=PMID:7744017,PMID:9268326
P0A8P8	UniProtKB	Mutagenesis	294	294	.	.	.	Note=Abolishes	DNA	recombination	(in	vitro).	H->Q%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10361305;Dbxref=PMID:10361305
P0A8P8	UniProtKB	Mutagenesis	295	295	.	.	.	Note=Abolishes	DNA	recombination	(in	vitro).	H->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10361305;Dbxref=PMID:10361305
P0A8P8	UniProtKB	Mutagenesis	297	297	.	.	.	Note=Abolishes	DNA	recombination	(in	vitro).	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10361305;Dbxref=PMID:10361305
P0A8P8	UniProtKB	Mutagenesis	298	298	.	.	.	Note=Reduces	chromosomal	recombination	but	not	plasmid	resolution.	A->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10361305;Dbxref=PMID:10361305
P27828	UniProtKB	Mutagenesis	15	15	.	.	.	Note=More	than	100-fold	increasin	KM	for	UDP-GlcNAc.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15210128;Dbxref=PMID:15210128
P27828	UniProtKB	Mutagenesis	95	95	.	.	.	Note=Strong	decrease	in	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15210128;Dbxref=PMID:15210128
P27828	UniProtKB	Mutagenesis	117	117	.	.	.	Note=Strong	decrease	in	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15210128;Dbxref=PMID:15210128
P27828	UniProtKB	Mutagenesis	131	131	.	.	.	Note=Strong	decrease	in	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15210128;Dbxref=PMID:15210128
P27828	UniProtKB	Mutagenesis	213	213	.	.	.	Note=30-fold	increase	in	KM	for	UDP-GlcNAc	and	50-fold	decrease	in	kcat.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15210128;Dbxref=PMID:15210128
P67444	UniProtKB	Mutagenesis	31	31	.	.	.	Note=Decrease	in	activity.	H->C%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	31	31	.	.	.	Note=Strong	decrease	in	activity.	H->K%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	31	31	.	.	.	Note=No	change	in	activity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	31	31	.	.	.	Note=Increase	of	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Highly	active.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Strong	decrease	in	activity.	N->C%2CD%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Loss	of	activity.	N->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Increase	of	activity.	N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Highly	active.	K->C%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	232	232	.	.	.	Note=Decrease	in	activity.	D->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	232	232	.	.	.	Note=Highly	active.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	258	258	.	.	.	Note=Decrease	in	activity.	Q->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	258	258	.	.	.	Note=Highly	active.	Q->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	272	272	.	.	.	Note=Loss	of	activity.	E->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	272	272	.	.	.	Note=Strong	decrease	in	activity.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	304	304	.	.	.	Note=Loss	of	activity.	D->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	304	304	.	.	.	Note=Strong	decrease	in	activity.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	385	385	.	.	.	Note=Decrease	in	activity.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	385	385	.	.	.	Note=Highly	active.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19581302;Dbxref=PMID:19581302
P67444	UniProtKB	Mutagenesis	421	421	.	.	.	Note=Strong	decrease	in	activity.	P->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18359771;Dbxref=PMID:18359771
P67444	UniProtKB	Mutagenesis	421	421	.	.	.	Note=Highly	active.	P->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18359771;Dbxref=PMID:18359771
P67444	UniProtKB	Mutagenesis	423	423	.	.	.	Note=Highly	active.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18359771;Dbxref=PMID:18359771
P67444	UniProtKB	Mutagenesis	424	424	.	.	.	Note=Highly	active.	I->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18359771;Dbxref=PMID:18359771
P67444	UniProtKB	Mutagenesis	425	425	.	.	.	Note=Strong	decrease	in	activity.	Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18359771;Dbxref=PMID:18359771
P67444	UniProtKB	Mutagenesis	427	427	.	.	.	Note=Decrease	in	activity.	L->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18359771;Dbxref=PMID:18359771
P67444	UniProtKB	Mutagenesis	430	430	.	.	.	Note=Loss	of	activity.	N->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18359771;Dbxref=PMID:18359771
P67444	UniProtKB	Mutagenesis	432	432	.	.	.	Note=Strong	decrease	in	activity.	I->A%2CS%2CT%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18359771;Dbxref=PMID:18359771
P67444	UniProtKB	Mutagenesis	432	432	.	.	.	Note=Loss	of	activity.	I->L%2CM%2CE%2CF;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18359771;Dbxref=PMID:18359771
P67444	UniProtKB	Mutagenesis	432	432	.	.	.	Note=Highly	active.	I->N%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18359771;Dbxref=PMID:18359771
P67444	UniProtKB	Mutagenesis	436	436	.	.	.	Note=Highly	active.	G->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18359771;Dbxref=PMID:18359771
P0A8P6	UniProtKB	Mutagenesis	243	243	.	.	.	Note=Abolishes	DNA	cleavage	activity.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7744017;Dbxref=PMID:7744017
P0A8P6	UniProtKB	Mutagenesis	252	254	.	.	.	Note=Abolishes	chromosomal	recombination	but	not	plasmid	resolution.	ESS->NHG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10635320;Dbxref=PMID:10635320
P0A8P6	UniProtKB	Mutagenesis	275	275	.	.	.	Note=Abolishes	DNA	cleavage	activity.	Y->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7744017,ECO:0000269|PubMed:8402918,ECO:0000269|PubMed:9268326;Dbxref=PMID:7744017,PMID:8402918,PMID:9268326
P76387	UniProtKB	Mutagenesis	467	467	.	.	.	Note=No	loss	of	autophosphorylation.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11751920;Dbxref=PMID:11751920
P76387	UniProtKB	Mutagenesis	491	491	.	.	.	Note=No	loss	of	autophosphorylation.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11751920;Dbxref=PMID:11751920
P76387	UniProtKB	Mutagenesis	540	540	.	.	.	Note=Loss	of	autophosphorylation.	K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11751920;Dbxref=PMID:11751920
P76387	UniProtKB	Mutagenesis	569	569	.	.	.	Note=Loss	of	autophosphorylation.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11751920;Dbxref=PMID:11751920
P76387	UniProtKB	Mutagenesis	636	636	.	.	.	Note=No	loss	of	autophosphorylation.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11751920;Dbxref=PMID:11751920
P76387	UniProtKB	Mutagenesis	668	668	.	.	.	Note=No	loss	of	autophosphorylation.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11751920;Dbxref=PMID:11751920
P0AGF4	UniProtKB	Mutagenesis	24	24	.	.	.	Note=Decreases	xylose	transport.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Abolishes	xylose	transport.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	133	133	.	.	.	Note=Abolishes	xylose	transport.	R->C%2CH%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Abolishes	xylose	transport.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	160	160	.	.	.	Note=Abolishes	xylose	transport.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	168	168	.	.	.	Note=Abolishes	xylose	transport.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	288	288	.	.	.	Note=Abolishes	xylose	transport.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	289	289	.	.	.	Note=Strongly	decreases	xylose	transport.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	294	294	.	.	.	Note=Abolishes	xylose	transport.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	298	298	.	.	.	Note=Abolishes	xylose	transport.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	325	325	.	.	.	Note=No	effect	on	xylose	transport.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	340	340	.	.	.	Note=Abolishes	xylose	transport.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	341	341	.	.	.	Note=Abolishes	xylose	transport.	R->A%2CW;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	392	392	.	.	.	Note=Abolishes	xylose	transport.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	397	397	.	.	.	Note=Abolishes	xylose	transport.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	404	404	.	.	.	Note=Strongly	decreases	xylose	transport.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0AGF4	UniProtKB	Mutagenesis	415	415	.	.	.	Note=Strongly	decreases	xylose	transport.	Q->A
P0AGF4	UniProtKB	Mutagenesis	416	416	.	.	.	Note=Strongly	decreases	xylose	transport.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23075985;Dbxref=PMID:23075985
P0A9M5	UniProtKB	Mutagenesis	59	59	.	.	.	Note=No	effect	on	catalytic	activity%3B	increased	stability.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8812991;Dbxref=PMID:8812991
P38506	UniProtKB	Mutagenesis	67	67	.	.	.	Note=Strongly	reduces	flap	endonuclease	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23821668;Dbxref=PMID:23821668
P64612	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Abolishes	ATPase	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24595368;Dbxref=PMID:24595368
P0A8D6	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Abolishes	enzyme	activity.	G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21257746;Dbxref=PMID:21257746
P0AE39	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Strong	induction	of	yhjX.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23222720;Dbxref=PMID:23222720
P0AE39	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Prevents	yhjX	induction.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23222720;Dbxref=PMID:23222720
P75862	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Does	not	interact	with	FtsZ%2C	but	shows	affinity	for	itself.	Reduces	GTPase	activity	by	less	than	10%25.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21216997;Dbxref=PMID:21216997
P0AA63	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Abolishes	the	ability	to	restoregrowth%2C	cell	division	or	drug	resistance	in	double	mutant.	E->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24277026;Dbxref=PMID:24277026
P0AA63	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Abolishes	the	ability	to	restoregrowth%2C	cell	division	or	drug	resistance	in	double	mutant.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24277026;Dbxref=PMID:24277026
P69348	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Loss	of	RNase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16109374;Dbxref=PMID:16109374
P69348	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Loss	of	RNase	activity%3B	still	see	mRNA	cleavage	in	association	with	70S	ribosomes.	H->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16109374,ECO:0000269|PubMed:19124462;Dbxref=PMID:16109374,PMID:19124462
P69348	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Loss	of	RNase	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16109374;Dbxref=PMID:16109374
P77247	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Loss	of	the	phosphatase	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16990279;Dbxref=PMID:16990279
P42620	UniProtKB	Mutagenesis	63	63	.	.	.	Note=Loss	of	GS-hydroquinone	reductase	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22955277;Dbxref=PMID:22955277
P42620	UniProtKB	Mutagenesis	195	195	.	.	.	Note=46-fold	reduction	in	GS-hydroquinone	reductase	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22955277;Dbxref=PMID:22955277
P42620	UniProtKB	Mutagenesis	253	253	.	.	.	Note=55-fold	reduction	in	GS-hydroquinone	reductase	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22955277;Dbxref=PMID:22955277
P42620	UniProtKB	Mutagenesis	296	296	.	.	.	Note=22-fold	reduction	in	GS-hydroquinone	reductase	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22955277;Dbxref=PMID:22955277
P0A8I1	UniProtKB	Mutagenesis	9	9	.	.	.	Note=Does	not	process	pre-16S	rRNA	in	70S	ribosomes%2C	binds	to	pre-16S	rRNA-containing	ribosomes.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25545592;Dbxref=PMID:25545592
P0A8I1	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Does	not	process	pre-16S	rRNA	in	70S	ribosomes.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25545592;Dbxref=PMID:25545592
P0A8I1	UniProtKB	Mutagenesis	100	100	.	.	.	Note=Does	not	process	pre-16S	rRNA	in	70S	ribosomes.	T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25545592;Dbxref=PMID:25545592
P0A8I1	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Allows	cell	growth%2C	i.e.	not	toxic.	A->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22353788;Dbxref=PMID:22353788
P0A8I1	UniProtKB	Mutagenesis	105	105	.	.	.	Note=Allows	cell	growth%2C	i.e.	not	toxic.	S->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22353788;Dbxref=PMID:22353788
P0A8I1	UniProtKB	Mutagenesis	108	115	.	.	.	Note=Does	not	process	pre-16S	rRNA	in	70S	ribosomes.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25545592;Dbxref=PMID:25545592
P0A8I1	UniProtKB	Mutagenesis	122	122	.	.	.	Note=Does	not	process	pre-16S	rRNA	in	70S	ribosomes%2C	binds	quite	strongly	to	pre-16S	rRNA-containing	ribosomes.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25545592;Dbxref=PMID:25545592
P0A8I1	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Allows	cell	growth%2C	i.e.	not	toxic.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22353788;Dbxref=PMID:22353788
P78067	UniProtKB	Mutagenesis	385	385	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19798741;Dbxref=PMID:19798741
P0A8Y8	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Loss	of	activity.	Q->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19193103,ECO:0000269|PubMed:25010423;Dbxref=PMID:19193103,PMID:25010423
P0A8Y8	UniProtKB	Mutagenesis	48	48	.	.	.	Note=290-fold	decrease	in	activittoward	salicylyl-CoA.	Q->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19193103;Dbxref=PMID:19193103
P0A8Y8	UniProtKB	Mutagenesis	54	54	.	.	.	Note=229-fold	decrease	in	activittoward	salicylyl-CoA.	Loss	of	activity	toward	benzoyl-CoA.	H->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19193103,ECO:0000269|PubMed:25010423;Dbxref=PMID:19193103,PMID:25010423
P0A8Y8	UniProtKB	Mutagenesis	63	63	.	.	.	Note=Loss	of	activity.	E->A%2CD%2CQ;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19193103,ECO:0000269|PubMed:25010423;Dbxref=PMID:19193103,PMID:25010423
P0A8Y8	UniProtKB	Mutagenesis	64	64	.	.	.	Note=13-fold	decrease	in	activittoward	salicylyl-CoA.	T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19193103;Dbxref=PMID:19193103
P0A8Y8	UniProtKB	Mutagenesis	67	67	.	.	.	Note=140-fold	decrease	in	activittoward	salicylyl-CoA.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19193103;Dbxref=PMID:19193103
P0A8Y8	UniProtKB	Mutagenesis	67	67	.	.	.	Note=104-fold	decrease	in	activittoward	salicylyl-CoA.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19193103;Dbxref=PMID:19193103
P0A8Y8	UniProtKB	Mutagenesis	68	68	.	.	.	Note=130-fold	decrease	in	activittoward	salicylyl-CoA.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19193103;Dbxref=PMID:19193103
P0A8Y8	UniProtKB	Mutagenesis	68	68	.	.	.	Note=47-fold	increase	in	catalytic	efficiency	toward	1%2C4-dihydroxy-2-naphthoyl-CoA	and	10-fold	increase	in	catalytic	efficiency	toward	lauroyl-CoA.	Does	not	affect	catalytic	efficiency	toward	benzoyl-CoA.	M->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24992697,ECO:0000269|PubMed:25010423;Dbxref=PMID:24992697,PMID:25010423
P0AEJ2	UniProtKB	Mutagenesis	303	303	.	.	.	Note=Loss	of	mutase	activity.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20079748;Dbxref=PMID:20079748
P0AEJ2	UniProtKB	Mutagenesis	304	304	.	.	.	Note=Loss	of	mutase	activity.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20079748;Dbxref=PMID:20079748
P0AEJ2	UniProtKB	Mutagenesis	327	327	.	.	.	Note=Loss	of	mutase	activity.	F->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20079748;Dbxref=PMID:20079748
P0AEJ2	UniProtKB	Mutagenesis	346	346	.	.	.	Note=Loss	of	mutase	activity.	I->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20079748;Dbxref=PMID:20079748
P0AEJ2	UniProtKB	Mutagenesis	359	359	.	.	.	Note=Loss	of	mutase	activity.	F->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20079748;Dbxref=PMID:20079748
P77488	UniProtKB	Mutagenesis	370	370	.	.	.	Note=Loss	of	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17135236;Dbxref=PMID:17135236
P77488	UniProtKB	Mutagenesis	392	392	.	.	.	Note=Slightly	increases	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17135236;Dbxref=PMID:17135236
P77488	UniProtKB	Mutagenesis	392	392	.	.	.	Note=Increases	activity	3-fold.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17135236;Dbxref=PMID:17135236
P77488	UniProtKB	Mutagenesis	398	398	.	.	.	Note=Loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17135236;Dbxref=PMID:17135236
P77488	UniProtKB	Mutagenesis	431	431	.	.	.	Note=No	effect	on	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17135236;Dbxref=PMID:17135236
P77488	UniProtKB	Mutagenesis	478	478	.	.	.	Note=Loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17135236;Dbxref=PMID:17135236
P0A9B6	UniProtKB	Mutagenesis	155	155	.	.	.	Note=No	significant	activity.	C->A%2CG%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9182530;Dbxref=PMID:9182530
P0A9B6	UniProtKB	Mutagenesis	182	182	.	.	.	Note=10-fold	reduction	in	activity.	Increases	affinity	for	D-erythrose-4-phosphate	and	reduces	affinity	for	glyceraldehyde	3-phosphate.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9182530;Dbxref=PMID:9182530
P0A9B6	UniProtKB	Mutagenesis	316	316	.	.	.	Note=Reduces	activity	and	affinitfor	D-erythrose-4-phosphate	and	increases	affinity	for	glyceraldehyde	3-phosphate.	C->A%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9182530;Dbxref=PMID:9182530
P71301	UniProtKB	Mutagenesis	179	179	.	.	.	Note=Slightly	increases	motility.	H->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22422754;Dbxref=PMID:22422754
P0CE48	UniProtKB	Mutagenesis	20	20	.	.	.	Note=No	change	in	binding	GDP	and	3-fold	reduction	in	binding	EF-Ts.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9468511;Dbxref=PMID:9468511
P0CE48	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Weaker	binding	for	GDP	and	for	EF-Ts.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9468511;Dbxref=PMID:9468511
P0CE48	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Reduces	affinity	for	GDP.	K->R%2CQ%2CE%2CI;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2498311;Dbxref=PMID:2498311
P0CE48	UniProtKB	Mutagenesis	139	139	.	.	.	Note=Reduces	affinity	for	GDP%3B	increases	affinity	for	XDP.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3308869;Dbxref=PMID:3308869
P0CE48	UniProtKB	Mutagenesis	223	223	.	.	.	Note=Inhibits	codon-induced	conformational	changes	leading	to	GTPase	activation	on	the	ribosome.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2508560;Dbxref=PMID:2508560
P0CE48	UniProtKB	Mutagenesis	262	263	.	.	.	Note=Still	associates	with	EF-Ts%2no	longer	forms	the	Qbeta	viral	RNA	polymerase	complex.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20798060;Dbxref=PMID:20798060
P0CE48	UniProtKB	Mutagenesis	262	262	.	.	.	Note=Still	associates	with	EF-Ts%2very	little	Qbeta	viral	RNA	polymerase	complex	forms.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20798060;Dbxref=PMID:20798060
P0CE48	UniProtKB	Mutagenesis	289	289	.	.	.	Note=50%25	loss	of	Qbeta	viral	RNA	polymerase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22245970;Dbxref=PMID:22245970
P0CE48	UniProtKB	Mutagenesis	349	349	.	.	.	Note=No	change	in	binding	GDP	but	higher	binding	constant	for	EF-Ts.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9468511;Dbxref=PMID:9468511
P0CE48	UniProtKB	Mutagenesis	378	378	.	.	.	Note=60%25	loss	of	Qbeta	viral	RNA	polymerase	elongation	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22245970;Dbxref=PMID:22245970
P0CE48	UniProtKB	Mutagenesis	382	382	.	.	.	Note=25%25	loss	of	Qbeta	viral	RNA	polymerase	elongation	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22245970;Dbxref=PMID:22245970
P0CE48	UniProtKB	Mutagenesis	383	383	.	.	.	Note=No	longer	phosphorylated	by	phage	protein	doc.	T->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24141193;Dbxref=PMID:24141193
P39276	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Lack	of	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21933132;Dbxref=PMID:21933132
P39276	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Decrease	in	activity.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21933132;Dbxref=PMID:21933132
P39276	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Decrease	in	activity.	Abolishes	the	pH	dependency.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21933132;Dbxref=PMID:21933132
P39276	UniProtKB	Mutagenesis	388	388	.	.	.	Note=Lack	of	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21933132;Dbxref=PMID:21933132
P39276	UniProtKB	Mutagenesis	388	388	.	.	.	Note=Decrease	in	activity.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21933132;Dbxref=PMID:21933132
P39276	UniProtKB	Mutagenesis	388	388	.	.	.	Note=Decrease	in	activity.	Does	not	bind	Ala-Lys	dipeptide.	E->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21933132,ECO:0000269|PubMed:22940668;Dbxref=PMID:21933132,PMID:22940668
Q47013	UniProtKB	Mutagenesis	313	313	.	.	.	Note=Abolishes	deubiquitinating	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17440617;Dbxref=PMID:17440617
P0AB83	UniProtKB	Mutagenesis	120	120	.	.	.	Note=100000-fold	decrease	in	activity	and	slight	decrease	in	substrate	affinity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7664751;Dbxref=PMID:7664751
P0AB83	UniProtKB	Mutagenesis	138	138	.	.	.	Note=100-fold	decrease	in	activitand	4-fold	increase	in	substrate	affinity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7664751;Dbxref=PMID:7664751
P0AB83	UniProtKB	Mutagenesis	191	191	.	.	.	Note=Slight	decrease	in	activitand	130-fold	increase	in	substrate	affinity.	K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7664751;Dbxref=PMID:7664751
P0A6N4	UniProtKB	Mutagenesis	31	31	.	.	.	Note=No	lysylation.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20729861;Dbxref=PMID:20729861
P0A6N4	UniProtKB	Mutagenesis	33	33	.	.	.	Note=No	lysylation.	Loss	of	in	vivo	EF-P	function	for	cell	growth.	G->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20729861;Dbxref=PMID:20729861
P0A6N4	UniProtKB	Mutagenesis	34	34	.	.	.	Note=No	lysylation	and	loss	of	EF-P	activity.	No	facilitation	of	translation	of	poly-Pro	stretches.	K->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20729861,ECO:0000269|PubMed:22128152,ECO:0000269|PubMed:23239623;Dbxref=PMID:20729861,PMID:22128152,PMID:23239623
P06968	UniProtKB	Mutagenesis	89	89	.	.	.	Note=Reduces	catalytic	activity	40000-fold.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15208312;Dbxref=PMID:15208312
P0A6P1	UniProtKB	Mutagenesis	24	24	.	.	.	Note=No	change	in	binding	to	EF-Tu	and	in	promoting	GDP	exchange.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9468511;Dbxref=PMID:9468511
P0A6P1	UniProtKB	Mutagenesis	81	81	.	.	.	Note=2	to	3-fold	less	active	in	promoting	GDP	exchange	and	slightly	lower	binding	constant	for	interaction	with	EF-Tu.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9468511;Dbxref=PMID:9468511
P0A6P1	UniProtKB	Mutagenesis	82	82	.	.	.	Note=2	to	3-fold	less	active	in	promoting	GDP	exchange	and	6-fold	less	active	in	binding	to	EF-Tu.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9468511;Dbxref=PMID:9468511
P0A6P1	UniProtKB	Mutagenesis	148	148	.	.	.	Note=At	least	100-fold	decrease	in	affinity	between	EF-Ts	and	EF-Tu	and	only	small	amount	of	GDP	exchange	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9468511;Dbxref=PMID:9468511
P0A6P1	UniProtKB	Mutagenesis	188	227	.	.	.	Note=Still	associates	with	EF-Tu%2no	longer	forms	the	Qbeta	viral	RNA	polymerase	complex.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20798060;Dbxref=PMID:20798060
P37690	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Retains	AmiA	and	AmiB	activation.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23796240;Dbxref=PMID:23796240
P37690	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Loss	of	AmiA	and	AmiB	activation%3B	does	not	complement	double	envC-nlpD	disruption%2C	protein	localizes	normally.	K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23796240;Dbxref=PMID:23796240
P37690	UniProtKB	Mutagenesis	324	324	.	.	.	Note=Retains	AmiA	and	AmiB	activation.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23796240;Dbxref=PMID:23796240
P37690	UniProtKB	Mutagenesis	324	324	.	.	.	Note=Loss	of	AmiA	and	AmiB	activation%3B	does	not	complement	double	envC-nlpD	disruption%2C	protein	localizes	normally.	V->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23796240;Dbxref=PMID:23796240
P37690	UniProtKB	Mutagenesis	350	350	.	.	.	Note=Loss	of	AmiA	and	AmiB	activation%3B	does	not	complement	double	envC-nlpD	disruption%2C	protein	localizes	normally.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23796240;Dbxref=PMID:23796240
P37690	UniProtKB	Mutagenesis	353	353	.	.	.	Note=Loss	of	AmiA	and	AmiB	activation%3B	does	not	complement	double	envC-nlpD	disruption%2C	protein	localizes	normally.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23796240;Dbxref=PMID:23796240
P37690	UniProtKB	Mutagenesis	366	366	.	.	.	Note=Partially	unstable%2C	loss	of	AmiA	and	AmiB	activation.	Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23796240;Dbxref=PMID:23796240
P37690	UniProtKB	Mutagenesis	401	401	.	.	.	Note=Partially	unstable%2C	loss	of	AmiA	and	AmiB	activation%3B	does	not	complement	double	envC-nlpD	disruption%2C	protein	localizes	normally.	Y->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23796240;Dbxref=PMID:23796240
P37690	UniProtKB	Mutagenesis	405	405	.	.	.	Note=Loss	of	activation	of	amidases%3B	does	not	complement	double	envC-nlpD	disruption%2C	protein	localizes	normally.	R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23796240;Dbxref=PMID:23796240
P10378	UniProtKB	Mutagenesis	437	437	.	.	.	Note=Catalyzes	the	adenylation	reactiowith	10%25	reduction	of	activity	compared	to	the	wild-type.	3%25	reduction	of	activity	compared	to	the	wild-type%3B	when	associated	with	D-473.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16632253;Dbxref=PMID:16632253
P10378	UniProtKB	Mutagenesis	473	473	.	.	.	Note=Catalyzes	the	adenylation	reactiowith	same	activity	as	the	wild-type.	3%25	reduction	of	activity	compared	to	the	wild-type%3B	when	associated	with	D-437.	K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16632253;Dbxref=PMID:16632253
P10378	UniProtKB	Mutagenesis	494	494	.	.	.	Note=Catalyzes	the	adenylation	reactiowith	same	activity	as	the	wild-type.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16632253;Dbxref=PMID:16632253
P23895	UniProtKB	Mutagenesis	4	4	.	.	.	Note=Still	binds	substrate.	No	transport	activity	in	the	presence	of	a	proton	gradient%2C	but	still	transports	substrate	in	the	absence	of	a	proton	gradient.	Resistance	to	toxicants	is	abolished.	Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16672221;Dbxref=PMID:16672221
P23895	UniProtKB	Mutagenesis	4	4	.	.	.	Note=No	effect	on	resistance	to	toxicants.	Y->F%2CW;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16672221;Dbxref=PMID:16672221
P23895	UniProtKB	Mutagenesis	6	6	.	.	.	Note=No	effect	on	resistance	to	toxicants.	Y->C%2CF%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16672221;Dbxref=PMID:16672221
P23895	UniProtKB	Mutagenesis	7	7	.	.	.	Note=No	substrate	binding.	Resistance	to	toxicants	is	abolished.	L->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12590142;Dbxref=PMID:12590142
P23895	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Still	binds	substrate%2C	with	lower	affinity.	Resistance	to	toxicants	is	abolished.	A->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12590142;Dbxref=PMID:12590142
P23895	UniProtKB	Mutagenesis	11	11	.	.	.	Note=Still	binds	substrate%2C	with	lower	affinity.	Resistance	to	toxicants	is	abolished.	I->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12590142;Dbxref=PMID:12590142
P23895	UniProtKB	Mutagenesis	14	14	.	.	.	Note=No	substrate	binding.	No	transport	activity.	Resistance	to	toxicants	is	abolished.	E->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10681497,ECO:0000269|PubMed:12590142;Dbxref=PMID:10681497,PMID:12590142
P23895	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Still	binds	substrate.	No	transport	activity	in	the	presence	of	a	proton	gradient%2C	but	still	transports	substrate	in	the	absence	of	a	proton	gradient.	Resistance	to	toxicants	is	abolished.	E->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10681497,ECO:0000269|PubMed:12590142;Dbxref=PMID:10681497,PMID:12590142
P23895	UniProtKB	Mutagenesis	17	17	.	.	.	Note=No	substrate	binding.	Resistance	to	toxicants	is	abolished.	G->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12590142;Dbxref=PMID:12590142
P23895	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Still	binds	substrate%2C	with	lower	affinity.	Resistance	to	toxicants	is	abolished.	T->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12590142;Dbxref=PMID:12590142
P23895	UniProtKB	Mutagenesis	40	40	.	.	.	Note=Modifies	substrate	specificity.	Y->C%2CF%2CL%2CM%2CS%2CT%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16672221;Dbxref=PMID:16672221
P23895	UniProtKB	Mutagenesis	53	53	.	.	.	Note=No	effect	on	resistance	to	toxicants.	Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16672221;Dbxref=PMID:16672221
P23895	UniProtKB	Mutagenesis	60	60	.	.	.	Note=Still	binds	substrate%2C	with	lower	affinity.	Resistance	to	toxicants	is	abolished.	Y->C%2CF;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16672221;Dbxref=PMID:16672221
P23895	UniProtKB	Mutagenesis	63	63	.	.	.	Note=No	transport	activity.	Resistance	to	toxicants	is	abolished.	W->C%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15882076;Dbxref=PMID:15882076
P23895	UniProtKB	Mutagenesis	63	63	.	.	.	Note=Still	binds	substrate%2C	with	two-fold	reduction	in	substrate	affinity.	Resistance	to	toxicants	is	abolished.	W->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15882076;Dbxref=PMID:15882076
P06616	UniProtKB	Mutagenesis	8	8	.	.	.	Note=In	era770%3B	20-fold	reduction	in	GTP-binding.	Confers	growth	sensitivity	at	42	degrees	Celsius%3B	when	associated	with	an	unpublished	22	residue	replacement	in	the	C-terminus.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2527846;Dbxref=PMID:2527846
P06616	UniProtKB	Mutagenesis	17	17	.	.	.	Note=In	era1%3B	suppresses	a	number	of	temperature-sensitive	mutations	affecting	cell	cycle.	P->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1526446,ECO:0000269|PubMed:9515700;Dbxref=PMID:1526446,PMID:9515700
P06616	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Confers	sensitivity	to	cold.	P->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1526446,ECO:0000269|PubMed:9515700;Dbxref=PMID:1526446,PMID:9515700
P06616	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Confers	sensitivity	to	cold%3Boverexpression	does	not	suppress	an	rbfA	disruption.	N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7729673;Dbxref=PMID:7729673
P06616	UniProtKB	Mutagenesis	39	49	.	.	.	Note=In	Era-de%3B	does	not	complement	a	disruption	mutant%2C	overexpression	in	a	wt	cells	inhibits	growth.	Binds	GTP	poorly%2C	Km	for	GTP	increases	5-fold%2C	Vmax	for	GTPase	is	55%25	that	of	wt.	Does	not	autophosphorylate.	Complements	cold-sensitivity	and	16S	rRNA	processing	in	an	rbfA	disruption	mutant.	KAQTTRHRIVG->R
P06616	UniProtKB	Mutagenesis	42	43	.	.	.	Note=Does	not	complement	a	disruption	mutant%2C	Km	for	GTP	increases	12-fold%2C	Vmax	for	GTPase	is	49%25	that	of	wt.	Overexpression	partially	suppresses	an	rbfA	disruption.	TT->AA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12753192,ECO:0000269|PubMed:8919456;Dbxref=PMID:12753192,PMID:8919456
P06616	UniProtKB	Mutagenesis	156	156	.	.	.	Note=Confers	sensitivity	to	cold%3Boverexpression	partially	suppresses	an	rbfA	disruption.	A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7729673;Dbxref=PMID:7729673
P06616	UniProtKB	Mutagenesis	200	200	.	.	.	Note=Confers	sensitivity	to	cold%2Ccells	do	not	divide	properly	but	do	replicate	DNA	and	segregate	nucleoids	normally.	16S	rRNA	processing	is	decreased%2C	ribosome	assembly	is	defective.	Suppressed	by	overexpression	of	RsmA.	Overexpression	does	not	suppress	an	rbfA	disruption%2C	while	at	37	degrees	Celsius	the	rbfA/era	E220K	mutant	grows	very	poorly%2C	a	dominant-negative	effect.	This	mutant	still	binds	30S	ribosomes.	E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12753192,ECO:0000269|PubMed:7729673;Dbxref=PMID:12753192,PMID:7729673
P0A9W3	UniProtKB	Mutagenesis	188	188	.	.	.	Note=Arrests	growth%2C	inhibits	tripeptide	but	not	dipeptide	formation%2C	stably	binds	70S	ribosomes%2C	probably	locked	in	an	ATP-bound	form	as	it	should	not	have	ATPase	activity%3B	when	associated	with	Q-470.	E->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24389465,ECO:0000269|PubMed:24389466;Dbxref=PMID:24389465,PMID:24389466
P0A9W3	UniProtKB	Mutagenesis	470	470	.	.	.	Note=Arrests	growth%2C	inhibits	tripeptide	but	not	dipeptide	formation%2C	stably	binds	70S	ribosomes%2C	probably	locked	in	an	ATP-bound	form	as	it	should	not	have	ATPase	activity%3B	when	associated	with	Q-188.	E->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24389465,ECO:0000269|PubMed:24389466;Dbxref=PMID:24389465,PMID:24389466
P0AEJ4	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Promotes	the	formation	of	alpha-helical	secondary	structure	of	the	HAMP	domain.	A->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17635923;Dbxref=PMID:17635923
P0AEJ4	UniProtKB	Mutagenesis	193	193	.	.	.	Note=No	effect.	A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17635923;Dbxref=PMID:17635923
P0AEJ4	UniProtKB	Mutagenesis	347	347	.	.	.	Note=Loss	of	ATP	binding%3B	loss	of	autophosphorylation.	N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9817206;Dbxref=PMID:9817206
P50465	UniProtKB	Mutagenesis	2	2	.	.	.	Note=Loss	of	glycosylase	and	AP	lyase	activity.	P->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11711552;Dbxref=PMID:11711552
P50465	UniProtKB	Mutagenesis	3	3	.	.	.	Note=Loss	of	glycosylase	activity.	No	effect	on	AP	lyase	activity.	E->A%2CQ;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11711552,ECO:0000269|PubMed:11847126;Dbxref=PMID:11711552,PMID:11847126
P50465	UniProtKB	Mutagenesis	3	3	.	.	.	Note=Much	reduced	glycosylase	activity.	No	effect	on	AP	lyase	activity.	E->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11711552,ECO:0000269|PubMed:11847126;Dbxref=PMID:11711552,PMID:11847126
P50465	UniProtKB	Mutagenesis	6	6	.	.	.	Note=Reduced	glycosylase	activity.	No	effect	on	AP	lyase	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11711552;Dbxref=PMID:11711552
P50465	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Loss	of	DNA	cleavage	at	sites	containing	oxidized	pyrimidine.	No	effect	on	AP	lyase	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11847126;Dbxref=PMID:11847126
P50465	UniProtKB	Mutagenesis	129	129	.	.	.	Note=Reduced	glycosylase	activity.	No	effect	on	AP	lyase	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11711552;Dbxref=PMID:11711552
P50465	UniProtKB	Mutagenesis	160	160	.	.	.	Note=No	effect	on	glycosylase	and	AP	lyase	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11711552;Dbxref=PMID:11711552
P50465	UniProtKB	Mutagenesis	174	174	.	.	.	Note=Loss	of	glycosylase	activity.	No	effect	on	AP	lyase	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11711552;Dbxref=PMID:11711552
P50465	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Slightly	reduced	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11847126;Dbxref=PMID:11847126
P50465	UniProtKB	Mutagenesis	253	253	.	.	.	Note=Reduced	DNA	cleavage	at	sites	containing	oxidized	pyrimidine.	No	effect	on	AP	lyase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11847126;Dbxref=PMID:11847126
P0A6P9	UniProtKB	Mutagenesis	168	168	.	.	.	Note=5%25	activity%3B	not	secreted.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15003462;Dbxref=PMID:15003462
P0A6P9	UniProtKB	Mutagenesis	209	209	.	.	.	Note=1%25	activity%3B	not	secreted.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15003462;Dbxref=PMID:15003462
P0A6P9	UniProtKB	Mutagenesis	342	342	.	.	.	Note=1%25	activity%3B	not	secreted.	K->A%2CQ%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15003462;Dbxref=PMID:15003462
P0A6P9	UniProtKB	Mutagenesis	342	342	.	.	.	Note=94%25	activity%3B	not	secreted.	K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15003462;Dbxref=PMID:15003462
P04995	UniProtKB	Mutagenesis	148	148	.	.	.	Note=Strongly	reduced	ssb-binding.	Reducedssb-dependent	nuclease	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P04995	UniProtKB	Mutagenesis	150	150	.	.	.	Note=About	2-fold	increased	ssb-binding.	Weakly	increased	ssb-independent	and	ssb-dependent	nuclease	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P04995	UniProtKB	Mutagenesis	181	181	.	.	.	Note=Residual	nuclease	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23609540;Dbxref=PMID:23609540
P04995	UniProtKB	Mutagenesis	207	207	.	.	.	Note=Strongly	reduced	ssb-binding.	Reducedssb-dependent	nuclease	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P04995	UniProtKB	Mutagenesis	227	227	.	.	.	Note=7-fold	reduced	ssb-binding.	Reducedssb-dependent	nuclease	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P04995	UniProtKB	Mutagenesis	311	311	.	.	.	Note=2-fold	reduced	ssb-binding.	Weakly	reduced	ssb-dependent	nuclease	activity.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P04995	UniProtKB	Mutagenesis	316	316	.	.	.	Note=Strongly	reduced	ssb-binding.	Stronglreduced	ssb-dependent	nuclease	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P04995	UniProtKB	Mutagenesis	318	318	.	.	.	Note=About	2-fold	increased	ssb-binding.	No	effect	on	ssb-dependent	nuclease	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P04995	UniProtKB	Mutagenesis	319	319	.	.	.	Note=2-fold	reduced	ssb-binding.	No	effect	on	ssb-dependent	nuclease	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P04995	UniProtKB	Mutagenesis	327	327	.	.	.	Note=No	effect	on	ssb-binding	and	on	ssb-dependent	nuclease	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P04995	UniProtKB	Mutagenesis	331	331	.	.	.	Note=No	effect	on	ssb-binding	and	on	ssb-dependent	nuclease	activity.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P04995	UniProtKB	Mutagenesis	338	338	.	.	.	Note=3-fold	reduced	ssb-binding.	Reducedssb-dependent	nuclease	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P04995	UniProtKB	Mutagenesis	448	448	.	.	.	Note=No	effect	on	ssb-binding	and	on	ssb-dependent	nuclease	activity.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P04995	UniProtKB	Mutagenesis	452	452	.	.	.	Note=No	effect	on	ssb-binding	and	on	ssb-dependent	nuclease	activity.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P11454	UniProtKB	Mutagenesis	1138	1138	.	.	.	Note=No	enterobactin	synthase	activity.	This	mutant	holo-EntF	is	still	able	to	adenylate	serine	and	to	autoacylate	itself	with	serine.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9485415;Dbxref=PMID:9485415
P0A8N7	UniProtKB	Mutagenesis	50	50	.	.	.	Note=No	effect	on	lysylation	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20729861;Dbxref=PMID:20729861
P0A8N7	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Loss	of	catalytic	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21841797;Dbxref=PMID:21841797
P0A8N7	UniProtKB	Mutagenesis	100	100	.	.	.	Note=Loss	of	lysylation	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20729861;Dbxref=PMID:20729861
P0A8N7	UniProtKB	Mutagenesis	102	102	.	.	.	Note=No	effect	on	lysylation	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20729861;Dbxref=PMID:20729861
P0A8N7	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Loss	of	lysylation	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20729861;Dbxref=PMID:20729861
P0A8N7	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Severe	reduction	in	lysylation	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20729861;Dbxref=PMID:20729861
P0A8N7	UniProtKB	Mutagenesis	185	185	.	.	.	Note=Slight	reduction	in	lysylation	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20729861;Dbxref=PMID:20729861
P0A8N7	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Slight	reduction	in	lysylation	activity.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20729861;Dbxref=PMID:20729861
P0A8N7	UniProtKB	Mutagenesis	244	244	.	.	.	Note=Loss	of	lysylation	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20729861;Dbxref=PMID:20729861
P0A8N7	UniProtKB	Mutagenesis	247	247	.	.	.	Note=Loss	of	lysylation	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20729861;Dbxref=PMID:20729861
P0A8N7	UniProtKB	Mutagenesis	298	298	.	.	.	Note=96%25	increase	in	the	affinity	for	L-alpha-lysine.	4-fold	decrease	in	the	catalytic	efficiency	of	the	(R)-beta-lysine	activation	reaction.	A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21841797;Dbxref=PMID:21841797
P0A8N7	UniProtKB	Mutagenesis	303	303	.	.	.	Note=Loss	of	lysylation	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20729861;Dbxref=PMID:20729861
P0A6Q6	UniProtKB	Mutagenesis	85	85	.	.	.	Note=In	sfhC21%3B	suppresses	an	ftsH	deletion	mutant	as	well	as	an	ftsH	temperature-sensitive	mutation.	Probably	stabilizes	the	enzyme.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10048027;Dbxref=PMID:10048027
P0A6R0	UniProtKB	Mutagenesis	112	112	.	.	.	Note=Loss	of	activity.	C->S
P0A6R0	UniProtKB	Mutagenesis	214	214	.	.	.	Note=Strongly	reduces	the	binding	to	malonyl-ACP	but	not	that	of	the	substrate.	K->E%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11078736;Dbxref=PMID:11078736
P0A6R0	UniProtKB	Mutagenesis	244	244	.	.	.	Note=Loss	of	activity.	H->A
P0A6R0	UniProtKB	Mutagenesis	249	249	.	.	.	Note=Abolishes	the	binding	to	malonyl-ACP	but	not	that	of	the	substrate.	R->E%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11078736;Dbxref=PMID:11078736
P0A6R0	UniProtKB	Mutagenesis	253	253	.	.	.	Note=Abolishes	both	binding	to	malonyl-ACP	and	binding	to	substrate.	A->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11078736;Dbxref=PMID:11078736
P0A6R0	UniProtKB	Mutagenesis	256	257	.	.	.	Note=Strongly	reduces	both	binding	to	malonyl-ACP	and	binding	to	substrate.	KK->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11078736;Dbxref=PMID:11078736
P0A6R0	UniProtKB	Mutagenesis	256	257	.	.	.	Note=Abolishes	the	binding	to	malonyl-ACP	but	not	that	of	the	substrate.	KK->EE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11078736;Dbxref=PMID:11078736
P0A6R0	UniProtKB	Mutagenesis	274	274	.	.	.	Note=Loss	of	activity.	N->A
P0ABZ1	UniProtKB	Mutagenesis	252	252	.	.	.	Note=Decreases	binding	to	YcgR%2C	significantly	improves	motility	in	a	yhjH	disruption	mutant.	Q->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P0ABZ1	UniProtKB	Mutagenesis	284	284	.	.	.	Note=Slightly	improves	motility	in	a	yhjH	disruption	mutant.	D->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P0ABZ1	UniProtKB	Mutagenesis	292	292	.	.	.	Note=Decreases	binding	to	YcgR%2C	significantly	improves	motility	in	a	yhjH	disruption	mutant.	N->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P0ABZ1	UniProtKB	Mutagenesis	295	295	.	.	.	Note=Decreases	binding	to	YcgR%2C	significantly	improves	motility	in	a	yhjH	disruption	mutant.	P->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P0ABZ1	UniProtKB	Mutagenesis	298	298	.	.	.	Note=Slightly	improves	motility	in	a	yhjH	disruption	mutant.	L->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P0AEK2	UniProtKB	Mutagenesis	151	151	.	.	.	Note=Defect	in	the	affinity	for	NADPH.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15016358;Dbxref=PMID:15016358
P0AEK2	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Decreases	in	the	thermolability	of	the	reductase%3B	when	associated	with	K-233.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14996818;Dbxref=PMID:14996818
P0AEK2	UniProtKB	Mutagenesis	155	155	.	.	.	Note=Defect	in	the	affinity	for	NADPH.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15016358;Dbxref=PMID:15016358
P0AEK2	UniProtKB	Mutagenesis	233	233	.	.	.	Note=Decreases	in	the	thermolability	of	the	reductase%3B	when	associated	with	T-154.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14996818;Dbxref=PMID:14996818
P0AEK4	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Diazaborine	resistance.	G->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1364817,ECO:0000269|PubMed:9707111;Dbxref=PMID:1364817,PMID:9707111
P0AEK4	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Triclosan	resistance.	G->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1364817,ECO:0000269|PubMed:9707111;Dbxref=PMID:1364817,PMID:9707111
P0AEK4	UniProtKB	Mutagenesis	146	146	.	.	.	Note=Large	impact	on	catalysis%2C	with	kcat	and	kcat/Km	for	DD-ACP	decreasing	by	around	50-fold	compared	with	wild-type.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17012233;Dbxref=PMID:17012233
P0AEK4	UniProtKB	Mutagenesis	156	156	.	.	.	Note=No	effect	on	substrate	reduction.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17012233;Dbxref=PMID:17012233
P0AEK4	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Triclosan	resistance.	M->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9707111;Dbxref=PMID:9707111
P0AEK4	UniProtKB	Mutagenesis	201	201	.	.	.	Note=No	effect	on	substrate	reduction.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17012233;Dbxref=PMID:17012233
P0AEK4	UniProtKB	Mutagenesis	201	201	.	.	.	Note=Little	activity	toward	DD-CoA	and	DD-ACP.	K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17012233;Dbxref=PMID:17012233
P0AEK4	UniProtKB	Mutagenesis	203	203	.	.	.	Note=Triclosan	resistance.	F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9707111;Dbxref=PMID:9707111
P0AEK4	UniProtKB	Mutagenesis	204	204	.	.	.	Note=No	effect	on	substrate	reduction.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17012233;Dbxref=PMID:17012233
P0AEK4	UniProtKB	Mutagenesis	204	204	.	.	.	Note=Causes	a	further	reduction	in	kcat/Km	for	reduction	of	DD-ACP	without	affecting	kcat/Km	for	the	DD-CoA	substrate.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17012233;Dbxref=PMID:17012233
P0AEK4	UniProtKB	Mutagenesis	205	205	.	.	.	Note=No	effect	on	substrate	reduction.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17012233;Dbxref=PMID:17012233
P0AEK4	UniProtKB	Mutagenesis	205	205	.	.	.	Note=Causes	a	further	reduction	in	kcat/Km	for	reduction	of	DD-ACP	without	affecting	kcat/Km	for	the	DD-CoA	substrate.	Has	a	larger	impact	on	substrate	reduction.	K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17012233;Dbxref=PMID:17012233
P0AEK4	UniProtKB	Mutagenesis	241	241	.	.	.	Note=Produces	temperature-sensitive	phenotype.	S->F
P32055	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Nearly	abolishes	catalytic	activity.	Minor	effect	of	affinity	for	NADPH	and	substrate.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11021971;Dbxref=PMID:11021971
P32055	UniProtKB	Mutagenesis	109	109	.	.	.	Note=Nearly	abolishes	catalytic	activity.	C->A
P32055	UniProtKB	Mutagenesis	136	136	.	.	.	Note=Abolishes	enzyme	activity.	Y->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11021971;Dbxref=PMID:11021971
P32055	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Reduces	catalytic	activity	20-fold.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11021971;Dbxref=PMID:11021971
P32055	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Nearly	abolishes	catalytic	activity.	K->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11021971;Dbxref=PMID:11021971
P32055	UniProtKB	Mutagenesis	179	179	.	.	.	Note=Nearly	abolishes	catalytic	activity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11021971;Dbxref=PMID:11021971
P32055	UniProtKB	Mutagenesis	187	187	.	.	.	Note=Decreases	affinity	for	the	substrate	GDP-4-keto-6-deoxymannose.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11021971;Dbxref=PMID:11021971
P0ACC3	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Does	not	complement	knockout.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17698959;Dbxref=PMID:17698959
P0ACC3	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Does	not	complement	knockout.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17698959;Dbxref=PMID:17698959
P0ACC3	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Does	not	complement	knockout.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17698959;Dbxref=PMID:17698959
P21177	UniProtKB	Mutagenesis	116	116	.	.	.	Note=Absence	of	both	enoyl-CoA	hydratase	and	3-hydroxyacyl-CoA	epimerase	activities.	Delta(3)-cis-Delta(2)-trans-enoyl-CoA	isomerase	is	only	slightly	affected.	G->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8454629;Dbxref=PMID:8454629
P21177	UniProtKB	Mutagenesis	322	322	.	.	.	Note=10-fold	increase	in	KM	for	NADH.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755745;Dbxref=PMID:8755745
P21177	UniProtKB	Mutagenesis	450	450	.	.	.	Note=Almost	complete	loss	of	3-hydroxyacyl-CoA	dehydrogenase	activity.	H->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755745;Dbxref=PMID:8755745
P0A8V6	UniProtKB	Mutagenesis	9	9	.	.	.	Note=Dominant	negative	to	wild-type%2C	decreased	DNA-binding.	A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9388199;Dbxref=PMID:9388199
P0A8V6	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Dominant	negative	to	wild-type%2C	decreased	DNA-binding.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9388199;Dbxref=PMID:9388199
P0A8V6	UniProtKB	Mutagenesis	49	49	.	.	.	Note=Dominant	negative	to	wild-type.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9388199;Dbxref=PMID:9388199
P0A8V6	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Dominant	negative	to	wild-type%2C	decreased	DNA-binding.	H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9388199;Dbxref=PMID:9388199
P0A8V6	UniProtKB	Mutagenesis	66	66	.	.	.	Note=Dominant	negative	to	wild-type%2C	decreased	DNA-binding.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9388199;Dbxref=PMID:9388199
P0A8V6	UniProtKB	Mutagenesis	67	67	.	.	.	Note=Dominant	negative	to	wild-type%2C	decreased	DNA-binding.	K->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9388199;Dbxref=PMID:9388199
P0A8V6	UniProtKB	Mutagenesis	215	215	.	.	.	Note=Loss	of	FadR	repression.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7836365;Dbxref=PMID:7836365
P0A8V6	UniProtKB	Mutagenesis	216	216	.	.	.	Note=Super-repressor%2C	non-inducible	phenotype%2C	cells	cannot	use	long	chain	fatty	acids	as	carbon	source.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7836365;Dbxref=PMID:7836365
P0A8V6	UniProtKB	Mutagenesis	218	218	.	.	.	Note=Reduced	ability	to	repress.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7836365;Dbxref=PMID:7836365
P0A8V6	UniProtKB	Mutagenesis	219	219	.	.	.	Note=Reduced	ability	to	repress.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7836365;Dbxref=PMID:7836365
P0A8V6	UniProtKB	Mutagenesis	219	219	.	.	.	Note=Super-repressor%2C	non-inducible	phenotype%2C	cells	cannot	use	long	chain	fatty	acids	as	carbon	source.	Protein	has	10-fold	decreased	affinity	for	C18:1-CoA%2C	can	still	bind	fabA	DNA	and	alter	transcription.	S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7836365;Dbxref=PMID:7836365
P0A8V6	UniProtKB	Mutagenesis	220	220	.	.	.	Note=Loss	of	FadR	repression.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7836365;Dbxref=PMID:7836365
P0A8V6	UniProtKB	Mutagenesis	223	223	.	.	.	Note=Super-repressor%2C	non-inducible	phenotype%2C	cells	cannot	use	long	chain	fatty	acids	as	carbon	source.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7836365;Dbxref=PMID:7836365
P0A8V6	UniProtKB	Mutagenesis	227	227	.	.	.	Note=Loss	of	FadR	repression.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7836365;Dbxref=PMID:7836365
P0A8V6	UniProtKB	Mutagenesis	228	228	.	.	.	Note=Reduced	ability	to	repress.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7836365;Dbxref=PMID:7836365
P0A8V6	UniProtKB	Mutagenesis	229	229	.	.	.	Note=Loss	of	FadR	repression.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7836365;Dbxref=PMID:7836365
P32177	UniProtKB	Mutagenesis	121	121	.	.	.	Note=Prevents	sulfur	transfer	from	IscS	and	impairs	FDH-H	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22194618;Dbxref=PMID:22194618
P32177	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Does	not	affect	sulfur	transfefrom	IscS%2C	but	abolishes	FDH-H	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22194618;Dbxref=PMID:22194618
P32177	UniProtKB	Mutagenesis	171	171	.	.	.	Note=Does	not	affect	overall	structural	integrity%2C	but	cannot	promote	FDH	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25649206;Dbxref=PMID:25649206
P32177	UniProtKB	Mutagenesis	240	240	.	.	.	Note=Strongly	impairs	FDH	activity.	S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25649206;Dbxref=PMID:25649206
P32177	UniProtKB	Mutagenesis	260	260	.	.	.	Note=Strongly	impairs	FDH	activity.	F->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25649206;Dbxref=PMID:25649206
P0A8S9	UniProtKB	Mutagenesis	2	2	.	.	.	Note=Partial	swarming	phenotype.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11169100;Dbxref=PMID:11169100
P0A8S9	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Partial	swarming	phenotype.	Affects	FlhD/FlhC	complex	formation.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11169100;Dbxref=PMID:11169100
P0A8S9	UniProtKB	Mutagenesis	34	34	.	.	.	Note=Partial	swarming	phenotype.	Affects	FlhD/FlhC	complex	formation.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11169100;Dbxref=PMID:11169100
P0A8S9	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Partial	swarming	phenotype.	Affects	FlhD/FlhC	complex	formation.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11169100;Dbxref=PMID:11169100
P0A8S9	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Partial	swarming	phenotype.	Affects	FlhD/FlhC	complex	formation.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11169100;Dbxref=PMID:11169100
P0A8S9	UniProtKB	Mutagenesis	82	82	.	.	.	Note=Partial	swarming	phenotype.	Does	not	affect	FlhD/FlhC	complex	formation%2C	but	affects	DNA	binding.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11169100;Dbxref=PMID:11169100
P0A8S9	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Partial	swarming	phenotype.	Does	not	affect	FlhD/FlhC	complex	formation%2C	but	affects	DNA	binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11169100;Dbxref=PMID:11169100
P0A8S9	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Partial	swarming	phenotype.	Does	not	affect	FlhD/FlhC	complex	formation%2C	but	affects	DNA	binding.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11169100;Dbxref=PMID:11169100
P0A8S9	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Partial	swarming	phenotype.	Affects	FlhD/FlhC	complex	formation.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11169100;Dbxref=PMID:11169100
P0A8S9	UniProtKB	Mutagenesis	92	92	.	.	.	Note=Non-swarming	phenotype.	AffectsFlhD/FlhC	complex	formation.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11169100;Dbxref=PMID:11169100
P0A8S9	UniProtKB	Mutagenesis	94	94	.	.	.	Note=Non-swarming	phenotype.	AffectsFlhD/FlhC	complex	formation.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11169100;Dbxref=PMID:11169100
P0A8S9	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Partial	swarming	phenotype.	Affects	FlhD/FlhC	complex	formation.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11169100;Dbxref=PMID:11169100
P16869	UniProtKB	Mutagenesis	44	44	.	.	.	Note=Abolishes	transport	activity.	V->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2162465;Dbxref=PMID:2162465
P16869	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Abolishes	transport	activity.	V->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2162465;Dbxref=PMID:2162465
P16869	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Impaired	transport	and	growth.G->A%2CV%2CN%2CD%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2162465;Dbxref=PMID:2162465
P05523	UniProtKB	Mutagenesis	3	3	.	.	.	Note=Strong	decrease	of	glycosylase	activity%3B	slight	decrease	of	AP	lyase	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11106507;Dbxref=PMID:11106507
P05523	UniProtKB	Mutagenesis	6	6	.	.	.	Note=Decrease	of	glycosylase	activity%3B	no	effect	on	AP	lyase	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11106507;Dbxref=PMID:11106507
P05523	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Increase	of	substrate	affinitand	decrease	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14607836;Dbxref=PMID:14607836
P05523	UniProtKB	Mutagenesis	107	107	.	.	.	Note=No	effect	on	glycosylase	and	AP	lyase	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11106507;Dbxref=PMID:11106507
P05523	UniProtKB	Mutagenesis	109	109	.	.	.	Note=Over	100-fold	decrease	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14607836;Dbxref=PMID:14607836
P05523	UniProtKB	Mutagenesis	110	110	.	.	.	Note=Over	100-fold	increase	of	substrate	affinity	and	decrease	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14607836;Dbxref=PMID:14607836
P05523	UniProtKB	Mutagenesis	132	132	.	.	.	Note=Decrease	of	glycosylase	activity%3B	slight	decrease	of	AP	lyase	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11106507;Dbxref=PMID:11106507
P05523	UniProtKB	Mutagenesis	160	160	.	.	.	Note=No	effect	on	glycosylase	and	AP	lyase	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11106507;Dbxref=PMID:11106507
P05523	UniProtKB	Mutagenesis	174	174	.	.	.	Note=Strong	decrease	of	glycosylase	activity%3B	slight	decrease	of	AP	lyase	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11106507;Dbxref=PMID:11106507
P05523	UniProtKB	Mutagenesis	218	218	.	.	.	Note=Slight	increase	of	substrate	affinity	and	decrease	of	activity.	K->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14607836;Dbxref=PMID:14607836
P78055	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Loss	of	activity.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11120740;Dbxref=PMID:11120740
P29131	UniProtKB	Mutagenesis	5	5	.	.	.	Note=Causes	significant	impairment	of	the	interaction	with	FtsA.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25496259;Dbxref=PMID:25496259
P29131	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Lack	of	activity.	W->L%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25496160;Dbxref=PMID:25496160
P29131	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Lack	of	activity.	Y->S%2CW;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25496160;Dbxref=PMID:25496160
P29131	UniProtKB	Mutagenesis	89	89	.	.	.	Note=Lack	of	activity.	L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25496160;Dbxref=PMID:25496160
P29131	UniProtKB	Mutagenesis	251	251	.	.	.	Note=Reduces	septal	localization	by	factor	of	at	least	3.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24056104;Dbxref=PMID:24056104
P29131	UniProtKB	Mutagenesis	251	251	.	.	.	Note=Severe	localization	defects.	Binds	peptidoglycan	poorly.	Q->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24056104;Dbxref=PMID:24056104
P29131	UniProtKB	Mutagenesis	252	252	.	.	.	Note=Severely	reduces	stability	of	the	protein.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24056104;Dbxref=PMID:24056104
P29131	UniProtKB	Mutagenesis	254	254	.	.	.	Note=Reduces	septal	localization	by	factor	of	at	least	3.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24056104;Dbxref=PMID:24056104
P29131	UniProtKB	Mutagenesis	254	254	.	.	.	Note=Binds	peptidoglycan	poorly.	S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24056104;Dbxref=PMID:24056104
P29131	UniProtKB	Mutagenesis	263	263	.	.	.	Note=Intermediate	localization	defectsT->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24056104;Dbxref=PMID:24056104
P29131	UniProtKB	Mutagenesis	270	270	.	.	.	Note=Intermediate	localization	defectsF->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24056104;Dbxref=PMID:24056104
P29131	UniProtKB	Mutagenesis	283	283	.	.	.	Note=Reduces	septal	localization	by	factor	of	at	least	3.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24056104;Dbxref=PMID:24056104
P29131	UniProtKB	Mutagenesis	283	283	.	.	.	Note=Severe	localization	defects.	W->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24056104;Dbxref=PMID:24056104
P29131	UniProtKB	Mutagenesis	285	285	.	.	.	Note=Reduces	septal	localization	by	factor	of	at	least	3.	Binds	peptidoglycan	poorly.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24056104;Dbxref=PMID:24056104
P29131	UniProtKB	Mutagenesis	312	312	.	.	.	Note=Severely	reduces	stability	of	the	protein.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24056104;Dbxref=PMID:24056104
P29131	UniProtKB	Mutagenesis	313	313	.	.	.	Note=Reduces	septal	localization	by	factor	of	at	least	3.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24056104;Dbxref=PMID:24056104
P06136	UniProtKB	Mutagenesis	29	29	.	.	.	Note=No	change	in	activity.	Correctly	assembled%2C	interacts	with	FtsB	and	FtsL%2C	but	fails	to	localize	efficiently	to	the	cell	division	site%3B	when	associated	with	R-32.	Does	not	insert	into	the	membrane	and	lack	of	activity%3B	when	associated	with	R-32	and	P-38.	L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17693520;Dbxref=PMID:17693520
P06136	UniProtKB	Mutagenesis	32	32	.	.	.	Note=No	change	in	activity.	Correctly	assembled%2C	interacts	with	FtsB	and	FtsL%2C	but	fails	to	localize	efficiently	to	the	cell	division	site%3B	when	associated	with	R-29.	Does	not	insert	into	the	membrane	and	lack	of	activity%3B	when	associated	with	R-29	and	P-38.	L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17693520;Dbxref=PMID:17693520
P06136	UniProtKB	Mutagenesis	38	38	.	.	.	Note=No	change	in	activity.	Does	not	insert	into	the	membrane	and	lack	of	activity%3B	when	associated	with	R-29	and	R-32.	V->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17693520;Dbxref=PMID:17693520
P06136	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Does	not	affect	localization.	D->K%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18312270;Dbxref=PMID:18312270
P06136	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Impairs	localization.	K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18312270;Dbxref=PMID:18312270
P06136	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Impairs	localization.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18312270;Dbxref=PMID:18312270
P06136	UniProtKB	Mutagenesis	237	237	.	.	.	Note=Localizes	to	mid-cell%2C	but	is	unable	to	form	a	functional	complex	with	FtsL/FtsB.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18312270;Dbxref=PMID:18312270
P0A9B2	UniProtKB	Mutagenesis	177	177	.	.	.	Note=Reduces	activity	about	50-foldH->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2659073;Dbxref=PMID:2659073
P20605	UniProtKB	Mutagenesis	55	55	.	.	.	Note=Inhibitory	effect	on	cell	divisioinduced	by	cAMP	with	temperature	sensitivity.	G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2546924;Dbxref=PMID:2546924
P0A998	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Initially	100-fold	slower	Fe(2+)	oxidation	rate.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24380371;Dbxref=PMID:24380371
P0A998	UniProtKB	Mutagenesis	24	24	.	.	.	Note=Initially	reduces	Fe(2+)/O(2)	stoichiometry	from	3.1	to	2.2.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24380371;Dbxref=PMID:24380371
P0A998	UniProtKB	Mutagenesis	49	49	.	.	.	Note=Initially	reduces	Fe(2+)/O(2)	stoichiometry	from	~3	to	~2.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24380371;Dbxref=PMID:24380371
P0A998	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Initially	6000-fold	slower	Fe(2+)	oxidation	rate.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24380371;Dbxref=PMID:24380371
P0A998	UniProtKB	Mutagenesis	94	94	.	.	.	Note=Initially	200-fold	slower	Fe(2+)	oxidation	rate.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24380371;Dbxref=PMID:24380371
P0A998	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Initially	reduces	Fe(2+)/O(2)	stoichiometry	from	~3	to	~2.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24380371;Dbxref=PMID:24380371
P0A998	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Initially	reduces	Fe(2+)/O(2)	stoichiometry	from	~3	to	~2.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24380371;Dbxref=PMID:24380371
P0AEM6	UniProtKB	Mutagenesis	73	73	.	.	.	Note=No	change	in	activity.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19400790;Dbxref=PMID:19400790
P0AEM6	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Decrease	in	activity.	R->A%2CW;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19400790;Dbxref=PMID:19400790
P0AEM6	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Decrease	in	activity.	A->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19400790;Dbxref=PMID:19400790
P0AEM6	UniProtKB	Mutagenesis	81	81	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19400790;Dbxref=PMID:19400790
P0AEM6	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19400790;Dbxref=PMID:19400790
P0AEM6	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19400790;Dbxref=PMID:19400790
P0AEM6	UniProtKB	Mutagenesis	92	92	.	.	.	Note=No	change	in	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19400790;Dbxref=PMID:19400790
P0AEM6	UniProtKB	Mutagenesis	94	94	.	.	.	Note=Decrease	in	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19400790;Dbxref=PMID:19400790
P0AEM6	UniProtKB	Mutagenesis	95	95	.	.	.	Note=No	change	in	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19400790;Dbxref=PMID:19400790
P0AEM6	UniProtKB	Mutagenesis	96	96	.	.	.	Note=No	change	in	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19400790;Dbxref=PMID:19400790
P0AEM6	UniProtKB	Mutagenesis	98	98	.	.	.	Note=Strong	decrease	in	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19400790;Dbxref=PMID:19400790
P00363	UniProtKB	Mutagenesis	45	45	.	.	.	Note=Inactivates	enzyme.	H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2668268;Dbxref=PMID:2668268
P00363	UniProtKB	Mutagenesis	45	45	.	.	.	Note=Decreased	ability	(greater	than	70%25)	to	reduce	fumarate.	H->S%2CC%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2668268;Dbxref=PMID:2668268
P00363	UniProtKB	Mutagenesis	233	233	.	.	.	Note=Severely	affect	succinate	oxidation	and	decrease	fumarate	oxidation	by	75%25.	H->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1856194;Dbxref=PMID:1856194
P00363	UniProtKB	Mutagenesis	248	248	.	.	.	Note=Does	not	inactivate	enzyme.C->S%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1856194;Dbxref=PMID:1856194
P00363	UniProtKB	Mutagenesis	249	249	.	.	.	Note=Inactivates	enzyme.	R->H%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1856194;Dbxref=PMID:1856194
P0ABH0	UniProtKB	Mutagenesis	210	210	.	.	.	Note=Does	not	bind	ATP.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11053380;Dbxref=PMID:11053380
P0ABH0	UniProtKB	Mutagenesis	408	408	.	.	.	Note=Prevents	localization	to	the	ring.	Lack	of	activity.	W->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15752196;Dbxref=PMID:15752196
P0ABH0	UniProtKB	Mutagenesis	409	409	.	.	.	Note=Prevents	localization	to	the	ring.	Lack	of	activity.	I->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15752196;Dbxref=PMID:15752196
P0ABH0	UniProtKB	Mutagenesis	411	411	.	.	.	Note=Does	not	affect	localization	or	function.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15752196;Dbxref=PMID:15752196
P0ABH0	UniProtKB	Mutagenesis	412	412	.	.	.	Note=Prevents	localization	to	the	ring.	Lack	of	activity.	L->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15752196;Dbxref=PMID:15752196
P0ABH0	UniProtKB	Mutagenesis	415	415	.	.	.	Note=Prevents	localization	to	the	ring.	Lack	of	activity.	W->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15752196;Dbxref=PMID:15752196
P0ABH0	UniProtKB	Mutagenesis	416	416	.	.	.	Note=Prevents	localization	to	the	ring.	Lack	of	activity.	L->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15752196;Dbxref=PMID:15752196
P0ABH0	UniProtKB	Mutagenesis	420	420	.	.	.	Note=Does	not	affect	localization	or	function.	F->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15752196;Dbxref=PMID:15752196
P46889	UniProtKB	Mutagenesis	58	58	.	.	.	Note=Loss	of	function.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10922461;Dbxref=PMID:10922461
P46889	UniProtKB	Mutagenesis	80	80	.	.	.	Note=In	Toe44%3B	loss	of	functiounder	extreme	conditions.	G->A
P46889	UniProtKB	Mutagenesis	135	135	.	.	.	Note=Impairs	the	ability	of	FtsK	to	function	in	cell	division.	Uncouples	invagination	of	the	inner	and	outer	membranes	and	results	in	cellular	voids.	D->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25002583;Dbxref=PMID:25002583
P46889	UniProtKB	Mutagenesis	136	136	.	.	.	Note=Impairs	the	ability	of	FtsK	to	function	in	cell	division.	Uncouples	invagination	of	the	inner	and	outer	membranes	and	results	in	cellular	voids.	D->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25002583;Dbxref=PMID:25002583
P46889	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Impairs	the	ability	of	FtsK	to	function	in	cell	division.	Uncouples	invagination	of	the	inner	and	outer	membranes	and	results	in	cellular	voids.	I->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25002583;Dbxref=PMID:25002583
P46889	UniProtKB	Mutagenesis	138	138	.	.	.	Note=Impairs	the	ability	of	FtsK	to	function	in	cell	division.	Uncouples	invagination	of	the	inner	and	outer	membranes	and	results	in	cellular	voids.	W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25002583;Dbxref=PMID:25002583
P46889	UniProtKB	Mutagenesis	997	997	.	.	.	Note=Does	not	activate	Xer	recombination.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15522074;Dbxref=PMID:15522074
P0ABG4	UniProtKB	Mutagenesis	145	145	.	.	.	Note=Loss	of	flippase	activity.	Does	not	affect	localization	at	the	division	site.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24711460;Dbxref=PMID:24711460
P0ABG4	UniProtKB	Mutagenesis	150	152	.	.	.	Note=Does	not	affect	flippase	activity.	ELT->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24711460;Dbxref=PMID:24711460
P0ABG4	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Loss	of	flippase	activity.	Does	not	affect	localization	at	the	division	site.	K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24711460;Dbxref=PMID:24711460
P0ABG4	UniProtKB	Mutagenesis	154	156	.	.	.	Note=Does	not	affect	flippase	activity.	LSL->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24711460;Dbxref=PMID:24711460
P0ABG4	UniProtKB	Mutagenesis	170	170	.	.	.	Note=In	ftsW201%3B	TS%3B	blocks	divisioat	the	initiation	stage.	E->K
P0ABG4	UniProtKB	Mutagenesis	172	172	.	.	.	Note=Does	not	affect	localization%2Cbut	affects	its	thermosensitivity.	R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15576787;Dbxref=PMID:15576787
P0ABG4	UniProtKB	Mutagenesis	181	181	.	.	.	Note=In	ftsW1640%3B	TS%3B	blocks	divisioat	a	late	stage.	P->L
P0ABG4	UniProtKB	Mutagenesis	243	243	.	.	.	Note=Lack	of	activity.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15576787;Dbxref=PMID:15576787
P0ABG4	UniProtKB	Mutagenesis	253	253	.	.	.	Note=In	ftsW263%3B	TS%3B	blocks	divisioat	the	initiation	stage.	P->L
P0ABG4	UniProtKB	Mutagenesis	311	311	.	.	.	Note=Thermosensitive.	Fails	to	localizto	the	division	site	at	42	degrees	Celsius.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15576787;Dbxref=PMID:15576787
P0ABG4	UniProtKB	Mutagenesis	368	368	.	.	.	Note=Cannot	recruit	FtsI	at	the	division	site%3B	when	associated	with	A-375.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15576787;Dbxref=PMID:15576787
P0ABG4	UniProtKB	Mutagenesis	375	375	.	.	.	Note=Cannot	recruit	FtsI	at	the	division	site%3B	when	associated	with	A-368.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15576787;Dbxref=PMID:15576787
P0ABG4	UniProtKB	Mutagenesis	402	402	.	.	.	Note=Does	not	affect	localization	and	activity.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15576787;Dbxref=PMID:15576787
P06974	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Decreases	binding	to	YcgR.	V->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P06974	UniProtKB	Mutagenesis	155	155	.	.	.	Note=Decreases	binding	to	YcgR.	N->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P06974	UniProtKB	Mutagenesis	156	156	.	.	.	Note=Obviates	binding	to	YcgR.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P06974	UniProtKB	Mutagenesis	160	160	.	.	.	Note=Obviates	binding	to	YcgR.	L->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P06974	UniProtKB	Mutagenesis	167	167	.	.	.	Note=Decreases	binding	to	YcgR.	D->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P06974	UniProtKB	Mutagenesis	176	176	.	.	.	Note=Decreases	binding	to	YcgR.	E->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P0AC47	UniProtKB	Mutagenesis	58	58	.	.	.	Note=Affects	center	1	(2Fe-2S).	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2174169;Dbxref=PMID:2174169
P0AC47	UniProtKB	Mutagenesis	63	63	.	.	.	Note=Affects	center	1	(2Fe-2S).	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2174169;Dbxref=PMID:2174169
P0AC47	UniProtKB	Mutagenesis	66	66	.	.	.	Note=Affects	center	1	(2Fe-2S).	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2174169;Dbxref=PMID:2174169
P0AC47	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Affects	center	1	(2Fe-2S).	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2174169;Dbxref=PMID:2174169
P10121	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Blocks	proteolytic	cleavage	and	impairs	activity	in	cotranslational	targeting.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18281057;Dbxref=PMID:18281057
P0A9A6	UniProtKB	Mutagenesis	1	32	.	.	.	Note=No	interaction	with	MreB	or	YeeV.	Missing
P0A9A6	UniProtKB	Mutagenesis	33	49	.	.	.	Note=No	interaction	with	CtpA.	Missing
P0A9A6	UniProtKB	Mutagenesis	105	105	.	.	.	Note=In	FtsZ-84%3B	loss	of	GTPase-activity	and	conversion	to	an	ATPase.	G->F
P0A9A6	UniProtKB	Mutagenesis	108	108	.	.	.	Note=In	FtsZ-Z3%3B	lethal%3B	greatlyreduced	GTP	binding.	T->A
P0A9A6	UniProtKB	Mutagenesis	317	383	.	.	.	Note=No	interaction	with	MreB	or	CbtA	(YeeV).	Missing
P0A9S1	UniProtKB	Mutagenesis	1	9	.	.	.	Note=Loss	of	enzyme	activity%2C	loss	of	dimerization.	MANRMILNE->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15995211;Dbxref=PMID:15995211
P0A9S1	UniProtKB	Mutagenesis	16	16	.	.	.	Note=No	effect	on	enzyme	activity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15995211;Dbxref=PMID:15995211
P0A9S1	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Enzyme	can	now	use	NADP.	D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15995211;Dbxref=PMID:15995211
P0A9S1	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Loss	of	NAD	binding	and	enzyme	activity.	G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15995211;Dbxref=PMID:15995211
P0A9S1	UniProtKB	Mutagenesis	195	195	.	.	.	Note=Complete	loss	of	iron-binding.	D->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15995211;Dbxref=PMID:15995211
P0A9S1	UniProtKB	Mutagenesis	199	199	.	.	.	Note=Complete	loss	of	iron-binding.	H->A%2CF;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15995211;Dbxref=PMID:15995211
P33650	UniProtKB	Mutagenesis	94	94	.	.	.	Note=No	effect.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12446835;Dbxref=PMID:12446835
P33650	UniProtKB	Mutagenesis	123	123	.	.	.	Note=Loss	of	guanine	nucleotide	specificity	and	Fe(2+)	uptake.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12446835;Dbxref=PMID:12446835
P07821	UniProtKB	Mutagenesis	50	50	.	.	.	Note=Lack	of	activity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1551849;Dbxref=PMID:1551849
P07821	UniProtKB	Mutagenesis	172	172	.	.	.	Note=Lack	of	activity.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1551849;Dbxref=PMID:1551849
P07822	UniProtKB	Mutagenesis	68	68	.	.	.	Note=Decreases	binding	of	coprogen.	Does	not	bind	aerobactin	and	ferrichrome.	Increases	resistance	to	albomycin.	W->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8522527;Dbxref=PMID:8522527
P23893	UniProtKB	Mutagenesis	265	265	.	.	.	Note=2%25	of	wild-type	activity.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1643048;Dbxref=PMID:1643048
P09391	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Reduced	catalytic	activity.	N->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16216077,ECO:0000269|PubMed:16621838;Dbxref=PMID:16216077,PMID:16621838
P09391	UniProtKB	Mutagenesis	199	199	.	.	.	Note=Loss	of	catalytic	activity.	G->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17493126;Dbxref=PMID:17493126
P09391	UniProtKB	Mutagenesis	201	201	.	.	.	Note=Loss	of	catalytic	activity.	S->A%2CC;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16216077,ECO:0000269|PubMed:16621838,ECO:0000269|PubMed:17099694,ECO:0000269|PubMed:17493126;Dbxref=PMID:16216077,PMID:16621838,PMID:17099694,PMID:17493126
P09391	UniProtKB	Mutagenesis	254	254	.	.	.	Note=Loss	of	catalytic	activity.	H->A%2CC;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16216077,ECO:0000269|PubMed:16621838,ECO:0000269|PubMed:17493126;Dbxref=PMID:16216077,PMID:16621838,PMID:17493126
P0A9D2	UniProtKB	Mutagenesis	5	5	.	.	.	Note=Does	not	significantly	affect	the	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7798255;Dbxref=PMID:7798255
P0A9D2	UniProtKB	Mutagenesis	10	10	.	.	.	Note=8-fold	decrease	in	affinitfor	GSH%2C	but	5-fold	increase	in	GSH	transferase	activity.	Loss	of	thiol:disulfideoxidoreductase	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18778244;Dbxref=PMID:18778244
P0A9D2	UniProtKB	Mutagenesis	10	10	.	.	.	Note=6-fold	decrease	in	affinitfor	GSH%2C	and	decrease	in	GSH	transferase	activity.	Loss	of	thiol:disulfide	oxidoreductase	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18778244;Dbxref=PMID:18778244
P0A9D2	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Decrease	in	affinity	for	GSH	while	nearly	no	effect	on	affinity	for	CDNB%2C	and	decrease	in	GSH	transferase	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18778244;Dbxref=PMID:18778244
P0A9D2	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Decrease	in	affinity	for	GSH%2C	while	nearly	no	effect	on	affinity	for	CDNB	and	on	GSH	transferase	activity.	H->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18778244;Dbxref=PMID:18778244
P0AC88	UniProtKB	Mutagenesis	133	133	.	.	.	Note=Strongly	reduces	activity.	T->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10673432;Dbxref=PMID:10673432
P0AC88	UniProtKB	Mutagenesis	135	135	.	.	.	Note=Strongly	reduces	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10673432;Dbxref=PMID:10673432
P0AC88	UniProtKB	Mutagenesis	157	157	.	.	.	Note=Strongly	reduces	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10673432;Dbxref=PMID:10673432
P0AC88	UniProtKB	Mutagenesis	161	161	.	.	.	Note=Strongly	reduces	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10673432;Dbxref=PMID:10673432
P32056	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Increases	Km	for	GDP-mannose	5-fold.	Reduces	activity	120-fold.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15966723;Dbxref=PMID:15966723
P32056	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Increases	Km	for	GDP-mannose	9-fold.	Reduces	activity	400-fold.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15966723;Dbxref=PMID:15966723
P32056	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Increases	Km	for	GDP-mannose	9-fold.	Reduces	activity	24-fold.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15966723;Dbxref=PMID:15966723
P32056	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Increases	Km	for	GDP-mannose	40-fold.	Reduces	activity	10-fold.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12196023;Dbxref=PMID:12196023
P32056	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Increases	Km	for	GDP-mannose	40-fold.	Reduces	activity	300-fold.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12196023;Dbxref=PMID:12196023
P32056	UniProtKB	Mutagenesis	64	64	.	.	.	Note=Increases	Km	for	GDP-mannose	80-fold.	Reduces	activity	24-fold.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12196023;Dbxref=PMID:12196023
P32056	UniProtKB	Mutagenesis	69	69	.	.	.	Note=Increases	Km	for	GDP-mannose	10-fold.	Increases	Km	for	magnesium	40-fold.	Reduces	activity	150-fold.	E->Q
P32056	UniProtKB	Mutagenesis	87	87	.	.	.	Note=Increases	Km	for	GDP-mannose	4-fold.	Reduces	activity	200-fold.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12196023;Dbxref=PMID:12196023
P32056	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Increases	Km	for	GDP-mannose	14-fold.	Reduces	activity	7-fold.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12196023;Dbxref=PMID:12196023
P32056	UniProtKB	Mutagenesis	102	102	.	.	.	Note=Increases	Km	for	GDP-mannose	7-fold.	Reduces	activity	100-fold.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15966723;Dbxref=PMID:15966723
P32056	UniProtKB	Mutagenesis	123	123	.	.	.	Note=Increases	Km	for	GDP-mannose	5-fold.	Reduces	activity	2000-fold.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12196023;Dbxref=PMID:12196023
P27249	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Loss	of	UTase	activity%2C	while	no	significant	effect	on	UR	activity.	G->L%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20363937;Dbxref=PMID:20363937
P27249	UniProtKB	Mutagenesis	94	94	.	.	.	Note=Loss	of	UTase	activity%2C	while	no	significant	effect	on	UR	activity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20363937;Dbxref=PMID:20363937
P27249	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Loss	of	UTase	activity%2C	while	no	significant	effect	on	UR	activity.	D->A%2CV%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20363937;Dbxref=PMID:20363937
P27249	UniProtKB	Mutagenesis	514	515	.	.	.	Note=Loss	of	UR	activity%2C	while	no	significant	effect	on	UTase	activity.	HD->AA%2CQN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20363937;Dbxref=PMID:20363937
P0AER0	UniProtKB	Mutagenesis	236	237	.	.	.	Note=No	detectable	water	or	glyceropermeability.	PL->FW
P0A9C9	UniProtKB	Mutagenesis	29	29	.	.	.	Note=2.4-fold	increase	in	FBPase	activity%2C	and	no	effect	on	substrate	affinity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	57	57	.	.	.	Note=Strong	decrease	in	FBPase	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	59	59	.	.	.	Note=5.5-fold	decrease	in	FBPase	activity%2C	and	1.4-fold	decrease	in	substrate	affinity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Great	decrease	in	FBPase	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Great	decrease	in	FBPase	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Strong	decrease	in	FBPase	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Strong	decrease	in	FBPase	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	119	119	.	.	.	Note=Strong	decrease	in	FBPase	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Strong	decrease	in	FBPase	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	166	166	.	.	.	Note=Strong	decrease	in	FBPase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	186	186	.	.	.	Note=5-fold	decrease	in	FBPase	activity%2C	and	3-fold	decrease	in	substrate	affinity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	188	188	.	.	.	Note=Great	decrease	in	FBPase	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Great	decrease	in	FBPase	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	235	235	.	.	.	Note=Nearly	no	effect	on	FBPase	activity%2C	and	3-fold	decrease	in	substrate	affinity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0A9C9	UniProtKB	Mutagenesis	239	239	.	.	.	Note=1.3-fold	increase	in	FBPase	activity%2C	and	1.4-fold	decrease	in	substrate	affinity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19073594;Dbxref=PMID:19073594
P0ABC3	UniProtKB	Mutagenesis	145	145	.	.	.	Note=In	hflC9%3B	stabilizes	overproduced	SecY	but	not	overproduced	cII	protein.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8947034;Dbxref=PMID:8947034
P0ABC3	UniProtKB	Mutagenesis	165	200	.	.	.	Note=No	effect	on	phage	lambda	lysogenization	frequency.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9159109;Dbxref=PMID:9159109
P0ACE3	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Does	not	affect	H-NS	bindingability.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21600204;Dbxref=PMID:21600204
P0ACE3	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Derepression	of	the	hly	operon%2C	impaired	H-NS	binding.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11790731;Dbxref=PMID:11790731
P0ACE3	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Does	not	affect	H-NS	bindingability.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21600204;Dbxref=PMID:21600204
P0ACE3	UniProtKB	Mutagenesis	25	25	.	.	.	Note=Affects	H-NS	binding	ability.	Decrease	in	the	ability	to	repress	the	expression	of	the	hly	operon.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21600204;Dbxref=PMID:21600204
P0ACE3	UniProtKB	Mutagenesis	29	29	.	.	.	Note=Does	not	affect	H-NS	bindingability.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21600204;Dbxref=PMID:21600204
P0ACE3	UniProtKB	Mutagenesis	34	34	.	.	.	Note=Does	not	affect	H-NS	bindingability.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21600204;Dbxref=PMID:21600204
P0ACE3	UniProtKB	Mutagenesis	37	37	.	.	.	Note=Does	not	affect	H-NS	bindingability.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21600204;Dbxref=PMID:21600204
P0ACE3	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Does	not	affect	H-NS	bindingability.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21600204;Dbxref=PMID:21600204
P0ACE3	UniProtKB	Mutagenesis	44	72	.	.	.	Note=Derepression	of	the	hly	operon%2C	impaired	H-NS	binding.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11790731;Dbxref=PMID:11790731
P0ACE3	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Abolishes	the	interaction	with	H-NS.	D->E%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21600204;Dbxref=PMID:21600204
P0ACE3	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Abolishes	the	interaction	with	H-NS.	Loss	of	the	ability	to	repress	the	expression	of	the	hly	operon.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21600204;Dbxref=PMID:21600204
P0ACE3	UniProtKB	Mutagenesis	50	50	.	.	.	Note=Derepression	of	the	hly	operon%2C	impaired	H-NS	binding.	R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11790731;Dbxref=PMID:11790731
P0ACE3	UniProtKB	Mutagenesis	58	72	.	.	.	Note=Derepression	of	the	hly	operon%2C	impaired	H-NS	binding.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11790731;Dbxref=PMID:11790731
P0ACE3	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Does	not	affect	H-NS	bindingability.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21600204;Dbxref=PMID:21600204
P0ACE3	UniProtKB	Mutagenesis	64	64	.	.	.	Note=Derepression	of	the	hly	operon%2C	impaired	H-NS	binding.	P->L%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11790731;Dbxref=PMID:11790731
P0ACE3	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Derepression	of	the	hly	operon%2C	impaired	H-NS	binding.	R->RHHHHHH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11790731;Dbxref=PMID:11790731
P0AET2	UniProtKB	Mutagenesis	55	56	.	.	.	Note=Folded%2C	but	does	not	form	homodimers	at	pH	7.	WW->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22138344;Dbxref=PMID:22138344
P06983	UniProtKB	Mutagenesis	7	7	.	.	.	Note=No	loss	of	activity.	R->L
P06983	UniProtKB	Mutagenesis	11	11	.	.	.	Note=Loss	of	activity.	R->L
P06983	UniProtKB	Mutagenesis	55	55	.	.	.	Note=No	loss	of	activity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2122889;Dbxref=PMID:2122889
P06983	UniProtKB	Mutagenesis	59	59	.	.	.	Note=25-fold	decrease	in	activity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2122889;Dbxref=PMID:2122889
P06983	UniProtKB	Mutagenesis	101	101	.	.	.	Note=No	loss	of	activity.	R->L
P06983	UniProtKB	Mutagenesis	131	131	.	.	.	Note=Complete	loss	of	activity.	R->L
P06983	UniProtKB	Mutagenesis	132	132	.	.	.	Note=Complete	loss	of	activity.	R->L
P06983	UniProtKB	Mutagenesis	155	155	.	.	.	Note=Loss	of	activity.	R->L
P06983	UniProtKB	Mutagenesis	176	176	.	.	.	Note=Loss	of	activity.	R->L
P60664	UniProtKB	Mutagenesis	5	5	.	.	.	Note=Loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11208798;Dbxref=PMID:11208798
P60664	UniProtKB	Mutagenesis	5	5	.	.	.	Note=Loss	of	IGP	synthase	activity.	Weak	IGP	synthase	activity	and	reduced	HisH	activity	in	vitro.	R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11208798;Dbxref=PMID:11208798
P60664	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Loss	of	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11208798;Dbxref=PMID:11208798
P60664	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Loss	of	IGP	synthase	activity.	Weak	IGP	synthase	and	HisH	activities	in	vitro.	E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11208798;Dbxref=PMID:11208798
P60664	UniProtKB	Mutagenesis	123	123	.	.	.	Note=Decrease	in	activity.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11208798;Dbxref=PMID:11208798
P60664	UniProtKB	Mutagenesis	123	123	.	.	.	Note=Loss	of	IGP	synthase	activity.	Weak	HisH	activity	in	vitro.	Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11208798;Dbxref=PMID:11208798
P60664	UniProtKB	Mutagenesis	124	124	.	.	.	Note=No	change	in	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11208798;Dbxref=PMID:11208798
P60664	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Loss	of	IGP	synthase	activity.	Weak	HisH	activity	in	vitro.	C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11208798;Dbxref=PMID:11208798
P0ACB2	UniProtKB	Mutagenesis	127	127	.	.	.	Note=No	significant	effect	on	activity%3B	when	associated	with	A-129.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7592604;Dbxref=PMID:7592604
P0ACB2	UniProtKB	Mutagenesis	129	129	.	.	.	Note=No	significant	effect	on	activity%3B	when	associated	with	A-127.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7592604;Dbxref=PMID:7592604
P31658	UniProtKB	Mutagenesis	77	77	.	.	.	Note=Loss	of	glyoxalase	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21696459;Dbxref=PMID:21696459
P31658	UniProtKB	Mutagenesis	185	185	.	.	.	Note=Loss	of	glyoxalase	and	aminopeptidase	activities.	C->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12939276,ECO:0000269|PubMed:15550391,ECO:0000269|PubMed:21696459;Dbxref=PMID:12939276,PMID:15550391,PMID:21696459
P31658	UniProtKB	Mutagenesis	186	186	.	.	.	Note=Shows	approximately	17%25	remaining	glyoxalase	activity	compared	with	that	of	the	wild-type.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21696459;Dbxref=PMID:21696459
P0AET8	UniProtKB	Mutagenesis	146	146	.	.	.	Note=Reduces	activity	by	over	65%25.	S->A%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9722677;Dbxref=PMID:9722677
P0AET8	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Loss	of	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9722677;Dbxref=PMID:9722677
P0AET8	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Reduces	activity	by	87%25.	Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9722677;Dbxref=PMID:9722677
P0AET8	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Reduces	activity	by	95%25.	K->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9722677;Dbxref=PMID:9722677
P0AET8	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Reduces	activity	by	35%25.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9722677;Dbxref=PMID:9722677
P0ABC7	UniProtKB	Mutagenesis	145	145	.	.	.	Note=In	hflK13%3B	stabilizes	overproduced	SecY	but	not	overproduced	cII	protein.	A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8947034;Dbxref=PMID:8947034
P0ACE7	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Abolishes	enzyme	activity.	H->A%2CG;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15703176,ECO:0000269|PubMed:20934431,ECO:0000269|PubMed:21754980;Dbxref=PMID:15703176,PMID:20934431,PMID:21754980
P0ACE7	UniProtKB	Mutagenesis	114	119	.	.	.	Note=Strongly	reduces	enzyme	activity.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20934431;Dbxref=PMID:20934431
P0ACE7	UniProtKB	Mutagenesis	117	119	.	.	.	Note=Abolishes	enzyme	activity.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20934431;Dbxref=PMID:20934431
P23873	UniProtKB	Mutagenesis	73	88	.	.	.	Note=Increased	half-life	in	vivo	and	in	vitro%2C	no	change	in	DNA	or	HipA-binding.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22720069;Dbxref=PMID:22720069
P23873	UniProtKB	Mutagenesis	88	88	.	.	.	Note=No	change	in	DNA	or	HipA-binding.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22720069;Dbxref=PMID:22720069
P77335	UniProtKB	Mutagenesis	88	90	.	.	.	Note=Abolishes	cytotoxic	activity.	GVA->DVD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383763;Dbxref=PMID:10383763
P77335	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Strongly	reduces	cytotoxic	activity.	Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11006277;Dbxref=PMID:11006277
P77335	UniProtKB	Mutagenesis	143	144	.	.	.	Note=Abolishes	cytotoxic	activity.	NA->DD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383763;Dbxref=PMID:10383763
P77335	UniProtKB	Mutagenesis	157	157	.	.	.	Note=Strongly	reduces	cytotoxic	activity.	N->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11006277;Dbxref=PMID:11006277
P77335	UniProtKB	Mutagenesis	165	165	.	.	.	Note=Strongly	reduces	cytotoxic	activity.	Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11006277;Dbxref=PMID:11006277
P77335	UniProtKB	Mutagenesis	183	186	.	.	.	Note=In	PMWK16%3B	retained	in	cytosol.	Loss	of	function.	Missing
P77335	UniProtKB	Mutagenesis	183	184	.	.	.	Note=Abolishes	cytotoxic	activity.	AG->DD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383763;Dbxref=PMID:10383763
P77335	UniProtKB	Mutagenesis	187	188	.	.	.	Note=Abolishes	cytotoxic	activity.	AG->DD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383763;Dbxref=PMID:10383763
P77335	UniProtKB	Mutagenesis	261	261	.	.	.	Note=Strongly	reduces	cytotoxic	activity.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11006277;Dbxref=PMID:11006277
P77335	UniProtKB	Mutagenesis	268	268	.	.	.	Note=Strongly	reduces	cytotoxic	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383763;Dbxref=PMID:10383763
P77335	UniProtKB	Mutagenesis	293	294	.	.	.	Note=Strongly	reduces	cytotoxic	activity.	GK->DA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383763;Dbxref=PMID:10383763
P23874	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Loss	of	toxicity%2C	does	not	confer	high	persistence.	Loss	of	toxicity%2C	high	persistence	and	cold	sensitivity%3B	in	hipA7%3B	when	associated	with	A-291.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14622409;Dbxref=PMID:14622409
P23874	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Loss	of	toxicity%2C	still	confers	high	persistence.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14622409;Dbxref=PMID:14622409
P23874	UniProtKB	Mutagenesis	150	150	.	.	.	Note=No	phosphorylation%3B	cells	grow	normally.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17041039;Dbxref=PMID:17041039
P23874	UniProtKB	Mutagenesis	291	291	.	.	.	Note=Retains	toxicity	and	high	persistence	but	not	cold-sensitive.	Loss	of	toxicity%2C	high	persistence	and	cold	sensitivity%3B	in	hipA7%3B	when	associated	with	S-22.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14622409;Dbxref=PMID:14622409
P23874	UniProtKB	Mutagenesis	309	309	.	.	.	Note=Loss	of	autophosphorylation%3B	cells	grow	normally%3B	protein	can	accumulate	to	high	levels	in	E.coli.	D->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17041039;Dbxref=PMID:17041039
P23874	UniProtKB	Mutagenesis	332	332	.	.	.	Note=Loss	of	autophosphorylation%3B	cells	grow	normally.	D->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17041039;Dbxref=PMID:17041039
P67910	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Severely	compromises	epimerase	activitie.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17316025;Dbxref=PMID:17316025
P67910	UniProtKB	Mutagenesis	178	178	.	.	.	Note=Severely	compromises	epimerase	activitie.	K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17316025;Dbxref=PMID:17316025
P67910	UniProtKB	Mutagenesis	208	208	.	.	.	Note=Activity	similar	to	that	of	the	wild-type.	K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17316025;Dbxref=PMID:17316025
P67910	UniProtKB	Mutagenesis	210	210	.	.	.	Note=Activity	similar	to	that	of	the	wild-type.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17316025;Dbxref=PMID:17316025
P24232	UniProtKB	Mutagenesis	29	29	.	.	.	Note=15	to	35-fold	reduction	in	NO	dioxygenase	activity.	Y->E%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10777548;Dbxref=PMID:10777548
P24232	UniProtKB	Mutagenesis	29	29	.	.	.	Note=30-fold	reduction	in	NO	dioxygenase	activity%2C	and	80-fold	increase	in	the	O(2)	dissociation	rate	constant.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10777548;Dbxref=PMID:10777548
P0A7B8	UniProtKB	Mutagenesis	2	2	.	.	.	Note=80%25	reduced	protease	activitin	the	absence	of	HslU.	Almost	no	effect	in	the	presence	of	HslU.	T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9257689;Dbxref=PMID:9257689
P0A7B8	UniProtKB	Mutagenesis	2	2	.	.	.	Note=No	protease	activity.	T->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9257689;Dbxref=PMID:9257689
P0A7B8	UniProtKB	Mutagenesis	3	3	.	.	.	Note=80%25	reduced	protease	activity.	T->S%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9257689;Dbxref=PMID:9257689
P0A7B8	UniProtKB	Mutagenesis	6	6	.	.	.	Note=No	effect.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9257689;Dbxref=PMID:9257689
P0A7B8	UniProtKB	Mutagenesis	104	104	.	.	.	Note=50%25	reduced	protease	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9257689;Dbxref=PMID:9257689
P0A7B8	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Almost	no	protease	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9257689;Dbxref=PMID:9257689
P0A7B8	UniProtKB	Mutagenesis	144	144	.	.	.	Note=No	effect.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9257689;Dbxref=PMID:9257689
P0A7B8	UniProtKB	Mutagenesis	160	160	.	.	.	Note=No	protease	activity.	Cannot	form	complexes	with	HslU.	C->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9722513;Dbxref=PMID:9722513
P0A7B8	UniProtKB	Mutagenesis	173	173	.	.	.	Note=Almost	no	protease	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9257689;Dbxref=PMID:9257689
P23894	UniProtKB	Mutagenesis	105	105	.	.	.	Note=Does	not	complement	a	double	ftsH/htpX	disruption	mutant.	N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12081643;Dbxref=PMID:12081643
P23894	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Does	not	complement	a	double	ftsH/htpX	disruption	mutant.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12081643;Dbxref=PMID:12081643
P23894	UniProtKB	Mutagenesis	139	139	.	.	.	Note=Does	not	complement	a	double	ftsH/htpX	disruption	mutant.	No	self-degradation.	H->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12081643;Dbxref=PMID:12081643
P23894	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Does	not	complement	a	double	ftsH/htpX	disruption	mutant.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12081643;Dbxref=PMID:12081643
P23894	UniProtKB	Mutagenesis	222	222	.	.	.	Note=Does	not	complement	a	double	ftsH/htpX	disruption	mutant.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12081643;Dbxref=PMID:12081643
P23894	UniProtKB	Mutagenesis	226	226	.	.	.	Note=Does	not	complement	a	double	ftsH/htpX	disruption	mutant.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12081643;Dbxref=PMID:12081643
P23894	UniProtKB	Mutagenesis	276	276	.	.	.	Note=Does	not	complement	a	double	ftsH/htpX	disruption	mutant.	H->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12081643;Dbxref=PMID:12081643
P0AEV9	UniProtKB	Mutagenesis	16	16	.	.	.	Note=No	protease	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10727938;Dbxref=PMID:10727938
P0AEV9	UniProtKB	Mutagenesis	62	62	.	.	.	Note=No	protease	activity.	D->N%2CM;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10727938;Dbxref=PMID:10727938
P0AEV9	UniProtKB	Mutagenesis	90	90	.	.	.	Note=A	little	protease	activity	remaining.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10727938;Dbxref=PMID:10727938
P16528	UniProtKB	Mutagenesis	143	143	.	.	.	Note=Strongly	reduced	promoter	bindingand	tetramerization.	L->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17426033;Dbxref=PMID:17426033
P16528	UniProtKB	Mutagenesis	146	146	.	.	.	Note=Strongly	reduced	promoter	bindingand	tetramerization.	M->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17426033;Dbxref=PMID:17426033
P16528	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Strongly	reduced	promoter	bindingand	tetramerization.	L->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17426033;Dbxref=PMID:17426033
P16528	UniProtKB	Mutagenesis	220	220	.	.	.	Note=Loss	of	promoter	bindingand	tetramerization.	L->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17426033;Dbxref=PMID:17426033
P0A6H5	UniProtKB	Mutagenesis	63	63	.	.	.	Note=Can	neither	bind	nor	hydrolyze	ATP.	Do	not	form	multimers%2C	but	stays	as	monomer.	K->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8977096;Dbxref=PMID:8977096
P0A6H5	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Some	effect	on	protease	activity.	K->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114186;Dbxref=PMID:11114186
P0A6H5	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Severly	reduced	protease	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114186;Dbxref=PMID:11114186
P0A6H5	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Partial	loss	of	protease	activity.	Y->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114186;Dbxref=PMID:11114186
P0A6H5	UniProtKB	Mutagenesis	92	92	.	.	.	Note=Partial	loss	of	protease	activity.	V->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114186;Dbxref=PMID:11114186
P0A6H5	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Almost	no	protease	or	ATP	hydrolysis	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114186;Dbxref=PMID:11114186
P0A6H5	UniProtKB	Mutagenesis	95	95	.	.	.	Note=Partial	loss	of	protease	activity.	E->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114186;Dbxref=PMID:11114186
P0A6H5	UniProtKB	Mutagenesis	262	262	.	.	.	Note=No	effect	on	ATP	hydrolysis.	Can	support	HslV-mediated	proteolysis	at	wild-type	levels.	C->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9722513;Dbxref=PMID:9722513
P0A6H5	UniProtKB	Mutagenesis	266	266	.	.	.	Note=No	effect.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114186;Dbxref=PMID:11114186
P0A6H5	UniProtKB	Mutagenesis	286	286	.	.	.	Note=Reduced	protease	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114186;Dbxref=PMID:11114186
P0A6H5	UniProtKB	Mutagenesis	288	288	.	.	.	Note=No	ATP	hydrolysis	activity.	Binds	ATP	with	lower	affinity	than	wild-type.	Can	support	HslV-mediated	proteolysis	to	some	extent.	C->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9722513;Dbxref=PMID:9722513
P0A6H5	UniProtKB	Mutagenesis	312	312	.	.	.	Note=No	effect.	I->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114186;Dbxref=PMID:11114186
P0A6H5	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Complete	loss	of	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114186;Dbxref=PMID:11114186
P0A6H5	UniProtKB	Mutagenesis	325	325	.	.	.	Note=Complete	loss	of	activity.	Forms	wild-type	complexes	with	HslV	and	is	able	to	bind	ATP.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114186;Dbxref=PMID:11114186
P0A6H5	UniProtKB	Mutagenesis	385	385	.	.	.	Note=No	effect.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114186;Dbxref=PMID:11114186
P0A6H5	UniProtKB	Mutagenesis	393	393	.	.	.	Note=Complete	loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114186;Dbxref=PMID:11114186
P0A6H5	UniProtKB	Mutagenesis	436	436	.	.	.	Note=Partial	loss	of	protease	activity%3B	when	associated	with	K-437.	E->K
P0A6H5	UniProtKB	Mutagenesis	437	437	.	.	.	Note=Partial	loss	of	protease	activity%3B	when	associated	with	K-436.	D->K
P0ACG4	UniProtKB	Mutagenesis	15	15	.	.	.	Note=No	action	on	toxicity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1943700;Dbxref=PMID:1943700
P0ACG4	UniProtKB	Mutagenesis	25	25	.	.	.	Note=Non-toxic.	T->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1943700;Dbxref=PMID:1943700
P0ACG4	UniProtKB	Mutagenesis	29	29	.	.	.	Note=Non-toxic.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1943700;Dbxref=PMID:1943700
P0ACG4	UniProtKB	Mutagenesis	30	30	.	.	.	Note=Prevents	the	formation	of	dimer.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1943700;Dbxref=PMID:1943700
P0ACG4	UniProtKB	Mutagenesis	41	41	.	.	.	Note=Non-toxic.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1943700;Dbxref=PMID:1943700
P0ACG4	UniProtKB	Mutagenesis	49	49	.	.	.	Note=Non-toxic.	S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1943700;Dbxref=PMID:1943700
P76658	UniProtKB	Mutagenesis	195	195	.	.	.	Note=Loss	of	activity.	N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16030223;Dbxref=PMID:16030223
P76658	UniProtKB	Mutagenesis	198	198	.	.	.	Note=Loss	of	activity.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16030223;Dbxref=PMID:16030223
P76658	UniProtKB	Mutagenesis	264	264	.	.	.	Note=Loss	of	activity.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16030223;Dbxref=PMID:16030223
P76658	UniProtKB	Mutagenesis	264	264	.	.	.	Note=Loss	of	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16030223;Dbxref=PMID:16030223
P03960	UniProtKB	Mutagenesis	377	377	.	.	.	Note=Loss	of	ATPase	activity.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16354672;Dbxref=PMID:16354672
P03960	UniProtKB	Mutagenesis	377	377	.	.	.	Note=Slight	decrease	in	ATPase	activity.	F->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16354672;Dbxref=PMID:16354672
P03960	UniProtKB	Mutagenesis	384	384	.	.	.	Note=Decrease	in	ATPase	activity.	S->A%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16354672;Dbxref=PMID:16354672
P03960	UniProtKB	Mutagenesis	395	395	.	.	.	Note=Strong	decrease	in	ATPase	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16354672;Dbxref=PMID:16354672
P03960	UniProtKB	Mutagenesis	399	399	.	.	.	Note=Decrease	in	ATPase	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16354672;Dbxref=PMID:16354672
P0A6B7	UniProtKB	Mutagenesis	328	328	.	.	.	Note=Loss	of	cysteine	desulfurization.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10739946;Dbxref=PMID:10739946
P0A6B7	UniProtKB	Mutagenesis	376	404	.	.	.	Note=Normal	cysteine	desulfurase	activity%2C	decreased	binding	to	IscU%2C	decreased	sulfur	transfer	to	IscU%2C	decreased	Fe-S	cluster	assembly.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11577100;Dbxref=PMID:11577100
P0A754	UniProtKB	Mutagenesis	41	41	.	.	.	Note=Strongly	reduced	potassium	efflux.D->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19523906;Dbxref=PMID:19523906
P0A754	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Does	not	bind	FMN.	Lacks	oxidoreductase	activity%2C	but	is	still	able	to	activate	potassium	efflux.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21742892;Dbxref=PMID:21742892
P0A754	UniProtKB	Mutagenesis	112	112	.	.	.	Note=Lacks	oxidoreductase	activity%2C	but	is	still	able	to	activate	potassium	efflux.	H->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21742892;Dbxref=PMID:21742892
P0A754	UniProtKB	Mutagenesis	149	149	.	.	.	Note=Lacks	oxidoreductase	activity%2C	but	is	still	able	to	activate	potassium	efflux.	F->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21742892;Dbxref=PMID:21742892
P45395	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Inactive.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19664604;Dbxref=PMID:19664604
P45395	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Shows	9.5%25	of	residual	activity	compared	to	the	wild-type.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20954237;Dbxref=PMID:20954237
P45395	UniProtKB	Mutagenesis	111	111	.	.	.	Note=Shows	62%25	of	residual	activity	compared	to	the	wild-type.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19664604;Dbxref=PMID:19664604
P45395	UniProtKB	Mutagenesis	152	152	.	.	.	Note=Shows	19%25	of	residual	activity	compared	to	the	wild-type.	It	is	able	to	support	growth.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19664604;Dbxref=PMID:19664604
P45395	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Inactive.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19664604;Dbxref=PMID:19664604
P30131	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Loss	of	activity.	R->E%2CH%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15291820;Dbxref=PMID:15291820
P30131	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Diminishes	activity.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15291820;Dbxref=PMID:15291820
P30131	UniProtKB	Mutagenesis	112	112	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12377778;Dbxref=PMID:12377778
P30131	UniProtKB	Mutagenesis	162	162	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12377778;Dbxref=PMID:12377778
P30131	UniProtKB	Mutagenesis	475	475	.	.	.	Note=Loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12377778;Dbxref=PMID:12377778
P30131	UniProtKB	Mutagenesis	476	476	.	.	.	Note=Carbamoyl	phosphate-dependent	ATP	hydrolysis	activity	diminished	in	vitro	but	sufficient	for	wild-type-like	phenotype.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15291820;Dbxref=PMID:15291820
P0A707	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Reduced	ribosome	binding.	Y->F%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1457399;Dbxref=PMID:1457399
P0A707	UniProtKB	Mutagenesis	110	110	.	.	.	Note=Reduced	ribosome	binding.	K->R%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1457399;Dbxref=PMID:1457399
P0A6X7	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Alters	DNA-binding	specificity.	P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1531459;Dbxref=PMID:1531459
P0A6X7	UniProtKB	Mutagenesis	66	66	.	.	.	Note=Alters	DNA-binding	specificity.	K->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1531459;Dbxref=PMID:1531459
P0A6Y1	UniProtKB	Mutagenesis	44	44	.	.	.	Note=Altered	DNA-binding	specificity.	E->G%2CK%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1531459;Dbxref=PMID:1531459
P0ADG7	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Causes	a	38-fold	increase	in	the	value	of	Km	for	K(+).	No	change	is	observed	in	the	value	of	Km	for	IMP.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9341229;Dbxref=PMID:9341229
P0ADG7	UniProtKB	Mutagenesis	50	50	.	.	.	Note=Causes	a	17-fold	increase	in	the	value	of	Km	for	K(+).	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9341229;Dbxref=PMID:9341229
P0ADG7	UniProtKB	Mutagenesis	54	54	.	.	.	Note=No	effect.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9341229;Dbxref=PMID:9341229
P0ADG7	UniProtKB	Mutagenesis	138	138	.	.	.	Note=No	effect.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9341229;Dbxref=PMID:9341229
P0ADG7	UniProtKB	Mutagenesis	200	200	.	.	.	Note=No	effect.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9341229;Dbxref=PMID:9341229
P0ADG7	UniProtKB	Mutagenesis	243	243	.	.	.	Note=No	effect.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9341229;Dbxref=PMID:9341229
P0ADG7	UniProtKB	Mutagenesis	248	248	.	.	.	Note=Causes	a	130-fold	decreasin	the	value	of	kcat.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9341229;Dbxref=PMID:9341229
P0ADG7	UniProtKB	Mutagenesis	338	338	.	.	.	Note=Decreases	the	value	of	kcat	by	600-fold.	Increases	the	value	of	Km	for	IMP	by	12-fold.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9341229;Dbxref=PMID:9341229
P0ADG7	UniProtKB	Mutagenesis	369	369	.	.	.	Note=No	effect.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9341229;Dbxref=PMID:9341229
P0ADG7	UniProtKB	Mutagenesis	373	373	.	.	.	Note=No	effect.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9341229;Dbxref=PMID:9341229
P0ADG7	UniProtKB	Mutagenesis	469	469	.	.	.	Note=Increases	the	value	of	Km	for	K(+)	by	17-fold.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9341229;Dbxref=PMID:9341229
P0AAN3	UniProtKB	Mutagenesis	117	117	.	.	.	Note=Important	decrease	in	GTPase	activity.	K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7601092;Dbxref=PMID:7601092
P0AAN3	UniProtKB	Mutagenesis	241	241	.	.	.	Note=85-fold	decrease	in	Kcat/KMvalue	of	GTPase	activity	and	loss	of	the	specificity	for	GTP.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7601092;Dbxref=PMID:7601092
P37595	UniProtKB	Mutagenesis	179	179	.	.	.	Note=Catalytically	inactive.	T->A;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:18323626;Dbxref=PMID:18323626
P39377	UniProtKB	Mutagenesis	77	77	.	.	.	Note=Reduces	activity	100000-fold.	E->D%2CQ;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15882050,ECO:0000269|PubMed:16289685;Dbxref=PMID:15882050,PMID:16289685
P39377	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Reduces	activity	1000-fold.	Y->A%2CF;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15882050,ECO:0000269|PubMed:16289685;Dbxref=PMID:15882050,PMID:16289685
P39377	UniProtKB	Mutagenesis	169	169	.	.	.	Note=Reduces	activity	1000-fold.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15882050;Dbxref=PMID:15882050
P39377	UniProtKB	Mutagenesis	169	169	.	.	.	Note=Loss	of	activity.	R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15882050;Dbxref=PMID:15882050
P39377	UniProtKB	Mutagenesis	233	233	.	.	.	Note=Reduces	activity	1000-fold.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15882050;Dbxref=PMID:15882050
P39377	UniProtKB	Mutagenesis	233	233	.	.	.	Note=Loss	of	activity.	R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15882050;Dbxref=PMID:15882050
P39377	UniProtKB	Mutagenesis	285	285	.	.	.	Note=Reduces	activity	100000-fold.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15882050;Dbxref=PMID:15882050
P0A705	UniProtKB	Mutagenesis	158	158	.	.	.	Note=Produces	35%25	of	isoform	beta	(i.e.	only	beta2).	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1374802;Dbxref=PMID:1374802
P0A705	UniProtKB	Mutagenesis	158	158	.	.	.	Note=Produces	70%25	of	isoform	beta	(i.e.	only	beta2).	V->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1374802;Dbxref=PMID:1374802
P0A705	UniProtKB	Mutagenesis	158	158	.	.	.	Note=Produces	66%25	of	isoform	beta	(i.e.	only	beta2).	V->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1374802;Dbxref=PMID:1374802
P0A705	UniProtKB	Mutagenesis	165	165	.	.	.	Note=Produces	reduces	amount	of	isoformbeta	(i.e.	only	beta1).	Reduced	growth	at	37	degrees	Celsius%2C	greatly	reduced	growth	at	30	degrees	Celsius.	Growth	is	more	impaired%3B	when	associated	with	silent	V-158	GUG	to	GUC.	M->I%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1374802;Dbxref=PMID:1374802
P08200	UniProtKB	Mutagenesis	100	100	.	.	.	Note=Abolishes	enzymatic	activity.	K->R%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21151122;Dbxref=PMID:21151122
P08200	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Reduced	affinity	for	isocitrate.	S->D%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2204109;Dbxref=PMID:2204109
P08200	UniProtKB	Mutagenesis	160	160	.	.	.	Note=Large	decrease	in	activitand	a	small	increase	in	substrate	affinity.	Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7761851,ECO:0000269|PubMed:7819221;Dbxref=PMID:7761851,PMID:7819221
P08200	UniProtKB	Mutagenesis	230	230	.	.	.	Note=Decrease	in	activity	and	substrate	affinity.	K->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7761851,ECO:0000269|PubMed:7819221;Dbxref=PMID:7761851,PMID:7819221
P08200	UniProtKB	Mutagenesis	242	242	.	.	.	Note=Strongly	impairs	enzymatic	activity.	K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21151122;Dbxref=PMID:21151122
P08200	UniProtKB	Mutagenesis	242	242	.	.	.	Note=Impairs	enzymatic	activity.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21151122;Dbxref=PMID:21151122
Q46822	UniProtKB	Mutagenesis	104	104	.	.	.	Note=Reduces	activity	by	99%25.	Y->A
Q46822	UniProtKB	Mutagenesis	104	104	.	.	.	Note=Reduces	activity	by	97%25.	Y->F
P62617	UniProtKB	Mutagenesis	8	8	.	.	.	Note=Loss	of	activity.	D->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11829504;Dbxref=PMID:11829504
P62617	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Loss	of	activity.	H->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11829504;Dbxref=PMID:11829504
P62617	UniProtKB	Mutagenesis	56	56	.	.	.	Note=35%25	decrease	of	activity.	D->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11829504;Dbxref=PMID:11829504
P62617	UniProtKB	Mutagenesis	142	142	.	.	.	Note=Little	effect	on	the	overallstructure%3B	when	associated	with	L-144.	R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16511114;Dbxref=PMID:16511114
P62617	UniProtKB	Mutagenesis	144	144	.	.	.	Note=Little	effect	on	the	overallstructure%3B	when	associated	with	M-142.	E->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16511114;Dbxref=PMID:16511114
P69441	UniProtKB	Mutagenesis	9	9	.	.	.	Note=No	loss	of	enzyme	activity.	P->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:2223776,ECO:0000269|PubMed:8451239;Dbxref=PMID:2223776,PMID:8451239
P69441	UniProtKB	Mutagenesis	10	10	.	.	.	Note=No	loss	of	enzyme	activity.	G->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:2223776,ECO:0000269|PubMed:2844237,ECO:0000269|PubMed:8451239;Dbxref=PMID:2223776,PMID:2844237,PMID:8451239
P69441	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Drastic	reduction	in	enzyme	activity.	K->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:2223776,ECO:0000269|PubMed:2844237;Dbxref=PMID:2223776,PMID:2844237
P62623	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Loss	of	activity.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15469281,ECO:0000269|PubMed:20080550;Dbxref=PMID:15469281,PMID:20080550
P62623	UniProtKB	Mutagenesis	41	41	.	.	.	Note=No	effect	on	the	activity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19569147;Dbxref=PMID:19569147
P62623	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Reduces	activity	2-fold.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19569147;Dbxref=PMID:19569147
P62623	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Loss	of	activity.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15469281,ECO:0000269|PubMed:20080550;Dbxref=PMID:15469281,PMID:20080550
P62623	UniProtKB	Mutagenesis	99	99	.	.	.	Note=No	effect	on	the	activity.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19569147;Dbxref=PMID:19569147
P62623	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Reduces	activity	100-fold.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19569147;Dbxref=PMID:19569147
P62623	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Reduces	activity	100-fold.	E->D%2CQ;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19569147,ECO:0000269|PubMed:22137895;Dbxref=PMID:19569147,PMID:22137895
P62623	UniProtKB	Mutagenesis	167	167	.	.	.	Note=Reduces	activity	3-fold.	T->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19569147,ECO:0000269|PubMed:22137895;Dbxref=PMID:19569147,PMID:22137895
P62623	UniProtKB	Mutagenesis	167	167	.	.	.	Note=No	effect	on	the	activity.	T->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19569147,ECO:0000269|PubMed:22137895;Dbxref=PMID:19569147,PMID:22137895
P62623	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Loss	of	activity.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15469281,ECO:0000269|PubMed:20080550;Dbxref=PMID:15469281,PMID:20080550
P62623	UniProtKB	Mutagenesis	225	225	.	.	.	Note=Reduces	activity	100-fold.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19569147;Dbxref=PMID:19569147
P62623	UniProtKB	Mutagenesis	227	227	.	.	.	Note=Reduces	activity	20-fold.	N->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19569147;Dbxref=PMID:19569147
P0AGK8	UniProtKB	Mutagenesis	92	92	.	.	.	Note=No	effect	on	activation	of	the	suf	operon%2C	no	effect	on	repression	of	rnlA.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16824106,ECO:0000269|PubMed:20421606;Dbxref=PMID:16824106,PMID:20421606
P0AGK8	UniProtKB	Mutagenesis	98	98	.	.	.	Note=No	effect	on	activation	of	the	suf	operon%2C	no	effect	on	repression	of	rnlA.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16824106,ECO:0000269|PubMed:20421606;Dbxref=PMID:16824106,PMID:20421606
P0AGK8	UniProtKB	Mutagenesis	104	104	.	.	.	Note=No	effect	on	activation	of	the	suf	operon%2C	no	effect	on	repression	of	rnlA.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16824106,ECO:0000269|PubMed:20421606;Dbxref=PMID:16824106,PMID:20421606
P0ACD4	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Stabilizes	apo-protein	in	the	S-state	(structured).	D->A%2CL%2CV;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22203963,ECO:0000269|PubMed:22734684;Dbxref=PMID:22203963,PMID:22734684
P0ACD4	UniProtKB	Mutagenesis	39	39	.	.	.	Note=No	effect	on	equilibrium	betweenS-	and	D-state	(disordered).	D->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22203963,ECO:0000269|PubMed:22734684;Dbxref=PMID:22203963,PMID:22734684
P0ACD4	UniProtKB	Mutagenesis	89	89	.	.	.	Note=Stabilizes	apo-protein	in	the	D-state%3B	Fe-S	cluster	assembly	3-fold	slower	than	wild-type.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22203963;Dbxref=PMID:22203963
P0ACD4	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Stabilizes	apo-protein	in	the	S-state%3B	biphasic	Fe-S	cluster	assembly	7-fold	slower	than	wild-type.	N->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22203963,ECO:0000269|PubMed:22734684;Dbxref=PMID:22203963,PMID:22734684
P0ACD4	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Stabilizes	apo-protein	in	the	D-state%3B	Fe-S	cluster	assembly	3-fold	slower	than	wild-type.	N->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22203963,ECO:0000269|PubMed:22734684;Dbxref=PMID:22203963,PMID:22734684
P0ACD4	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Stabilizes	apo-protein	in	the	S-state%3B	biphasic	Fe-S	cluster	assembly	7-fold	slower	than	wild-type.	S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22203963,ECO:0000269|PubMed:22734684;Dbxref=PMID:22203963,PMID:22734684
P0ACD4	UniProtKB	Mutagenesis	111	111	.	.	.	Note=Stabilizes	apo-protein	in	the	S-state%3B	biphasic	Fe-S	cluster	assembly	7-fold	slower	than	wild-type.	E->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22203963,ECO:0000269|PubMed:22734684;Dbxref=PMID:22203963,PMID:22734684
Q46893	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Strong	decrease	in	activity.	K->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11427897;Dbxref=PMID:11427897
Q46893	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Loss	of	activity.	T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12859972;Dbxref=PMID:12859972
Q46893	UniProtKB	Mutagenesis	191	191	.	.	.	Note=Loss	of	activity.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12859972;Dbxref=PMID:12859972
Q46893	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Decrease	in	activity.	K->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11427897;Dbxref=PMID:11427897
P62615	UniProtKB	Mutagenesis	239	239	.	.	.	Note=Loss	of	activity.	G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12859972;Dbxref=PMID:12859972
P62615	UniProtKB	Mutagenesis	240	240	.	.	.	Note=Loss	of	activity.	T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12859972;Dbxref=PMID:12859972
P0AAC8	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Decrease	of	iron	binding	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15247288;Dbxref=PMID:15247288
P0AAC8	UniProtKB	Mutagenesis	99	99	.	.	.	Note=Loss	of	iron	binding	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15247288;Dbxref=PMID:15247288
P0AAC8	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Loss	of	iron	binding	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15247288;Dbxref=PMID:15247288
P62620	UniProtKB	Mutagenesis	322	322	.	.	.	Note=Loss	of	activity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12859972;Dbxref=PMID:12859972
P62620	UniProtKB	Mutagenesis	328	328	.	.	.	Note=Loss	of	activity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12859972;Dbxref=PMID:12859972
P62620	UniProtKB	Mutagenesis	335	335	.	.	.	Note=Loss	of	activity.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12859972;Dbxref=PMID:12859972
P0A7A9	UniProtKB	Mutagenesis	21	21	.	.	.	Note=16%25	activity.	E->D
P0A7A9	UniProtKB	Mutagenesis	30	30	.	.	.	Note=2%25	activity.	K->R
P0A7A9	UniProtKB	Mutagenesis	32	32	.	.	.	Note=6%25	activity.	E->D
P0A7A9	UniProtKB	Mutagenesis	44	44	.	.	.	Note=10%25	activity.	R->K
P0A7A9	UniProtKB	Mutagenesis	52	52	.	.	.	Note=64%25	activity.	Y->F
P0A7A9	UniProtKB	Mutagenesis	56	56	.	.	.	Note=7%25	activity.	Y->F
P0A7A9	UniProtKB	Mutagenesis	66	66	.	.	.	Note=6%25	activity.	D->E
P0A7A9	UniProtKB	Mutagenesis	68	68	.	.	.	Note=1%25	activity.	D->E
P0A7A9	UniProtKB	Mutagenesis	71	71	.	.	.	Note=No	activity.	D->E
P0A7A9	UniProtKB	Mutagenesis	98	98	.	.	.	Note=22%25	activity.	D->E
P0A7A9	UniProtKB	Mutagenesis	98	98	.	.	.	Note=No	activity.	D->V
P0A7A9	UniProtKB	Mutagenesis	99	99	.	.	.	Note=33%25	activity.	E->V
P0A7A9	UniProtKB	Mutagenesis	103	103	.	.	.	Note=3%25	activity.	D->E
P0A7A9	UniProtKB	Mutagenesis	103	103	.	.	.	Note=No	activity.	D->V
P0A7A9	UniProtKB	Mutagenesis	105	105	.	.	.	Note=No	activity.	K->I
P0A7A9	UniProtKB	Mutagenesis	105	105	.	.	.	Note=3%25	activity.	K->R
P0A7A9	UniProtKB	Mutagenesis	142	142	.	.	.	Note=22%25	activity.	Y->F
P0AAN9	UniProtKB	Mutagenesis	9	9	.	.	.	Note=Loss	of	ability	to	interacwith	RssB.	L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16600914;Dbxref=PMID:16600914
P03959	UniProtKB	Mutagenesis	232	232	.	.	.	Note=Decrease	in	K(+)	affinity	and	loss	of	cation	selectivity.	G->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12218037;Dbxref=PMID:12218037
P03961	UniProtKB	Mutagenesis	140	150	.	.	.	Note=Cell	does	not	grow	at	low	potassium	concentrations.	QIPRVAKARNL->AIPAASKSANA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21711450;Dbxref=PMID:21711450
P03819	UniProtKB	Mutagenesis	262	262	.	.	.	Note=Increases	potassium	efflux	in	the	absence	of	glutathione%2C	but	not	in	the	presence	of	glutathione.	Increases	constitutive	potassium	efflux%3B	when	associated	with	D-551.	E->K
P03819	UniProtKB	Mutagenesis	264	264	.	.	.	Note=Increases	constitutive	potassium	efflux.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19523906;Dbxref=PMID:19523906
P03819	UniProtKB	Mutagenesis	412	412	.	.	.	Note=Increases	constitutive	potassium	efflux	and	reduces	glutathione-mediated	inhibition	of	potassium	efflux.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21041667;Dbxref=PMID:21041667
P03819	UniProtKB	Mutagenesis	412	412	.	.	.	Note=Increases	constitutive	potassium	efflux	and	abolishes	regulation	of	potassium	efflux	by	glutathione	and	glutathione	adducts.	Q->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21041667;Dbxref=PMID:21041667
P03819	UniProtKB	Mutagenesis	416	416	.	.	.	Note=Increases	constitutive	potassium	efflux	and	abolishes	regulation	of	potassium	efflux	by	glutathione	and	glutathione	adducts%3B	when	associated	with	A-516	and	A-551.	R->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19523906,ECO:0000269|PubMed:21041667;Dbxref=PMID:19523906,PMID:21041667
P03819	UniProtKB	Mutagenesis	416	416	.	.	.	Note=Increased	constitutive	potassium	efflux.	R->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19523906,ECO:0000269|PubMed:21041667;Dbxref=PMID:19523906,PMID:21041667
P03819	UniProtKB	Mutagenesis	441	441	.	.	.	Note=Reduced	activation	of	potassium	efflux	by	glutathione	adducts.	F->D%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21041667;Dbxref=PMID:21041667
P03819	UniProtKB	Mutagenesis	441	441	.	.	.	Note=No	effect	on	activation	of	potassium	efflux	by	glutathione	adducts.	F->W%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21041667;Dbxref=PMID:21041667
P03819	UniProtKB	Mutagenesis	499	499	.	.	.	Note=Strongly	reduced	activation	of	potassium	efflux	by	glutathione	adducts.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21041667;Dbxref=PMID:21041667
P03819	UniProtKB	Mutagenesis	499	499	.	.	.	Note=Mildly	reduced	activation	of	potassium	efflux	by	glutathione	adducts.	D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21041667;Dbxref=PMID:21041667
P03819	UniProtKB	Mutagenesis	499	499	.	.	.	Note=No	effect	on	potassium	efflux.D->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21041667;Dbxref=PMID:21041667
P03819	UniProtKB	Mutagenesis	516	516	.	.	.	Note=Increases	constitutive	potassium	efflux	and	abolishes	regulation	of	potassium	efflux	by	glutathione	and	glutathione	adducts%3B	when	associated	with	A-416	and	A-551.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21041667;Dbxref=PMID:21041667
P03819	UniProtKB	Mutagenesis	520	520	.	.	.	Note=Strongly	reduced	potassium	efflux.E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19523906;Dbxref=PMID:19523906
P03819	UniProtKB	Mutagenesis	522	522	.	.	.	Note=Strongly	reduced	potassium	efflux.A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19523906;Dbxref=PMID:19523906
P03819	UniProtKB	Mutagenesis	526	526	.	.	.	Note=Strongly	reduced	potassium	efflux.G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19523906;Dbxref=PMID:19523906
P03819	UniProtKB	Mutagenesis	551	551	.	.	.	Note=Increases	constitutive	potassium	efflux	and	abolishes	regulation	of	potassium	efflux	by	glutathione	and	glutathione	adducts%3B	when	associated	with	A-416	and	A-516.	N->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19523906,ECO:0000269|PubMed:21041667;Dbxref=PMID:19523906,PMID:21041667
P03819	UniProtKB	Mutagenesis	551	551	.	.	.	Note=Increases	constitutive	potassium	efflux%3B	when	associated	with	K-262.	N->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19523906,ECO:0000269|PubMed:21041667;Dbxref=PMID:19523906,PMID:21041667
P0A717	UniProtKB	Mutagenesis	220	220	.	.	.	Note=4-fold	decrease	in	the	affinity	binding	for	Rib-5-P	in	the	presence	of	magnesium	ions.	In	the	presence	of	cobalt	ions%2C	it	shows	a	15-fold	decrease	in	the	affinity	binding	for	Rib-5-PD->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8679571;Dbxref=PMID:8679571
P0A717	UniProtKB	Mutagenesis	220	220	.	.	.	Note=With	magnesium	or	manganese	ions%2C	the	affinity	binding	values	for	ATP	and	Rib-5-P	are	comparable	to	those	of	the	wild-type.	D->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8679571;Dbxref=PMID:8679571
P0A717	UniProtKB	Mutagenesis	221	221	.	.	.	Note=The	affinity	binding	for	ATP	is	comparable	to	those	of	the	wild-type%2C	apart	from	a	slight	decrease	in	the	presence	of	manganese	ions.	The	affinity	binding	for	Rib-5-P	is	greatlydecreased	in	the	presence	of	both	manganese	and	cobalt	ions	but	only	about	2-fold	in	the	presence	of	magnesium	ions.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8679571;Dbxref=PMID:8679571
P0A717	UniProtKB	Mutagenesis	224	224	.	.	.	Note=With	magnesium	or	manganese	ions%2C	the	affinity	binding	values	for	ATP	and	Rib-5-P	are	comparable	to	those	of	the	wild-type.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8679571;Dbxref=PMID:8679571
P0A717	UniProtKB	Mutagenesis	224	224	.	.	.	Note=With	magnesium	or	manganese	ions%2C	the	affinity	binding	values	for	ATP	and	Rib-5-P	are	comparable	to	those	of	the	wild-type.	D->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8679571;Dbxref=PMID:8679571
P02943	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Reduces	ligand	affinity	and	pore	size%2C	no	longer	selective	for	maltodextrins.	R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3301537;Dbxref=PMID:3301537
P02943	UniProtKB	Mutagenesis	99	99	.	.	.	Note=Decreases	starch	affinity%2C	slightlincreases	maltose	affinity.	W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3301537;Dbxref=PMID:3301537
P02943	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Decreases	maltodextrin	affinity%2C	increases	sucrose	binding	and	transport.	R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3301537;Dbxref=PMID:3301537
P02943	UniProtKB	Mutagenesis	134	134	.	.	.	Note=Considerable	increase	in	pore	size	and	sucrose	transport%2C	slight	decrease	in	maltose	transport%3B	when	associated	with	A-143.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11742115;Dbxref=PMID:11742115
P02943	UniProtKB	Mutagenesis	134	134	.	.	.	Note=Slight	increase	in	pore	size%3B	increase	in	sucrose	transport	and	slight	decrease	in	maltose	transport%3B	when	associated	with	D-143	and	F-146.	R->D%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11742115;Dbxref=PMID:11742115
P02943	UniProtKB	Mutagenesis	143	143	.	.	.	Note=Increases	affinity	for	starch	and	maltose%2C	pore	size	and	transport	of	maltohexaose.	Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11742115,ECO:0000269|PubMed:3301537;Dbxref=PMID:11742115,PMID:3301537
P02943	UniProtKB	Mutagenesis	146	146	.	.	.	Note=Increases	affinity	for	large	dextrins.	D->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11742115,ECO:0000269|PubMed:3301537;Dbxref=PMID:11742115,PMID:3301537
P02920	UniProtKB	Mutagenesis	237	237	.	.	.	Note=Defect	in	melibiose	transport.	D->N%2CG
P02920	UniProtKB	Mutagenesis	358	358	.	.	.	Note=Defect	in	melibiose	transport.	K->T
P0AB58	UniProtKB	Mutagenesis	184	184	.	.	.	Note=Does	not	affect	metal	binding%3B	when	associated	with	S-258.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24187084;Dbxref=PMID:24187084
P0AB58	UniProtKB	Mutagenesis	258	258	.	.	.	Note=Does	not	affect	metal	binding%3B	when	associated	with	S-184.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24187084;Dbxref=PMID:24187084
P0AB58	UniProtKB	Mutagenesis	357	357	.	.	.	Note=Lack	of	activity%3B	when	associated	with	S-360%3B	S-371	and	S-374.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24187084;Dbxref=PMID:24187084
P0AB58	UniProtKB	Mutagenesis	360	360	.	.	.	Note=Lack	of	activity%3B	when	associated	with	S-357%3B	S-371	and	S-374.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24187084;Dbxref=PMID:24187084
P0AB58	UniProtKB	Mutagenesis	371	371	.	.	.	Note=Lack	of	activity.	C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24722986;Dbxref=PMID:24722986
P0AB58	UniProtKB	Mutagenesis	371	371	.	.	.	Note=Lack	of	activity%3B	when	associated	with	S-357%3B	S-360	and	S-374.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24187084;Dbxref=PMID:24187084
P0AB58	UniProtKB	Mutagenesis	372	372	.	.	.	Note=Lack	of	activity.	P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24722986;Dbxref=PMID:24722986
P0AB58	UniProtKB	Mutagenesis	374	374	.	.	.	Note=Lack	of	activity%3B	when	associated	with	S-357%3B	S-360	and	S-371.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24187084;Dbxref=PMID:24187084
P0AB58	UniProtKB	Mutagenesis	378	378	.	.	.	Note=Lack	of	activity.	S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24722986;Dbxref=PMID:24722986
P00547	UniProtKB	Mutagenesis	139	139	.	.	.	Note=35-fold	decrease	in	kinase	activity.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8973190;Dbxref=PMID:8973190
P00547	UniProtKB	Mutagenesis	203	203	.	.	.	Note=2-fold	decrease	in	kinase	activity	but	nearly	no	change	in	substrates	affinity.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8973190;Dbxref=PMID:8973190
P00547	UniProtKB	Mutagenesis	206	206	.	.	.	Note=3500-fold	decrease	in	kinase	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8973190;Dbxref=PMID:8973190
P00547	UniProtKB	Mutagenesis	235	235	.	.	.	Note=250-fold	decrease	in	kinase	activity	but	no	change	in	substrates	affinity.	R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8973190;Dbxref=PMID:8973190
P00547	UniProtKB	Mutagenesis	235	235	.	.	.	Note=26200-fold	decrease	in	catalytic	efficiency.	R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8973190;Dbxref=PMID:8973190
P76143	UniProtKB	Mutagenesis	57	57	.	.	.	Note=No	activiy.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25225400;Dbxref=PMID:25225400
P76143	UniProtKB	Mutagenesis	203	203	.	.	.	Note=No	activiy.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25225400;Dbxref=PMID:25225400
P76143	UniProtKB	Mutagenesis	251	251	.	.	.	Note=No	activiy.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25225400;Dbxref=PMID:25225400
P0ADV9	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Impairs	LPS	transport.	Does	not	abolish	interaction	with	LptA.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21169485;Dbxref=PMID:21169485
P0ADV9	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Impairs	LPS	transport.	Fails	to	interacts	with	LptA.	G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21169485;Dbxref=PMID:21169485
P0ADV9	UniProtKB	Mutagenesis	177	191	.	.	.	Note=Fails	to	interact	with	LptA.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21169485;Dbxref=PMID:21169485
P31554	UniProtKB	Mutagenesis	529	538	.	.	.	Note=Impairs	assembly	of	the	LptD/LptE	complex.	Does	not	form	native	disulfide	bonds.	Severely	compromises	outer	membrane	integrity.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21257904;Dbxref=PMID:21257904
P75831	UniProtKB	Mutagenesis	47	47	.	.	.	Note=Lack	of	activity.	K->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17214741;Dbxref=PMID:17214741
P75831	UniProtKB	Mutagenesis	169	169	.	.	.	Note=Lack	of	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17214741;Dbxref=PMID:17214741
P68183	UniProtKB	Mutagenesis	190	190	.	.	.	Note=Reduction	of	transport	rate.	E->A%2CC%2CK%2CL;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10809785,ECO:0000269|PubMed:9214624;Dbxref=PMID:10809785,PMID:9214624
P68183	UniProtKB	Mutagenesis	192	192	.	.	.	Note=Loss	of	transport	and	MalK	dissociation	from	the	membrane.	A->D%2CS%2CL;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10809785,ECO:0000269|PubMed:9214624;Dbxref=PMID:10809785,PMID:9214624
P68183	UniProtKB	Mutagenesis	196	196	.	.	.	Note=No	effect.	G->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10809785,ECO:0000269|PubMed:9214624;Dbxref=PMID:10809785,PMID:9214624
P68183	UniProtKB	Mutagenesis	196	196	.	.	.	Note=Loss	of	transport	and	MalK	dissociation	from	the	membrane.	G->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10809785,ECO:0000269|PubMed:9214624;Dbxref=PMID:10809785,PMID:9214624
P68183	UniProtKB	Mutagenesis	209	209	.	.	.	Note=No	effect.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9214624;Dbxref=PMID:9214624
P0AE18	UniProtKB	Mutagenesis	79	79	.	.	.	Note=Reduces	activity	100000-fold	for	the	Co(2+)-complexed	enzyme%2C	but	only	2.6-fold	for	the	Mn(2+)-complexed	enzyme.	H->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10387007,ECO:0000269|PubMed:18855426;Dbxref=PMID:10387007,PMID:18855426
P0AE18	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Reduces	activity	50-	to	580-fold	depending	on	the	metal	ion	bound.	Binds	only	one	equivalent	of	the	divalenmetal	cation	with	affinities	identical	to	the	wild-type	enzyme.	D->A%2CE%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19019076;Dbxref=PMID:19019076
P0AE18	UniProtKB	Mutagenesis	178	178	.	.	.	Note=Reduces	activity	9000-fold	for	the	Co(2+)-complexed	enzyme.	Binds	only	one	equivalent	of	the	divalent	metal	cation	with	affinities	identical	to	the	wild-type	enzyme.	H->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10387007,ECO:0000269|PubMed:12755633;Dbxref=PMID:10387007,PMID:12755633
P0ADC1	UniProtKB	Mutagenesis	117	119	.	.	.	Note=Affects	interaction	with	LptD	and	LptD	biogenesis.	Increases	outer	membrane	permeability.	PIS->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21257909;Dbxref=PMID:21257909
P64461	UniProtKB	Mutagenesis	25	25	.	.	.	Note=3-fold	lower	specific	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21454635;Dbxref=PMID:21454635
P64461	UniProtKB	Mutagenesis	54	54	.	.	.	Note=No	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21454635;Dbxref=PMID:21454635
P64461	UniProtKB	Mutagenesis	65	65	.	.	.	Note=No	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21454635;Dbxref=PMID:21454635
P64461	UniProtKB	Mutagenesis	70	70	.	.	.	Note=100-fold	lower	specific	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21454635;Dbxref=PMID:21454635
P68187	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Suppressor	of	EAA	loop	mutations	in	MalFG.	A->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9214624;Dbxref=PMID:9214624
P68187	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Suppressor	of	EAA	loop	mutations	in	MalFG.	K->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10809785;Dbxref=PMID:10809785
P68187	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Suppressor	of	EAA	loop	mutations	in	MalFG.	V->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10809785;Dbxref=PMID:10809785
P68187	UniProtKB	Mutagenesis	117	117	.	.	.	Note=Suppressor	of	EAA	loop	mutations	in	MalFG.	V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9214624;Dbxref=PMID:9214624
P68187	UniProtKB	Mutagenesis	119	119	.	.	.	Note=Resistant	to	inhibitory	effectsof	alpha-methylglucoside	but	retains	transport	capacity.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2007546;Dbxref=PMID:2007546
P68187	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Resistant	to	inhibitory	effectsof	alpha-methylglucoside	but	retains	transport	capacity.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2250006;Dbxref=PMID:2250006
P68187	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Loss	of	maltose	transport.	Has	greater	ability	to	decrease	mal	gene	expression	than	wild-type	MalK.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2007546;Dbxref=PMID:2007546
P68187	UniProtKB	Mutagenesis	158	158	.	.	.	Note=Loss	of	maltose	transport	but	retains	ability	to	repress	mal	genes.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2007546;Dbxref=PMID:2007546
P68187	UniProtKB	Mutagenesis	228	228	.	.	.	Note=Resistant	to	inhibitory	effectsof	alpha-methylglucoside	but	retains	transport	capacity.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2007546;Dbxref=PMID:2007546
P68187	UniProtKB	Mutagenesis	241	241	.	.	.	Note=Resistant	to	inhibitory	effectsof	alpha-methylglucoside	but	retains	transport	capacity.	F->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2250006;Dbxref=PMID:2250006
P68187	UniProtKB	Mutagenesis	267	267	.	.	.	Note=Normal	maltose	transport	but	constitutive	mal	gene	expression.	W->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2007546;Dbxref=PMID:2007546
P68187	UniProtKB	Mutagenesis	278	278	.	.	.	Note=Resistant	to	inhibitory	effectsof	alpha-methylglucoside	but	retains	transport	capacity.	G->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2250006;Dbxref=PMID:2250006
P68187	UniProtKB	Mutagenesis	282	282	.	.	.	Note=Resistant	to	inhibitory	effectsof	alpha-methylglucoside	but	retains	transport	capacity.	S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2007546;Dbxref=PMID:2007546
P68187	UniProtKB	Mutagenesis	284	284	.	.	.	Note=Resistant	to	inhibitory	effectsof	alpha-methylglucoside	but	retains	transport	capacity.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2250006;Dbxref=PMID:2250006
P68187	UniProtKB	Mutagenesis	302	302	.	.	.	Note=Resistant	to	inhibitory	effectsof	alpha-methylglucoside	but	retains	transport	capacity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2007546;Dbxref=PMID:2007546
P68187	UniProtKB	Mutagenesis	308	308	.	.	.	Note=Maltose	transport	is	affectebut	retains	ability	to	interact	with	MalT.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11709552;Dbxref=PMID:11709552
P68187	UniProtKB	Mutagenesis	322	322	.	.	.	Note=Resistant	to	inhibitory	effectsof	alpha-methylglucoside	but	retains	transport	capacity.	S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2007546;Dbxref=PMID:2007546
P68187	UniProtKB	Mutagenesis	340	340	.	.	.	Note=Maltose	transport	is	affectebut	retains	ability	to	interact	with	MalT.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11709552;Dbxref=PMID:11709552
P68187	UniProtKB	Mutagenesis	346	346	.	.	.	Note=Normal	maltose	transport	but	constitutive	mal	gene	expression.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2007546;Dbxref=PMID:2007546
P68187	UniProtKB	Mutagenesis	355	355	.	.	.	Note=Maltose	transport	is	affectebut	retains	ability	to	interact	with	MalT.	F->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11709552;Dbxref=PMID:11709552
P0ADV1	UniProtKB	Mutagenesis	36	36	.	.	.	Note=No	change	in	activity.	I->D%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18534617;Dbxref=PMID:18534617
P0ADV1	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Decrease	in	activity.	I->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18534617;Dbxref=PMID:18534617
P0ADV1	UniProtKB	Mutagenesis	38	38	.	.	.	Note=No	change	in	activity.	I->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18534617;Dbxref=PMID:18534617
P0ADV1	UniProtKB	Mutagenesis	76	76	.	.	.	Note=No	change	in	activity.	R->D%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18534617;Dbxref=PMID:18534617
P0ADV1	UniProtKB	Mutagenesis	95	95	.	.	.	Note=No	change	in	activity.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18534617;Dbxref=PMID:18534617
P0ACV0	UniProtKB	Mutagenesis	132	132	.	.	.	Note=Almost	loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18656959;Dbxref=PMID:18656959
P0ACV0	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Almost	loss	of	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18656959;Dbxref=PMID:18656959
P0ACV0	UniProtKB	Mutagenesis	169	169	.	.	.	Note=169-fold	decrease	in	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18656959;Dbxref=PMID:18656959
P0ACV0	UniProtKB	Mutagenesis	200	200	.	.	.	Note=14-fold	decrease	in	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18656959;Dbxref=PMID:18656959
P0ACV0	UniProtKB	Mutagenesis	238	238	.	.	.	Note=Slight	decrease	in	activity.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18656959;Dbxref=PMID:18656959
P76445	UniProtKB	Mutagenesis	190	190	.	.	.	Note=Lack	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20384697;Dbxref=PMID:20384697
P23256	UniProtKB	Mutagenesis	233	233	.	.	.	Note=Loss	of	enzymatic	activity%3B	but	no	loss	of	repression	function.	K->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7665481;Dbxref=PMID:7665481
P27245	UniProtKB	Mutagenesis	45	45	.	.	.	Note=Increased	transcription	of	the	region	II	transcript.	V->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10760140;Dbxref=PMID:10760140
P27245	UniProtKB	Mutagenesis	77	77	.	.	.	Note=Increased	transcription	of	the	region	II	transcript.	R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10760140;Dbxref=PMID:10760140
P27245	UniProtKB	Mutagenesis	123	144	.	.	.	Note=Increased	transcription	of	the	region	II	transcript.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10760140;Dbxref=PMID:10760140
P0ABU0	UniProtKB	Mutagenesis	89	89	.	.	.	Note=Strongly	decreases	affinity	for	substrate	and	DHNA-CoA	synthase	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23658663;Dbxref=PMID:23658663
P0ABU0	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Loss	of	DHNA-CoA	synthasactivity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23658663;Dbxref=PMID:23658663
P0ABU0	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Loss	of	DHNA-CoA	synthasactivity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21830810;Dbxref=PMID:21830810
P0ABU0	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Reduces	the	specific	DHNA-Cosynthase	activity	by	15-fold%2C	whereas	its	affinity	for	hydrogencarbonate	is	reducedby	36-fold.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20643650;Dbxref=PMID:20643650
P0ABU0	UniProtKB	Mutagenesis	156	156	.	.	.	Note=Loss	of	DHNA-CoA	synthasactivity.	G->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20643650,ECO:0000269|PubMed:21830810;Dbxref=PMID:20643650,PMID:21830810
P0ABU0	UniProtKB	Mutagenesis	184	184	.	.	.	Note=Reduces	the	specific	DHNA-Cosynthase	activity	by	530-fold%2C	whereas	its	affinity	for	hydrogencarbonate	is	reducedby	20-fold.	W->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20643650;Dbxref=PMID:20643650
P0ABU0	UniProtKB	Mutagenesis	267	267	.	.	.	Note=Strongly	decreases	affinity	for	substrate	and	DHNA-CoA	synthase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23658663;Dbxref=PMID:23658663
P0ABU0	UniProtKB	Mutagenesis	270	270	.	.	.	Note=Strongly	decreases	affinity	for	substrate	and	DHNA-CoA	synthase	activity.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23658663;Dbxref=PMID:23658663
P0ABU0	UniProtKB	Mutagenesis	273	273	.	.	.	Note=Impairs	protein	folding.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23658663;Dbxref=PMID:23658663
P77781	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Almost	loss	of	activity	with	benzoyl-CoA	as	substrate.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25010423;Dbxref=PMID:25010423
P77781	UniProtKB	Mutagenesis	48	48	.	.	.	Note=51-fold	decrease	in	catalytic	efficiency	toward	benzoyl-CoA.	Q->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25010423;Dbxref=PMID:25010423
P77781	UniProtKB	Mutagenesis	54	54	.	.	.	Note=514-fold	decrease	in	catalytic	efficiency	toward	benzoyl-CoA.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25010423;Dbxref=PMID:25010423
P77781	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Almost	loss	of	activity	with	benzoyl-CoA	as	substrate.	H->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25010423;Dbxref=PMID:25010423
P77781	UniProtKB	Mutagenesis	63	63	.	.	.	Note=Loss	of	activity	with	benzoyl-CoA	as	substrate.	E->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25010423;Dbxref=PMID:25010423
P77781	UniProtKB	Mutagenesis	63	63	.	.	.	Note=Almost	loss	of	activity	with	benzoyl-CoA	as	substrate.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25010423;Dbxref=PMID:25010423
P77781	UniProtKB	Mutagenesis	64	64	.	.	.	Note=Almost	no	change	in	catalytic	efficiency	toward	benzoyl-CoA.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25010423;Dbxref=PMID:25010423
P77781	UniProtKB	Mutagenesis	67	67	.	.	.	Note=Almost	no	change	in	catalytic	efficiency	toward	benzoyl-CoA.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25010423;Dbxref=PMID:25010423
P77781	UniProtKB	Mutagenesis	68	68	.	.	.	Note=10-fold	decrease	in	catalytic	efficiency	toward	lauroyl-CoA.	Does	not	affect	catalytic	efficiency	toward	1%2C4-dihydroxy-2-naphthoyl-CoA	and	benzoyl-CoA.	V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24992697;Dbxref=PMID:24992697
P77781	UniProtKB	Mutagenesis	71	71	.	.	.	Note=Does	not	affect	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24992697;Dbxref=PMID:24992697
P77781	UniProtKB	Mutagenesis	89	89	.	.	.	Note=156-fold	decrease	in	catalytic	efficiency	toward	benzoyl-CoA.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25010423;Dbxref=PMID:25010423
P77781	UniProtKB	Mutagenesis	91	91	.	.	.	Note=9-fold	decrease	in	catalytic	efficiency	toward	benzoyl-CoA.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25010423;Dbxref=PMID:25010423
P77781	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Almost	no	change	in	catalytic	efficiency	toward	benzoyl-CoA.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25010423;Dbxref=PMID:25010423
P77781	UniProtKB	Mutagenesis	109	109	.	.	.	Note=Almost	no	change	in	catalytic	efficiency	toward	benzoyl-CoA.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25010423;Dbxref=PMID:25010423
P0C0T5	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Strongly	reduces	enzyme	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15292190;Dbxref=PMID:15292190
P0C0T5	UniProtKB	Mutagenesis	120	120	.	.	.	Note=Strongly	reduces	enzyme	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15292190;Dbxref=PMID:15292190
P0C0T5	UniProtKB	Mutagenesis	209	209	.	.	.	Note=Strongly	reduces	enzyme	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15292190;Dbxref=PMID:15292190
P0C0T5	UniProtKB	Mutagenesis	211	211	.	.	.	Note=Strongly	reduces	enzyme	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15292190;Dbxref=PMID:15292190
P61889	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Loss	of	interaction	with	substrate.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11389141;Dbxref=PMID:11389141
P25665	UniProtKB	Mutagenesis	641	641	.	.	.	Note=Impaired	activity%2C	lower	affinitfor	zinc	binding.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10625458;Dbxref=PMID:10625458
P25665	UniProtKB	Mutagenesis	641	641	.	.	.	Note=Impaired	activity%2C	lower	affinitfor	zinc	binding.	Binds	homocysteine	2-4x	more	weakly	than	wild-type.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10625458;Dbxref=PMID:10625458
P25665	UniProtKB	Mutagenesis	643	643	.	.	.	Note=Impaired	activity%2C	lower	affinitfor	zinc	binding.	Binds	homocysteine	7x	tighter	than	wild-type.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10625458;Dbxref=PMID:10625458
P25665	UniProtKB	Mutagenesis	726	726	.	.	.	Note=Impaired	activity%2C	lower	affinitfor	zinc	binding.	Binds	homocysteine	2-4x	more	weakly	than	wild-type.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10625458,ECO:0000269|PubMed:8823155;Dbxref=PMID:10625458,PMID:8823155
P02916	UniProtKB	Mutagenesis	334	334	.	.	.	Note=Ability	to	transport	lactosein	a	saturable	manner.	L->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9401026;Dbxref=PMID:9401026
P02916	UniProtKB	Mutagenesis	372	372	.	.	.	Note=Growth	on	maltose	but	not	on	media	containing	either	maltoheptaose	or	maltoheptaose	plus	maltose.	L->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8636026;Dbxref=PMID:8636026
P02916	UniProtKB	Mutagenesis	376	376	.	.	.	Note=No	growth	on	maltose.	N->K%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8636026;Dbxref=PMID:8636026
P02916	UniProtKB	Mutagenesis	380	380	.	.	.	Note=No	growth	on	maltose.	G->C%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8636026;Dbxref=PMID:8636026
P02916	UniProtKB	Mutagenesis	401	401	.	.	.	Note=Reduction	of	transport	rate.	E->A%2CC%2CK%2CL;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10809785,ECO:0000269|PubMed:9214624;Dbxref=PMID:10809785,PMID:9214624
P02916	UniProtKB	Mutagenesis	403	403	.	.	.	Note=Reduction	of	transport	rate.	S->C%2CD%2CK%2CL;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10809785,ECO:0000269|PubMed:9214624;Dbxref=PMID:10809785,PMID:9214624
P02916	UniProtKB	Mutagenesis	407	407	.	.	.	Note=No	effect.	G->A%2CP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9214624;Dbxref=PMID:9214624
P02916	UniProtKB	Mutagenesis	420	420	.	.	.	Note=No	effect.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9214624;Dbxref=PMID:9214624
P0AEY3	UniProtKB	Mutagenesis	95	95	.	.	.	Note=Does	not	affect	nucleotide	pyrophosphohydrolysis	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0AEY3	UniProtKB	Mutagenesis	119	119	.	.	.	Note=Does	not	affect	the	nucleotide	pyrophosphohydrolysis	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0AEY3	UniProtKB	Mutagenesis	168	168	.	.	.	Note=Does	not	affect	nucleotide	pyrophosphohydrolysis	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0AEY3	UniProtKB	Mutagenesis	171	171	.	.	.	Note=Does	not	affect	nucleotide	pyrophosphohydrolysis	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0AEY3	UniProtKB	Mutagenesis	172	172	.	.	.	Note=Loss	of	pyrophosphohydrolysis	activity	against	both	ATP	and	dTTP.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0AEY3	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Does	not	affect	nucleotide	pyrophosphohydrolysis	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0AEY3	UniProtKB	Mutagenesis	189	189	.	.	.	Note=Does	not	affect	nucleotide	pyrophosphohydrolysis	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0AEY3	UniProtKB	Mutagenesis	192	192	.	.	.	Note=Does	not	affect	nucleotide	pyrophosphohydrolysis	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0AEY3	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Loss	of	pyrophosphohydrolysis	activity	against	both	ATP	and	dTTP.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0AEY3	UniProtKB	Mutagenesis	196	196	.	.	.	Note=Loss	of	pyrophosphohydrolysis	activity	against	both	ATP	and	dTTP.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0AEY3	UniProtKB	Mutagenesis	222	222	.	.	.	Note=Loss	of	pyrophosphohydrolysis	activity	against	both	ATP	and	dTTP.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0AEY3	UniProtKB	Mutagenesis	226	226	.	.	.	Note=Loss	of	pyrophosphohydrolysis	activity	against	both	ATP	and	dTTP.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0AEY3	UniProtKB	Mutagenesis	253	253	.	.	.	Note=Loss	of	pyrophosphohydrolysis	activity	against	both	ATP	and	dTTP.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0AEY3	UniProtKB	Mutagenesis	257	257	.	.	.	Note=Loss	of	pyrophosphohydrolysis	activity	against	both	ATP	and	dTTP.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18353782;Dbxref=PMID:18353782
P0ACH8	UniProtKB	Mutagenesis	222	222	.	.	.	Note=No	effect.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1445207;Dbxref=PMID:1445207
P0ACH8	UniProtKB	Mutagenesis	269	269	.	.	.	Note=No	effect.	R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1445207;Dbxref=PMID:1445207
P0ACH8	UniProtKB	Mutagenesis	271	271	.	.	.	Note=50%25	reduced	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1445207;Dbxref=PMID:1445207
P0ACH8	UniProtKB	Mutagenesis	272	272	.	.	.	Note=75%25	reduced	activity.	S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1445207;Dbxref=PMID:1445207
P0AE72	UniProtKB	Mutagenesis	8	8	.	.	.	Note=Binds	poorly	to	DNA.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12743116;Dbxref=PMID:12743116
P0AE72	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Does	not	bind	to	DNA.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12743116;Dbxref=PMID:12743116
P0AEY8	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Loss	of	ethidium	bromideefflux	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14717607;Dbxref=PMID:14717607
P0AEY8	UniProtKB	Mutagenesis	26	26	.	.	.	Note=No	change	in	ethidium	bromideefflux	activity.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14717607;Dbxref=PMID:14717607
P0AEY8	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Almost	no	chloramphenicol	efflux	activity.	Loss	of	ethidium	bromide	efflux	activity.	E->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14717607;Dbxref=PMID:14717607
P0AEY8	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Slight	decrease	in	chloramphenicol	efflux	activity.	Exhibits	low	ethidium	bromide	efflux	activity.	E->I%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14717607;Dbxref=PMID:14717607
P0AEY8	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Decrease	in	TPP	efflux	activity.	Exhibits	low	ethidium	bromide	efflux	activity.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14717607;Dbxref=PMID:14717607
P0AEY8	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Strong	decrease	in	chloramphenicol	efflux	activity.	Loss	of	ethidium	bromide	and	TPP	efflux	activities.	E->L%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14717607;Dbxref=PMID:14717607
P0AEY8	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Slight	decrease	in	chloramphenicol	efflux	activity.	Loss	of	ethidium	bromide	efflux	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14717607;Dbxref=PMID:14717607
P0AEY8	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Strong	decrease	in	chloramphenicol	efflux	activity.	Loss	of	ethidium	bromide	efflux	activity.	E->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14717607;Dbxref=PMID:14717607
P0AE70	UniProtKB	Mutagenesis	17	28	.	.	.	Note=Changes	loop	1	to	poly-G%3B	loss	of	endoribonuclease	activity.	FDPTKGSEQAGH->GGGGGGGGGGG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23280569;Dbxref=PMID:23280569
P0AE70	UniProtKB	Mutagenesis	17	28	.	.	.	Note=Changes	loop	1	to	MazF6	M.tuberculosis	sequence%3B	loss	of	endoribonuclease	activity.	FDPTKGSEQAGH->LGPPSGSQPAKR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23280569;Dbxref=PMID:23280569
P0AE70	UniProtKB	Mutagenesis	17	28	.	.	.	Note=Changes	loop	1	to	MazF	M.xanthus	sequence%3B	loss	of	endoribonuclease	activity.	FDPTKGSEQAGH->PDDSRGPVPSYS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23280569;Dbxref=PMID:23280569
P0AE70	UniProtKB	Mutagenesis	24	24	.	.	.	Note=Greatly	reduces	toxicity%2C	about	10-fold	less	RNA	cleavage	activity.	Expression	in	the	presence	of	wt	MazF	has	a	dominant-negative	phenotype%2C	causing	cell	death	as	it	titrates	out	the	MazE	antitoxin%3B	still	activates	operon	transcription.	E->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16413577,ECO:0000269|PubMed:24375411;Dbxref=PMID:16413577,PMID:24375411
P0AE70	UniProtKB	Mutagenesis	28	28	.	.	.	Note=No	changes	in	toxicity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24375411;Dbxref=PMID:24375411
P0AE70	UniProtKB	Mutagenesis	53	61	.	.	.	Note=Changes	loop	2	to	poly-G%3B	reduces	endoribonuclease	activity%2C	alters	cleavage	sites.	TQSKGYPFE->GGGGGGGG%2CGGGGGGGGGGG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23280569;Dbxref=PMID:23280569
P0AE70	UniProtKB	Mutagenesis	53	61	.	.	.	Note=Changes	loop	2	to	MazF	M.xanthus	sequence%3B	reduces	endoribonuclease	activity%2C	alters	cleavage	sites.	TQSKGYPFE->SNLHRASEPGN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23280569;Dbxref=PMID:23280569
P0AE70	UniProtKB	Mutagenesis	53	61	.	.	.	Note=Changes	loop	2	to	MazF6	M.tuberculosis	sequence%3B	reduces	endoribonuclease	activity%2C	alters	cleavage	sites.	TQSKGYPFE->SNTALAAMPGN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23280569;Dbxref=PMID:23280569
P61316	UniProtKB	Mutagenesis	64	64	.	.	.	Note=Loss	of	ability	to	transfelipoproteins	to	LolB.	R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11587539;Dbxref=PMID:11587539
P61316	UniProtKB	Mutagenesis	68	68	.	.	.	Note=Loss	of	ability	to	bind	lipoproteins.	F->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12297303;Dbxref=PMID:12297303
P0A9M0	UniProtKB	Mutagenesis	362	362	.	.	.	Note=Loss	of	proteolytic	activitand	ATP-binding.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7988699;Dbxref=PMID:7988699
P0A9M0	UniProtKB	Mutagenesis	665	665	.	.	.	Note=Loss	of	proteolytic	activity.	H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9490010;Dbxref=PMID:9490010
P0A9M0	UniProtKB	Mutagenesis	667	667	.	.	.	Note=Loss	of	proteolytic	activity.	H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9490010;Dbxref=PMID:9490010
P0A9M0	UniProtKB	Mutagenesis	676	676	.	.	.	Note=Loss	of	proteolytic	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9490010;Dbxref=PMID:9490010
P0A9M0	UniProtKB	Mutagenesis	679	679	.	.	.	Note=Loss	of	proteolytic	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8226758;Dbxref=PMID:8226758
P0A9M0	UniProtKB	Mutagenesis	743	743	.	.	.	Note=No	effect.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9490010;Dbxref=PMID:9490010
P75830	UniProtKB	Mutagenesis	353	353	.	.	.	Note=2-fold	increase	in	susceptibility	to	macrolides.	Does	not	affect	oligomerization	and	ability	to	interact	with	MacB	and	TolC%2C	but	changes	the	structure	of	the	MP	region.	Does	not	stimulate	MacB	ATPase	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21696464;Dbxref=PMID:21696464
P75830	UniProtKB	Mutagenesis	353	353	.	.	.	Note=4-fold	increase	in	susceptibility	to	macrolides.	Does	not	stimulate	MacB	ATPase	activity.	G->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21696464;Dbxref=PMID:21696464
P75830	UniProtKB	Mutagenesis	353	353	.	.	.	Note=2-fold	increase	in	susceptibility	to	macrolides.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21696464;Dbxref=PMID:21696464
P75830	UniProtKB	Mutagenesis	357	357	.	.	.	Note=2-fold	increase	in	susceptibility	to	macrolides.	Does	not	stimulate	MacB	ATPase	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21696464;Dbxref=PMID:21696464
P75830	UniProtKB	Mutagenesis	357	357	.	.	.	Note=Does	not	affect	susceptibility	to	macrolides.	G->C%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21696464;Dbxref=PMID:21696464
P69210	UniProtKB	Mutagenesis	5	5	.	.	.	Note=Decrease	in	spermidine	excretion.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18039771;Dbxref=PMID:18039771
P69210	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Decrease	in	spermidine	excretion.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18039771;Dbxref=PMID:18039771
P69210	UniProtKB	Mutagenesis	60	60	.	.	.	Note=Decrease	in	spermidine	excretion.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18039771;Dbxref=PMID:18039771
P69210	UniProtKB	Mutagenesis	68	68	.	.	.	Note=Decrease	in	spermidine	excretion.	W->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18039771;Dbxref=PMID:18039771
P69210	UniProtKB	Mutagenesis	81	81	.	.	.	Note=Decrease	in	spermidine	excretion.	W->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18039771;Dbxref=PMID:18039771
P37330	UniProtKB	Mutagenesis	338	338	.	.	.	Note=Has	a	specific	activitwhich	is	only	6.6%25	of	the	wild-type	activity.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12930982;Dbxref=PMID:12930982
P37330	UniProtKB	Mutagenesis	617	617	.	.	.	Note=Affinity	binding	for	acetyl-CoA	is	more	than	five	times	greater	than	that	of	wild-type%2C	although	its	specific	activity	is	comparable.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12930982;Dbxref=PMID:12930982
P37330	UniProtKB	Mutagenesis	631	631	.	.	.	Note=Absence	of	malate	synthase	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12930982;Dbxref=PMID:12930982
P69212	UniProtKB	Mutagenesis	4	4	.	.	.	Note=Decrease	in	spermidine	excretion.	Y->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18039771;Dbxref=PMID:18039771
P69212	UniProtKB	Mutagenesis	5	5	.	.	.	Note=Decrease	in	spermidine	excretion.	W->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18039771;Dbxref=PMID:18039771
P69212	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Decrease	in	spermidine	excretion.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18039771;Dbxref=PMID:18039771
P69212	UniProtKB	Mutagenesis	45	45	.	.	.	Note=Decrease	in	spermidine	excretion.	Y->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18039771;Dbxref=PMID:18039771
P69212	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Decrease	in	spermidine	excretion.	Y->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18039771;Dbxref=PMID:18039771
P69212	UniProtKB	Mutagenesis	82	82	.	.	.	Note=Decrease	in	spermidine	excretion.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18039771;Dbxref=PMID:18039771
P02921	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Loses	ability	to	catalyze	Na(+)	or	H(+)-coupled	melibiose	transport	against	a	concentration	gradient.	D->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1872836;Dbxref=PMID:1872836
P38051	UniProtKB	Mutagenesis	190	190	.	.	.	Note=Lack	of	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17240978;Dbxref=PMID:17240978
P38051	UniProtKB	Mutagenesis	240	240	.	.	.	Note=Lack	of	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17240978;Dbxref=PMID:17240978
P38051	UniProtKB	Mutagenesis	255	255	.	.	.	Note=Decrease	in	activity.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17240978;Dbxref=PMID:17240978
P38051	UniProtKB	Mutagenesis	344	344	.	.	.	Note=Lack	of	activity.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17240978;Dbxref=PMID:17240978
P38051	UniProtKB	Mutagenesis	387	387	.	.	.	Note=Lack	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17240978;Dbxref=PMID:17240978
P0AEI1	UniProtKB	Mutagenesis	157	157	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11882645;Dbxref=PMID:11882645
P0AEI1	UniProtKB	Mutagenesis	161	161	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11882645;Dbxref=PMID:11882645
P0AEI1	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11882645;Dbxref=PMID:11882645
P0ABR9	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Complete	loss	of	extradiol	cleavage	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15491145;Dbxref=PMID:15491145
P0ABR9	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Low	level	of	catalytic	activity%2C	600-fold	lower	than	the	wild-type	enzyme.	More	than	8000-fold	decrease	in	affinity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15491145;Dbxref=PMID:15491145
P0ABR9	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Complete	loss	of	extradiol	cleavage	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15491145;Dbxref=PMID:15491145
P0ABR9	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Complete	loss	of	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15491145;Dbxref=PMID:15491145
P0ABR9	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Complete	loss	of	activity.	H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15491145;Dbxref=PMID:15491145
P0ABR9	UniProtKB	Mutagenesis	179	179	.	.	.	Note=Complete	loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15491145;Dbxref=PMID:15491145
P0ABR9	UniProtKB	Mutagenesis	179	179	.	.	.	Note=Complete	loss	of	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15491145;Dbxref=PMID:15491145
P0ABR9	UniProtKB	Mutagenesis	179	179	.	.	.	Note=Complete	loss	of	activity.	H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15491145;Dbxref=PMID:15491145
P0ABR9	UniProtKB	Mutagenesis	181	181	.	.	.	Note=More	than	2-fold	decrease	in	catalytic	activity	and	100-fold	decrease	in	affinity.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15491145;Dbxref=PMID:15491145
P0ABR9	UniProtKB	Mutagenesis	181	181	.	.	.	Note=More	than	60-fold	decrease	in	catalytic	activity	and	affinity.	P->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15491145;Dbxref=PMID:15491145
P28306	UniProtKB	Mutagenesis	218	218	.	.	.	Note=Lack	of	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26507882;Dbxref=PMID:26507882
P64512	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Still	represses	PhoP-regulated	transcription.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22267510;Dbxref=PMID:22267510
P64512	UniProtKB	Mutagenesis	28	28	.	.	.	Note=No	longer	represses	PhoP-regulated	transcription.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22267510;Dbxref=PMID:22267510
P64512	UniProtKB	Mutagenesis	39	39	.	.	.	Note=No	longer	represses	PhoP-regulated	transcription.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22267510;Dbxref=PMID:22267510
P50456	UniProtKB	Mutagenesis	257	257	.	.	.	Note=Strongly	reduced	activity.	C->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15929984;Dbxref=PMID:15929984
P50456	UniProtKB	Mutagenesis	259	259	.	.	.	Note=Strongly	reduced	activity.	C->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15929984;Dbxref=PMID:15929984
P77589	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Lack	of	3HPP	transport	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23934492;Dbxref=PMID:23934492
P77589	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Slight	decrease	in	3HPP	transport	activity.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23934492;Dbxref=PMID:23934492
P77589	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Lack	of	3HPP	transport	activity.	D->A%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23934492;Dbxref=PMID:23934492
P77589	UniProtKB	Mutagenesis	272	272	.	.	.	Note=30%25	increase	in	3HPP	transport	activity.	A->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23934492;Dbxref=PMID:23934492
P77589	UniProtKB	Mutagenesis	276	276	.	.	.	Note=Lack	of	3HPP	transport	activity.	K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23934492;Dbxref=PMID:23934492
P37355	UniProtKB	Mutagenesis	86	86	.	.	.	Note=1400-fold	decrease	in	catalytic	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18284213;Dbxref=PMID:18284213
P37355	UniProtKB	Mutagenesis	210	210	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18284213;Dbxref=PMID:18284213
P37355	UniProtKB	Mutagenesis	232	232	.	.	.	Note=Loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18284213;Dbxref=PMID:18284213
P0AFV4	UniProtKB	Mutagenesis	94	94	.	.	.	Note=Loss	of	DD-endopeptidase	activity%2C	no	complementation	of	double	mepS-mepM	deletion	mutants.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23062283;Dbxref=PMID:23062283
P0AEZ1	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Abolishes	enzyme	activity.	E->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11371182,ECO:0000269|PubMed:16114881;Dbxref=PMID:11371182,PMID:16114881
P0AEZ1	UniProtKB	Mutagenesis	120	120	.	.	.	Note=Strongly	reduces	enzyme	activity.	Strongly	reduces	affinity	for	5-methyltetrahydrofolate.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11371182;Dbxref=PMID:11371182
P0AEZ1	UniProtKB	Mutagenesis	177	177	.	.	.	Note=Increases	the	propensity	to	lose	its	essential	flavin	cofactor.	A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10201405;Dbxref=PMID:10201405
P0AEZ1	UniProtKB	Mutagenesis	223	223	.	.	.	Note=Strongly	decreases	substrate	and	NADH	binding.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19610625;Dbxref=PMID:19610625
P0AEZ1	UniProtKB	Mutagenesis	223	223	.	.	.	Note=Slightly	reduced	enzyme	activity.	F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19610625;Dbxref=PMID:19610625
P17109	UniProtKB	Mutagenesis	55	55	.	.	.	Note=Loss	of	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14621995;Dbxref=PMID:14621995
P13009	UniProtKB	Mutagenesis	310	310	.	.	.	Note=Loss	of	zinc	binding.	Loss	of	catalytic	activity.	C->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9201956;Dbxref=PMID:9201956
P13009	UniProtKB	Mutagenesis	311	311	.	.	.	Note=Loss	of	zinc	binding.	Loss	of	catalytic	activity.	C->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9201956;Dbxref=PMID:9201956
P13009	UniProtKB	Mutagenesis	757	757	.	.	.	Note=Decreases	activity	by	about	70%25.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8652590;Dbxref=PMID:8652590
P13009	UniProtKB	Mutagenesis	757	757	.	.	.	Note=Decreases	activity	by	about	45%25.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8652590;Dbxref=PMID:8652590
P13009	UniProtKB	Mutagenesis	759	759	.	.	.	Note=Loss	of	catalytic	activity.	H->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8652590;Dbxref=PMID:8652590
P13009	UniProtKB	Mutagenesis	810	810	.	.	.	Note=Decreases	activity	by	about	40%25.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8652590;Dbxref=PMID:8652590
P77044	UniProtKB	Mutagenesis	44	44	.	.	.	Note=2-fold	decrease	in	catalytic	efficiency	and	more	than	5-fold	increase	in	affinity	for	the	natural	substrate.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15663941;Dbxref=PMID:15663941
P77044	UniProtKB	Mutagenesis	113	113	.	.	.	Note=200-fold	decrease	in	catalytic	activity	and	almost	2-fold	increase	in	affinity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17029402;Dbxref=PMID:17029402
P77044	UniProtKB	Mutagenesis	113	113	.	.	.	Note=350-fold	decrease	in	catalytic	activity	and	almost	2-fold	increase	in	affinity.	N->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17029402;Dbxref=PMID:17029402
P77044	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Weakly	active.	3-fold	decrease	in	affinity.	Fast	ketonisation	and	slow	C-C	cleavage.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15663941;Dbxref=PMID:15663941
P77044	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Weakly	active.	3-fold	decrease	in	affinity.	Fast	ketonisation	and	slow	C-C	cleavage.	S->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15663941;Dbxref=PMID:15663941
P77044	UniProtKB	Mutagenesis	118	118	.	.	.	Note=More	than	2-fold	decrease	in	catalytic	efficiency	and	3-fold	increase	affinity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15663941;Dbxref=PMID:15663941
P77044	UniProtKB	Mutagenesis	177	177	.	.	.	Note=100-fold	decrease	in	catalytic	activity.	F->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17029402;Dbxref=PMID:17029402
P77044	UniProtKB	Mutagenesis	177	177	.	.	.	Note=4-fold	and	8-fold	decrease	in	catalytic	activity	and	affinity%2C	respectively.	F->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17029402;Dbxref=PMID:17029402
P77044	UniProtKB	Mutagenesis	192	192	.	.	.	Note=40-fold	and	5-fold	decrease	in	catalytic	activity	and	affinity%2C	respectively.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17029402;Dbxref=PMID:17029402
P77044	UniProtKB	Mutagenesis	192	192	.	.	.	Note=280-fold	and	10-fold	decrease	in	catalytic	activity	and	affinity%2C	respectively.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17029402;Dbxref=PMID:17029402
P77044	UniProtKB	Mutagenesis	265	265	.	.	.	Note=2-fold	decrease	in	catalytic	activity	and	almost	2-fold	increase	in	affinity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17029402;Dbxref=PMID:17029402
P77044	UniProtKB	Mutagenesis	267	267	.	.	.	Note=Weakly	active%2C	1000-fold	decrease	in	catalytic	efficiency.	Very	slow	ketonisation	and	C-C	cleavage.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15663941;Dbxref=PMID:15663941
P77044	UniProtKB	Mutagenesis	268	268	.	.	.	Note=10-fold	and	20-fold	decrease	in	catalytic	activity	and	affinity%2C	respectively.	W->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17029402;Dbxref=PMID:17029402
P77182	UniProtKB	Mutagenesis	64	64	.	.	.	Note=Loss	of	methyltransferase	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18186482;Dbxref=PMID:18186482
P77182	UniProtKB	Mutagenesis	178	178	.	.	.	Note=Strong	decrease	in	methyltransferase	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18186482;Dbxref=PMID:18186482
P77182	UniProtKB	Mutagenesis	180	180	.	.	.	Note=Strong	decrease	in	methyltransferase	activity.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18186482;Dbxref=PMID:18186482
P77182	UniProtKB	Mutagenesis	271	271	.	.	.	Note=4-fold	decrease	in	activity%2C	but	no	change	in	FAD	binding.	G->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18186482;Dbxref=PMID:18186482
P77182	UniProtKB	Mutagenesis	567	567	.	.	.	Note=Loss	of	activity%2C	but	no	change	in	FAD	binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18186482;Dbxref=PMID:18186482
P77182	UniProtKB	Mutagenesis	618	618	.	.	.	Note=Loss	of	activity%2C	but	no	change	in	FAD	binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18186482;Dbxref=PMID:18186482
P0AEZ3	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Less	effective	then	wild-type.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1836760;Dbxref=PMID:1836760
P0AEZ3	UniProtKB	Mutagenesis	16	17	.	.	.	Note=Loss	of	activity.	KT->QR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1836760;Dbxref=PMID:1836760
P0AEZ3	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Loss	of	activity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1836760;Dbxref=PMID:1836760
P12282	UniProtKB	Mutagenesis	14	14	.	.	.	Note=No	effect.	R->A%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11713534;Dbxref=PMID:11713534
P12282	UniProtKB	Mutagenesis	14	14	.	.	.	Note=No	activity%3B	when	associated	with	A-73.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11713534;Dbxref=PMID:11713534
P12282	UniProtKB	Mutagenesis	44	44	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11463785;Dbxref=PMID:11463785
P12282	UniProtKB	Mutagenesis	73	73	.	.	.	Note=No	effect.	No	activity%3B	when	associated	with	A-14.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11713534;Dbxref=PMID:11713534
P12282	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Substantially	reduced	activity.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11713534;Dbxref=PMID:11713534
P12282	UniProtKB	Mutagenesis	128	128	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11463785;Dbxref=PMID:11463785
P12282	UniProtKB	Mutagenesis	128	128	.	.	.	Note=No	activity.	C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11463785;Dbxref=PMID:11463785
P12282	UniProtKB	Mutagenesis	130	130	.	.	.	Note=No	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11713534;Dbxref=PMID:11713534
P12282	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Substantially	reduced	activity.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11713534;Dbxref=PMID:11713534
P12282	UniProtKB	Mutagenesis	142	142	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11463785;Dbxref=PMID:11463785
P12282	UniProtKB	Mutagenesis	172	172	.	.	.	Note=No	zinc	bound	and	no	enzyme	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11463785;Dbxref=PMID:11463785
P12282	UniProtKB	Mutagenesis	175	175	.	.	.	Note=No	zinc	bound	and	no	enzyme	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11463785;Dbxref=PMID:11463785
P12282	UniProtKB	Mutagenesis	187	187	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11463785;Dbxref=PMID:11463785
P12282	UniProtKB	Mutagenesis	231	231	.	.	.	Note=No	effect.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11463785;Dbxref=PMID:11463785
P12282	UniProtKB	Mutagenesis	244	244	.	.	.	Note=No	zinc	bound	and	almost	no	enzyme	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11463785;Dbxref=PMID:11463785
P12282	UniProtKB	Mutagenesis	247	247	.	.	.	Note=No	zinc	bound	and	almost	no	enzyme	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11463785;Dbxref=PMID:11463785
P09348	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Suppresses	yhjH	disruption	motilitmutant%2C	swimming	velocity	is	wild-type.	G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20303158;Dbxref=PMID:20303158
P09348	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Suppresses	yhjH	disruption	motilitmutant%2C	swimming	velocity	is	between	disruption	and	wild-type.	G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20303158;Dbxref=PMID:20303158
P09348	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Suppresses	yhjH	disruption	motilitmutant%2C	swimming	velocity	is	between	disruption	and	wild-type.	In	the	wt	background	velocity	is	reduced.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20303158;Dbxref=PMID:20303158
P09348	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Suppresses	yhjH	disruption	motilitmutant%2C	swimming	velocity	is	between	disruption	and	wild-type.	In	the	wt	background	velocity	is	reduced.	S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20303158;Dbxref=PMID:20303158
P25745	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
P25745	UniProtKB	Mutagenesis	37	37	.	.	.	Note=Reduces	activity	by	60%25.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
P25745	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Loss	of	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
P25745	UniProtKB	Mutagenesis	99	99	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
P25745	UniProtKB	Mutagenesis	102	102	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
P25745	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Reduces	activity	by	75%25.	K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
P25745	UniProtKB	Mutagenesis	128	128	.	.	.	Note=Reduces	activity	by	90%25.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
P25745	UniProtKB	Mutagenesis	149	149	.	.	.	Note=Loss	of	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
P25745	UniProtKB	Mutagenesis	151	151	.	.	.	Note=Loss	of	activity.	Q->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
P25745	UniProtKB	Mutagenesis	199	199	.	.	.	Note=Abolishes	the	incorporation	of	sulfur	from	the	sulfur-relay	system%3B	loss	of	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
P25745	UniProtKB	Mutagenesis	200	200	.	.	.	Note=Reduces	activity	by	60%25.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
P25745	UniProtKB	Mutagenesis	239	239	.	.	.	Note=Reduces	activity	by	50%25.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
P25745	UniProtKB	Mutagenesis	311	311	.	.	.	Note=Reduces	activity	by	75%25.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
P25745	UniProtKB	Mutagenesis	344	344	.	.	.	Note=Loss	of	activity.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16871210;Dbxref=PMID:16871210
Q46810	UniProtKB	Mutagenesis	9	11	.	.	.	Note=12-fold	decrease	in	affinitfor	CTP	and	3-fold	decrease	in	catalytic	activity.	Displays	a	3-fold	decreasin	activity	with	CTP	and	gains	a	low	activity	with	GTP	as	substrate%3B	when	associated	with	79-P--G-82.	TAA->LAG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21081498;Dbxref=PMID:21081498
Q46810	UniProtKB	Mutagenesis	79	82	.	.	.	Note=15-fold	decrease	in	affinitfor	CTP	and	1.5-fold	decrease	in	catalytic	activity.	Displays	a	3-fold	decrease	in	activity	with	CTP	and	gains	a	low	activity	with	GTP	as	substrate%3B	when	associated	with	9-L--G-11.	LLTS->PLAG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21081498;Dbxref=PMID:21081498
Q46864	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Decreases	DNA-binding%2C	decreases	thermostability	of	MqsR-MqsA	complex.	R->A%2CD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23172222;Dbxref=PMID:23172222
Q46864	UniProtKB	Mutagenesis	97	101	.	.	.	Note=Abolishes	DNA-binding%2C	including	binding	to	the	rpoS	promoter.	NAFSR->AAFSA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21068382,ECO:0000269|PubMed:21516113;Dbxref=PMID:21068382,PMID:21516113
Q46864	UniProtKB	Mutagenesis	97	97	.	.	.	Note=50-fold	reduction	in	DNA-binding.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21068382;Dbxref=PMID:21068382
Q46864	UniProtKB	Mutagenesis	101	101	.	.	.	Note=10-fold	reduction	in	DNA-binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21068382;Dbxref=PMID:21068382
Q46865	UniProtKB	Mutagenesis	55	55	.	.	.	Note=No	change	in	toxicity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20041169;Dbxref=PMID:20041169
Q46865	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Loss	of	toxicity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20041169;Dbxref=PMID:20041169
Q46865	UniProtKB	Mutagenesis	58	58	.	.	.	Note=No	change	in	toxicity.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20041169;Dbxref=PMID:20041169
Q46865	UniProtKB	Mutagenesis	68	68	.	.	.	Note=Loss	of	toxicity.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20041169;Dbxref=PMID:20041169
Q46865	UniProtKB	Mutagenesis	72	72	.	.	.	Note=No	change	in	toxicity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20041169;Dbxref=PMID:20041169
Q46865	UniProtKB	Mutagenesis	81	81	.	.	.	Note=Loss	of	toxicity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20041169;Dbxref=PMID:20041169
Q46865	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Loss	of	toxicity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20041169;Dbxref=PMID:20041169
P32173	UniProtKB	Mutagenesis	12	14	.	.	.	Note=7.5-fold	decrease	in	affinitfor	GTP	and	nearly	no	effect	on	catalytic	activity.	Displays	a	3-fold	decreasin	activity	with	GTP	and	gains	a	low	activity	with	CTP	as	substrate%3B	when	associated	with	79-LLTS-82.	LAG->TAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21081498;Dbxref=PMID:21081498
P32173	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Complete	loss	of	catalytic	activity.	Still	capable	of	binding	MPT	and	MGD	and	interacting	with	both	MoeA	and	MobB.	G->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12719427;Dbxref=PMID:12719427
P32173	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Slight	reduction	in	catalytic	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12719427;Dbxref=PMID:12719427
P32173	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Nearly	no	effect	on	catalytic	activity.	G->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12719427;Dbxref=PMID:12719427
P32173	UniProtKB	Mutagenesis	25	25	.	.	.	Note=Marked	reduction	in	catalytic	activity.	Still	capable	of	interacting	with	both	MoeA	and	MobB.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12719427;Dbxref=PMID:12719427
P32173	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Nearly	no	effect	on	catalytic	activity.	G->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12719427;Dbxref=PMID:12719427
P32173	UniProtKB	Mutagenesis	79	82	.	.	.	Note=11-fold	decrease	in	affinitfor	GTP	and	nearly	no	effect	on	catalytic	activity.	Displays	a	3-fold	decreasin	activity	with	GTP	and	gains	a	low	activity	with	CTP	as	substrate%3B	when	associated	with	12-TAA-14.	PLAG->LLTS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21081498;Dbxref=PMID:21081498
P32173	UniProtKB	Mutagenesis	82	82	.	.	.	Note=Slight	reduction	in	catalytic	activity.	G->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12719427;Dbxref=PMID:12719427
P32173	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Complete	loss	of	catalytic	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12719427;Dbxref=PMID:12719427
P32173	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Marked	reduction	in	catalytic	activity.	Still	capable	of	interacting	with	both	MoeA	and	MobB.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12719427;Dbxref=PMID:12719427
P32173	UniProtKB	Mutagenesis	156	156	.	.	.	Note=Nearly	no	effect	on	catalytic	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12719427;Dbxref=PMID:12719427
P32173	UniProtKB	Mutagenesis	180	180	.	.	.	Note=Nearly	no	effect	on	catalytic	activity.	N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12719427;Dbxref=PMID:12719427
P32173	UniProtKB	Mutagenesis	182	182	.	.	.	Note=Nearly	no	effect	on	catalytic	activity.	N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12719427;Dbxref=PMID:12719427
P22186	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Abolishes	DNA	binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24659771;Dbxref=PMID:24659771
P0A6U3	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Decrease	in	FAD	binding	and	partial	loss	of	activity.	Loss	of	activity%3B	when	associated	with	A-15.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17062623;Dbxref=PMID:17062623
P0A6U3	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Decrease	in	FAD	binding	and	partial	loss	of	activity.	Loss	of	activity%3B	when	associated	with	A-13.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17062623;Dbxref=PMID:17062623
P0A769	UniProtKB	Mutagenesis	34	34	.	.	.	Note=Loss	of	function.	D->E%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15630547;Dbxref=PMID:15630547
P0A769	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Loss	of	function.	P->N%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15630547;Dbxref=PMID:15630547
P0A769	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Loss	of	function.	G->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15630547;Dbxref=PMID:15630547
P0A769	UniProtKB	Mutagenesis	37	37	.	.	.	Note=Loss	of	function.	N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15630547;Dbxref=PMID:15630547
P0A769	UniProtKB	Mutagenesis	102	102	.	.	.	Note=Loss	of	function.	E->D%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15630547;Dbxref=PMID:15630547
P0A769	UniProtKB	Mutagenesis	109	109	.	.	.	Note=Transports	manganese	to	a	very	low	level.	D->E%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15630547;Dbxref=PMID:15630547
P0A769	UniProtKB	Mutagenesis	112	112	.	.	.	Note=Transports	manganese	to	a	very	low	level.	E->D%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15630547;Dbxref=PMID:15630547
P0A769	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Loss	of	function.	G->A%2CP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15630547;Dbxref=PMID:15630547
P0A769	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Transports	manganese	to	a	level	half	of	that	of	wild-type.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15630547;Dbxref=PMID:15630547
P0A769	UniProtKB	Mutagenesis	238	238	.	.	.	Note=Transports	manganese	to	a	very	low	level.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15630547;Dbxref=PMID:15630547
P0A9G8	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Partial	loss	of	repression	by	ModE.	A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8550508;Dbxref=PMID:8550508
P0A9G8	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Transcription	repression	by	ModE	even	in	the	absence	of	molybdate.	T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8550508;Dbxref=PMID:8550508
P0A9G8	UniProtKB	Mutagenesis	133	133	.	.	.	Note=Transcription	repression	by	ModE	even	in	the	absence	of	molybdate.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8550508;Dbxref=PMID:8550508
P0A9G8	UniProtKB	Mutagenesis	216	262	.	.	.	Note=Transcription	repression	by	ModE	even	in	the	absence	of	molybdate.	Missing
P17952	UniProtKB	Mutagenesis	344	344	.	.	.	Note=In	murC3.	G->D
P45425	UniProtKB	Mutagenesis	84	84	.	.	.	Note=12-fold	increase	in	catalytic	efficiency	for	glucose	phosphorylation.	2-fold	decrease	in	catalytic	efficiency	for	N-acetylmannosamine	phosphorylation.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17979299;Dbxref=PMID:17979299
P45425	UniProtKB	Mutagenesis	138	138	.	.	.	Note=6-fold	increase	in	catalytic	efficiency	for	glucose	phosphorylation.	No	change	in	catalytic	efficiency	for	N-acetylmannosamine	phosphorylation.	V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17979299;Dbxref=PMID:17979299
P06722	UniProtKB	Mutagenesis	28	28	.	.	.	Note=In	TS7%3B	temperature-sensitive.	T->L
P06722	UniProtKB	Mutagenesis	157	157	.	.	.	Note=In	TS28%3B	temperature-sensitive.	D->N
P11458	UniProtKB	Mutagenesis	291	291	.	.	.	Note=Activity	is	3.3-fold	lower	under	oxic	conditions	than	under	anoxic	conditions.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18651751;Dbxref=PMID:18651751
P11458	UniProtKB	Mutagenesis	294	294	.	.	.	Note=Activity	is	13-fold	lower	under	oxic	conditions	than	under	anoxic	conditions.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18651751;Dbxref=PMID:18651751
P0A759	UniProtKB	Mutagenesis	118	118	.	.	.	Note=50%25	of	wild-type	activity%2C	but	2-fold	decrease	in	substrate	affinity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1734962;Dbxref=PMID:1734962
P0A759	UniProtKB	Mutagenesis	141	141	.	.	.	Note=Large	decrease	in	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11513596;Dbxref=PMID:11513596
P0A759	UniProtKB	Mutagenesis	143	143	.	.	.	Note=Loss	of	activity	for	the	deamination	reaction	but	not	for	the	reverse	reaction%3B	complete	loss	of	the	homotropic	cooperativity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11513596;Dbxref=PMID:11513596
P0A759	UniProtKB	Mutagenesis	148	148	.	.	.	Note=Large	decrease	in	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11513596;Dbxref=PMID:11513596
P0A759	UniProtKB	Mutagenesis	174	174	.	.	.	Note=Loss	of	activity	in	the	absence	of	the	allosteric	activator.	F->A
P0A759	UniProtKB	Mutagenesis	239	239	.	.	.	Note=50%25	of	wild-type	activity%2C	but	2-fold	decrease	in	substrate	affinity%3B	decrease	in	allosteric	interaction	energy.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1734962;Dbxref=PMID:1734962
P42615	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Loss	of	activity.	Decreases	interaction	with	EnvZ.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20889743;Dbxref=PMID:20889743
P42615	UniProtKB	Mutagenesis	67	67	.	.	.	Note=No	change	in	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20889743;Dbxref=PMID:20889743
P42615	UniProtKB	Mutagenesis	74	74	.	.	.	Note=No	change	in	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20889743;Dbxref=PMID:20889743
P42615	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Loss	of	activity.	Decreases	interaction	with	EnvZ.	I->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20889743;Dbxref=PMID:20889743
P39371	UniProtKB	Mutagenesis	30	30	.	.	.	Note=No	effect	on	catalytic	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18063573;Dbxref=PMID:18063573
P39371	UniProtKB	Mutagenesis	228	228	.	.	.	Note=Great	decrease	in	catalytic	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18063573;Dbxref=PMID:18063573
P39371	UniProtKB	Mutagenesis	234	234	.	.	.	Note=Decrease	in	catalytic	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18063573;Dbxref=PMID:18063573
P39371	UniProtKB	Mutagenesis	297	297	.	.	.	Note=No	effect	on	catalytic	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18063573;Dbxref=PMID:18063573
P39371	UniProtKB	Mutagenesis	302	302	.	.	.	Note=No	effect	on	catalytic	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18063573;Dbxref=PMID:18063573
P39371	UniProtKB	Mutagenesis	328	328	.	.	.	Note=No	effect	on	catalytic	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18063573;Dbxref=PMID:18063573
P39371	UniProtKB	Mutagenesis	344	344	.	.	.	Note=No	effect	on	catalytic	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18063573;Dbxref=PMID:18063573
P0A6Z6	UniProtKB	Mutagenesis	3	3	.	.	.	Note=Loss	of	DNA-binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10595554;Dbxref=PMID:10595554
P0A7B3	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Does	not	exhibit	NADH	kinase	activity	in	addition	to	NAD	kinase	activity.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15855156;Dbxref=PMID:15855156
P0A7B3	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Exhibits	NADH	kinase	activity	in	addition	to	NAD	kinase	activity.	Reduces	the	Vmax	of	the	NAD	kinase	activity.	R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15855156;Dbxref=PMID:15855156
P0A7B3	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Exhibits	NADH	kinase	activity	in	addition	to	NAD	kinase	activity.	R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15855156;Dbxref=PMID:15855156
P0A7B3	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Does	not	exhibit	NADH	kinase	activity	in	addition	to	NAD	kinase	activity.	R->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15855156;Dbxref=PMID:15855156
P0A7B3	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Does	not	exhibit	NADH	kinase	activity	in	addition	to	NAD	kinase	activity.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15855156;Dbxref=PMID:15855156
P0A7B3	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Exhibits	NADH	kinase	activity	in	addition	to	NAD	kinase	activity.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15855156;Dbxref=PMID:15855156
P0A7B3	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Exhibits	NADH	kinase	activity	in	addition	to	NAD	kinase	activity.	R->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15855156;Dbxref=PMID:15855156
Q46877	UniProtKB	Mutagenesis	413	479	.	.	.	Note=Unable	to	accept	electrons	from	nitric	oxide	reductase	FlrD-NAD(+)	reductase	(norW).	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11123953;Dbxref=PMID:11123953
P68739	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Lack	of	activity	on	RNA.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23912683;Dbxref=PMID:23912683
P09152	UniProtKB	Mutagenesis	50	50	.	.	.	Note=Loss	of	activity.	H->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9585550;Dbxref=PMID:9585550
P77567	UniProtKB	Mutagenesis	127	127	.	.	.	Note=No	change	in	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23452042;Dbxref=PMID:23452042
P77567	UniProtKB	Mutagenesis	127	127	.	.	.	Note=Significant	decrease	in	activity.	G->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23452042;Dbxref=PMID:23452042
P77567	UniProtKB	Mutagenesis	214	214	.	.	.	Note=Decreases	O-acetyltransferase	activity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23452042;Dbxref=PMID:23452042
P77567	UniProtKB	Mutagenesis	214	214	.	.	.	Note=Slightly	decreases	acetylation	level.	Decreases	O-	and	N-acetyltransferase	activities.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23452042;Dbxref=PMID:23452042
P77567	UniProtKB	Mutagenesis	281	281	.	.	.	Note=Decreases	O-acetyltransferase	activity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23452042;Dbxref=PMID:23452042
P77567	UniProtKB	Mutagenesis	281	281	.	.	.	Note=Markedly	decreases	acetylation	level.	Decreases	O-	and	N-acetyltransferase	activities.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23452042;Dbxref=PMID:23452042
P0A9G2	UniProtKB	Mutagenesis	134	134	.	.	.	Note=In	nhaR1%3B	increases	the	transcription	of	NhaA.	E->A
P63020	UniProtKB	Mutagenesis	39	39	.	.	.	Note=No	effect	on	activity	in	vivo.	Still	able	to	bind	a	Fe/S	cluster	in	vitro.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18339628;Dbxref=PMID:18339628
P63020	UniProtKB	Mutagenesis	44	44	.	.	.	Note=No	effect	on	activity	in	vivo.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18339628;Dbxref=PMID:18339628
P63020	UniProtKB	Mutagenesis	149	149	.	.	.	Note=Loss	of	activity	in	vivo.	Still	able	to	bind	a	Fe/S	cluster	in	vitro.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18339628;Dbxref=PMID:18339628
P63020	UniProtKB	Mutagenesis	152	152	.	.	.	Note=Loss	of	activity	in	vivo.	Still	able	to	bind	a	Fe/S	cluster	in	vitro.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18339628;Dbxref=PMID:18339628
P13738	UniProtKB	Mutagenesis	133	133	.	.	.	Note=Loss	of	antiport	activity.	Abolishes	ability	to	grow	on	high	salt	medium.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7737413;Dbxref=PMID:7737413
P13738	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Loss	of	antiport	activity.	D->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11258962,ECO:0000269|PubMed:7737413;Dbxref=PMID:11258962,PMID:7737413
P13738	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Loss	of	antiport	activity.	Abolishes	ability	to	grow	on	high	salt	medium.	D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11258962,ECO:0000269|PubMed:7737413;Dbxref=PMID:11258962,PMID:7737413
P13738	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Loss	of	antiport	activity.	Abolishes	ability	to	grow	on	high	salt	medium.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7737413;Dbxref=PMID:7737413
P13738	UniProtKB	Mutagenesis	225	225	.	.	.	Note=Loss	of	antiport	activity.	Abolishes	ability	to	grow	at	alkaline	pH.	H->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11258962,ECO:0000269|PubMed:7592922;Dbxref=PMID:11258962,PMID:7592922
P13738	UniProtKB	Mutagenesis	225	225	.	.	.	Note=Slightly	reduced	antiport	activity.	No	effect	on	pH	sensitivity.	H->C%2CS;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11258962,ECO:0000269|PubMed:7592922;Dbxref=PMID:11258962,PMID:7592922
P13738	UniProtKB	Mutagenesis	225	225	.	.	.	Note=Shifts	threshold	for	pH-sensitive	inactivation.	H->D%2CR;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11258962,ECO:0000269|PubMed:7592922;Dbxref=PMID:11258962,PMID:7592922
P13738	UniProtKB	Mutagenesis	338	338	.	.	.	Note=Loss	of	pH-sensitivity.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11258962;Dbxref=PMID:11258962
P0AF18	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Large	decrease	in	catalytic	activity	and	substrate	affinity%2C	and	increase	in	the	average	amount	of	Zn	bound	to	the	protein%2C	suggesting	that	an	additional	metal	ion	can	bind	to	this	mutant%3B	when	associated	with	H-61.	Q->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17567047,ECO:0000269|PubMed:17567048;Dbxref=PMID:17567047,PMID:17567048
P0AF18	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Large	decrease	in	catalytic	activity	and	substrate	affinity%2C	and	increase	in	the	average	amount	of	Zn	bound	to	the	protein%2C	suggesting	that	an	additional	metal	ion	can	bind	to	this	mutant%3B	when	associated	with	H-59.	N->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17567047;Dbxref=PMID:17567047
P0AF18	UniProtKB	Mutagenesis	131	131	.	.	.	Note=Large	reduction	in	the	amount	of	the	metal	cofactor	bound	to	the	enzyme.	E->Q%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17567047;Dbxref=PMID:17567047
P0AF18	UniProtKB	Mutagenesis	143	143	.	.	.	Note=Dramatic	decrease	in	catalytic	activity	and	moderate	decrease	in	substrate	affinity%2C	producing	a	6000-fold	decrease	in	catalytic	efficiency.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17567047;Dbxref=PMID:17567047
P0AF18	UniProtKB	Mutagenesis	143	143	.	.	.	Note=180-fold	decrease	in	catalytic	efficiency.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17567047;Dbxref=PMID:17567047
P0AF18	UniProtKB	Mutagenesis	251	251	.	.	.	Note=500-fold	decrease	in	catalytic	efficiency.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17567047;Dbxref=PMID:17567047
P0AF18	UniProtKB	Mutagenesis	273	273	.	.	.	Note=Loss	of	catalytic	activity.	D->N%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17567047;Dbxref=PMID:17567047
P37758	UniProtKB	Mutagenesis	87	87	.	.	.	Note=Loss	of	activity.	R->F%2CH%2CK%2CL%2CN%2CP%2CQ;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15667293,ECO:0000269|PubMed:18691156;Dbxref=PMID:15667293,PMID:18691156
P37758	UniProtKB	Mutagenesis	99	99	.	.	.	Note=No	change	in	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	99	99	.	.	.	Note=Decrease	in	activity.	G->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	113	113	.	.	.	Note=No	change	in	activity.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Decrease	in	activity.	P->C%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	139	139	.	.	.	Note=Loss	of	activity.	G->E%2CI;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	145	145	.	.	.	Note=Loss	of	activity.	F->E%2CW;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	162	162	.	.	.	Note=Loss	of	activity.	G->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	172	172	.	.	.	Note=No	change	in	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	172	172	.	.	.	Note=Loss	of	activity.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Loss	of	activity.	G->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	261	261	.	.	.	Note=No	change	in	activity.	Y->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	266	266	.	.	.	Note=Loss	of	activity.	G->A%2CP%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	303	303	.	.	.	Note=Loss	of	activity.	R->C%2CD%2CK%2CL%2CN%2CP%2CQ;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15667293,ECO:0000269|PubMed:18691156;Dbxref=PMID:15667293,PMID:18691156
P37758	UniProtKB	Mutagenesis	307	307	.	.	.	Note=Loss	of	activity.	G->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	311	311	.	.	.	Note=Loss	of	activity.	D->G%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	405	405	.	.	.	Note=Loss	of	activity.	G->A%2CL%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P37758	UniProtKB	Mutagenesis	414	414	.	.	.	Note=No	change	in	activity.	G->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18691156;Dbxref=PMID:18691156
P17117	UniProtKB	Mutagenesis	203	203	.	.	.	Note=Strong	decrease	in	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11034992;Dbxref=PMID:11034992
P17117	UniProtKB	Mutagenesis	208	208	.	.	.	Note=No	change	in	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11034992;Dbxref=PMID:11034992
P0ABK9	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Almost	complete	loss	of	nitrite	reductase	activity.	K->H%2CI%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9593308;Dbxref=PMID:9593308
P0ABK9	UniProtKB	Mutagenesis	263	263	.	.	.	Note=Increases	affinity	for	nitritewithout	changing	Vmax.	Q->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18311941;Dbxref=PMID:18311941
P40710	UniProtKB	Mutagenesis	21	21	.	.	.	Note=No	longer	induces	degP	when	overexpressed%2C	targeted	to	the	periplasm.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15252048;Dbxref=PMID:15252048
P40710	UniProtKB	Mutagenesis	22	23	.	.	.	Note=Slightly	stronger	than	normal	induction	of	degP	when	overexpressed%2C	mistargeted	to	inner	membrane.	NN->DD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15252048;Dbxref=PMID:15252048
P40710	UniProtKB	Mutagenesis	51	54	.	.	.	Note=Forms	oxidized	monomers.	CADC->SADS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17698001;Dbxref=PMID:17698001
P40710	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Forms	oxidized	monomers.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17698001;Dbxref=PMID:17698001
P40710	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Forms	oxidized	monomers.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17698001;Dbxref=PMID:17698001
P40710	UniProtKB	Mutagenesis	165	165	.	.	.	Note=No	oxidized	monomer	forms%3B	when	associated	with	Ser-231.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17698001;Dbxref=PMID:17698001
P40710	UniProtKB	Mutagenesis	231	231	.	.	.	Note=No	oxidized	monomer	forms%3B	when	associated	with	Ser-165.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17698001;Dbxref=PMID:17698001
P0AFB1	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Loss	of	interaction	with	Prc	and	IbpB	leading	to	thermosensitivity.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15047720;Dbxref=PMID:15047720
P0AFB1	UniProtKB	Mutagenesis	282	294	.	.	.	Note=Loss	of	activity	leadingto	thermosensitivity.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15047720;Dbxref=PMID:15047720
P0AFB1	UniProtKB	Mutagenesis	283	294	.	.	.	Note=No	phenotype.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15047720;Dbxref=PMID:15047720
P0AFB1	UniProtKB	Mutagenesis	284	294	.	.	.	Note=No	phenotype.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15047720;Dbxref=PMID:15047720
P75960	UniProtKB	Mutagenesis	92	92	.	.	.	Note=42-fold	decrease	in	desuccinylase	activity.	3-fold	decrease	in	deacetylase	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24176774;Dbxref=PMID:24176774
P75960	UniProtKB	Mutagenesis	95	95	.	.	.	Note=100-fold	decrease	in	desuccinylase	activity.	3-fold	decrease	in	deacetylase	activity.	R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24176774;Dbxref=PMID:24176774
P06959	UniProtKB	Mutagenesis	603	603	.	.	.	Note=Abolishes	catalytic	activity.	H->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2201286;Dbxref=PMID:2201286
P64453	UniProtKB	Mutagenesis	1	1	.	.	.	Note=Not	toxic	as	no	proteinis	produced.	M->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25643179;Dbxref=PMID:25643179
P64453	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Reduced	toxicity.	F->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25643179;Dbxref=PMID:25643179
P05041	UniProtKB	Mutagenesis	258	258	.	.	.	Note=The	reaction	is	extremely	slow.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16605270;Dbxref=PMID:16605270
P05041	UniProtKB	Mutagenesis	258	258	.	.	.	Note=The	reaction	is	extremely	slow.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16605270;Dbxref=PMID:16605270
P05041	UniProtKB	Mutagenesis	274	274	.	.	.	Note=Absence	of	covalent	intermediate.	Addition	of	ammonia	allows	the	formation	of	the	covalent	intermediate	and	shows	that	ammonia	can	replace	the	function	of	K-274.	Reduced	catalytic	efficiency.	K->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14982443,ECO:0000269|PubMed:16605270;Dbxref=PMID:14982443,PMID:16605270
P05041	UniProtKB	Mutagenesis	274	274	.	.	.	Note=Absence	of	covalent	intermediate.	K->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14982443,ECO:0000269|PubMed:16605270;Dbxref=PMID:14982443,PMID:16605270
P05041	UniProtKB	Mutagenesis	274	274	.	.	.	Note=Reduced	catalytic	efficiency.	K->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14982443,ECO:0000269|PubMed:16605270;Dbxref=PMID:14982443,PMID:16605270
P05041	UniProtKB	Mutagenesis	275	275	.	.	.	Note=Catalytically	inactive	for	both	the	glutamine-dependent	and	ammonia-dependent	reactions	and	fails	to	interact	with	PabA.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8679677;Dbxref=PMID:8679677
P05041	UniProtKB	Mutagenesis	311	311	.	.	.	Note=Catalytically	active	in	the	NH3-dependent%2C	but	inactive	for	the	glutamine-dependent	reactions	and	fails	to	complexwith	PabA.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8679677;Dbxref=PMID:8679677
P05041	UniProtKB	Mutagenesis	316	316	.	.	.	Note=Catalytically	inactive	for	both	the	glutamine-dependent	and	ammonia-dependent	reactions	and	fails	to	interact	with	PabA.	R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8679677;Dbxref=PMID:8679677
P05041	UniProtKB	Mutagenesis	322	322	.	.	.	Note=Complete	loss	of	aminodeoxychorismate	synthase	activity.	S->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8679677;Dbxref=PMID:8679677
P05041	UniProtKB	Mutagenesis	339	339	.	.	.	Note=Catalytically	inactive	for	both	the	glutamine-dependent	and	ammonia-dependent	reactions	and	fails	to	interact	with	PabA.	H->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8679677;Dbxref=PMID:8679677
P0ACQ4	UniProtKB	Mutagenesis	199	199	.	.	.	Note=No	activation	following	redox	signaling.	C->S%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9497290;Dbxref=PMID:9497290
P0ACQ4	UniProtKB	Mutagenesis	208	208	.	.	.	Note=No	activation	following	redox	signaling.	C->S%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9497290;Dbxref=PMID:9497290
P0AFE4	UniProtKB	Mutagenesis	25	26	.	.	.	Note=Retains	14%25	dNADH	oxidase	and	dNADH-DB	reductase	activity.	RR->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15996109;Dbxref=PMID:15996109
P0AFE4	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Retains	2%25	dNADH	oxidase	and	dNADH-DB	reductase	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15996109;Dbxref=PMID:15996109
P0AFE4	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Retains	2%25	dNADH	oxidase	and	dNADH-DB	reductase	activity%2C	neither	a	membrane	potential	nor	a	proton	gradient	can	be	formed	by	isolated	membranes.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15996109;Dbxref=PMID:15996109
P0AFE4	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Retains	43%25	dNADH	oxidase	and	dNADH-DB	reductase	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15996109;Dbxref=PMID:15996109
P0AFE4	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Retains	22%25	dNADH	oxidase	and	dNADH-DB	reductase	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15996109;Dbxref=PMID:15996109
P0AFF0	UniProtKB	Mutagenesis	1	1	.	.	.	Note=Shows	20%25	of	the	wild-type	rate	of	deamino-NADH	oxidase.	M->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12718520;Dbxref=PMID:12718520
P0AFF0	UniProtKB	Mutagenesis	158	158	.	.	.	Note=Shows	50%25	of	the	wild-type	rate	of	deamino-NADH	oxidase.	Inhibited	by	30-50%25	upon	addition	of	0.25	mM	of	decylubiquinone.	K->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12718520;Dbxref=PMID:12718520
P0AFF0	UniProtKB	Mutagenesis	217	217	.	.	.	Note=Loss	of	activity.	K->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12718520;Dbxref=PMID:12718520
P0AFF0	UniProtKB	Mutagenesis	217	217	.	.	.	Note=Shows	40%25	of	the	wild-type	rate	of	deamino-NADH	oxidase.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12718520;Dbxref=PMID:12718520
P0AFF0	UniProtKB	Mutagenesis	224	224	.	.	.	Note=Shows	40%25	of	the	wild-type	rate	of	deamino-NADH	oxidase.	Inhibited	by	20-30%25	upon	addition	of	0.25	mM	of	decylubiquinone.	H->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12718520;Dbxref=PMID:12718520
P0AFF0	UniProtKB	Mutagenesis	247	247	.	.	.	Note=Shows	7%25	of	the	wild-type	rate	of	deamino-NADH	oxidase.	K->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12718520;Dbxref=PMID:12718520
P0AFF0	UniProtKB	Mutagenesis	391	391	.	.	.	Note=Shows	90%25	of	the	wild-type	rate	of	deamino-NADH	oxidase.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12718520;Dbxref=PMID:12718520
P0AFF0	UniProtKB	Mutagenesis	395	395	.	.	.	Note=Shows	5%25	of	the	wild-type	rate	of	deamino-NADH	oxidase.	K->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12718520;Dbxref=PMID:12718520
P0AFF0	UniProtKB	Mutagenesis	395	395	.	.	.	Note=Shows	30%25	of	the	wild-type	rate	of	deamino-NADH	oxidase.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12718520;Dbxref=PMID:12718520
P04391	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Much	less	active	than	the	wild-type.	S->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8845761;Dbxref=PMID:8845761
P04391	UniProtKB	Mutagenesis	58	58	.	.	.	Note=The	mutant	is	drastically	inefficient	in	catalysis%2C	but	affects	only	moderately	the	binding	of	carbamoyl	phosphate.	R->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:2674127,ECO:0000269|PubMed:3072022;Dbxref=PMID:2674127,PMID:3072022
P04391	UniProtKB	Mutagenesis	87	87	.	.	.	Note=Much	less	active	than	the	wild-type.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8845761;Dbxref=PMID:8845761
P04391	UniProtKB	Mutagenesis	274	274	.	.	.	Note=Zinc	ion	is	no	longer	tight-binding	inhibitor	and	does	not	promote	isomerization.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2405164;Dbxref=PMID:2405164
P04391	UniProtKB	Mutagenesis	320	320	.	.	.	Note=Much	less	active	than	the	wild-type.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8845761;Dbxref=PMID:8845761
P04391	UniProtKB	Mutagenesis	326	326	.	.	.	Note=Activity	greater	than	the	wild-type	and	Km	for	ornithwinas	increases	about	twofold.	A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8845761;Dbxref=PMID:8845761
P0A9J4	UniProtKB	Mutagenesis	31	31	.	.	.	Note=Increases	KM	for	NADP	4-fold.R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16884311;Dbxref=PMID:16884311
P0A9J4	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Increases	KM	for	NADP	10-foldK->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17229734;Dbxref=PMID:17229734
P0A9J4	UniProtKB	Mutagenesis	98	98	.	.	.	Note=Increases	KM	for	ketopantoate	140-fold.	Strongly	decreases	catalytic	activity.	N->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16884311,ECO:0000269|PubMed:17242510;Dbxref=PMID:16884311,PMID:17242510
P0A9J4	UniProtKB	Mutagenesis	176	176	.	.	.	Note=Increases	KM	for	ketopantoate	1400-fold.	Decreases	Vmax	230-fold.	Loss	of	activity%3B	when	associated	with	A-256.	K->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11123955,ECO:0000269|PubMed:17242510;Dbxref=PMID:11123955,PMID:17242510
P0A9J4	UniProtKB	Mutagenesis	244	244	.	.	.	Note=Increases	KM	for	ketopantoate	230-fold.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17229734;Dbxref=PMID:17229734
P0A9J4	UniProtKB	Mutagenesis	256	256	.	.	.	Note=Increases	KM	for	ketopantoate	1100-fold.	Decreases	Vmax	40-fold.	Loss	of	activity%3B	when	associated	with	A-176.	E->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11123955,ECO:0000269|PubMed:17242510;Dbxref=PMID:11123955,PMID:17242510
P0A921	UniProtKB	Mutagenesis	172	172	.	.	.	Note=Inactive	protein.	S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8300539;Dbxref=PMID:8300539
P77455	UniProtKB	Mutagenesis	256	256	.	.	.	Note=Catalyzes	the	formation	of	3-oxo-5%2C6-dehydrosuberyl-CoA	semialdehyde	instead	of	3-oxo-5%2C6-dehydrosuberyl-CoA.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21296885;Dbxref=PMID:21296885
P0AFH0	UniProtKB	Mutagenesis	102	102	.	.	.	Note=Little	effect	on	the	activity.	C->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1520330;Dbxref=PMID:1520330
P0AFH0	UniProtKB	Mutagenesis	139	139	.	.	.	Note=Eliminates	the	activity.	C->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1520330;Dbxref=PMID:1520330
P37001	UniProtKB	Mutagenesis	58	58	.	.	.	Note=Drastically	reduces	palmitoyltransferase	activity	while	leaving	expression	and	membrane	insertion	intact.	H->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12357033;Dbxref=PMID:12357033
P37001	UniProtKB	Mutagenesis	58	58	.	.	.	Note=Drastically	reduces	palmitoyltransferase	activity	while	leaving	expression	and	membrane	insertion	intact.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12357033;Dbxref=PMID:12357033
P37001	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Drastically	reduces	palmitoyltransferase	activity	while	leaving	expression	and	membrane	insertion	intact.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12357033;Dbxref=PMID:12357033
P37001	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Drastically	reduces	palmitoyltransferase	activity	while	leaving	expression	and	membrane	insertion	intact.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12357033;Dbxref=PMID:12357033
P37001	UniProtKB	Mutagenesis	102	102	.	.	.	Note=Drastically	reduces	palmitoyltransferase	activity	while	leaving	expression	and	membrane	insertion	intact.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12357033;Dbxref=PMID:12357033
P37001	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Mutant	with	longer	amino-acid	side	chains	at	position	113	preferentially	transfers	pentadecane	chain	(15:0).	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15272304;Dbxref=PMID:15272304
P37001	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Mutants	with	longer	amino-acid	side	chains	at	position	113	preferentially	transfers	myristate	chain	(14:0).	G->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15272304;Dbxref=PMID:15272304
P37001	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Mutants	with	longer	amino-acid	side	chains	at	position	113	preferentially	transfers	laurate	chain	(12:0).	G->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15272304;Dbxref=PMID:15272304
P37001	UniProtKB	Mutagenesis	155	155	.	.	.	Note=Fully	functional.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12357033;Dbxref=PMID:12357033
P37001	UniProtKB	Mutagenesis	172	172	.	.	.	Note=Does	not	cause	significant	structural	perturbations	of	the	enzyme%2C	but	induces	a	2-fold	increase	in	the	palmitoyltransferase	activity.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20826347;Dbxref=PMID:20826347
P37001	UniProtKB	Mutagenesis	172	172	.	.	.	Note=Does	not	cause	significant	structural	perturbations	of	the	enzyme%2C	but	induces	a	2.3-fold	increase	in	the	palmitoyltransferase	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20826347;Dbxref=PMID:20826347
P37613	UniProtKB	Mutagenesis	45	45	.	.	.	Note=Retains	affinity	for	PanD%2Cbut	is	unable	to	enhance	cleavage	of	the	PanD	proenzyme.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23170229;Dbxref=PMID:23170229
P02919	UniProtKB	Mutagenesis	233	233	.	.	.	Note=Loss	of	wild-type	glycan	chain	elongation	activity.	No	complementation	in	strain	defective	in	PBP-1b.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10564478;Dbxref=PMID:10564478
P02919	UniProtKB	Mutagenesis	234	234	.	.	.	Note=7-fold	decrease	in	catalytic	activity.	No	complementation	in	strain	defective	in	PBP-1b.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10564478;Dbxref=PMID:10564478
P02919	UniProtKB	Mutagenesis	290	290	.	.	.	Note=11-fold	decrease	in	catalytic	activity.	Shows	complementation	activity	in	strain	defective	in	PBP-1b.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10564478;Dbxref=PMID:10564478
P76084	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Reduces	activity	1000-fold.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16464851;Dbxref=PMID:16464851
P76084	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Reduces	activity	100-fold.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16464851;Dbxref=PMID:16464851
P76084	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16464851;Dbxref=PMID:16464851
P00903	UniProtKB	Mutagenesis	79	79	.	.	.	Note=10000-fold	decrease	in	catalytic	efficiency.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8096767;Dbxref=PMID:8096767
P00903	UniProtKB	Mutagenesis	168	168	.	.	.	Note=Loss	of	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8096767;Dbxref=PMID:8096767
P00903	UniProtKB	Mutagenesis	170	170	.	.	.	Note=150-fold	decrease	in	catalytic	efficiency.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8096767;Dbxref=PMID:8096767
P00903	UniProtKB	Mutagenesis	170	170	.	.	.	Note=4-fold	decrease	in	catalytic	efficiency.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8096767;Dbxref=PMID:8096767
P00903	UniProtKB	Mutagenesis	170	170	.	.	.	Note=Loss	of	activity.	E->K%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8096767;Dbxref=PMID:8096767
P0AFI2	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Confers	resistance	to	quinolones.	No	effect	on	catalytic	activity.	S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12269820;Dbxref=PMID:12269820
P0AFI2	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Strongly	reduced	enzyme	activity.	Increases	stability	of	covalent	reaction	intermediate	with	DNA.	Confers	resistance	to	quinolones.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12269820;Dbxref=PMID:12269820
P0AFI2	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Confers	resistance	to	quinolones.	E->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12269820;Dbxref=PMID:12269820
P22259	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Slightly	lower	catalytic	efficiency	compared	to	wild-type	and	the	affinity	binding	for	OAA	is	330-fold	higher	than	for	wild-type.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17475535;Dbxref=PMID:17475535
P22259	UniProtKB	Mutagenesis	268	268	.	.	.	Note=In	PCK51%3B	altered-activity	mutant	that	catalyzes	the	conversion	from	oxaloacetate	to	pyruvate	(OAA	decarboxylase	activity).	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7883719;Dbxref=PMID:7883719
P22259	UniProtKB	Mutagenesis	284	284	.	.	.	Note=In	PCK53%3B	shows	reduced-activity.	G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7883719;Dbxref=PMID:7883719
P0A796	UniProtKB	Mutagenesis	128	128	.	.	.	Note=18000-fold	reduction	of	catalytic	rate.	D->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2953977;Dbxref=PMID:2953977
P0A796	UniProtKB	Mutagenesis	172	172	.	.	.	Note=3.4-fold	reduction	in	turnovenumbers.	R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2953977;Dbxref=PMID:2953977
P16692	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Has	a	1000-fold	lower	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21830807;Dbxref=PMID:21830807
P16692	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Has	40-fold	lower	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21830807;Dbxref=PMID:21830807
P16692	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Has	250-fold	lower	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21830807;Dbxref=PMID:21830807
P16692	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Has	1000-fold	lower	activity%2C	and	has	100-fold	lower	affinity	for	manganese.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19366688;Dbxref=PMID:19366688
P16692	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Has	a	1000-fold	lower	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21830807;Dbxref=PMID:21830807
P16692	UniProtKB	Mutagenesis	187	187	.	.	.	Note=No	effect.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21830807;Dbxref=PMID:21830807
P16692	UniProtKB	Mutagenesis	200	200	.	.	.	Note=Has	10-fold	lower	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21830807;Dbxref=PMID:21830807
P16692	UniProtKB	Mutagenesis	222	222	.	.	.	Note=Has	9-fold	lower	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21830807;Dbxref=PMID:21830807
P75906	UniProtKB	Mutagenesis	115	115	.	.	.	Note=High	decrease	in	catalytic	activity.	Unable	to	support	biofilm	formation	and	PGA	secretion.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18359807;Dbxref=PMID:18359807
P75906	UniProtKB	Mutagenesis	184	184	.	.	.	Note=Unable	to	support	biofilm	formation	and	PGA	secretion.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18359807;Dbxref=PMID:18359807
P0ABF8	UniProtKB	Mutagenesis	60	60	.	.	.	Note=In	pgsA3%3B	lower	activity.	T->P
P0ABF8	UniProtKB	Mutagenesis	92	92	.	.	.	Note=In	pgsA10%3B	lower	activity.	T->I
P0A9J8	UniProtKB	Mutagenesis	11	11	.	.	.	Note=Important	decrease	in	catalytic	efficiency	and	affinity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P0A9J8	UniProtKB	Mutagenesis	11	11	.	.	.	Note=Important	decrease	in	catalytic	efficiency	and	affinity.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P0A9J8	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Important	decrease	in	catalytic	efficiency	and	affinity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P0A9J8	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Important	decrease	in	catalytic	efficiency	and	affinity.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P0A9J8	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Important	decrease	in	catalytic	efficiency	and	affinity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P0A9J8	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Important	decrease	in	catalytic	efficiency	and	affinity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P0A9J8	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Important	decrease	in	catalytic	efficiency	and	affinity.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P0A9J8	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Important	decrease	in	catalytic	efficiency	and	affinity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P0A9J8	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Important	decrease	in	catalytic	efficiency	and	affinity.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P0A9J8	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Important	decrease	in	catalytic	efficiency	and	affinity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P0A9J8	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Important	decrease	in	catalytic	efficiency	and	affinity.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P0A9J8	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Important	decrease	in	catalytic	efficiency	and	affinity.	Q->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P0A9J8	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Important	decrease	in	catalytic	efficiency	and	affinity.	Q->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P02932	UniProtKB	Mutagenesis	351	351	.	.	.	Note=Less	resistant	to	trypsinF->Y%2CN%2CS%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1848301;Dbxref=PMID:1848301
P06999	UniProtKB	Mutagenesis	190	190	.	.	.	Note=Causes	a	50-fold	decrease	in	the	kcat	value	and	a	15-fold	increment	in	the	apparent	KM	for	ATP.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16866375;Dbxref=PMID:16866375
P0AD65	UniProtKB	Mutagenesis	330	330	.	.	.	Note=No	longer	binds	penicillin.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3148617;Dbxref=PMID:3148617
P0AFI7	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Reduces	affinity	for	substrate	about	7-fold%2C	but	has	no	effect	on	catalytic	activity.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11786019;Dbxref=PMID:11786019
P0AFI7	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Reduces	affinity	for	substrate	about	9-fold%2C	but	has	no	effect	on	catalytic	activity.	R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11786019;Dbxref=PMID:11786019
P0AFI7	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Reduces	affinity	for	substrate	3-fold%2C	but	has	about	5-fold	increase	in	catalytic	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11786019;Dbxref=PMID:11786019
P0AFI7	UniProtKB	Mutagenesis	49	49	.	.	.	Note=Reduces	affinity	for	substrate	3-fold	and	catalytic	activity	2-fold.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11786019;Dbxref=PMID:11786019
P0AFI7	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Reduces	affinity	for	substrate	8000-fold	and	catalytic	activity	16-fold.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11786019;Dbxref=PMID:11786019
P0AFI7	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Reduces	affinity	for	substrate	300-fold	and	catalytic	activity	about	4-fold.	R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11786019;Dbxref=PMID:11786019
P0AFI7	UniProtKB	Mutagenesis	199	199	.	.	.	Note=Reduces	affinity	for	substrate	230-fold%2C	but	has	no	effect	on	catalytic	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11786019;Dbxref=PMID:11786019
P0AFI7	UniProtKB	Mutagenesis	199	199	.	.	.	Note=Reduces	catalytic	activity	about	4-fold%2C	but	has	no	effect	on	affinity	for	substrate.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11786019;Dbxref=PMID:11786019
P17888	UniProtKB	Mutagenesis	226	226	.	.	.	Note=Strong	decrease	in	ATPase	and	helicase	activities.	Does	not	affect	DNA	binding.	T->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12622722;Dbxref=PMID:12622722
P17888	UniProtKB	Mutagenesis	230	230	.	.	.	Note=Lack	of	ATPase	activity	and	strong	decrease	in	helicase	activity.	Does	not	affect	DNA	binding.	K->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10356325,ECO:0000269|PubMed:12622722;Dbxref=PMID:10356325,PMID:12622722
P17888	UniProtKB	Mutagenesis	230	230	.	.	.	Note=Lack	of	helicase	activity.	Decreases	Mu	DNA	replication.	K->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10356325,ECO:0000269|PubMed:12622722;Dbxref=PMID:10356325,PMID:12622722
P17888	UniProtKB	Mutagenesis	320	320	.	.	.	Note=Strong	decrease	in	ATPase	and	helicase	activities.	Decreases	DNA	binding.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12622722;Dbxref=PMID:12622722
P17888	UniProtKB	Mutagenesis	584	584	.	.	.	Note=Does	not	affect	DNA	binding%2C	but	impairs	ATPase	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12622722;Dbxref=PMID:12622722
P15373	UniProtKB	Mutagenesis	91	111	.	.	.	Note=In	prlF1%3B	suppresses	overproduction	lethality	of	lamB-lacZ	gene	fusions%2C	leads	to	decreased	beta-galactosidase	activity.	Partially	alleviates	YhaV	toxic	activity.	QGKKLVAGMDVNIDDEIGDDE->HSTRKETCRWHGRQH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2152898;Dbxref=PMID:2152898
P77541	UniProtKB	Mutagenesis	123	123	.	.	.	Note=Inactive.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15723538;Dbxref=PMID:15723538
P0A8T1	UniProtKB	Mutagenesis	285	285	.	.	.	Note=Great	decrease	in	activity.	W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7715456;Dbxref=PMID:7715456
P55799	UniProtKB	Mutagenesis	78	78	.	.	.	Note=In	prpB17%3B	loss	of	function.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9130712;Dbxref=PMID:9130712
P07001	UniProtKB	Mutagenesis	151	161	.	.	.	Note=Dimerizes%3B	affinity	for	PntB	unchanged%2C	but	maximum	transhydrogenation	rate	lowered	significantly.	Missing
P0AFL3	UniProtKB	Mutagenesis	136	136	.	.	.	Note=Enhances	susceptibility	to	CSA	inhibition.	F->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2001362;Dbxref=PMID:2001362
P0ADY1	UniProtKB	Mutagenesis	312	312	.	.	.	Note=Loss	of	activity.	G->A%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9670013;Dbxref=PMID:9670013
P0ADY1	UniProtKB	Mutagenesis	313	313	.	.	.	Note=Loss	of	activity.	G->A%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9670013;Dbxref=PMID:9670013
P0ADY1	UniProtKB	Mutagenesis	347	347	.	.	.	Note=Loss	of	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9670013;Dbxref=PMID:9670013
P0ADY1	UniProtKB	Mutagenesis	350	350	.	.	.	Note=Loss	of	activity.	I->A%2CF;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9670013;Dbxref=PMID:9670013
P0A7B1	UniProtKB	Mutagenesis	375	375	.	.	.	Note=Loss	of	enzyme	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10660553;Dbxref=PMID:10660553
P0A7B1	UniProtKB	Mutagenesis	380	380	.	.	.	Note=Loss	of	enzyme	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10660553;Dbxref=PMID:10660553
P0A7B1	UniProtKB	Mutagenesis	424	424	.	.	.	Note=No	effect	on	enzyme	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8962061;Dbxref=PMID:8962061
P0A7B1	UniProtKB	Mutagenesis	435	435	.	.	.	Note=Loss	of	enzyme	activity.	H->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8962061;Dbxref=PMID:8962061
P0A7B1	UniProtKB	Mutagenesis	454	454	.	.	.	Note=Loss	of	enzyme	activity.	H->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8962061;Dbxref=PMID:8962061
P0A7B1	UniProtKB	Mutagenesis	488	488	.	.	.	Note=Loss	of	enzyme	activity.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10660553;Dbxref=PMID:10660553
P0A7B1	UniProtKB	Mutagenesis	507	507	.	.	.	Note=Loss	of	enzyme	activity.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10660553;Dbxref=PMID:10660553
P0A7B1	UniProtKB	Mutagenesis	564	564	.	.	.	Note=Loss	of	enzyme	activity%2C	but	retains	low	autophosphorylation	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10660553;Dbxref=PMID:10660553
P0A7B1	UniProtKB	Mutagenesis	592	592	.	.	.	Note=Slightly	reduced	enzyme	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8962061;Dbxref=PMID:8962061
P0A7B1	UniProtKB	Mutagenesis	621	621	.	.	.	Note=Loss	of	enzyme	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10660553;Dbxref=PMID:10660553
P0A7B1	UniProtKB	Mutagenesis	674	674	.	.	.	Note=Loss	of	enzyme	activity.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10660553;Dbxref=PMID:10660553
P08839	UniProtKB	Mutagenesis	189	189	.	.	.	Note=Very	strong	decrease	of	the	affinity	and	catalytic	efficiency	for	PEP.	Inactive%3B	when	associated	with	A-502.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12705838;Dbxref=PMID:12705838
P08839	UniProtKB	Mutagenesis	502	502	.	.	.	Note=Inactive%3B	when	associated	with	A-189.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12705838;Dbxref=PMID:12705838
P23865	UniProtKB	Mutagenesis	397	397	.	.	.	Note=Loss	of	activity.	Perturbprotein	structure.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7499412;Dbxref=PMID:7499412
P23865	UniProtKB	Mutagenesis	398	398	.	.	.	Note=Loss	of	activity.	Perturbprotein	structure.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7499412;Dbxref=PMID:7499412
P23865	UniProtKB	Mutagenesis	452	452	.	.	.	Note=Loss	of	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7499412;Dbxref=PMID:7499412
P23865	UniProtKB	Mutagenesis	452	452	.	.	.	Note=Reduces	activity	by	over	90%25.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7499412;Dbxref=PMID:7499412
P23865	UniProtKB	Mutagenesis	455	455	.	.	.	Note=Loss	of	activity.	Perturbprotein	structure.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7499412;Dbxref=PMID:7499412
P23865	UniProtKB	Mutagenesis	463	463	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7499412;Dbxref=PMID:7499412
P23865	UniProtKB	Mutagenesis	463	463	.	.	.	Note=Reduces	activity	by	90%25.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7499412;Dbxref=PMID:7499412
P23865	UniProtKB	Mutagenesis	474	474	.	.	.	Note=Loss	of	activity.	Perturbprotein	structure.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7499412;Dbxref=PMID:7499412
P23865	UniProtKB	Mutagenesis	477	477	.	.	.	Note=Loss	of	activity.	No	apparent	effect	on	protein	structure.	K->A%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7499412;Dbxref=PMID:7499412
P23865	UniProtKB	Mutagenesis	477	477	.	.	.	Note=Loss	of	activity.	Perturbprotein	structure.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7499412;Dbxref=PMID:7499412
P69783	UniProtKB	Mutagenesis	4	4	.	.	.	Note=Same	activity	as	the	wild-type.	F->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2657735;Dbxref=PMID:2657735
P69783	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Unable	to	transfer	phosphoryl	group.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2657735;Dbxref=PMID:2657735
P69783	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Unable	to	be	phosphorylated	by	Hpr.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2657735;Dbxref=PMID:2657735
P69797	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Loss	of	phosphotransferase	activity.	Unable	to	dimerize.	H->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8262947;Dbxref=PMID:8262947
P69797	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Results	in	the	formation	of	a	single	complex	corresponding	to	the	productive	phosphoryl	transfer	complex.	H->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18270202;Dbxref=PMID:18270202
P69797	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Slight	phosphotransferase	activity.	Unable	to	dimerize.	W->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8262947;Dbxref=PMID:8262947
P69797	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Retains	more	than	50%25	of	phosphotransferase	activity.	K->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8262947;Dbxref=PMID:8262947
P69797	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Slight	phosphotransferase	activity.	Unable	to	dimerize.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8262947;Dbxref=PMID:8262947
P69797	UniProtKB	Mutagenesis	86	86	.	.	.	Note=Loss	of	phosphotransferase	activity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8262947;Dbxref=PMID:8262947
P69797	UniProtKB	Mutagenesis	110	110	.	.	.	Note=Retains	more	than	50%25	of	phosphotransferase	activity.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8262947;Dbxref=PMID:8262947
P69797	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Loss	of	phosphotransferase	activity.	H->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8262947;Dbxref=PMID:8262947
P69797	UniProtKB	Mutagenesis	219	219	.	.	.	Note=Slight	phosphotransferase	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8262947;Dbxref=PMID:8262947
P05458	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Loss	of	activity	and	of	Zn-binding.	H->R
P05458	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Loss	of	activity.	E->Q
P05458	UniProtKB	Mutagenesis	92	92	.	.	.	Note=Loss	of	activity	and	of	Zn-binding.	H->R
P05458	UniProtKB	Mutagenesis	162	162	.	.	.	Note=20%25	loss	of	activity.	E->Q
P05458	UniProtKB	Mutagenesis	169	169	.	.	.	Note=Loss	of	activity	and	of	Zn-binding.	E->Q
P05458	UniProtKB	Mutagenesis	204	204	.	.	.	Note=No	loss	of	activity.	E->Q
P0AAH0	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Loss	of	phosphate	transport.	G->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8682808;Dbxref=PMID:8682808
P0AAH0	UniProtKB	Mutagenesis	49	49	.	.	.	Note=Loss	of	phosphate	transport.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8682808;Dbxref=PMID:8682808
P69795	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Unable	to	be	phosphorylated	by	EIIA.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10913119,ECO:0000269|PubMed:10913122;Dbxref=PMID:10913119,PMID:10913122
P08179	UniProtKB	Mutagenesis	70	70	.	.	.	Note=Loss	of	homodimerization.	No	effect	on	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9698564;Dbxref=PMID:9698564
P08179	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Reduces	activity	about	2000-fold.	N->A%2CD%2CG%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8688421;Dbxref=PMID:8688421
P08179	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Loss	of	activity.	N->E%2CH%2CI%2CK%2CL%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8688421;Dbxref=PMID:8688421
P08179	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Loss	of	activity.	H->A%2CG%2CM%2CN%2CQ%2CR;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10433709,ECO:0000269|PubMed:8688421;Dbxref=PMID:10433709,PMID:8688421
P08179	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Reduces	activity	about	1000-fold.	H->E%2CS%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8688421;Dbxref=PMID:8688421
P08179	UniProtKB	Mutagenesis	119	119	.	.	.	Note=No	effect.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8688421;Dbxref=PMID:8688421
P08179	UniProtKB	Mutagenesis	121	121	.	.	.	Note=Increases	Km	for	5'-phosphoribosylglycinamide	4-fold.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10433709;Dbxref=PMID:10433709
P08179	UniProtKB	Mutagenesis	135	135	.	.	.	Note=Reduces	activity	about	1000-fold.	S->A%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8688421;Dbxref=PMID:8688421
P08179	UniProtKB	Mutagenesis	137	137	.	.	.	Note=No	effect.	H->F%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8688421;Dbxref=PMID:8688421
P08179	UniProtKB	Mutagenesis	144	144	.	.	.	Note=Reduces	activity	about	1000-fold.	D->A%2CE%2CS%2CY;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10433709,ECO:0000269|PubMed:8688421;Dbxref=PMID:10433709,PMID:8688421
P08179	UniProtKB	Mutagenesis	144	144	.	.	.	Note=Loss	of	activity.	D->C%2CF%2CH%2CK%2CL%2CN%2CP%2CQ%2CR%2CT%2CV;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:2204419,ECO:0000269|PubMed:8688421;Dbxref=PMID:2204419,PMID:8688421
P0ACC1	UniProtKB	Mutagenesis	36	36	.	.	.	Note=17%25	of	wild-type	RF1	methylation	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16364916;Dbxref=PMID:16364916
P0ACC1	UniProtKB	Mutagenesis	40	40	.	.	.	Note=60%25	of	wild-type	RF1	methylation	activity.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16364916;Dbxref=PMID:16364916
P0ACC1	UniProtKB	Mutagenesis	41	41	.	.	.	Note=7%25	of	wild-type	RF1	methylation	activity.	Strongly	reduced	affinity	for	S-adenosyl-L-methionine.	A->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16364916;Dbxref=PMID:16364916
P0ACC1	UniProtKB	Mutagenesis	42	42	.	.	.	Note=40%25	of	wild-type	RF1	methylation	activity.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16364916;Dbxref=PMID:16364916
P0ACC1	UniProtKB	Mutagenesis	44	44	.	.	.	Note=62%25	of	wild-type	RF1	methylation	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16364916;Dbxref=PMID:16364916
P0ACC1	UniProtKB	Mutagenesis	44	44	.	.	.	Note=33%25	of	wild-type	RF1	methylation	activity.	E->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16364916;Dbxref=PMID:16364916
P0ACC1	UniProtKB	Mutagenesis	183	183	.	.	.	Note=Less	than	2%25	of	wild-type	RF1	methylation	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16364916;Dbxref=PMID:16364916
P55798	UniProtKB	Mutagenesis	24	24	.	.	.	Note=Loss	of	function.	D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9130712;Dbxref=PMID:9130712
P55798	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Loss	of	function.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9130712;Dbxref=PMID:9130712
P55798	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Loss	of	function.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9130712;Dbxref=PMID:9130712
P55798	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Loss	of	function.	L->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9130712;Dbxref=PMID:9130712
P33025	UniProtKB	Mutagenesis	31	31	.	.	.	Note=7500-fold	decrease	in	reactiorate	while	little	change	in	substrate	affinity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23066817;Dbxref=PMID:23066817
P33025	UniProtKB	Mutagenesis	93	93	.	.	.	Note=17-fold	decrease	in	reactiorate	while	modest	decrease	in	substrate	affinity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23066817;Dbxref=PMID:23066817
P33025	UniProtKB	Mutagenesis	149	149	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23066817;Dbxref=PMID:23066817
P33025	UniProtKB	Mutagenesis	166	166	.	.	.	Note=2900-fold	decrease	in	reactiorate	while	no	change	in	substrate	affinity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23066817;Dbxref=PMID:23066817
P33025	UniProtKB	Mutagenesis	289	289	.	.	.	Note=17-fold	decrease	in	reactiorate	while	modest	decrease	in	substrate	affinity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23066817;Dbxref=PMID:23066817
P69786	UniProtKB	Mutagenesis	204	204	.	.	.	Note=Destabilizes	the	protein	structure%3B	when	associated	with	S-326.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3129430;Dbxref=PMID:3129430
P69786	UniProtKB	Mutagenesis	326	326	.	.	.	Note=Destabilizes	the	protein	structure%3B	when	associated	with	S-204.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3129430;Dbxref=PMID:3129430
P69786	UniProtKB	Mutagenesis	421	421	.	.	.	Note=Unable	to	be	phosphorylated	and	to	catalyze	the	phosphoryl	exchange	between	glucose	and	glucose	6-phosphate	at	equilibrium.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3129430;Dbxref=PMID:3129430
P69786	UniProtKB	Mutagenesis	449	449	.	.	.	Note=Interaction	with	Mlc	is	hardly	detectable.	V->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18319344;Dbxref=PMID:18319344
P69786	UniProtKB	Mutagenesis	451	451	.	.	.	Note=The	complex	with	mlc	shows	much	weaker	association	than	the	wild-type.	A->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18319344;Dbxref=PMID:18319344
P69786	UniProtKB	Mutagenesis	456	456	.	.	.	Note=Interaction	with	Mlc	is	hardly	detectable.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18319344;Dbxref=PMID:18319344
P0AB89	UniProtKB	Mutagenesis	171	171	.	.	.	Note=Reduces	catalytic	activity	about	500-fold.	H->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17531264;Dbxref=PMID:17531264
P0AB89	UniProtKB	Mutagenesis	295	295	.	.	.	Note=Reduces	catalytic	activity	about	1000-fold.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17531264;Dbxref=PMID:17531264
P0ACP7	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Slight	decrease	in	operatoDNA	affinity.	L->M
P0ACP7	UniProtKB	Mutagenesis	55	55	.	.	.	Note=Decrease	in	operator	DNA	affinity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10438625;Dbxref=PMID:10438625
P0ACP7	UniProtKB	Mutagenesis	147	147	.	.	.	Note=14-fold	increase	in	corepressor	affinity.	Large	increase	in	repressor	activity.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781089;Dbxref=PMID:11781089
P0ACP7	UniProtKB	Mutagenesis	147	147	.	.	.	Note=Large	decrease	in	corepressor	affinity	and	in	repressor	activity.	W->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781089;Dbxref=PMID:11781089
P0ACP7	UniProtKB	Mutagenesis	147	147	.	.	.	Note=8-fold	increase	in	corepressor	affinity.	Large	increase	in	repressor	activity.	W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781089;Dbxref=PMID:11781089
P0ACP7	UniProtKB	Mutagenesis	190	190	.	.	.	Note=Functional	repressor.	Corepressor	specificity	is	expanded	since	it	allows	binding	of	adenine	and	6-methylpurine.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9454587;Dbxref=PMID:9454587
P0ACP7	UniProtKB	Mutagenesis	190	190	.	.	.	Note=Functional	repressor.	Corepressor	specificity	is	expanded	since	it	allows	binding	of	adenine.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9454587;Dbxref=PMID:9454587
P0A8K1	UniProtKB	Mutagenesis	254	254	.	.	.	Note=No	processing	of	the	proenzyme%2C	complete	loss	of	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2406271;Dbxref=PMID:2406271
P0A8K1	UniProtKB	Mutagenesis	254	254	.	.	.	Note=Reduced	processing%2C	16%25	wild-type	activity.	S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2406271;Dbxref=PMID:2406271
P0A8K1	UniProtKB	Mutagenesis	254	254	.	.	.	Note=Reduced	processing%2C	2%25	wild-type	activity.	S->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2406271;Dbxref=PMID:2406271
P04982	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Loss	of	pyranase	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15060078;Dbxref=PMID:15060078
P04982	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Retains	one-third	of	the	original	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15060078;Dbxref=PMID:15060078
P0A7H0	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Weakly	active.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1542576;Dbxref=PMID:1542576
P32156	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Loss	of	mutarotase	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15876375;Dbxref=PMID:15876375
P77215	UniProtKB	Mutagenesis	29	29	.	.	.	Note=Loss	of	activity	due	to	absence	of	substrate	binding.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18754693;Dbxref=PMID:18754693
P77215	UniProtKB	Mutagenesis	277	277	.	.	.	Note=35-fold	decrease	in	activity.	59-fold	decrease	in	substrate	affinity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18754693;Dbxref=PMID:18754693
P77215	UniProtKB	Mutagenesis	325	325	.	.	.	Note=Loss	of	activity.	2-fold	decrease	in	substrate	affinity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18754693;Dbxref=PMID:18754693
P0AG30	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Defective	for	RNA-binding.	F->L%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2461932;Dbxref=PMID:2461932
P0AG30	UniProtKB	Mutagenesis	64	64	.	.	.	Note=Defective	for	RNA-binding.	F->L%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2461932;Dbxref=PMID:2461932
P0AG30	UniProtKB	Mutagenesis	181	181	.	.	.	Note=Partial	loss	of	ATPase%2C	helicase	and	termination	activity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2461932;Dbxref=PMID:2461932
P0AG30	UniProtKB	Mutagenesis	184	184	.	.	.	Note=Improves	ATPase	and	helicase	activity	but	reduced	termination	activity.	K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2461932;Dbxref=PMID:2461932
P0AG30	UniProtKB	Mutagenesis	202	202	.	.	.	Note=Does	not	affect	the	kineticof	ATP	hydrolysis	and	inhibition	by	bicyclomycin.	C->G%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7487110;Dbxref=PMID:7487110
P0AG30	UniProtKB	Mutagenesis	265	265	.	.	.	Note=Loss	of	ATPase	activity%2C	helicase	and	termination	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2461932;Dbxref=PMID:2461932
P0A7J0	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Loss	of	activity.	D->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Reduces	activity	by	85%25.	E->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	37	37	.	.	.	Note=Loss	of	activity.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Loss	of	activity.	E->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	40	40	.	.	.	Note=Loss	of	activity.	E->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Loss	of	activity.	D->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	67	67	.	.	.	Note=Reduces	activity	by	80%25.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Loss	of	activity.	T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	110	110	.	.	.	Note=Reduces	activity	by	85%25.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Reduces	activity	by	88%25.	D->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	117	117	.	.	.	Note=Reduces	activity	by	75%25.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	136	136	.	.	.	Note=Loss	of	activity.	H->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	150	150	.	.	.	Note=Loss	of	activity.	R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Loss	of	activity.	H->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	155	155	.	.	.	Note=Reduces	activity	by	83%25.	E->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P0A7J0	UniProtKB	Mutagenesis	174	174	.	.	.	Note=Loss	of	activity.	E->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11687623;Dbxref=PMID:11687623
P00452	UniProtKB	Mutagenesis	441	441	.	.	.	Note=Loss	of	activity.	E->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9395490;Dbxref=PMID:9395490
P00452	UniProtKB	Mutagenesis	441	441	.	.	.	Note=Decrease	in	activity.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9395490;Dbxref=PMID:9395490
P00452	UniProtKB	Mutagenesis	730	730	.	.	.	Note=Loss	of	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8702814;Dbxref=PMID:8702814
P00452	UniProtKB	Mutagenesis	731	731	.	.	.	Note=Loss	of	activity.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8702814;Dbxref=PMID:8702814
P07012	UniProtKB	Mutagenesis	252	252	.	.	.	Note=Loss	of	methylation.	Q->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11847124;Dbxref=PMID:11847124
P33022	UniProtKB	Mutagenesis	82	82	.	.	.	Note=Increases	KM	for	uridine	2-fold.Increases	Kcat	3-fold.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15130467;Dbxref=PMID:15130467
P33022	UniProtKB	Mutagenesis	239	239	.	.	.	Note=Increases	KM	for	uridine	13-foldNo	effect	on	Kcat.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15130467;Dbxref=PMID:15130467
P32171	UniProtKB	Mutagenesis	69	69	.	.	.	Note=Same	kinase	activity	as	the	wild-type%3B	when	associated	with	A-70	and	A-73.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16674975;Dbxref=PMID:16674975
P32171	UniProtKB	Mutagenesis	70	70	.	.	.	Note=Same	kinase	activity	as	the	wild-type%3B	when	associated	with	A-69	and	A-73.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16674975;Dbxref=PMID:16674975
P32171	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Same	kinase	activity	as	the	wild-type%3B	when	associated	with	A-69	and	A-70.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16674975;Dbxref=PMID:16674975
P32169	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Severe	loss	of	enzymatic	activity.	R->A%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12962479;Dbxref=PMID:12962479
P32169	UniProtKB	Mutagenesis	29	29	.	.	.	Note=Severe	loss	of	enzymatic	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12962479;Dbxref=PMID:12962479
P32169	UniProtKB	Mutagenesis	117	117	.	.	.	Note=Loss	of	enzymatic	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12962479;Dbxref=PMID:12962479
P32169	UniProtKB	Mutagenesis	171	171	.	.	.	Note=Loss	of	enzymatic	activity.	E->S%2CA%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12962479;Dbxref=PMID:12962479
P32169	UniProtKB	Mutagenesis	192	192	.	.	.	Note=No	effect	on	enzymatic	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12962479;Dbxref=PMID:12962479
P09377	UniProtKB	Mutagenesis	201	201	.	.	.	Note=48%25	of	wild-type	activity.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	202	202	.	.	.	Note=4%25	of	wild-type	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	205	205	.	.	.	Note=28%25	of	wild-type	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	206	206	.	.	.	Note=0.1%25	of	wild-type	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	246	246	.	.	.	Note=66%25	of	wild-type	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	247	247	.	.	.	Note=6.2%25	of	wild-type	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	247	247	.	.	.	Note=0.9%25	of	wild-type	activity.	G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	248	248	.	.	.	Note=0.9%25	of	wild-type	activity.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	248	248	.	.	.	Note=3.3%25	of	wild-type	activity.	F->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	249	249	.	.	.	Note=93%25	of	wild-type	activity.	S->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	250	250	.	.	.	Note=8.3%25	of	wild-type	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	251	251	.	.	.	Note=87%25	of	wild-type	activity.	S->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	252	252	.	.	.	Note=31%25	of	wild-type	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	252	252	.	.	.	Note=0.4%25	of	wild-type	activity.	N->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	252	252	.	.	.	Note=0.3%25	of	wild-type	activity.	N->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	252	252	.	.	.	Note=37%25	of	wild-type	activity.	N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	253	253	.	.	.	Note=48%25	of	wild-type	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	253	253	.	.	.	Note=32%25	of	wild-type	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	254	254	.	.	.	Note=1.2%25	of	wild-type	activity.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	255	255	.	.	.	Note=80%25	of	wild-type	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P09377	UniProtKB	Mutagenesis	256	256	.	.	.	Note=61%25	of	wild-type	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10464186;Dbxref=PMID:10464186
P76469	UniProtKB	Mutagenesis	49	49	.	.	.	Note=Loss	of	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18754683;Dbxref=PMID:18754683
P76469	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18754683;Dbxref=PMID:18754683
P0A7X6	UniProtKB	Mutagenesis	106	107	.	.	.	Note=3-fold	decreased	growth	rate%3Bloss	of	association	with	30S	ribosomal	subunit%3B	loss	of	interaction	with	S19.	YY->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11514519;Dbxref=PMID:11514519
P69411	UniProtKB	Mutagenesis	7	7	.	.	.	Note=Does	not	affect	exopolysaccharide	biosynthesis.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21471196;Dbxref=PMID:21471196
P69411	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Strongly	decreases	exopolysaccharide	biosynthesis.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21471196;Dbxref=PMID:21471196
P69411	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Mucoid	phenotype.	Decreases	exopolysaccharide	biosynthesis.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21454485,ECO:0000269|PubMed:21471196;Dbxref=PMID:21454485,PMID:21471196
P69411	UniProtKB	Mutagenesis	89	89		.	.	.	Note=Does	not	affect	exopolysaccharide	biosynthesis%3B	when	associated	with	A-90.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21471196;Dbxref=PMID:21471196
P69411	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Does	not	affect	exopolysaccharide	biosynthesis%3B	when	associated	with	A-89.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21471196;Dbxref=PMID:21471196
P69411	UniProtKB	Mutagenesis	109	109	.	.	.	Note=Does	not	activate	the	production	of	capsule	polysaccharides.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21454485,ECO:0000269|PubMed:21471196;Dbxref=PMID:21454485,PMID:21471196
P69411	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Mucoid	phenotype.	Decreases	exopolysaccharide	biosynthesis.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21454485,ECO:0000269|PubMed:21471196;Dbxref=PMID:21454485,PMID:21471196
P69411	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Does	not	activate	the	production	of	capsule	polysaccharides.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21454485,ECO:0000269|PubMed:21471196;Dbxref=PMID:21454485,PMID:21471196
P08394	UniProtKB	Mutagenesis	29	29	.	.	.	Note=Subunit	loses	ATPase	and	3'-5'	helicase	activity%2C	holoenzyme	has	3-5	fold	less	helicase	activity%2C	20-fold	less	processivity.	K->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815437,ECO:0000269|PubMed:16041061,ECO:0000269|PubMed:23851395;Dbxref=PMID:12815437,PMID:16041061,PMID:23851395
P08394	UniProtKB	Mutagenesis	803	803	.	.	.	Note=Large	decrease	in	recombination%2C	loss	of	Chi	hotspot	activity%2C	decreased	RecB	helicase	rate%2C	retains	nucleasactivity	but	not	Chi-sequence	specificity%2C	does	not	load	RecA.	Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18079176;Dbxref=PMID:18079176
P08394	UniProtKB	Mutagenesis	804	804	.	.	.	Note=Large	decrease	in	recombination%2C	loss	of	Chi	hotspot	activity%2C	decreased	RecB	helicase	rate%2C	retains	nucleasactivity	but	not	Chi-sequence	specificity%2C	does	not	load	RecA.	V->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18079176;Dbxref=PMID:18079176
P08394	UniProtKB	Mutagenesis	807	807	.	.	.	Note=In	recB-2109%3B	absence	of	nucleasmodification	at	Chi	sites.	T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10766864;Dbxref=PMID:10766864
P08394	UniProtKB	Mutagenesis	1067	1067	.	.	.	Note=Subunit	loses	nuclease	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16388588;Dbxref=PMID:16388588
P08394	UniProtKB	Mutagenesis	1080	1080	.	.	.	Note=Loss	of	holoenzyme	nucleasactivity%2C	retains	full	helicase	activity%2C	does	not	act	at	Chi%2C	no	loading	of	RecA	on	ssDNA	and	no	recombinational	repair.	D->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10518611,ECO:0000269|PubMed:16388588,ECO:0000269|PubMed:9790841;Dbxref=PMID:10518611,PMID:16388588,PMID:9790841
P04993	UniProtKB	Mutagenesis	177	177	.	.	.	Note=Loss	of	ATP-dependent	exonuclease	activity	in	holoenzyme.	Subunit	loses	ATPase	and	has	~5%25	5'-3'	helicase	activity%2C	holoenzyme	has	2-4	fold	less	helicase	activity%2C	5-fold	less	processivity.	K->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815437,ECO:0000269|PubMed:12815438,ECO:0000269|PubMed:16041061,ECO:0000269|PubMed:1618858,ECO:0000269|PubMed:18079176,ECO:0000269|PubMed:23851395;Dbxref=PMID:12815437,PMID:12815438,PMID:16041061,PMID:1618858,PMID:18079176,PMID:23851395
P0A7I7	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Loss	of	zinc	binding.	Loss	of	ring-opening	activity.	Can	still	remove	phosphate	from	GTP.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12392559;Dbxref=PMID:12392559
P0A7I7	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Loss	of	zinc	binding.	Loss	of	ring-opening	activity.	Can	still	remove	phosphate	from	GTP.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12392559;Dbxref=PMID:12392559
P0A7I7	UniProtKB	Mutagenesis	67	67	.	.	.	Note=Loss	of	zinc	binding.	Loss	of	ring-opening	activity.	Can	still	remove	phosphate	from	GTP.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12392559;Dbxref=PMID:12392559
P30176	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Loss	of	enzymatic	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25431972;Dbxref=PMID:25431972
P30176	UniProtKB	Mutagenesis	89	89	.	.	.	Note=Large	decrease	in	enzymatic	activity.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25431972;Dbxref=PMID:25431972
P30176	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Loss	of	enzymatic	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25431972;Dbxref=PMID:25431972
P30176	UniProtKB	Mutagenesis	133	133	.	.	.	Note=Loss	of	enzymatic	activity.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25431972;Dbxref=PMID:25431972
P0C079	UniProtKB	Mutagenesis	7	7	.	.	.	Note=Loss	of	DNA	binding%2C	100-fold	derepression	of	operon%2C	still	binds	RelE.	R->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18501926,ECO:0000269|PubMed:19747491;Dbxref=PMID:18501926,PMID:19747491
P0C079	UniProtKB	Mutagenesis	8	8	.	.	.	Note=43-fold	derepression	of	operon%2C	partial	loss	of	DNA-binding%2C	still	binds	RelE.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19747491;Dbxref=PMID:19747491
P0C079	UniProtKB	Mutagenesis	13	13	.	.	.	Note=83-fold	derepression	of	operon%2C	loss	of	DNA-binding%2C	still	binds	RelE.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19747491;Dbxref=PMID:19747491
P0C079	UniProtKB	Mutagenesis	28	28	.	.	.	Note=100-fold	derepression	of	operon%2C	loss	of	DNA-binding%2C	still	binds	RelE.	S->L%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19747491;Dbxref=PMID:19747491
P0C079	UniProtKB	Mutagenesis	39	39	.	.	.	Note=In	relB101%3B	a	delayed	relaxedphenotype.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2990907;Dbxref=PMID:2990907
P0C079	UniProtKB	Mutagenesis	45	45	.	.	.	Note=In	relB102%3B	a	delayed	relaxedphenotype.	P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2990907;Dbxref=PMID:2990907
P0C079	UniProtKB	Mutagenesis	45	45	.	.	.	Note=In	relB35%3B	a	delayed	relaxedphenotype.	P->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2990907;Dbxref=PMID:2990907
P0C079	UniProtKB	Mutagenesis	66	79	.	.	.	Note=Protein	no	longer	tetramerizes.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18501926;Dbxref=PMID:18501926
P0C079	UniProtKB	Mutagenesis	71	79	.	.	.	Note=Protein	still	tetramerizes.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18501926;Dbxref=PMID:18501926
P0A7I0	UniProtKB	Mutagenesis	235	235	.	.	.	Note=Loss	of	methylation.	Q->E%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11847124;Dbxref=PMID:11847124
P0A894	UniProtKB	Mutagenesis	270	270	.	.	.	Note=Lack	of	activity.	Does	not	bind	GlmY	and	GlmZ%3B	when	associated	with	A-281%3B	A-282	and	A-283.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23475961;Dbxref=PMID:23475961
P0A894	UniProtKB	Mutagenesis	281	281	.	.	.	Note=Lack	of	activity.	Does	not	bind	GlmY	and	GlmZ%3B	when	associated	with	A-270%3B	A-282	and	A-283.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23475961;Dbxref=PMID:23475961
P0A894	UniProtKB	Mutagenesis	282	282	.	.	.	Note=Lack	of	activity.	Does	not	bind	GlmY	and	GlmZ%3B	when	associated	with	A-270%3B	A-281	and	A-283.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23475961;Dbxref=PMID:23475961
P0A894	UniProtKB	Mutagenesis	283	283	.	.	.	Note=Lack	of	activity.	Does	not	bind	GlmY	and	GlmZ%3B	when	associated	with	A-270%3B	A-281	and	A-282.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23475961;Dbxref=PMID:23475961
P33230	UniProtKB	Mutagenesis	1	1	.	.	.	Note=No	protein	should	be	translated%2C	DNA	region	still	acts	as	an	antitoxin	to	RalR.	M->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24748661;Dbxref=PMID:24748661
P33230	UniProtKB	Mutagenesis	9	69	.	.	.	Note=No	protein	should	be	translated%2C	DNA	region	still	acts	as	an	antitoxin	to	RalR.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24748661;Dbxref=PMID:24748661
P0C077	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Reduces	mRNA	cleavage	rate	constant	2100-fold.	Reduces	mRNA	cleavage	rate	constant	1000000-fold%3B	when	associated	with	F-87.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24251350;Dbxref=PMID:24251350
P0C077	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Reduces	mRNA	cleavage	rate	constant	2700-fold.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24251350;Dbxref=PMID:24251350
P0C077	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Reduces	mRNA	cleavage	rate	constant	2700000-fold.	R->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20005802,ECO:0000269|PubMed:24251350;Dbxref=PMID:20005802,PMID:24251350
P0C077	UniProtKB	Mutagenesis	81	83	.	.	.	Note=Significant	reduction	in	endonuclease	activity%2C	still	binds	RelB.	RER->AEA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19297318;Dbxref=PMID:19297318
P0C077	UniProtKB	Mutagenesis	81	81	.	.	.	Note=Reduces	mRNA	cleavage	rate	constant	60000-fold%2C	significantly	less	translation	inhibition	which	is	countered	by	RelB.	Almost	complete	loss	of	mRNA	cleavage%3B	when	associated	with	F-87.	R->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12123459,ECO:0000269|PubMed:20005802,ECO:0000269|PubMed:24251350;Dbxref=PMID:12123459,PMID:20005802,PMID:24251350
P0C077	UniProtKB	Mutagenesis	87	87	.	.	.	Note=Reduces	mRNA	cleavage	rate	constant	180000-fold.	Y->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20005802,ECO:0000269|PubMed:24251350;Dbxref=PMID:20005802,PMID:24251350
P0C077	UniProtKB	Mutagenesis	87	87	.	.	.	Note=Reduces	mRNA	cleavage	rate	constant	130-fold.	Almost	complete	loss	of	mRNA	cleavage%3B	when	associated	with	A-81	(Ref.20).	Reduces	mRNA	cleavage	rate	constant	1000000-fold%3B	when	associated	with	A-52	(Ref.18).	Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20005802,ECO:0000269|PubMed:24251350;Dbxref=PMID:20005802,PMID:24251350
P0C077	UniProtKB	Mutagenesis	90	95	.	.	.	Note=Does	not	inhibit	translation.	AVKRIL->VTVTVT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12123459;Dbxref=PMID:12123459
P0A7J3	UniProtKB	Mutagenesis	156	165	.	.	.	Note=Generation	time	doubles%2C	only	L12	dimer	binds	to	the	ribosome.	Decreased	association	of	IF-2	with	L7/L12	and	decreased	stimulation	of	GTPase	activity	of	EF-G	by	L7/L12.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22102582;Dbxref=PMID:22102582
P0ADY3	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Reduced	RsfS	binding.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22829778;Dbxref=PMID:22829778
P0ADY3	UniProtKB	Mutagenesis	98	98	.	.	.	Note=Reduced	RsfS	binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22829778;Dbxref=PMID:22829778
P0ADY3	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Reduced	RsfS	binding.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22829778;Dbxref=PMID:22829778
P0ADY3	UniProtKB	Mutagenesis	117	117	.	.	.	Note=No	change	in	RsfS	binding.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22829778;Dbxref=PMID:22829778
P0A8V2	UniProtKB	Mutagenesis	813	813	.	.	.	Note=Disrupts	the	enzyme's	active	center.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2068078;Dbxref=PMID:2068078
P0A7S9	UniProtKB	Mutagenesis	83	118	.	.	.	Note=Decreased	growth	rate	at	all	temperatures.	Decreased	affinity	of	the	30S	subunit	P	site	for	tRNA	in	vitro.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15308780;Dbxref=PMID:15308780
P0A7S9	UniProtKB	Mutagenesis	114	118	.	.	.	Note=Decreased	growth	rate	at	all	temperatures.	Decreased	affinity	of	the	30S	subunit	P	site	for	tRNA	in	vitro.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15308780;Dbxref=PMID:15308780
P00579	UniProtKB	Mutagenesis	596	596	.	.	.	Note=2-fold	reduction	in	activation	of	class	II	Crp-dependent	promoters.	R->D%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10860740;Dbxref=PMID:10860740
P0A776	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Loss	of	function.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18202662;Dbxref=PMID:18202662
P13445	UniProtKB	Mutagenesis	173	173	.	.	.	Note=Eliminates	RpoS	proteolysis.	Lack	of	interaction	with	RssB.	K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10339606;Dbxref=PMID:10339606
P13445	UniProtKB	Mutagenesis	174	174	.	.	.	Note=2-fold	increase	in	RpoS	half-life.	Does	not	affect	interaction	with	RssB.	E->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10339606;Dbxref=PMID:10339606
P13445	UniProtKB	Mutagenesis	177	177	.	.	.	Note=3-fold	increase	in	RpoS	half-life.	V->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10339606;Dbxref=PMID:10339606
P13445	UniProtKB	Mutagenesis	178	178	.	.	.	Note=Does	not	affect	RpoS	half-life.	Y->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10339606;Dbxref=PMID:10339606
P0A7X3	UniProtKB	Mutagenesis	105	130	.	.	.	Note=Cold	sensitive	for	growth	at	30	degrees	Celsius.	350-fold	reduced	affinity	of	the	30S	subunit	P	site	for	certain	tRNAs	in	vitro.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15308780;Dbxref=PMID:15308780
P0A7X3	UniProtKB	Mutagenesis	128	130	.	.	.	Note=Very	cold	sensitive	for	growth	at	30	degrees	Celsius.	Almost	no	P	site	binding	of	certain	tRNAs	in	vitro.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15308780;Dbxref=PMID:15308780
P0AG67	UniProtKB	Mutagenesis	205	205	.	.	.	Note=Decreased	binding	of	Q	beta-derived	M-site	RNA%2C	80%25	synthesis	of	(-)	strand	RNA%2C	in	construct	expressing	residue1-273.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25122749;Dbxref=PMID:25122749
P0AG67	UniProtKB	Mutagenesis	208	208	.	.	.	Note=Decreased	binding	of	Q	beta-derived	M-site	RNA%2C	50%25	synthesis	of	(-)	strand	RNA%2C	in	construct	expressing	residue1-273.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25122749;Dbxref=PMID:25122749
P0AG67	UniProtKB	Mutagenesis	219	219	.	.	.	Note=Decreased	binding	of	Q	beta-derived	M-site	RNA%2C	40%25	synthesis	of	(-)	strand	RNA%2C	in	construct	expressing	residue1-273.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25122749;Dbxref=PMID:25122749
P0AG67	UniProtKB	Mutagenesis	254	254	.	.	.	Note=Decreased	binding	of	Q	beta-derived	M-site	RNA%2C	40%25	synthesis	of	(-)	strand	RNA%2C	in	construct	expressing	residue1-273.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25122749;Dbxref=PMID:25122749
P39406	UniProtKB	Mutagenesis	86	86	.	.	.	Note=Reduces	activity	by	84%25%3when	associated	with	S-88.	K->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17576679;Dbxref=PMID:17576679
P39406	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Reduces	activity	by	84%25%3when	associated	with	S-86.	K->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17576679;Dbxref=PMID:17576679
P39406	UniProtKB	Mutagenesis	202	202	.	.	.	Note=Abolishes	affinity	for	S-adenosyl-L-methionine.	Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17576679;Dbxref=PMID:17576679
P39406	UniProtKB	Mutagenesis	227	227	.	.	.	Note=Strongly	reduces	affinity	for	S-adenosyl-L-methionine.	Reduces	activity	by	87%25.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17576679;Dbxref=PMID:17576679
P39406	UniProtKB	Mutagenesis	268	268	.	.	.	Note=Reduces	affinity	for	S-adenosyl-L-methionine.	Reduces	activity	by	80%25.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17576679;Dbxref=PMID:17576679
P0A6U5	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Lack	of	activity.	Low-level	streptomycin	resistance.	Slight	decrease	in	AdoMet	affinity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8
P0A6U5	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Decrease	in	activity.	Very	low-level	streptomycin	resistance.	Slight	decrease	in	AdoMet	affinity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0A6U5	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Strong	decrease	in	activity.	Low-level	streptomycin	resistance.	Slight	decrease	in	AdoMet	affinity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0A6U5	UniProtKB	Mutagenesis	71	71	.	.	.	Note=Lack	of	activity.	Low-level	streptomycin	resistance.	10-fold	increase	in	AdoMet	affinity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0A6U5	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Slight	decrease	in	activity.	Streptomycin-sensitive.	Slight	decrease	in	AdoMet	affinity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0A6U5	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Lack	of	activity.	Low-level	streptomycin	resistance.	24-fold	decrease	in	AdoMet	affinity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0A6U5	UniProtKB	Mutagenesis	77	77	.	.	.	Note=Lack	of	activity.	Low-level	streptomycin	resistance.	10-fold	decrease	in	AdoMet	affinity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0A6U5	UniProtKB	Mutagenesis	79	79	.	.	.	Note=Lack	of	activity.	Low-level	streptomycin	resistance.	11-fold	decrease	in	AdoMet	affinity.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0A6U5	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Lack	of	activity.	Low-level	streptomycin	resistance.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0A6U5	UniProtKB	Mutagenesis	100	101	.	.	.	Note=Lack	of	activity.	Low-level	streptomycin	resistance.	KR->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0A6U5	UniProtKB	Mutagenesis	123	123	.	.	.	Note=Slight	decrease	in	activity.	Streptomycin-sensitive.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0A6U5	UniProtKB	Mutagenesis	139	139	.	.	.	Note=Lack	of	activity.	Low-level	streptomycin	resistance.	No	change	in	AdoMet	affinity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0A6U5	UniProtKB	Mutagenesis	139	139	.	.	.	Note=Decrease	in	activity.	Very	low-level	streptomycin	resistance.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0A6U5	UniProtKB	Mutagenesis	165	165	.	.	.	Note=Slight	decrease	in	activity.	Streptomycin-sensitive.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0A6U5	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Strong	decrease	in	activity.	Low-level	streptomycin	resistance.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22337945;Dbxref=PMID:22337945
P0AA43	UniProtKB	Mutagenesis	102	102	.	.	.	Note=Loss	of	activity.	D->N%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10376875;Dbxref=PMID:10376875
P0A7V3	UniProtKB	Mutagenesis	131	135	.	.	.	Note=Decreases	mRNA	unwinding	abilityof	the	ribosome.	RRAMK->AAAMA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15652481;Dbxref=PMID:15652481
P0A7V8	UniProtKB	Mutagenesis	44	47	.	.	.	Note=Decreases	mRNA	unwinding	abilityof	the	ribosome.	RKPR->AKPA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15652481;Dbxref=PMID:15652481
P36929	UniProtKB	Mutagenesis	325	325	.	.	.	Note=Reduces	activity	3-fold.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10899996,ECO:0000269|PubMed:14656444;Dbxref=PMID:10899996,PMID:14656444
P36929	UniProtKB	Mutagenesis	375	375	.	.	.	Note=Loss	of	activity.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10899996,ECO:0000269|PubMed:14656444;Dbxref=PMID:10899996,PMID:14656444
P02359	UniProtKB	Mutagenesis	2	18	.	.	.	Note=Defective	in	ribosome	assembly%3B	accumulates	to	abnormally	high	levels	on	polysomes%3B	significantly	decreases	affinitfor	its	own	mRNA.	Missing
P02359	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Defective	in	ribosome	assembly.	K->A%2CE
P02359	UniProtKB	Mutagenesis	116	116	.	.	.	Note=Significantly	decreases	affinitfor	its	own	mRNA.	M->G
P0AFX7	UniProtKB	Mutagenesis	1	28	.	.	.	Note=Loss	of	anti-sigma	factor	activity.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9159522;Dbxref=PMID:9159522
P0AFX7	UniProtKB	Mutagenesis	11	11	.	.	.	Note=Loss	of	anti-sigma	factor	activity.	D->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9159522;Dbxref=PMID:9159522
P0AFX7	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Loss	of	anti-sigma	factor	activity.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9159522;Dbxref=PMID:9159522
P0AFX7	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Loss	of	anti-sigma	factor	activity.	W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9159522;Dbxref=PMID:9159522
P0AFX7	UniProtKB	Mutagenesis	79	79	.	.	.	Note=No	binding	of	N-terminal	fragmento	SspB.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15880122;Dbxref=PMID:15880122
P0AFX7	UniProtKB	Mutagenesis	85	85	.	.	.	Note=No	binding	of	N-terminal	fragmento	SspB.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15880122;Dbxref=PMID:15880122
P0AFX7	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Reduced	binding	of	N-terminal	fragment	to	SspB.	M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15880122;Dbxref=PMID:15880122
P0AFX7	UniProtKB	Mutagenesis	107	108	.	.	.	Note=Significantly	less	degradation	by	ClpX-ClpP	when	present	as	a	1-108	peptide	fragment.	AA->DD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15371343;Dbxref=PMID:15371343
P0AFX7	UniProtKB	Mutagenesis	146	146	.	.	.	Note=No	effect	on	protein	cleavage.	S->X;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19706448;Dbxref=PMID:19706448
P0AFX7	UniProtKB	Mutagenesis	147	147	.	.	.	Note=No	effect	on	protein	cleavage	in	vitro	and	in	vivo.	P->X;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19706448,ECO:0000269|PubMed:23016873;Dbxref=PMID:19706448,PMID:23016873
P0AFX7	UniProtKB	Mutagenesis	148	148	.	.	.	Note=Normal	cleavage	by	DegS	and	RseP	in	vitro	(PubMed:19706448)%2C	for	A-148	decreased	cleavage	by	DegS	in	vivo	(PubMed:23016873).	V->A%2CC%2CI%2CL%2CM%2CN%2CT;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19706448,ECO:0000269|PubMed:23016873;Dbxref=PMID:19706448,PMID:23016873
P0AFX7	UniProtKB	Mutagenesis	148	148	.	.	.	Note=Not	cleaved	by	DegS	nor	RseP	in	vitro	(PubMed:19706448).	V->D%2CE%2CG%2CF%2CP;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19706448,ECO:0000269|PubMed:23016873;Dbxref=PMID:19706448,PMID:23016873
P0AFX7	UniProtKB	Mutagenesis	148	148	.	.	.	Note=Cleaved	by	DegS	but	not	by	RseP	in	vitro	(PubMed:19706448)%2C	for	R-148	and	S-148	decreased	cleavage	by	DegS	in	vivo	(PubMed:23016873).	V->H%2CK%2CQ%2CR%2CS%2CY;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19706448,ECO:0000269|PubMed:23016873;Dbxref=PMID:19706448,PMID:23016873
P0AFX7	UniProtKB	Mutagenesis	162	169	.	.	.	Note=RseA	is	degraded	by	RseP	in	the	absence	of	DegS.	QQQQVQEQ->AAAAVAEA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14633997;Dbxref=PMID:14633997
P0AFX7	UniProtKB	Mutagenesis	172	172	.	.	.	Note=Still	binds	RseB.	No	bindingto	RseB%3B	when	associated	with	A-185.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17496148;Dbxref=PMID:17496148
P0AFX7	UniProtKB	Mutagenesis	172	172	.	.	.	Note=No	binding	to	RseB.	R->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17496148;Dbxref=PMID:17496148
P0AFX7	UniProtKB	Mutagenesis	185	185	.	.	.	Note=Still	binds	RseB.	No	bindingto	RseB%3B	when	associated	with	A-172.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17496148;Dbxref=PMID:17496148
P0AFX7	UniProtKB	Mutagenesis	185	185	.	.	.	Note=No	binding	to	RseB.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17496148;Dbxref=PMID:17496148
P0AFX7	UniProtKB	Mutagenesis	190	200	.	.	.	Note=RseA	is	degraded	by	RseP	in	the	absence	of	DegS.	QLQFEQAQTQQ->ALAFFAAATAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14633997;Dbxref=PMID:14633997
P0AEV1	UniProtKB	Mutagenesis	58	58	.	.	.	Note=Lack	of	phosphorylation.	Cannot	bind	RpoS.	D->P%2CQ%2CR;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11442836,ECO:0000269|PubMed:24352426,ECO:0000269|PubMed:9515704;Dbxref=PMID:11442836,PMID:24352426,PMID:9515704
P0AEV1	UniProtKB	Mutagenesis	67	67	.	.	.	Note=Lack	of	phosphorylation.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24352426;Dbxref=PMID:24352426
P0AEV1	UniProtKB	Mutagenesis	109	109	.	.	.	Note=Resistant	to	IraP	but	not	to	IraD.	Increases	stabilization	by	IraM.	Decreases	phosphorylation.	P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24352426;Dbxref=PMID:24352426
P0AEV1	UniProtKB	Mutagenesis	143	143	.	.	.	Note=Resistant	to	both	IraP	and	IraD.	Increases	stabilization	by	IraM.	W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24352426;Dbxref=PMID:24352426
P0AEV1	UniProtKB	Mutagenesis	214	214	.	.	.	Note=Resistant	to	IraP	and	IraD.	L->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24352426;Dbxref=PMID:24352426
P0AEV1	UniProtKB	Mutagenesis	216	216	.	.	.	Note=Resistant	to	IraP%2C	IraD	and	IraM.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24352426;Dbxref=PMID:24352426
P0AEV1	UniProtKB	Mutagenesis	218	218	.	.	.	Note=Resistant	to	IraP%2C	IraD	and	IraM.	L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24352426;Dbxref=PMID:24352426
P0AEV1	UniProtKB	Mutagenesis	255	255	.	.	.	Note=Resistant	to	IraM.	A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24352426;Dbxref=PMID:24352426
P46849	UniProtKB	Mutagenesis	103	103	.	.	.	Note=No	effect	on	RNA	cyclase	activitand	RtcA	adenylation.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20399182;Dbxref=PMID:20399182
P46849	UniProtKB	Mutagenesis	128	128	.	.	.	Note=No	effect	on	RNA	cyclase	activitand	RtcA	adenylation.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20399182;Dbxref=PMID:20399182
P46849	UniProtKB	Mutagenesis	130	130	.	.	.	Note=33%25	of	wild-type	RNA	cyclase	activity	and	13%25	of	wild-type	RtcA	adenylation.	P->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20399182;Dbxref=PMID:20399182
P46849	UniProtKB	Mutagenesis	134	134	.	.	.	Note=3%25	of	wild-type	RNA	cyclase	activity	and	2%25	of	wild-type	RtcA	adenylation.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20399182;Dbxref=PMID:20399182
P46849	UniProtKB	Mutagenesis	250	250	.	.	.	Note=28%25	of	wild-type	RNA	cyclase	activity	and	38%25	of	wild-type	RtcA	adenylation.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20399182;Dbxref=PMID:20399182
P46849	UniProtKB	Mutagenesis	269	269	.	.	.	Note=Nearly	no	effect	on	RNA	cyclase	activity	and	2-fold	decrease	in	RtcA	adenylation.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20399182;Dbxref=PMID:20399182
P46849	UniProtKB	Mutagenesis	283	283	.	.	.	Note=12%25	of	wild-type	RNA	cyclase	activity	and	2%25	of	wild-type	RtcA	adenylation.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20399182;Dbxref=PMID:20399182
P46849	UniProtKB	Mutagenesis	286	286	.	.	.	Note=Loss	of	RNA	cyclase	activitand	RtcA	adenylation.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20399182;Dbxref=PMID:20399182
P46849	UniProtKB	Mutagenesis	287	287	.	.	.	Note=Loss	of	RNA	cyclase	activitand	RtcA	adenylation.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20399182;Dbxref=PMID:20399182
P46849	UniProtKB	Mutagenesis	308	308	.	.	.	Note=Loss	of	RNA	cyclase	activitand	RtcA	adenylation.	H->A%2CG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20399182;Dbxref=PMID:20399182
P0A7W1	UniProtKB	Mutagenesis	20	29	.	.	.	Note=No	effect	on	mRNA	unwinding	ability	of	the	ribosome.	RVSKTVKGGR->AVSKTVKGGA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15652481;Dbxref=PMID:15652481
P39286	UniProtKB	Mutagenesis	220	220	.	.	.	Note=Reduction	in	GTPase	activity.	Strong	reduction%3B	when	associated	with	A-221.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12220175;Dbxref=PMID:12220175
P39286	UniProtKB	Mutagenesis	221	221	.	.	.	Note=Reduction	in	GTPase	activity.	Strong	reduction%3B	when	associated	with	A-220.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12220175;Dbxref=PMID:12220175
P0AFZ5	UniProtKB	Mutagenesis	39	39	.	.	.	Note=No	effect	on	degradation	by	Lon	protease.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Loss	of	degradation	by	Lon	protease.	R->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:8752322,ECO:0000269|PubMed:9180687;Dbxref=PMID:8752322,PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Loss	of	activity	due	to	loss	of	ability	to	bind	to	FtsZ.	R->C%2CH%2CS;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:8752322,ECO:0000269|PubMed:9180687;Dbxref=PMID:8752322,PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	67	67	.	.	.	Note=Loss	of	degradation	by	Lon	protease.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	72	72	.	.	.	Note=No	effect	on	degradation	by	Lon	protease.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	75	75	.	.	.	Note=No	effect	on	degradation	by	Lon	protease.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	76	76	.	.	.	Note=No	effect	on	degradation	by	Lon	protease.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	77	77	.	.	.	Note=Loss	of	degradation	by	Lon	protease.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Loss	of	activity	due	to	loss	of	ability	to	bind	to	FtsZ.	L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8752322;Dbxref=PMID:8752322
P0AFZ5	UniProtKB	Mutagenesis	87	87	.	.	.	Note=Loss	of	degradation	by	Lon	protease.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	98	98	.	.	.	Note=No	effect	on	degradation	by	Lon	protease.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	105	105	.	.	.	Note=No	effect	on	degradation	by	Lon	protease.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	108	108	.	.	.	Note=No	effect	on	degradation	by	Lon	protease.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	115	115	.	.	.	Note=No	effect	on	degradation	by	Lon	protease.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	117	117	.	.	.	Note=No	effect	on	degradation	by	Lon	protease.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	126	126	.	.	.	Note=No	effect	on	degradation	by	Lon	protease.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	128	128	.	.	.	Note=No	effect	on	degradation	by	Lon	protease.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9180687;Dbxref=PMID:9180687
P0AFZ5	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Slight	decrease	in	degradation	by	Lon	protease.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10788793;Dbxref=PMID:10788793
P0AFZ5	UniProtKB	Mutagenesis	164	164	.	.	.	Note=No	effect	on	degradation	by	Lon	protease.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10788793;Dbxref=PMID:10788793
P0AFZ5	UniProtKB	Mutagenesis	167	167	.	.	.	Note=Slight	decrease	in	degradation	by	Lon	protease.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10788793;Dbxref=PMID:10788793
P0AFZ5	UniProtKB	Mutagenesis	169	169	.	.	.	Note=Great	decrease	in	degradation	by	Lon	protease.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10788793;Dbxref=PMID:10788793
P60651	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Loss	of	activity.	H->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10527864;Dbxref=PMID:10527864
P32138	UniProtKB	Mutagenesis	288	288	.	.	.	Note=Loss	of	catalytic	activitagainst	para-nitrophenyl	alpha-sulfoquinovoside%2C	but	in	contrast	to	wild-type%2C	possesses	a	very	weak	alpha-glucosidase	activity	against	para-nitrophenyl	alpha-D-glucopyranosideQ->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26878550;Dbxref=PMID:26878550
P32138	UniProtKB	Mutagenesis	301	301	.	.	.	Note=Loss	of	catalytic	activity.	R->A%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26878550;Dbxref=PMID:26878550
P32138	UniProtKB	Mutagenesis	301	301	.	.	.	Note=Almost	complete	loss	of	catalytic	activity.	R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26878550;Dbxref=PMID:26878550
P32138	UniProtKB	Mutagenesis	301	301	.	.	.	Note=13-fold	decrease	in	substrate	affinity	and	4600-fold	decrease	in	catalytic	activity.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26878550;Dbxref=PMID:26878550
P32138	UniProtKB	Mutagenesis	304	304	.	.	.	Note=Loss	of	catalytic	activity.	W->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26878550;Dbxref=PMID:26878550
P32138	UniProtKB	Mutagenesis	405	405	.	.	.	Note=Loss	of	catalytic	activity.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26878550;Dbxref=PMID:26878550
P32138	UniProtKB	Mutagenesis	472	472	.	.	.	Note=Loss	of	catalytic	activity.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26878550;Dbxref=PMID:26878550
P09158	UniProtKB	Mutagenesis	158	158	.	.	.	Note=Completely	inactive.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23001854;Dbxref=PMID:23001854
P09158	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Reduction	of	23%25	of	the	aminopropyltransferase	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23001854;Dbxref=PMID:23001854
P09158	UniProtKB	Mutagenesis	159	159	.	.	.	Note=No	influence	on	aminopropyltransferase	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23001854;Dbxref=PMID:23001854
P09158	UniProtKB	Mutagenesis	160	160	.	.	.	Note=Reduction	of	aminopropyltransferase	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23001854;Dbxref=PMID:23001854
P09158	UniProtKB	Mutagenesis	161	161	.	.	.	Note=Completely	inactive.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23001854;Dbxref=PMID:23001854
P09158	UniProtKB	Mutagenesis	162	162	.	.	.	Note=No	influence	on	aminopropyltransferase	activity.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23001854;Dbxref=PMID:23001854
P09158	UniProtKB	Mutagenesis	163	163	.	.	.	Note=No	influence	on	aminopropyltransferase	activity.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23001854;Dbxref=PMID:23001854
P09158	UniProtKB	Mutagenesis	165	165	.	.	.	Note=Reduction	of	aminopropyltransferase	activity.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23001854;Dbxref=PMID:23001854
P0AGE0	UniProtKB	Mutagenesis	5	5	.	.	.	Note=Increased	frequency	of	preciseexcision	of	transposon	Tn10	derivatives	(mutant	SSB-200).	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3301414;Dbxref=PMID:3301414
P0AGE0	UniProtKB	Mutagenesis	11	11	.	.	.	Note=Increased	frequency	of	preciseexcision	of	transposon	Tn10	derivatives	(mutant	SSB-202).	L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3301414;Dbxref=PMID:3301414
P0AGE0	UniProtKB	Mutagenesis	25	25	.	.	.	Note=Increased	frequency	of	preciseexcision	of	transposon	Tn10	derivatives	(mutant	SSB-202).	P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3301414;Dbxref=PMID:3301414
P0AGE0	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Reduces	DNA-binding	affinity.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3301414;Dbxref=PMID:3301414
P0AGE0	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Destabilizes	the	tetramer	(mutant	SSB-1).	H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3301414;Dbxref=PMID:3301414
P0AGE0	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Reduces	DNA-binding	affinity.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3301414;Dbxref=PMID:3301414
P0AGE0	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Increased	frequency	of	preciseexcision	of	transposon	Tn10	derivatives	(mutant	SSB-201).	V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3301414;Dbxref=PMID:3301414
P0AGE0	UniProtKB	Mutagenesis	177	177	.	.	.	Note=Strongly	reduced	exonuclease	I	(sbcB)	stimulation.	P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18591666;Dbxref=PMID:18591666
P0AFZ3	UniProtKB	Mutagenesis	52	52	.	.	.	Note=No	folded	protein.	V->D%2CM%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15880122;Dbxref=PMID:15880122
P0AFZ3	UniProtKB	Mutagenesis	52	52	.	.	.	Note=2.5-fold	reduction	in	bindingof	RseA%2C	no	effect	on	ssrA-tag	binding.	V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15880122;Dbxref=PMID:15880122
P0AFZ3	UniProtKB	Mutagenesis	59	59	.	.	.	Note=10-fold	reduction	in	bindingof	ssrA	tag	and	RseA.	A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15880122;Dbxref=PMID:15880122
P0AFZ3	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Severe	reduction	in	bindingof	ssrA	tag	(40-fold)	and	RseA	(100-fold).	A->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15880122;Dbxref=PMID:15880122
P0C0K3	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Partial	loss	of	kinase	activity%2C	only	partially	protects	bacteria	against	hyperlethal	stress.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23416055;Dbxref=PMID:23416055
P0C0K3	UniProtKB	Mutagenesis	217	217	.	.	.	Note=Loss	of	kinase	activity%3B	does	not	protect	bacteria	against	hyperlethal	stress.	D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17302814,ECO:0000269|PubMed:23416055;Dbxref=PMID:17302814,PMID:23416055
P0AGE9	UniProtKB	Mutagenesis	209	209	.	.	.	Note=Prevents	phosphorylation	of	the	enzyme	intermediate	by	succinyl-CoA	and	phosphate.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781092;Dbxref=PMID:11781092
P76194	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Abolishes	cysteine	desulfurase	activity.	C->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12876288,ECO:0000269|PubMed:12941942,ECO:0000269|PubMed:14644425;Dbxref=PMID:12876288,PMID:12941942,PMID:14644425
P0AG24	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Obviates	hydrolysis	of	ppGpp%2moderately	decreases	biofilm	formation%2C	loss	of	biofilm	induction	in	response	to	translation	inhibitors.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19460094;Dbxref=PMID:19460094
P0AG24	UniProtKB	Mutagenesis	259	259	.	.	.	Note=Obviates	synthesis	of	ppGpp%2strongly	increases	biofilm	formation.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19460094;Dbxref=PMID:19460094
P0AG24	UniProtKB	Mutagenesis	293	293	.	.	.	Note=Unable	to	restore	(p)ppGpp	synthesis	nor	complement	a	relA/spoT	double	disruption.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12596879;Dbxref=PMID:12596879
P0AG24	UniProtKB	Mutagenesis	294	294	.	.	.	Note=Synthesizes	(p)ppGpp%2C	complements	a	relA/spoT	double	disruption.	Y->I
P0A832	UniProtKB	Mutagenesis	137	139	.	.	.	Note=Almost	complete	loss	of	protein	tagging	by	trans-translation%2C	binds	tmRNA	normally%2C	binds	ribosomes	normally.	DKR->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15699355;Dbxref=PMID:15699355
P0A832	UniProtKB	Mutagenesis	138	139	.	.	.	Note=About	half	loss	of	proteintagging	by	trans-translation%2C	binds	tmRNA	normally%2C	binds	ribosomes	normally.	KR->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15699355;Dbxref=PMID:15699355
P0A832	UniProtKB	Mutagenesis	139	139	.	.	.	Note=About	half	loss	of	proteintagging	by	trans-translation%2C	binds	tmRNA	normally%2C	binds	ribosomes	normally.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15699355;Dbxref=PMID:15699355
P0A832	UniProtKB	Mutagenesis	140	160	.	.	.	Note=Complete	loss	of	protein	taggingby	trans-translation%2C	binds	tmRNA	normally%2C	binds	ribosomes	normally.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15699355;Dbxref=PMID:15699355
P0A832	UniProtKB	Mutagenesis	147	147	.	.	.	Note=70%25	loss	of	tagging	by	trans-translation%2C	binds	tmRNA	normally.	W->C%2CD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20348441;Dbxref=PMID:20348441
P0A832	UniProtKB	Mutagenesis	147	147	.	.	.	Note=97%25	loss	of	tagging	by	trans-translation%2C	binds	tmRNA	normally%2C	altered	binding	of	the	tmRNA-SmpB	complex	in	the	ribosomes	A-site.	W->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20348441;Dbxref=PMID:20348441
P0A832	UniProtKB	Mutagenesis	152	160	.	.	.	Note=Complete	loss	of	protein	taggingby	trans-translation%2C	binds	ribosomes	normally.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15699355;Dbxref=PMID:15699355
P0A832	UniProtKB	Mutagenesis	154	160	.	.	.	Note=Almost	complete	loss	of	protein	tagging	by	trans-translation%2C	binds	tmRNA	normally.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15699355;Dbxref=PMID:15699355
P0A832	UniProtKB	Mutagenesis	154	155	.	.	.	Note=Decreased	protein	tagging	by	trans-translation%2C	binds	ribosomes	normally.	IM->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15699355;Dbxref=PMID:15699355
P0A832	UniProtKB	Mutagenesis	154	155	.	.	.	Note=Loss	of	protein	tagging	by	trans-translation%2C	binds	tmRNA	and	ribosomes	normally.	IM->DE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15699355;Dbxref=PMID:15699355
P0A832	UniProtKB	Mutagenesis	154	155	.	.	.	Note=No	effect	on	protein	tagging	by	trans-translation.	IM->LI%2CRK%2CQQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15699355;Dbxref=PMID:15699355
P0A832	UniProtKB	Mutagenesis	155	160	.	.	.	Note=Slightly	increased	protein	taggingby	trans-translation%2C	binds	ribosomes	normally.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15699355;Dbxref=PMID:15699355
P0A832	UniProtKB	Mutagenesis	156	160	.	.	.	Note=No	effect	on	protein	tagging	by	trans-translation%2C	binds	ribosomes	normally.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15699355;Dbxref=PMID:15699355
P77754	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Increased	chaperone	activity%2C	substrate	affinity	and	chaperone	flexibility.	Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24497545;Dbxref=PMID:24497545
P77754	UniProtKB	Mutagenesis	55	55	.	.	.	Note=Increased	chaperone	activity%2C	substrate	affinity	and	chaperone	flexibility.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24497545;Dbxref=PMID:24497545
P77754	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Increased	chaperone	activity%2C	substrate	affinity	and	chaperone	flexibility%2C	despite	decreased	Spy	stability.	Q->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24497545;Dbxref=PMID:24497545
P77754	UniProtKB	Mutagenesis	119	119	.	.	.	Note=Increased	chaperone	activity%2C	substrate	affinity	and	chaperone	flexibility.	H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24497545;Dbxref=PMID:24497545
P77754	UniProtKB	Mutagenesis	123	123	.	.	.	Note=Increased	chaperone	activity%2C	substrate	affinity	and	chaperone	flexibility.	Q->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24497545;Dbxref=PMID:24497545
P77754	UniProtKB	Mutagenesis	138	138	.	.	.	Note=Increased	chaperone	activity%2C	substrate	affinity	and	chaperone	flexibility.	F->I%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24497545;Dbxref=PMID:24497545
P0A836	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Prevents	phosphorylation	of	the	enzyme	intermediate	in	both	reaction	directions.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781092;Dbxref=PMID:11781092
P0A836	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Prevents	phosphorylation	of	the	enzyme	intermediate	by	ATP.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11781092;Dbxref=PMID:11781092
P77444	UniProtKB	Mutagenesis	55	55	.	.	.	Note=No	effect.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11983074;Dbxref=PMID:11983074
P77444	UniProtKB	Mutagenesis	123	123	.	.	.	Note=Loss	of	function%3B	possibldue	to	destabilization	of	PLP	in	the	active	site.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11983074;Dbxref=PMID:11983074
P77444	UniProtKB	Mutagenesis	364	364	.	.	.	Note=Abolishes	activity	towards	L-cysteine	but	not	towards	selenocysteine.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10739946;Dbxref=PMID:10739946
P77444	UniProtKB	Mutagenesis	379	379	.	.	.	Note=Loss	of	function.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11983074;Dbxref=PMID:11983074
P04805	UniProtKB	Mutagenesis	98	98	.	.	.	Note=10-fold	decrease	in	activity.	Strong	decrease	in	zinc	content.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7797500;Dbxref=PMID:7797500
P04805	UniProtKB	Mutagenesis	100	100	.	.	.	Note=Loss	of	activity.	Strong	decrease	in	zinc	content.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14764088,ECO:0000269|PubMed:7797500;Dbxref=PMID:14764088,PMID:7797500
P04805	UniProtKB	Mutagenesis	100	100	.	.	.	Note=Does	not	prevent	zinc	bindingReduces	only	2-fold	the	binding	affinity	for	tRNA(Glu)%2C	but	reduces	more	than	10-fold	the	affinity	for	glutamate	in	the	presence	of	tRNA(Glu).	C->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14764088,ECO:0000269|PubMed:7797500;Dbxref=PMID:14764088,PMID:7797500
P04805	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Loss	of	activity.	Strong	decrease	in	zinc	content.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7797500;Dbxref=PMID:7797500
P04805	UniProtKB	Mutagenesis	127	127	.	.	.	Note=10-fold	decrease	in	activity.	Strong	decrease	in	zinc	content.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7797500;Dbxref=PMID:7797500
P04805	UniProtKB	Mutagenesis	129	129	.	.	.	Note=No	change	in	activity	or	in	zinc	content.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7797500;Dbxref=PMID:7797500
P04805	UniProtKB	Mutagenesis	131	131	.	.	.	Note=No	change	in	activity	or	in	zinc	content.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7797500;Dbxref=PMID:7797500
P04805	UniProtKB	Mutagenesis	132	132	.	.	.	Note=No	change	in	activity	or	in	zinc	content.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7797500;Dbxref=PMID:7797500
P04805	UniProtKB	Mutagenesis	138	138	.	.	.	Note=No	change	in	activity	or	in	zinc	content.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7797500;Dbxref=PMID:7797500
P04805	UniProtKB	Mutagenesis	239	239	.	.	.	Note=Does	not	aminoacylate	tRNA(Glu)%2C	not	phosphorylated	by	HipA.	S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24095282;Dbxref=PMID:24095282
P80645	UniProtKB	Mutagenesis	298	298	.	.	.	Note=Loss	of	activity.	R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10480865;Dbxref=PMID:10480865
P0ACG1	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Partial	loss	of	repressor	function	when	overexpressed	in	the	absence	of	hns.	L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755860;Dbxref=PMID:8755860
P0ACG1	UniProtKB	Mutagenesis	65	134	.	.	.	Note=Partial	loss	of	repressor	function	when	overexpressed	in	the	absence	of	hns.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755860;Dbxref=PMID:8755860
P0ACG1	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Partial	loss	of	repressor	function	when	overexpressed	in	the	absence	of	hns.	Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755860;Dbxref=PMID:8755860
P0ACG1	UniProtKB	Mutagenesis	116	116	.	.	.	Note=Partial	loss	of	repressor	function	when	overexpressed	in	the	absence	of	hns.	P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8755860;Dbxref=PMID:8755860
P0ACG1	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Higher	RNA	chaperone	activitthan	wild-type%2C	decreased	ability	to	bind	structured	RNA.	G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17267410;Dbxref=PMID:17267410
P00956	UniProtKB	Mutagenesis	94	94	.	.	.	Note=6000-fold	increase	in	Km	for	isoleucine	and	4-fold	increase	in	Km	for	ATP%2C	with	no	effect	on	activity.	G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3282306;Dbxref=PMID:3282306
P00956	UniProtKB	Mutagenesis	97	97	.	.	.	Note=No	effect	on	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3282306;Dbxref=PMID:3282306
P00956	UniProtKB	Mutagenesis	102	102	.	.	.	Note=No	significant	effect	on	activity.	I->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3282306;Dbxref=PMID:3282306
P00956	UniProtKB	Mutagenesis	183	183	.	.	.	Note=Abolishes	translocation	from	the	aminoacylation	site	to	the	editing	site%2C	without	effect	on	aminoacylation	activity	and	posttransfer	editing%3B	when	associated	with	A-421.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12515858;Dbxref=PMID:12515858
P00956	UniProtKB	Mutagenesis	241	241	.	.	.	Note=Nearly	the	same	editing	activitas	the	wild-type.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9554847;Dbxref=PMID:9554847
P00956	UniProtKB	Mutagenesis	242	242	.	.	.	Note=Abolishes	editing	activity	againstvaline%2C	with	little	change	in	aminoacylation	activity%3B	when	associated	with	A-250.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10889024;Dbxref=PMID:10889024
P00956	UniProtKB	Mutagenesis	242	242	.	.	.	Note=Abolishes	editing	activity	againstvaline%2C	with	little	change	in	aminoacylation	activity.	T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10889024;Dbxref=PMID:10889024
P00956	UniProtKB	Mutagenesis	243	243	.	.	.	Note=Abolishes	editing	activity	againstvaline%2C	with	little	change	in	aminoacylation	activity.	T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11864608,ECO:0000269|PubMed:9554847;Dbxref=PMID:11864608,PMID:9554847
P00956	UniProtKB	Mutagenesis	243	243	.	.	.	Note=Abolishes	pretransfer	editing.	T->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11864608,ECO:0000269|PubMed:9554847;Dbxref=PMID:11864608,PMID:9554847
P00956	UniProtKB	Mutagenesis	246	246	.	.	.	Note=Nearly	the	same	editing	activitas	the	wild-type.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9554847;Dbxref=PMID:9554847
P00956	UniProtKB	Mutagenesis	250	250	.	.	.	Note=Abolishes	editing	activity	againstvaline%2C	with	little	change	in	aminoacylation	activity.	N->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10889024,ECO:0000269|PubMed:9554847;Dbxref=PMID:10889024,PMID:9554847
P00956	UniProtKB	Mutagenesis	333	333	.	.	.	Note=Alters	the	specificity	for	hydrolysis	of	the	aminoacyl	tRNA	ester%2C	with	no	effect	on	pretransfer	editingH->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11864608;Dbxref=PMID:11864608
P00956	UniProtKB	Mutagenesis	342	342	.	.	.	Note=Strong	decrease	in	total	editing	and	deacylation	activities.	Severely	deficient	in	translocation	from	the	aminoacylation	site	to	the	editing	site.	D->A%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11782529;Dbxref=PMID:11782529
P00956	UniProtKB	Mutagenesis	342	342	.	.	.	Note=Reduces	2-	to	3-fold	the	total	editing	activity	and	2-fold	the	deacylation	activity.	Moderately	reduces	translocation	from	the	aminoacylation	site	to	the	editing	site.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11782529;Dbxref=PMID:11782529
P00956	UniProtKB	Mutagenesis	421	421	.	.	.	Note=Abolishes	translocation	from	the	aminoacylation	site	to	the	editing	site%2C	without	effect	on	aminoacylation	activity	and	posttransfer	editing%3B	when	associated	with	A-183.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12515858;Dbxref=PMID:12515858
P00959	UniProtKB	Mutagenesis	336	336	.	.	.	Note=Loss	of	activity.	K->Q%2CA%2CE%2CR;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1959615,ECO:0000269|PubMed:8515465;Dbxref=PMID:1959615,PMID:8515465
P33226	UniProtKB	Mutagenesis	329	329	.	.	.	Note=Decrease	in	expression	of	the	torCAD	operon.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11562502;Dbxref=PMID:11562502
P39453	UniProtKB	Mutagenesis	453	453	.	.	.	Note=Loss	of	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9135110;Dbxref=PMID:9135110
P39453	UniProtKB	Mutagenesis	733	733	.	.	.	Note=Loss	of	activity.	D->A%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9135110;Dbxref=PMID:9135110
P39453	UniProtKB	Mutagenesis	860	860	.	.	.	Note=Decrease	in	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9135110;Dbxref=PMID:9135110
P76562	UniProtKB	Mutagenesis	287	287	.	.	.	Note=Loss	of	ATPase	activity%2C	but	no	change	in	tRNA-binding.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19322199;Dbxref=PMID:19322199
P76562	UniProtKB	Mutagenesis	291	291	.	.	.	Note=Loss	of	ATPase	activity%2C	but	no	change	in	tRNA-binding.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19322199;Dbxref=PMID:19322199
P76562	UniProtKB	Mutagenesis	292	292	.	.	.	Note=Loss	of	ATPase	activity%2C	but	no	change	in	tRNA-binding.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19322199;Dbxref=PMID:19322199
P76562	UniProtKB	Mutagenesis	296	296	.	.	.	Note=Decrease	in	ATPase	activity	and	loss	of	tRNA-binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19322199;Dbxref=PMID:19322199
P76562	UniProtKB	Mutagenesis	301	301	.	.	.	Note=Decrease	in	ATPase	activity	and	loss	of	tRNA-binding.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19322199;Dbxref=PMID:19322199
P76562	UniProtKB	Mutagenesis	319	319	.	.	.	Note=Loss	of	ATPase	activity%2C	but	no	change	in	tRNA-binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19322199;Dbxref=PMID:19322199
P76562	UniProtKB	Mutagenesis	327	327	.	.	.	Note=Loss	of	ATPase	activity%2C	but	no	change	in	tRNA-binding.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19322199;Dbxref=PMID:19322199
P76562	UniProtKB	Mutagenesis	377	377	.	.	.	Note=Decrease	in	ATPase	activity	and	loss	of	tRNA-binding.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19322199;Dbxref=PMID:19322199
P76562	UniProtKB	Mutagenesis	387	387	.	.	.	Note=Abolishes	the	tRNA-binding	capacity%2C	but	no	loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19322199;Dbxref=PMID:19322199
P76562	UniProtKB	Mutagenesis	460	460	.	.	.	Note=Loss	of	tRNA-binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19322199;Dbxref=PMID:19322199
P0A8I5	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Reduces	catalytic	activity	over	10-fold.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15789416;Dbxref=PMID:15789416
P0A8I5	UniProtKB	Mutagenesis	144	144	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15789416;Dbxref=PMID:15789416
P0A8I5	UniProtKB	Mutagenesis	150	150	.	.	.	Note=Reduces	catalytic	activity	about	3-fold.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15789416;Dbxref=PMID:15789416
P0A8I5	UniProtKB	Mutagenesis	151	151	.	.	.	Note=Reduces	catalytic	activity	over	10-fold.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15789416;Dbxref=PMID:15789416
P0A8I5	UniProtKB	Mutagenesis	152	152	.	.	.	Note=No	effect.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15789416;Dbxref=PMID:15789416
P0A8I5	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15789416;Dbxref=PMID:15789416
P0A8I5	UniProtKB	Mutagenesis	155	155	.	.	.	Note=Loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15789416;Dbxref=PMID:15789416
P0A8I5	UniProtKB	Mutagenesis	180	180	.	.	.	Note=Reduces	catalytic	activity	over	10-fold.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15789416;Dbxref=PMID:15789416
P0A8I5	UniProtKB	Mutagenesis	217	217	.	.	.	Note=Reduces	catalytic	activity	over	10-fold.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15789416;Dbxref=PMID:15789416
P0A8I5	UniProtKB	Mutagenesis	220	220	.	.	.	Note=Reduces	catalytic	activity	10-fold.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15789416;Dbxref=PMID:15789416
P0A853	UniProtKB	Mutagenesis	294	294	.	.	.	Note=Identical	to	wild-type.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2659590;Dbxref=PMID:2659590
P0A853	UniProtKB	Mutagenesis	298	298	.	.	.	Note=Alters	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2659590;Dbxref=PMID:2659590
P45748	UniProtKB	Mutagenesis	50	50	.	.	.	Note=Loss	of	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19287007;Dbxref=PMID:19287007
P45748	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19287007;Dbxref=PMID:19287007
P45748	UniProtKB	Mutagenesis	56	56	.	.	.	Note=No	change	in	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19287007;Dbxref=PMID:19287007
P45748	UniProtKB	Mutagenesis	110	110	.	.	.	Note=No	change	in	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19287007;Dbxref=PMID:19287007
P23003	UniProtKB	Mutagenesis	358	358	.	.	.	Note=Loss	of	catalytic	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18451029;Dbxref=PMID:18451029
P0A890	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Loss	of	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16387657;Dbxref=PMID:16387657
P0A890	UniProtKB	Mutagenesis	21	21	.	.	.	Note=In	sirA1%3B	affects	the	stability	of	sigma-S	during	the	logarithmic	growth	phase.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9555915;Dbxref=PMID:9555915
P0A890	UniProtKB	Mutagenesis	56	56	.	.	.	Note=No	effect.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16387657;Dbxref=PMID:16387657
P0A873	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Loss	of	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Loss	of	activity%3B	no	effect	on	tRNA	binding.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Increases	Km	for	S-adenosyl-L-methionine	24-fold.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	117	117	.	.	.	Note=Loss	of	activity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	119	119	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	121	121	.	.	.	Note=Loss	of	activity%3B	no	effect	on	tRNA	binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	128	128	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	135	135	.	.	.	Note=Loss	of	activity%3B	no	effect	on	tRNA	binding.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	136	136	.	.	.	Note=Increases	Km	for	S-adenosyl-L-methionine	68-fold.	Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	141	141	.	.	.	Note=Increases	Km	for	S-adenosyl-L-methionine	82-fold.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Loss	of	activity%3B	no	effect	on	tRNA	binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	169	169	.	.	.	Note=Loss	of	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	171	171	.	.	.	Note=Loss	of	activity.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	184	184	.	.	.	Note=Loss	of	activity%3B	no	effect	on	tRNA	binding.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	192	192	.	.	.	Note=Loss	of	activity%3B	no	effect	on	tRNA	binding.	V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Loss	of	activity%3B	no	effect	on	tRNA	binding.	P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	196	196	.	.	.	Note=Loss	of	activity%3B	no	effect	on	tRNA	binding.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Loss	of	activity%3B	no	effect	on	tRNA	binding.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	204	204	.	.	.	Note=Loss	of	activity%3B	no	effect	on	tRNA	binding.	I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	207	207	.	.	.	Note=Loss	of	activity%3B	no	effect	on	tRNA	binding.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	207	207	.	.	.	Note=Small	decrease	in	activity.	W->F%2CH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P0A873	UniProtKB	Mutagenesis	208	208	.	.	.	Note=Loss	of	activity%3B	no	effect	on	tRNA	binding.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14583191;Dbxref=PMID:14583191
P45531	UniProtKB	Mutagenesis	76	76	.	.	.	Note=No	effect.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16472754;Dbxref=PMID:16472754
P45531	UniProtKB	Mutagenesis	79	79	.	.	.	Note=No	effect.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16472754;Dbxref=PMID:16472754
P0AA41	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Loss	of	activity.	D->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11720289;Dbxref=PMID:11720289
P28634	UniProtKB	Mutagenesis	92	92	.	.	.	Note=Inhibits	tRNA	m(6)t(6)A37	formation.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25063302;Dbxref=PMID:25063302
P28634	UniProtKB	Mutagenesis	136	136	.	.	.	Note=Inhibits	tRNA	m(6)t(6)A37	formation.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25063302;Dbxref=PMID:25063302
P28634	UniProtKB	Mutagenesis	194	194	.	.	.	Note=Inhibits	tRNA	m(6)t(6)A37	formation%3B	when	associtaed	with	A-196.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25063302;Dbxref=PMID:25063302
P28634	UniProtKB	Mutagenesis	196	196	.	.	.	Note=Inhibits	tRNA	m(6)t(6)A37	formation%3B	when	associtaed	with	A-194.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25063302;Dbxref=PMID:25063302
P60340	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Reduced	structural	stability	and	decrease	in	activity.	K->M%2CR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10924141;Dbxref=PMID:10924141
P60340	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Reduced	structural	stability	and	no	change	in	activity.	P->G%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10924141;Dbxref=PMID:10924141
P60340	UniProtKB	Mutagenesis	43	43	.	.	.	Note=330-fold	decrease	in	catalytic	efficiency.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15581587;Dbxref=PMID:15581587
P60340	UniProtKB	Mutagenesis	43	43	.	.	.	Note=2-fold	decrease	in	catalytic	efficiency.	H->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15581587;Dbxref=PMID:15581587
P60340	UniProtKB	Mutagenesis	43	43	.	.	.	Note=250-fold	decrease	in	catalytic	efficiency.	H->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15581587;Dbxref=PMID:15581587
P60340	UniProtKB	Mutagenesis	43	43	.	.	.	Note=180-fold	decrease	in	catalytic	efficiency.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15581587;Dbxref=PMID:15581587
P60340	UniProtKB	Mutagenesis	43	43	.	.	.	Note=50-fold	decrease	in	catalytic	efficiency.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15581587;Dbxref=PMID:15581587
P60340	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Loss	of	activity.	D->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11142385;Dbxref=PMID:11142385
P60340	UniProtKB	Mutagenesis	58	58	.	.	.	Note=Slight	increase	in	activity.	Slight	increase	in	activity%3B	when	associated	with	A-174	and	A-193.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10529181;Dbxref=PMID:10529181
P60340	UniProtKB	Mutagenesis	174	174	.	.	.	Note=Slight	increase	in	activity.	Slight	increase	in	activity%3B	when	associated	with	A-58	and	A-193.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10529181;Dbxref=PMID:10529181
P60340	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Slight	increase	in	activity%3B	when	associated	with	A-58	and	A-174.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10529181;Dbxref=PMID:10529181
P60340	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Slight	increase	in	activity.	C->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10529181;Dbxref=PMID:10529181
Q2EES9	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Loss	of	all	excisionase	activity.	Y->F%2CS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16079126;Dbxref=PMID:16079126
Q2EES9	UniProtKB	Mutagenesis	45	45	.	.	.	Note=Retains	approximately	10%25	excisionase	activity.	R->K%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16079126;Dbxref=PMID:16079126
P02930	UniProtKB	Mutagenesis	384	384	.	.	.	Note=Partial	channel	opening.	Increases	sensitivity	to	vancomycin%2C	by	allowing	its	passive	diffusion	across	the	outer	membrane%3B	when	associated	with	E-389.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18406332;Dbxref=PMID:18406332
P02930	UniProtKB	Mutagenesis	389	389	.	.	.	Note=Partial	channel	opening.	Increases	sensitivity	to	vancomycin%2C	by	allowing	its	passive	diffusion	across	the	outer	membrane%3B	when	associated	with	F-382.	R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18406332;Dbxref=PMID:18406332
P02930	UniProtKB	Mutagenesis	393	393	.	.	.	Note=Decreases	inhibition	by	hexaamminecobalt(3+).	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342230;Dbxref=PMID:15342230
P02930	UniProtKB	Mutagenesis	396	396	.	.	.	Note=Decreases	inhibition	by	hexaamminecobalt(3+).	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342230;Dbxref=PMID:15342230
P07649	UniProtKB	Mutagenesis	58	58	.	.	.	Note=Loss	of	activity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17466622;Dbxref=PMID:17466622
P0AB18	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Loss	of	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16387657;Dbxref=PMID:16387657
P45532	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Loss	of	activity.	C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16387657,ECO:0000269|PubMed:16472754;Dbxref=PMID:16387657,PMID:16472754
P45532	UniProtKB	Mutagenesis	122	122	.	.	.	Note=Reduced	activity.	C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16472754;Dbxref=PMID:16472754
P26602	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Increases	the	inhibition	by	product	by	about	40%25.	No	effect	on	substrate	affinity.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16343413;Dbxref=PMID:16343413
P26602	UniProtKB	Mutagenesis	156	156	.	.	.	Note=Loss	of	activity.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8012607;Dbxref=PMID:8012607
P0A887	UniProtKB	Mutagenesis	142	142	.	.	.	Note=In	ubiE401%3B	defective.	G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9045837;Dbxref=PMID:9045837
Q46821	UniProtKB	Mutagenesis	37	37	.	.	.	Note=Lack	of	activity.	H->K%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	37	37	.	.	.	Note=Strong	decrease	in	activity.	H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	100	100	.	.	.	Note=Decrease	in	activity	with	uric	acid.	Highly	active	with	xanthine.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	100	100	.	.	.	Note=Decrease	in	activity.	T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	256	256	.	.	.	Note=Almost	no	change	in	activity.	S->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	259	259	.	.	.	Note=Almost	no	change	in	activity.	T->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	270	270	.	.	.	Note=Lack	of	activity.	E->D%2CN%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	278	278	.	.	.	Note=Almost	no	change	in	activity.	L->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	298	298	.	.	.	Note=Strong	decrease	in	activity.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	298	298	.	.	.	Note=Lack	of	activity.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	317	317	.	.	.	Note=Decrease	in	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	318	318	.	.	.	Note=Strong	decrease	in	activity.	Q->E%2CN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	319	319	.	.	.	Note=Lack	of	activity.	N->D%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	320	320	.	.	.	Note=Lack	of	activity.	V->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	327	327	.	.	.	Note=Almost	no	change	in	activity.	R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q46821	UniProtKB	Mutagenesis	426	426	.	.	.	Note=Almost	no	change	in	activity.	S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22437829;Dbxref=PMID:22437829
Q57261	UniProtKB	Mutagenesis	31	31	.	.	.	Note=3-fold	decrease	in	activity.	E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19664587;Dbxref=PMID:19664587
Q57261	UniProtKB	Mutagenesis	31	31	.	.	.	Note=Loss	of	activity.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19664587;Dbxref=PMID:19664587
Q57261	UniProtKB	Mutagenesis	79	79	.	.	.	Note=20-fold	decrease	in	activity.	K->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19664587;Dbxref=PMID:19664587
Q57261	UniProtKB	Mutagenesis	79	79	.	.	.	Note=10-fold	decrease	in	activity.	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19664587;Dbxref=PMID:19664587
Q57261	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Loss	of	activity.	D->N%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12756329;Dbxref=PMID:12756329
Q57261	UniProtKB	Mutagenesis	87	87	.	.	.	Note=3-fold	decrease	in	activity.	Q->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19664587;Dbxref=PMID:19664587
Q57261	UniProtKB	Mutagenesis	129	129	.	.	.	Note=Loss	of	activity.	N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19664587;Dbxref=PMID:19664587
Q57261	UniProtKB	Mutagenesis	131	131	.	.	.	Note=1.5-fold	decrease	in	activity.	F->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19664587;Dbxref=PMID:19664587
P39304	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Loss	of	activity.	E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15157077;Dbxref=PMID:15157077
P39304	UniProtKB	Mutagenesis	64	64	.	.	.	Note=16%25	of	wild-type	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15157077;Dbxref=PMID:15157077
P39304	UniProtKB	Mutagenesis	67	67	.	.	.	Note=5%25	of	wild-type	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15157077;Dbxref=PMID:15157077
P39304	UniProtKB	Mutagenesis	112	112	.	.	.	Note=0.5%25	of	wild-type	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15157077;Dbxref=PMID:15157077
P39304	UniProtKB	Mutagenesis	136	136	.	.	.	Note=5%25	of	wild-type	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15157077;Dbxref=PMID:15157077
P39304	UniProtKB	Mutagenesis	139	139	.	.	.	Note=17%25	of	wild-type	activity.	R->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15157077;Dbxref=PMID:15157077
Q47149	UniProtKB	Mutagenesis	87	87	.	.	.	Note=Loss	of	mRNA	cleavage%2C	loss	of	toxic	effect.	Still	associates	with	the	ribosome.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19210620;Dbxref=PMID:19210620
P0A898	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Loss	of	activity.	R->A%2CE;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20807199,ECO:0000269|PubMed:23273979;Dbxref=PMID:20807199,PMID:23273979
P0A898	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Loss	of	activity.	H->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20807199,ECO:0000269|PubMed:23273979;Dbxref=PMID:20807199,PMID:23273979
P0A898	UniProtKB	Mutagenesis	118	118	.	.	.	Note=No	change	in	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20807199;Dbxref=PMID:20807199
P0A898	UniProtKB	Mutagenesis	124	124	.	.	.	Note=No	change	in	activity.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20807199;Dbxref=PMID:20807199
P69346	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Loss	of	DNA-binding	and	transcriptional	repression.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19028895;Dbxref=PMID:19028895
P69346	UniProtKB	Mutagenesis	31	31	.	.	.	Note=Loss	of	DNA-binding	and	transcriptional	repression.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19028895;Dbxref=PMID:19028895
P0AAR3	UniProtKB	Mutagenesis	30	30	.	.	.	Note=>100-fold	decrease	in	Cys-tRNA(Pro)	deacylation	activity.	Fails	to	gain	Ala-tRNA(Pro)	deacylation	activity.	G->C%2CI%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23185990;Dbxref=PMID:23185990
P0AAR3	UniProtKB	Mutagenesis	136	136	.	.	.	Note=6-fold	decrease	in	Cys-tRNA(Pro)	deacylation	activity.	D->A%2CC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23185990;Dbxref=PMID:23185990
P0AD14	UniProtKB	Mutagenesis	382	382	.	.	.	Note=Lack	of	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22685278;Dbxref=PMID:22685278
P77526	UniProtKB	Mutagenesis	9	9	.	.	.	Note=No	effect	on	GSH	transferase	activity.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17018556;Dbxref=PMID:17018556
P77526	UniProtKB	Mutagenesis	11	11	.	.	.	Note=Loss	of	GSH	transferase	activity.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17018556;Dbxref=PMID:17018556
P77526	UniProtKB	Mutagenesis	14	14	.	.	.	Note=10-fold	reduction	in	GSH	transferase	activity.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17018556;Dbxref=PMID:17018556
P77526	UniProtKB	Mutagenesis	166	166	.	.	.	Note=No	effect	on	disulfide-bond	reductase	activity.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19537707;Dbxref=PMID:19537707
P77365	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Very	poorly	expressed.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15252048;Dbxref=PMID:15252048
P77365	UniProtKB	Mutagenesis	22	23	.	.	.	Note=Still	induces	degP	when	overexpressed%2C	remains	in	inner	membrane.	DD->SS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15252048;Dbxref=PMID:15252048
P77365	UniProtKB	Mutagenesis	60	60	.	.	.	Note=5-fold	decrease	in	degP	induction	when	overexpressed.	D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15252048;Dbxref=PMID:15252048
P77365	UniProtKB	Mutagenesis	61	61	.	.	.	Note=3-fold	decrease	in	degP	induction	when	overexpressed.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15252048;Dbxref=PMID:15252048
P77365	UniProtKB	Mutagenesis	136	136	.	.	.	Note=2-fold	decrease	in	degP	induction	when	overexpressed.	Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15252048;Dbxref=PMID:15252048
Q46948	UniProtKB	Mutagenesis	47	47	.	.	.	Note=Is	not	impaired	in	the	formation	of	mixed	disulfide	with	a	sulfenylated	protein.	Has	a	monomeric	quaternary	structure.	C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22157000,ECO:0000269|PubMed:22321799;Dbxref=PMID:22157000,PMID:22321799
Q46948	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Is	impaired	in	the	formation	of	mixed	disulfide	with	cytoplasmic	and	sulfenylated	proteins.	Does	not	complement	a	disruption	mutant.	C->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20124404,ECO:0000269|PubMed:22157000,ECO:0000269|PubMed:22321799;Dbxref=PMID:20124404,PMID:22157000,PMID:22321799
Q46948	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Does	not	complement	a	disruption	mutant.	C->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20124404;Dbxref=PMID:20124404
P0AFT5	UniProtKB	Mutagenesis	54	54	.	.	.	Note=2-fold	increase	in	yjiY	induction.	D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22685278;Dbxref=PMID:22685278
P0AFT5	UniProtKB	Mutagenesis	54	54	.	.	.	Note=10-fold	decrease	in	yjiY	induction.	D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22685278;Dbxref=PMID:22685278
P77302	UniProtKB	Mutagenesis	334	335	.	.	.	Note=No	longer	complements	a	ydaM	disruption%2C	loss	of	csgB	induction.	EE->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17010156;Dbxref=PMID:17010156
P31129	UniProtKB	Mutagenesis	206	207	.	.	.	Note=Cells	overexpressing	this	mutant	are	no	longer	swimming	suppressed.	GG->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18713317;Dbxref=PMID:18713317
P31129	UniProtKB	Mutagenesis	208	208	.	.	.	Note=Significantly	decreased	biofilmformation.	E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19460094;Dbxref=PMID:19460094
P0A6D5	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Kinetically	unchanged	as	compared	with	the	wild-type.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15596430;Dbxref=PMID:15596430
P0A6D5	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Kinetically	unchanged	as	compared	with	the	wild-type.	Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15596430;Dbxref=PMID:15596430
P0A6D5	UniProtKB	Mutagenesis	67	67	.	.	.	Note=Reduces	activity	towards	quinateabout	6-fold%2C	but	has	a	little	effect	on	shikimate	conversion.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15596430;Dbxref=PMID:15596430
P0A6D5	UniProtKB	Mutagenesis	71	71	.	.	.	Note=3200-fold	decrease	in	the	affinity	for	quinate.	170-fold	decrease	in	the	affinity	for	shikimate.	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15596430;Dbxref=PMID:15596430
P0A6D5	UniProtKB	Mutagenesis	71	71	.	.	.	Note=10-fold	greater	reduction	in	catalytic	efficiency	is	observed	with	quinate	than	with	shikimate.	K->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15596430;Dbxref=PMID:15596430
P0A6D5	UniProtKB	Mutagenesis	92	92	.	.	.	Note=Alters	protein	structure.	Loss	of	activity	for	both	substrates.	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15596430;Dbxref=PMID:15596430
P0A6D5	UniProtKB	Mutagenesis	106	106	.	.	.	Note=2000-fold	decrease	in	the	affinity	for	quinate.	70-fold	decrease	in	the	affinity	for	shikimate.	10-fold	greaterreduction	in	catalytic	efficiency	is	observed	with	quinate	than	with	shikimate.	T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15596430;Dbxref=PMID:15596430
P0A6D5	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Loss	of	activity	towardsquinate.	20000-fold	decrease	in	the	affinity	for	shikimate.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15596430;Dbxref=PMID:15596430
P0A6D5	UniProtKB	Mutagenesis	262	262	.	.	.	Note=3-fold	reduction	in	catalytic	efficiency	for	both	substrates.	Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15596430;Dbxref=PMID:15596430
O52982	UniProtKB	Mutagenesis	60	61	.	.	.	Note=3-fold	improved	induction	of	degP	upon	overexpression%3B	when	associated	with	Q-136.	GF->DY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15252048;Dbxref=PMID:15252048
O52982	UniProtKB	Mutagenesis	136	136	.	.	.	Note=3-fold	improved	induction	of	degP	upon	overexpression%3B	when	associated	with	60-D-Y-61.	R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15252048;Dbxref=PMID:15252048
P37646	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Loss	of	c-di-GMP	phosphodiesterase	activity.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18765794;Dbxref=PMID:18765794
P0A8H6	UniProtKB	Mutagenesis	65	65	.	.	.	Note=No	change	in	ability	to	stimulate	Der	GTPase.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20434458;Dbxref=PMID:20434458
P0A8H6	UniProtKB	Mutagenesis	135	135	.	.	.	Note=No	change	in	ability	to	stimulate	Der	GTPase.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20434458;Dbxref=PMID:20434458
P0A8H6	UniProtKB	Mutagenesis	164	164	.	.	.	Note=No	change	in	ability	to	stimulate	Der	GTPase.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20434458;Dbxref=PMID:20434458
P0A8H6	UniProtKB	Mutagenesis	167	167	.	.	.	Note=No	change	in	ability	to	stimulate	Der	GTPase.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20434458;Dbxref=PMID:20434458
P0AA93	UniProtKB	Mutagenesis	371	371	.	.	.	Note=Lack	of	activity.	H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23222720;Dbxref=PMID:23222720
P77544	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Nearly	no	effect	on	GSH	transferase	activity.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17018556;Dbxref=PMID:17018556
P77544	UniProtKB	Mutagenesis	16	16	.	.	.	Note=2%25	of	wild-type	GSH	transferase	activity.	S->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17018556;Dbxref=PMID:17018556
P45470	UniProtKB	Mutagenesis	104	104	.	.	.	Note=Unable	to	complement	the	gene	deletion	mutant%2C	in	contrast	to	the	wild-type	allele	that	rescues	the	oxidative-stress	and	thermal-stress	sensitive	phenotypes.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17933887;Dbxref=PMID:17933887
P0A8Y5	UniProtKB	Mutagenesis	9	9	.	.	.	Note=Loss	of	the	phosphatase	activity.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16990279;Dbxref=PMID:16990279
P39277	UniProtKB	Mutagenesis	24	24	.	.	.	Note=Strong	decrease	in	methionine	efflux.	T->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26319875;Dbxref=PMID:26319875
P39277	UniProtKB	Mutagenesis	25	25	.	.	.	Note=Strong	decrease	in	methionine	efflux.	G->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26319875;Dbxref=PMID:26319875
P39277	UniProtKB	Mutagenesis	195	195	.	.	.	Note=Strong	decrease	in	methionine	efflux.	W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26319875;Dbxref=PMID:26319875
C1P609	UniProtKB	Mutagenesis	2	2	.	.	.	Note=Protein	mostly	C-terminus	inside.Both	orientations	found%3B	when	associated	with	24-G.	K->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21778229;Dbxref=PMID:21778229
C1P609	UniProtKB	Mutagenesis	24	24	.	.	.	Note=Protein	mostly	C-terminus	outsideBoth	orientations	found%3B	when	associated	with	2-G.	K->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21778229;Dbxref=PMID:21778229
P76536	UniProtKB	Mutagenesis	215	215	.	.	.	Note=Strong	decrease	in	affinitfor	heme	and	protoporphyrin.	H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19564607;Dbxref=PMID:19564607
P25714	UniProtKB	Mutagenesis	24	27	.	.	.	Note=Cold-sensitive	at	30	degreesCelsius%3B	when	associated	with	334-W--G-338.	Protein	accumulates	stably.	EQDK->IEGR
P25714	UniProtKB	Mutagenesis	334	338	.	.	.	Note=Cold-sensitive	at	30	degreesCelsius%3B	when	associated	with	24-I--R-27.	Protein	accumulates	stably.	WFISQ->LEVLFQG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12707259;Dbxref=PMID:12707259
P25714	UniProtKB	Mutagenesis	361	361	.	.	.	Note=Loss	of	function.	I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14506280;Dbxref=PMID:14506280
P25714	UniProtKB	Mutagenesis	436	436	.	.	.	Note=Loss	of	function.	L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14506280;Dbxref=PMID:14506280
P25714	UniProtKB	Mutagenesis	483	487	.	.	.	Note=Temperature-sensitive	at	42	degrees	Celsius%3B	when	associated	with	512-ENLYFQG.	Protein	is	not	stable.	PTTVT->LVPRGS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12707259;Dbxref=PMID:12707259
P25714	UniProtKB	Mutagenesis	512	512	.	.	.	Note=Temperature-sensitive	at	42	degrees	Celsius%3B	when	associated	with	483-L--S-487.	Protein	is	not	stable.	G->ENLYFQG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12707259;Dbxref=PMID:12707259
P0AAX8	UniProtKB	Mutagenesis	210	210	.	.	.	Note=Protein	is	unable	to	form	sulfenic	acid	adducts.	C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19965429;Dbxref=PMID:19965429
P75908	UniProtKB	Mutagenesis	359	360	.	.	.	Note=Cells	overexpressing	this	mutant	are	no	longer	swimming	suppressed.	GG->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18713317;Dbxref=PMID:18713317
P76010	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Suppression	of	the	yhjH	disruption	motility	phenotype.	K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P76010	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Signficant	suppression	of	the	yhjH	disruption	motility	phenotype%2C	less	binding	to	FliG.	N->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P76010	UniProtKB	Mutagenesis	81	81	.	.	.	Note=Signficant	suppression	of	the	yhjH	disruption	motility	phenotype%2C	less	binding	to	FliG.	K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P76010	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Complete	loss	of	c-di-GMP	binding	in	vitro%2C	suppresses	yhjH	disruption	(PubMed:16920715).	Somewhat	reduced	bindingto	FliM%2C	stimulated	by	c-di-GMP%2C	greatly	reduced	binding	to	FliG	(PubMed:20346719).	R->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16920715,ECO:0000269|PubMed:20346719;Dbxref=PMID:16920715,PMID:20346719
P76010	UniProtKB	Mutagenesis	147	147	.	.	.	Note=Slight	increase	in	affinitfor	c-di-GMP.	S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16920715;Dbxref=PMID:16920715
P76010	UniProtKB	Mutagenesis	223	223	.	.	.	Note=Signficant	suppression	of	the	yhjH	disruption	motility	phenotype%2C	no	binding	to	FliM.	Q->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P76010	UniProtKB	Mutagenesis	223	223	.	.	.	Note=Signficant	suppression	of	the	yhjH	disruption	motility	phenotype.	Q->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P76010	UniProtKB	Mutagenesis	227	227	.	.	.	Note=Some	suppression	of	the	yhjH	disruption	motility	phenotype%2C	no	binding	to	FliM.	I->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20346719;Dbxref=PMID:20346719
P0ABU2	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Shows	similar	hydrolysis	activities	in	the	presence	of	K(+)	or	Na(+).	N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21527254;Dbxref=PMID:21527254
P0ABU2	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Shows	similar	hydrolysis	activities	in	the	presence	of	K(+)	or	Na(+).	K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21527254;Dbxref=PMID:21527254
P0ABU2	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Retains	K(+)-dependent	stimulation	of	ATPase	activity	and	differentiates	between	K(+)	and	Na(+).	K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21527254;Dbxref=PMID:21527254
P0AAC6	UniProtKB	Mutagenesis	1	12	.	.	.	Note=Protein	is	as	sensitive	to	FtsH	degradation	as	the	wild-type.	MDRIVSSSHDRT->MTMITPSLHDRI;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10357810;Dbxref=PMID:10357810
P0AAC6	UniProtKB	Mutagenesis	5	12	.	.	.	Note=In	yccA11%3B	increases	the	half-life	of	overexpressed	SecY%2C	F(0)	ATP	synthase	subunit	a	and	itself	in	an	HflKC-dependent	fashion%2C	but	has	no	effect	on	degradation	of	cytosolic	substrates	sigma-32	or	the	phage	lambda	cII	protein.	Partially	dominant	over	the	wild-type	allele.	This	protein	interacts	with	but	is	not	degraded	by	FtsH.	Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9636708;Dbxref=PMID:9636708
P0AA60	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Abolishes	the	ability	to	restoregrowth%2C	cell	division	or	drug	resistance	in	double	mutant.	E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24277026;Dbxref=PMID:24277026
P0AA60	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Abolishes	the	ability	to	restoregrowth%2C	cell	division	or	drug	resistance	in	double	mutant.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24277026;Dbxref=PMID:24277026
P37665	UniProtKB	Mutagenesis	116	116	.	.	.	Note=Does	not	suppress	BamB	ts-mutants.	F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21228468;Dbxref=PMID:21228468
P37665	UniProtKB	Mutagenesis	150	150	.	.	.	Note=Partially	suppresses	BamB	ts-mutants.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21228468;Dbxref=PMID:21228468
P37665	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Does	not	suppress	BamB	ts-mutants.	D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21228468;Dbxref=PMID:21228468
P37665	UniProtKB	Mutagenesis	156	156	.	.	.	Note=Does	not	suppress	BamB	ts-mutants.	G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21228468;Dbxref=PMID:21228468
P37665	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Partially	suppresses	BamB	ts-mutants.	L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21228468;Dbxref=PMID:21228468
P37665	UniProtKB	Mutagenesis	168	168	.	.	.	Note=Does	not	suppress	BamB	ts-mutants.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21228468;Dbxref=PMID:21228468
P64594	UniProtKB	Mutagenesis	85	94	.	.	.	Note=Complete	loss	of	toxicity.	RVKFGAGRYR->AVKFGAGRYA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17706670;Dbxref=PMID:17706670
P64594	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Partial	loss	of	toxicity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17706670;Dbxref=PMID:17706670
P64594	UniProtKB	Mutagenesis	94	94	.	.	.	Note=Partial	loss	of	toxicity.	R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17706670;Dbxref=PMID:17706670